sampleID _INTEGRATION _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy adjacent_hepatic_tissue_inflammation_extent_type age_at_initial_pathologic_diagnosis albumin_result_lower_limit albumin_result_specified_value albumin_result_upper_limit bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode bilirubin_lower_limit bilirubin_upper_limit cancer_first_degree_relative child_pugh_classification_grade creatinine_lower_level creatinine_upper_limit creatinine_value_in_mg_dl days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_additional_surgery_procedure days_to_new_tumor_event_after_initial_treatment eastern_cancer_oncology_group fetoprotein_outcome_lower_limit fetoprotein_outcome_upper_limit fetoprotein_outcome_value fibrosis_ishak_score followup_case_report_form_submission_reason form_completion_date gender height hist_hepato_carc_fact hist_hepato_carcinoma_risk histological_type history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified initial_weight inter_norm_ratio_lower_limit intern_norm_ratio_upper_limit is_ffpe lost_follow_up neoplasm_histologic_grade new_neoplasm_event_occurrence_anatomic_site new_neoplasm_event_type new_neoplasm_occurrence_anatomic_site_text new_tumor_event_ablation_embo_tx new_tumor_event_additional_surgery_procedure new_tumor_event_after_initial_treatment new_tumor_event_liver_transplant oct_embedded other_dx pathologic_M pathologic_N pathologic_T pathologic_stage pathology_report_file_name patient_id person_neoplasm_cancer_status platelet_result_count platelet_result_lower_limit platelet_result_upper_limit post_op_ablation_embolization_tx postoperative_rx_tx prothrombin_time_result_value radiation_therapy relative_family_cancer_history residual_disease_post_new_tumor_event_margin_status residual_tumor sample_type sample_type_id specimen_collection_method_name system_version tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site total_bilirubin_upper_limit tumor_tissue_site vascular_tumor_cell_type vial_number viral_hepatitis_serology vital_status weight year_of_initial_pathologic_diagnosis _GENOMIC_ID_TCGA_LIHC_gistic2 _GENOMIC_ID_TCGA_LIHC_gistic2thd _GENOMIC_ID_TCGA_LIHC_mutation_bcm_gene _GENOMIC_ID_TCGA_LIHC_miRNA_HiSeq _GENOMIC_ID_TCGA_LIHC_PDMRNAseq _GENOMIC_ID_TCGA_LIHC_RPPA _GENOMIC_ID_TCGA_LIHC_exp_HiSeqV2_percentile _GENOMIC_ID_TCGA_LIHC_mutation_bcgsc_gene _GENOMIC_ID_data/public/TCGA/LIHC/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_LIHC_PDMRNAseqCNV _GENOMIC_ID_TCGA_LIHC_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_LIHC_mutation_ucsc_maf_gene _GENOMIC_ID_TCGA_LIHC_exp_HiSeqV2 _GENOMIC_ID_TCGA_LIHC_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_LIHC_mutation_broad_gene _GENOMIC_ID_TCGA_LIHC_hMethyl450 TCGA-2V-A95S-01 TCGA-2V-A95S-01 TCGA-2V-A95S TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Severe 3.5 4.2 5.2 TCGA-2V-A95S TCGA-2V-A95S-01A 0 1.5 A .7 1.2 .6 4 0 8 10793 6 - Established Cirrhosis 2015-6-15 MALE 173 Other former smoker Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 2 3 NO G3 false No MX NX T2 Stage II TCGA-2V-A95S.BE263DC7-2250-42E2-8AD6-D99A6DF679B6.pdf A95S WITH TUMOR 107 140 370 NO NO 2.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES 2V .2 Liver Micro A LIVING 78 TCGA-2V-A95S-01A-11D-A36W-01 TCGA-2V-A95S-01A-11D-A36W-01 TCGA-2V-A95S-01A-11D-A36X-10 TCGA-2V-A95S-01 TCGA-2V-A95S-01 53796be6-1c87-448a-9928-3c640e9d3414 TCGA-2V-A95S-01 TCGA-2V-A95S-01 53796be6-1c87-448a-9928-3c640e9d3414 53796be6-1c87-448a-9928-3c640e9d3414 53796be6-1c87-448a-9928-3c640e9d3414 TCGA-2V-A95S-01A-11D-A36Y-05 TCGA-2Y-A9GS-01 TCGA-2Y-A9GS-01 TCGA-2Y-A9GS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 58 3.5 4 5 TCGA-2Y-A9GS TCGA-2Y-A9GS-01A 0.2 0.7 0.8 1.5 1.6 -21318 2558 724 0 0 6 74 2014-11-3 MALE 162 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 8.3 11.5 NO G2 YES true No MX NX T2 [Discrepancy] TCGA-2Y-A9GS.DAA3D158-0488-41C9-8B3F-BE6D05E036D8.pdf A9GS WITH TUMOR 168 143 382 NO NO 9.9 NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES 2Y 1.3 Liver A HCV Genotype|Hepatitis B Surface Antigen|HBV Core Antibody DECEASED 92 2006 TCGA-2Y-A9GS-01A-12D-A381-01 TCGA-2Y-A9GS-01A-12D-A381-01 TCGA-2Y-A9GS-01A-12D-A382-10 TCGA-2Y-A9GS-01 TCGA-2Y-A9GS-01 7b0d0cd1-3770-4e1c-9a64-93e41825a3b7 TCGA-2Y-A9GS-01 TCGA-2Y-A9GS-01 7b0d0cd1-3770-4e1c-9a64-93e41825a3b7 7b0d0cd1-3770-4e1c-9a64-93e41825a3b7 7b0d0cd1-3770-4e1c-9a64-93e41825a3b7 TCGA-2Y-A9GS-01A-12D-A383-05 TCGA-2Y-A9GT-01 TCGA-2Y-A9GT-01 TCGA-2Y-A9GT TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 51 3.5 3.7 5 TCGA-2Y-A9GT 0.2 0.4 1 C 0.8 1.5 0.8 -18768 1624 0 0 7 17 2014-11-3 MALE 182 Alcohol consumption|Hepatitis B|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 11.5 G2 YES No MX NX T1 Stage I A9GT WITH TUMOR 187 143 382 NO 9.8 NO YES R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES 2Y 1.3 Liver None Hepatitis C Virus R|Hepatitis B Surface Antigen|HBV Core Antibody|HBV D DECEASED 122 2006 TCGA-2Y-A9GT-01A-11D-A381-01 TCGA-2Y-A9GT-01A-11D-A381-01 TCGA-2Y-A9GT-01A-11D-A382-10 TCGA-2Y-A9GT-01 TCGA-2Y-A9GT-01 e1ab65b5-ee17-4e86-93aa-446c8f387ef1 TCGA-2Y-A9GT-01 TCGA-2Y-A9GT-01 e1ab65b5-ee17-4e86-93aa-446c8f387ef1 e1ab65b5-ee17-4e86-93aa-446c8f387ef1 e1ab65b5-ee17-4e86-93aa-446c8f387ef1 TCGA-2Y-A9GT-01A-11D-A383-05 TCGA-2Y-A9GU-01 TCGA-2Y-A9GU-01 TCGA-2Y-A9GU TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 55 3.5 4.4 5 TCGA-2Y-A9GU-F69082 TCGA-2Y-A9GU TCGA-2Y-A9GU-01A 0.2 0.3 2 0.8 1.5 0.9 -20187 1752 0 1939 0 0 6 304 2014-12-29 FEMALE 154 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 8.3 11.5 NO NO G2 NO true No MX NX T1 Stage I TCGA-2Y-A9GU.5585C485-B57A-4CA8-A3E3-F093A7E6AC76.pdf A9GU TUMOR FREE 281 143 382 NO NO 10.8 NO YES R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES 2Y 1.3 Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody LIVING 78 2009 TCGA-2Y-A9GU-01A-11D-A381-01 TCGA-2Y-A9GU-01A-11D-A381-01 TCGA-2Y-A9GU-01A-11D-A382-10 TCGA-2Y-A9GU-01 TCGA-2Y-A9GU-01 6f3f7f73-b031-424e-ba7c-263f802dd6cf TCGA-2Y-A9GU-01 TCGA-2Y-A9GU-01 6f3f7f73-b031-424e-ba7c-263f802dd6cf 6f3f7f73-b031-424e-ba7c-263f802dd6cf 6f3f7f73-b031-424e-ba7c-263f802dd6cf TCGA-2Y-A9GU-01A-11D-A383-05 TCGA-2Y-A9GV-01 TCGA-2Y-A9GV-01 TCGA-2Y-A9GV TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 54 3.5 4.2 5 TCGA-2Y-A9GV 0.2 0.3 0.8 1.5 0.6 -20011 2532 0 2 7 6 2014-11-3 FEMALE 167 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 11.5 G1 YES Yes MX NX T1 Stage I A9GV WITH TUMOR 370 143 382 NO YES 9.5 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES 2Y 1.3 Liver Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody DECEASED 85 2007 TCGA-2Y-A9GV-01A-11D-A381-01 TCGA-2Y-A9GV-01A-11D-A381-01 TCGA-2Y-A9GV-01A-11D-A382-10 TCGA-2Y-A9GV-01 TCGA-2Y-A9GV-01 c0bcdbc7-9bed-49b7-93ca-f82ffc2929a1 TCGA-2Y-A9GV-01 TCGA-2Y-A9GV-01 c0bcdbc7-9bed-49b7-93ca-f82ffc2929a1 c0bcdbc7-9bed-49b7-93ca-f82ffc2929a1 c0bcdbc7-9bed-49b7-93ca-f82ffc2929a1 TCGA-2Y-A9GV-01A-11D-A383-05 TCGA-2Y-A9GW-01 TCGA-2Y-A9GW-01 TCGA-2Y-A9GW TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 64 3.5 4.5 5 TCGA-2Y-A9GW TCGA-2Y-A9GW-01A 0.2 0.6 1 0.8 1.5 1 -23587 2375 1271 0 0 6 2 2014-11-3 MALE 182 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 8.3 11.5 NO G2 YES true No MX N0 T1 Stage I TCGA-2Y-A9GW.5846FA3D-E3AD-4530-8A5F-5D90CD17F539.pdf A9GW WITH TUMOR 175 143 382 NO NO 9.7 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES 2Y 1.3 Liver A DECEASED 139 2007 TCGA-2Y-A9GW-01A-11D-A381-01 TCGA-2Y-A9GW-01A-11D-A381-01 TCGA-2Y-A9GW-01A-11D-A382-10 TCGA-2Y-A9GW-01 TCGA-2Y-A9GW-01 6d979d21-8d92-40aa-a19f-f4a6c55384cf TCGA-2Y-A9GW-01 TCGA-2Y-A9GW-01 6d979d21-8d92-40aa-a19f-f4a6c55384cf 6d979d21-8d92-40aa-a19f-f4a6c55384cf 6d979d21-8d92-40aa-a19f-f4a6c55384cf TCGA-2Y-A9GW-01A-11D-A383-05 TCGA-2Y-A9GX-01 TCGA-2Y-A9GX-01 TCGA-2Y-A9GX TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 68 3.5 4.3 5 TCGA-2Y-A9GX-F69170 TCGA-2Y-A9GX 0.2 0.4 0.8 1.5 0.7 -24963 0 2442 2133 1 0 7 1 2014-12-30 MALE 175 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 11.5 NO G2 Liver Locoregional Recurrence No NO YES No No MX NX T1 Stage I A9GX WITH TUMOR 155 143 382 NO NO 10.3 NO NO R1 Primary Tumor 01 Segmentectomy, Single 6th NO YES 2Y 1.3 Liver Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 104 2007 TCGA-2Y-A9GX-01A-11D-A381-01 TCGA-2Y-A9GX-01A-11D-A381-01 TCGA-2Y-A9GX-01A-11D-A382-10 TCGA-2Y-A9GX-01 TCGA-2Y-A9GX-01 c4b50fbc-9dbb-4670-88b7-93c77d7d3547 TCGA-2Y-A9GX-01 TCGA-2Y-A9GX-01 c4b50fbc-9dbb-4670-88b7-93c77d7d3547 c4b50fbc-9dbb-4670-88b7-93c77d7d3547 c4b50fbc-9dbb-4670-88b7-93c77d7d3547 TCGA-2Y-A9GX-01A-11D-A383-05 TCGA-2Y-A9GY-01 TCGA-2Y-A9GY-01 TCGA-2Y-A9GY TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 64 3.5 4.2 5 TCGA-2Y-A9GY 0.2 0.4 2 0.8 1.5 0.6 -23435 757 0 0 7 27600 2014-11-3 FEMALE 161 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 11.5 G3 YES No MX NX T2 Stage II A9GY WITH TUMOR 207 143 382 NO NO 9.5 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES 2Y 1.3 Liver DECEASED 92 2007 TCGA-2Y-A9GY-01A-11D-A381-01 TCGA-2Y-A9GY-01A-11D-A381-01 TCGA-2Y-A9GY-01A-11D-A382-10 TCGA-2Y-A9GY-01 TCGA-2Y-A9GY-01 f21c811b-a31a-4b4b-88a0-2488fa59b20d TCGA-2Y-A9GY-01 TCGA-2Y-A9GY-01 f21c811b-a31a-4b4b-88a0-2488fa59b20d f21c811b-a31a-4b4b-88a0-2488fa59b20d f21c811b-a31a-4b4b-88a0-2488fa59b20d TCGA-2Y-A9GY-01A-11D-A383-05 TCGA-2Y-A9GZ-01 TCGA-2Y-A9GZ-01 TCGA-2Y-A9GZ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 82 3.5 4.5 5 TCGA-2Y-A9GZ 0.2 0.7 4 A 0.8 1.5 1.1 -30082 848 0 0 7 7 2014-11-3 FEMALE 153 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 11.5 G2 YES No MX NX T2 Stage II A9GZ WITH TUMOR 318 143 382 NO YES 9.9 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES 2Y 1.3 Liver Hepatitis C Antibody|HBV Core Antibody DECEASED 51 2007 TCGA-2Y-A9GZ-01A-11D-A38W-01 TCGA-2Y-A9GZ-01A-11D-A38W-01 TCGA-2Y-A9GZ-01A-11D-A38X-10 TCGA-2Y-A9GZ-01 TCGA-2Y-A9GZ-01 b40fc694-28d2-4b49-a5ff-4182156a9654 TCGA-2Y-A9GZ-01 TCGA-2Y-A9GZ-01 b40fc694-28d2-4b49-a5ff-4182156a9654 b40fc694-28d2-4b49-a5ff-4182156a9654 b40fc694-28d2-4b49-a5ff-4182156a9654 TCGA-2Y-A9GZ-01A-11D-A39G-05 TCGA-2Y-A9H0-01 TCGA-2Y-A9H0-01 TCGA-2Y-A9H0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 49 3.5 2 5 TCGA-2Y-A9H0-F69171 TCGA-2Y-A9H0 TCGA-2Y-A9H0-01A 0.2 0.8 0.8 1.5 0.8 -18109 3538 0 3675 0 0 8 7598 2014-12-30 MALE 180 Alcohol consumption|Hepatitis B|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 130 8.3 11.5 NO NO G1 NO true No M0 N0 T3 Stage IIIA TCGA-2Y-A9H0.33EB4235-F58D-4AB6-8944-F2B59374A5F0.pdf A9H0 TUMOR FREE 207 143 382 NO NO 12.2 NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES 2Y 1.3 Liver A LIVING 89 2004 TCGA-2Y-A9H0-01A-11D-A381-01 TCGA-2Y-A9H0-01A-11D-A381-01 TCGA-2Y-A9H0-01A-11D-A382-10 TCGA-2Y-A9H0-01 TCGA-2Y-A9H0-01 73769c40-ad9d-4b11-925e-46e3e762d3f4 TCGA-2Y-A9H0-01 TCGA-2Y-A9H0-01 73769c40-ad9d-4b11-925e-46e3e762d3f4 73769c40-ad9d-4b11-925e-46e3e762d3f4 73769c40-ad9d-4b11-925e-46e3e762d3f4 TCGA-2Y-A9H0-01A-11D-A383-05 TCGA-2Y-A9H1-01 TCGA-2Y-A9H1-01 TCGA-2Y-A9H1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 58 3.5 4.4 5 TCGA-2Y-A9H1 0.2 0.5 0.8 1.5 0.9 -21222 1229 0 1 0 7 3 1,2 - Portal Fibrosis 2014-11-3 MALE 171 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 11.5 G2 YES No MX NX T1 Stage I A9H1 WITH TUMOR 213 143 382 YES NO 10 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES 2Y 1.3 Liver Hepatitis C Antibody DECEASED 89 2010 TCGA-2Y-A9H1-01A-11D-A381-01 TCGA-2Y-A9H1-01A-11D-A381-01 TCGA-2Y-A9H1-01A-11D-A382-10 TCGA-2Y-A9H1-01 TCGA-2Y-A9H1-01 dd08761a-17e5-4d03-820d-2ee5d8d6c2b8 TCGA-2Y-A9H1-01 TCGA-2Y-A9H1-01 dd08761a-17e5-4d03-820d-2ee5d8d6c2b8 dd08761a-17e5-4d03-820d-2ee5d8d6c2b8 dd08761a-17e5-4d03-820d-2ee5d8d6c2b8 TCGA-2Y-A9H1-01A-11D-A383-05 TCGA-2Y-A9H2-01 TCGA-2Y-A9H2-01 TCGA-2Y-A9H2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 64 3.5 4.5 5 TCGA-2Y-A9H2-F69173 TCGA-2Y-A9H2 TCGA-2Y-A9H2-01A 0.2 0.4 0.8 1.5 1.4 -23653 1443 0 1731 0 0 7 2 2014-12-30 FEMALE 176 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 8.3 11.5 NO NO G3 NO true No MX N0 T1 Stage I TCGA-2Y-A9H2.4C19CF84-5E30-4854-A084-F6EE53A80543.pdf A9H2 TUMOR FREE 386 143 382 NO NO 10.8 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES 2Y 1.3 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody LIVING 55 2010 TCGA-2Y-A9H2-01A-12D-A381-01 TCGA-2Y-A9H2-01A-12D-A381-01 TCGA-2Y-A9H2-01A-12D-A382-10 TCGA-2Y-A9H2-01 TCGA-2Y-A9H2-01 959e5067-014b-4a33-92d6-6827383efb00 TCGA-2Y-A9H2-01 TCGA-2Y-A9H2-01 959e5067-014b-4a33-92d6-6827383efb00 959e5067-014b-4a33-92d6-6827383efb00 959e5067-014b-4a33-92d6-6827383efb00 TCGA-2Y-A9H2-01A-12D-A383-05 TCGA-2Y-A9H3-01 TCGA-2Y-A9H3-01 TCGA-2Y-A9H3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 45 3.5 5.3 5 TCGA-2Y-A9H3-F69086 TCGA-2Y-A9H3 0.2 0.3 3 0.8 1.5 0.9 -16443 0 1516 2 0 7 5640 1,2 - Portal Fibrosis 2014-12-29 MALE 179 Alcohol consumption|Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 11.5 NO G1 NO No MX NX T2 Stage II A9H3 TUMOR FREE 245 143 382 [Discrepancy] NO 10.5 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES 2Y 1.3 Liver Micro Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 105 2010 TCGA-2Y-A9H3-01A-11D-A381-01 TCGA-2Y-A9H3-01A-11D-A381-01 TCGA-2Y-A9H3-01A-11D-A382-10 TCGA-2Y-A9H3-01 TCGA-2Y-A9H3-01 a9559d4e-1403-4d7f-8638-d74d31dafcd3 TCGA-2Y-A9H3-01 TCGA-2Y-A9H3-01 a9559d4e-1403-4d7f-8638-d74d31dafcd3 a9559d4e-1403-4d7f-8638-d74d31dafcd3 a9559d4e-1403-4d7f-8638-d74d31dafcd3 TCGA-2Y-A9H3-01A-11D-A383-05 TCGA-2Y-A9H4-01 TCGA-2Y-A9H4-01 TCGA-2Y-A9H4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 68 3.5 4.6 5 TCGA-2Y-A9H4-F69087 TCGA-2Y-A9H4 TCGA-2Y-A9H4-01A 0.2 0.3 2 A 0.8 1.5 1.2 -25096 1210 0 1452 0 0 7 11 2014-12-29 MALE 167 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 8.3 11.5 NO NO G2 NO true No MX N0 T1 Stage I TCGA-2Y-A9H4.8A93B07B-8DCC-4DF4-B792-212C80E203FB.pdf A9H4 TUMOR FREE 223 143 382 NO NO 11 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES 2Y 1.3 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 61 2010 TCGA-2Y-A9H4-01A-11D-A381-01 TCGA-2Y-A9H4-01A-11D-A381-01 TCGA-2Y-A9H4-01A-11D-A382-10 TCGA-2Y-A9H4-01 TCGA-2Y-A9H4-01 5b8cde2d-a8bf-4f84-b4c4-9515a2b97226 TCGA-2Y-A9H4-01 TCGA-2Y-A9H4-01 5b8cde2d-a8bf-4f84-b4c4-9515a2b97226 5b8cde2d-a8bf-4f84-b4c4-9515a2b97226 5b8cde2d-a8bf-4f84-b4c4-9515a2b97226 TCGA-2Y-A9H4-01A-11D-A383-05 TCGA-2Y-A9H5-01 TCGA-2Y-A9H5-01 TCGA-2Y-A9H5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 59 3.5 4.9 5 TCGA-2Y-A9H5 TCGA-2Y-A9H5-01A 0.2 0.3 2 0.8 1.5 0.6 -21818 1101 555 0 0 7 11700 1,2 - Portal Fibrosis 2014-11-3 FEMALE 157 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 8.3 11.5 NO G3 YES true No MX N0 T1 Stage I TCGA-2Y-A9H5.99FC2CC9-19F1-4BCB-81E6-5FED4619B331.pdf A9H5 WITH TUMOR 204 143 382 NO NO 10.2 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES 2Y 1.3 Liver None A Hepatitis C Antibody|Hepatitis C Virus R|HCV Genotype DECEASED 69 2010 TCGA-2Y-A9H5-01A-11D-A381-01 TCGA-2Y-A9H5-01A-11D-A381-01 TCGA-2Y-A9H5-01A-11D-A382-10 TCGA-2Y-A9H5-01 TCGA-2Y-A9H5-01 2599cb92-686e-4939-a97f-c17f2065adcc TCGA-2Y-A9H5-01 TCGA-2Y-A9H5-01 2599cb92-686e-4939-a97f-c17f2065adcc 2599cb92-686e-4939-a97f-c17f2065adcc 2599cb92-686e-4939-a97f-c17f2065adcc TCGA-2Y-A9H5-01A-11D-A383-05 TCGA-2Y-A9H6-01 TCGA-2Y-A9H6-01 TCGA-2Y-A9H6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 68 3.5 4 5 TCGA-2Y-A9H6-F69088 TCGA-2Y-A9H6 TCGA-2Y-A9H6-01A 0.3 0.3 1 0.8 1.5 1.8 -24982 982 0 357 0 0 7 114 2014-12-29 FEMALE 156 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 8.3 11.5 NO YES G2 NO true Yes MX NX T1 Stage I TCGA-2Y-A9H6.0B39CB6A-D208-4128-AB46-50C7DB072865.pdf A9H6 224 143 382 NO NO 10.5 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES 2Y 1.3 Liver Macro A LIVING 99 2011 TCGA-2Y-A9H6-01A-11D-A38W-01 TCGA-2Y-A9H6-01A-11D-A38W-01 TCGA-2Y-A9H6-01A-11D-A38X-10 TCGA-2Y-A9H6-01 TCGA-2Y-A9H6-01 1493a0e1-08ca-4054-b432-f8103e47563c TCGA-2Y-A9H6-01 TCGA-2Y-A9H6-01 1493a0e1-08ca-4054-b432-f8103e47563c 1493a0e1-08ca-4054-b432-f8103e47563c 1493a0e1-08ca-4054-b432-f8103e47563c TCGA-2Y-A9H6-01A-11D-A39G-05 TCGA-2Y-A9H7-01 TCGA-2Y-A9H7-01 TCGA-2Y-A9H7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 81 3.5 3.4 5 TCGA-2Y-A9H7-F69176 TCGA-2Y-A9H7 TCGA-2Y-A9H7-01A 0.2 0.3 A 0.8 1.5 1.2 -29752 846 0 1168 1117 2 0 7 6 3,4 - Fibrous Speta 2014-12-30 FEMALE 157 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 8.3 11.5 NO NO G2 Liver Locoregional Recurrence Yes NO YES No true Yes MX N0 T1 Stage I TCGA-2Y-A9H7.80E07DD4-2925-4F58-B4DA-07041673A13F.pdf A9H7 WITH TUMOR 165 143 382 [Discrepancy] NO 10.8 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES 2Y 1.3 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 104 2011 TCGA-2Y-A9H7-01A-11D-A38W-01 TCGA-2Y-A9H7-01A-11D-A38W-01 TCGA-2Y-A9H7-01A-11D-A38X-10 TCGA-2Y-A9H7-01 TCGA-2Y-A9H7-01 185beb02-4b0d-457c-8eee-4e4c51362feb TCGA-2Y-A9H7-01 TCGA-2Y-A9H7-01 185beb02-4b0d-457c-8eee-4e4c51362feb 185beb02-4b0d-457c-8eee-4e4c51362feb 185beb02-4b0d-457c-8eee-4e4c51362feb TCGA-2Y-A9H7-01A-11D-A39G-05 TCGA-2Y-A9H8-01 TCGA-2Y-A9H8-01 TCGA-2Y-A9H8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 85 3.5 4.2 5 TCGA-2Y-A9H8 TCGA-2Y-A9H8-01A 0.2 0.3 2 0.8 1.5 0.6 -31322 792 633 0 2 0 7 234000 2014-11-3 FEMALE 150 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 8.3 11.5 NO G2 YES true No MX NX T1 [Discrepancy] TCGA-2Y-A9H8.61B5E3D4-727D-45ED-BAC3-9125A0E03F40.pdf A9H8 WITH TUMOR 255 143 382 NO NO 10.3 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES 2Y 1.3 Liver A Hepatitis C Virus R|HBV Surface Antibody|HBV D DECEASED 40 2011 TCGA-2Y-A9H8-01A-11D-A38W-01 TCGA-2Y-A9H8-01A-11D-A38W-01 TCGA-2Y-A9H8-01A-11D-A38X-10 TCGA-2Y-A9H8-01 TCGA-2Y-A9H8-01 327757e4-c3b3-4be0-bdbf-2ad718f92da0 TCGA-2Y-A9H8-01 TCGA-2Y-A9H8-01 327757e4-c3b3-4be0-bdbf-2ad718f92da0 327757e4-c3b3-4be0-bdbf-2ad718f92da0 327757e4-c3b3-4be0-bdbf-2ad718f92da0 TCGA-2Y-A9H8-01A-11D-A39G-05 TCGA-2Y-A9H9-01 TCGA-2Y-A9H9-01 TCGA-2Y-A9H9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 70 3.5 4.7 5 TCGA-2Y-A9H9-F69092 TCGA-2Y-A9H9 TCGA-2Y-A9H9-01A 0.2 0.6 2 A 0.8 1.2 0.8 -25670 731 0 697 701 0 0 7 12 2014-12-29 MALE 178 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 8.3 11.5 NO NO G2 Liver Intrahepatic Recurrence No NO YES No true No MX N0 T1 Stage I TCGA-2Y-A9H9.36C343AC-443B-4196-8B6D-7D9213F2DAE1.pdf A9H9 WITH TUMOR 203 143 382 NO NO 11 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES 2Y 1.3 Liver A LIVING 88 2011 TCGA-2Y-A9H9-01A-21D-A38W-01 TCGA-2Y-A9H9-01A-21D-A38W-01 TCGA-2Y-A9H9-01A-21D-A38X-10 TCGA-2Y-A9H9-01 TCGA-2Y-A9H9-01 946a3961-1616-4f45-a10a-2c6778491fb9 TCGA-2Y-A9H9-01 TCGA-2Y-A9H9-01 946a3961-1616-4f45-a10a-2c6778491fb9 946a3961-1616-4f45-a10a-2c6778491fb9 946a3961-1616-4f45-a10a-2c6778491fb9 TCGA-2Y-A9H9-01A-21D-A39G-05 TCGA-2Y-A9HA-01 TCGA-2Y-A9HA-01 TCGA-2Y-A9HA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 70 3.5 3.5 5 TCGA-2Y-A9HA TCGA-2Y-A9HA-01A 0.2 0.6 A 0.8 1.5 0.8 -25892 713 36 0 0 0 7 114 3,4 - Fibrous Speta 2014-11-3 MALE 169 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 90 8.3 11.5 NO G2 NO true No MX NX T2 Stage II TCGA-2Y-A9HA.C07BBEDC-59CE-41B9-9D47-EDFD8AEB26B9.pdf A9HA WITH TUMOR 153 143 382 YES NO 10.6 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES 2Y 1.3 Liver A Hepatitis C Antibody DECEASED 69 2012 TCGA-2Y-A9HA-01A-11D-A38W-01 TCGA-2Y-A9HA-01A-11D-A38W-01 TCGA-2Y-A9HA-01A-11D-A38X-10 TCGA-2Y-A9HA-01 TCGA-2Y-A9HA-01 8a5081d6-358e-4e94-a794-5d9fcdf467fb TCGA-2Y-A9HA-01 TCGA-2Y-A9HA-01 8a5081d6-358e-4e94-a794-5d9fcdf467fb 8a5081d6-358e-4e94-a794-5d9fcdf467fb 8a5081d6-358e-4e94-a794-5d9fcdf467fb TCGA-2Y-A9HA-01A-11D-A39G-05 TCGA-2Y-A9HB-01 TCGA-2Y-A9HB-01 TCGA-2Y-A9HB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 66 3.5 3.9 5 TCGA-2Y-A9HB-F69098 TCGA-2Y-A9HB 0.2 0.6 0.8 1.5 0.8 -24359 0 260 0 0 7 21 2014-12-29 MALE 167 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 11.5 YES G2 NO No MX NX T1 Stage I A9HB TUMOR FREE 124 143 382 NO NO 11.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES 2Y 1.3 Liver None Hepatitis C Virus R|HCV Genotype LIVING 74 2012 TCGA-2Y-A9HB-01A-11D-A38W-01 TCGA-2Y-A9HB-01A-11D-A38W-01 TCGA-2Y-A9HB-01A-11D-A38X-10 TCGA-2Y-A9HB-01 TCGA-2Y-A9HB-01 fca9f607-7939-4f89-bf60-785f6e848c24 TCGA-2Y-A9HB-01 TCGA-2Y-A9HB-01 fca9f607-7939-4f89-bf60-785f6e848c24 fca9f607-7939-4f89-bf60-785f6e848c24 fca9f607-7939-4f89-bf60-785f6e848c24 TCGA-2Y-A9HB-01A-11D-A39G-05 TCGA-3K-AAZ8-01 TCGA-3K-AAZ8-01 TCGA-3K-AAZ8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 65 TCGA-3K-AAZ8-F69330 TCGA-3K-AAZ8 -24046 0 396 304 5 - Nodular Formation and Incomplete Cirrhosis 2015-1-5 MALE 172 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G1 Liver Locoregional Recurrence No NO YES No No MX NX T3b Stage IIIB AAZ8 WITH TUMOR NO YES NO NO RX Primary Tumor 01 Segmentectomy, Multiple 7th YES NO 3K Liver LIVING 84 2013 TCGA-3K-AAZ8-01A-12D-A38W-01 TCGA-3K-AAZ8-01A-12D-A38W-01 TCGA-3K-AAZ8-01A-12D-A38X-10 TCGA-3K-AAZ8-01 TCGA-3K-AAZ8-01 ab14829c-defd-41b9-b35d-2876049cb46b TCGA-3K-AAZ8-01 TCGA-3K-AAZ8-01 ab14829c-defd-41b9-b35d-2876049cb46b ab14829c-defd-41b9-b35d-2876049cb46b ab14829c-defd-41b9-b35d-2876049cb46b TCGA-3K-AAZ8-01A-12D-A39G-05 TCGA-4R-AA8I-01 TCGA-4R-AA8I-01 TCGA-4R-AA8I TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 66 3.5 3.8 4.8 TCGA-4R-AA8I-F67448 TCGA-4R-AA8I 0.4 1.2 A 0.6 1.3 0.7 -24279 262 0 216 247 1 0 9 5 6 - Established Cirrhosis 2014-11-5 MALE 171 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.1 NO G2 Liver Locoregional Recurrence NO YES No Yes MX NX T2 Stage II AA8I WITH TUMOR 96 150 450 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES 4R 1.5 Liver Micro Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 103 2013 TCGA-4R-AA8I-01A-11D-A381-01 TCGA-4R-AA8I-01A-11D-A381-01 TCGA-4R-AA8I-01A-11D-A382-10 TCGA-4R-AA8I-01 TCGA-4R-AA8I-01 da85d30e-2db7-45eb-8a28-6416c0e07b1f TCGA-4R-AA8I-01 TCGA-4R-AA8I-01 da85d30e-2db7-45eb-8a28-6416c0e07b1f da85d30e-2db7-45eb-8a28-6416c0e07b1f da85d30e-2db7-45eb-8a28-6416c0e07b1f TCGA-4R-AA8I-01A-11D-A383-05 TCGA-5C-A9VG-01 TCGA-5C-A9VG-01 TCGA-5C-A9VG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 58 TCGA-5C-A9VG-F68936 TCGA-5C-A9VG A -21273 0 328 0 2014-12-23 MALE 170 Other Worker at steel factory Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G2 NO No M0 N0 T2 Stage II A9VG TUMOR FREE NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO 5C Liver Micro LIVING 73 2013 TCGA-5C-A9VG-01A-11D-A36W-01 TCGA-5C-A9VG-01A-11D-A36W-01 TCGA-5C-A9VG-01A-11D-A36X-10 TCGA-5C-A9VG-01 TCGA-5C-A9VG-01 c0c2c272-ac73-445e-85a9-d7ba6ff53391 TCGA-5C-A9VG-01 TCGA-5C-A9VG-01 c0c2c272-ac73-445e-85a9-d7ba6ff53391 c0c2c272-ac73-445e-85a9-d7ba6ff53391 c0c2c272-ac73-445e-85a9-d7ba6ff53391 TCGA-5C-A9VG-01A-11D-A36Y-05 TCGA-5C-A9VH-01 TCGA-5C-A9VH-01 TCGA-5C-A9VH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 70 TCGA-5C-A9VH-F68937 TCGA-5C-A9VH TCGA-5C-A9VH-01A A -25608 127 0 322 0 2014-12-23 MALE 165 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 90 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-5C-A9VH.938BCE76-BF7D-4470-A409-805FD012D05D.pdf A9VH TUMOR FREE NO NO NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO 5C Liver None A LIVING 69 2013 TCGA-5C-A9VH-01A-11D-A36W-01 TCGA-5C-A9VH-01A-11D-A36W-01 TCGA-5C-A9VH-01A-11D-A36X-10 TCGA-5C-A9VH-01 TCGA-5C-A9VH-01 859c895b-14f8-4155-9b35-bf6e7abb2c5d TCGA-5C-A9VH-01 TCGA-5C-A9VH-01 859c895b-14f8-4155-9b35-bf6e7abb2c5d 859c895b-14f8-4155-9b35-bf6e7abb2c5d 859c895b-14f8-4155-9b35-bf6e7abb2c5d TCGA-5C-A9VH-01A-11D-A36Y-05 TCGA-5C-AAPD-01 TCGA-5C-AAPD-01 TCGA-5C-AAPD TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 61 TCGA-5C-AAPD-F68938 TCGA-5C-AAPD TCGA-5C-AAPD-01A A -22552 55 0 20 1 2014-12-23 MALE 172 Hepatitis B Hepatocholangiocarcinoma (Mixed) No C22.0 8180/3 C22.0 YES 140 NO NO G1 NO true No M0 N0 T2 Stage II TCGA-5C-AAPD.E4DB31C4-89F3-4D8D-A32E-B42C599904E1.pdf AAPD TUMOR FREE NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO 5C Liver None A HBV Surface Antibody LIVING 69 2013 TCGA-5C-AAPD-01A-21D-A38W-01 TCGA-5C-AAPD-01A-21D-A38W-01 TCGA-5C-AAPD-01A-21D-A38X-10 TCGA-5C-AAPD-01 TCGA-5C-AAPD-01 4aced91c-f8c4-4eb7-8911-4924c1ffcd99 TCGA-5C-AAPD-01 TCGA-5C-AAPD-01 4aced91c-f8c4-4eb7-8911-4924c1ffcd99 4aced91c-f8c4-4eb7-8911-4924c1ffcd99 4aced91c-f8c4-4eb7-8911-4924c1ffcd99 TCGA-5C-AAPD-01A-21D-A39G-05 TCGA-5R-AA1C-01 TCGA-5R-AA1C-01 TCGA-5R-AA1C TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 57 3.2 3.0 4.6 TCGA-5R-AA1C-F72055 TCGA-5R-AA1C TCGA-5R-AA1C-01A 0 1.8 B 0.5 1.3 1.0 -21073 60 0 520 1 0 15 2 1,2 - Portal Fibrosis 2015-4-6 MALE 174 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 750 11 15 NO NO G2 NO false No M0 N0 T2 Stage II TCGA-5R-AA1C.AF0BACCE-3975-4E9F-9272-404229EC77C9.pdf AA1C TUMOR FREE 223000 150000 450000 NO NO 18 NO NO R0 Primary Tumor 01 Extended Lobectomy 7th YES NO 5R 1.2 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 90 2013 TCGA-5R-AA1C-01A-11D-A40Q-01 TCGA-5R-AA1C-01A-11D-A40Q-01 TCGA-5R-AA1C-01A-11D-A40R-10 TCGA-5R-AA1C-01 TCGA-5R-AA1C-01 55844917-3a31-4f8b-a955-14ca0f139368 TCGA-5R-AA1C-01 TCGA-5R-AA1C-01 55844917-3a31-4f8b-a955-14ca0f139368 55844917-3a31-4f8b-a955-14ca0f139368 55844917-3a31-4f8b-a955-14ca0f139368 TCGA-5R-AA1C-01A-11D-A40S-05 TCGA-5R-AA1D-01 TCGA-5R-AA1D-01 TCGA-5R-AA1D TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 17 3.2 3.3 4.6 TCGA-5R-AA1D-F70155 TCGA-5R-AA1D 0 0.5 B 0.5 1.3 0.7 -6545 0 449 1 0 15 5 0 - No Fibrosis 2015-1-28 FEMALE 161 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 11 15 NO G3 NO No M0 N0 T3a Stage IIIA AA1D TUMOR FREE 333000 150000 450000 NO NO 19 YES NO R0 Primary Tumor 01 Extended Lobectomy 7th YES NO 5R 1.2 Liver Micro Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 59 2013 TCGA-5R-AA1D-01A-11D-A381-01 TCGA-5R-AA1D-01A-11D-A381-01 TCGA-5R-AA1D-01A-11D-A382-10 TCGA-5R-AA1D-01 TCGA-5R-AA1D-01 cd5cb20c-a12b-44e2-8ebc-874b1296758b TCGA-5R-AA1D-01 TCGA-5R-AA1D-01 cd5cb20c-a12b-44e2-8ebc-874b1296758b cd5cb20c-a12b-44e2-8ebc-874b1296758b cd5cb20c-a12b-44e2-8ebc-874b1296758b TCGA-5R-AA1D-01A-11D-A383-05 TCGA-5R-AAAM-01 TCGA-5R-AAAM-01 TCGA-5R-AAAM TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Severe 65 3.2 3.0 4.6 TCGA-5R-AAAM TCGA-5R-AAAM-01A 0 0.6 A 0.5 1.3 0.7 -24020 35 46 0 1 0 15 32 6 - Established Cirrhosis 2014-11-14 FEMALE 163 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 730 11 15 NO G2 NO true No M0 N0 T2 Stage II TCGA-5R-AAAM.B07C5DBA-634E-4028-A32D-61FE7445BDEE.pdf AAAM TUMOR FREE 68000 150000 450000 NO NO NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO 5R 1.2 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 80 2013 TCGA-5R-AAAM-01A-12D-A40Q-01 TCGA-5R-AAAM-01A-12D-A40Q-01 TCGA-5R-AAAM-01A-12D-A40R-10 TCGA-5R-AAAM-01 TCGA-5R-AAAM-01 9bfa35f8-31cf-4644-b860-b7aba3de3e5d TCGA-5R-AAAM-01 TCGA-5R-AAAM-01 9bfa35f8-31cf-4644-b860-b7aba3de3e5d 9bfa35f8-31cf-4644-b860-b7aba3de3e5d 9bfa35f8-31cf-4644-b860-b7aba3de3e5d TCGA-5R-AAAM-01A-12D-A40S-05 TCGA-BC-4072-01 TCGA-BC-4072-01 TCGA-BC-4072 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 74 3.5 4.4 5.0 TCGA-BC-4072-F6875 TCGA-BC-4072 TCGA-BC-4072-01B 0 .5 7 .7 1.1 1 -27162 2256 1490 0 475 2010-12-20 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 270 NO G3 Lymph Node(s) Extrahepatic Recurrence No NO YES false No M0 N0 T3 Stage IIIA TCGA-BC-4072.CF0E1E81-A89B-4D33-A02E-C77DAE5E8E30.pdf 4072 WITH TUMOR 268 150 440 NO NO 1 NO YES R1 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES BC 1.2 Liver Macro B DECEASED 2005 TCGA-BC-4072-01B-11D-A151-01 TCGA-BC-4072-01B-11D-A151-01 TCGA-BC-4072-01 TCGA-BC-4072-01 6A51966A-B269-41D9-94AF-B46475CDB7A4 091c332c-1596-4db6-88e7-e40ef85f15dd TCGA-BC-4072-01 TCGA-BC-4072-01 091c332c-1596-4db6-88e7-e40ef85f15dd 091c332c-1596-4db6-88e7-e40ef85f15dd 091c332c-1596-4db6-88e7-e40ef85f15dd TCGA-BC-4072-01B-11D-A153-05 TCGA-BC-4073-01 TCGA-BC-4073-01 TCGA-BC-4073 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 73 TCGA-BC-4073-F30829 TCGA-BC-4073 TCGA-BC-4073-01B 0.0 0.7 3 0.7 1.3 1.5 -26795 398 0 849 0 Scheduled Follow-up Submission 2012-4-17 MALE Hemochromatosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 230 NO G3 NO true No MX N0 T3 Stage IIIA TCGA-BC-4073.1C53BF2E-0AA8-477F-8281-63455E0D36E2.pdf 4073 WITH TUMOR 253 150 440 NO NO 1.0 NO YES R1 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES BC 1.2 Liver Macro B LIVING 2009 TCGA-BC-4073-01B-02D-A12Y-01 TCGA-BC-4073-01B-02D-A12Y-01 TCGA-BC-4073-01B-02D-A12Z-10 TCGA-BC-4073-01 TCGA-BC-4073-01 8b3062fd-dd51-4bc0-a858-6783b3b5fe08 TCGA-BC-4073-01B-02D-A12Z-10 TCGA-BC-4073-01 TCGA-BC-4073-01 8b3062fd-dd51-4bc0-a858-6783b3b5fe08 TCGA-BC-4073-01B-02D-A12Z-10 8b3062fd-dd51-4bc0-a858-6783b3b5fe08 8b3062fd-dd51-4bc0-a858-6783b3b5fe08 TCGA-BC-4073-01B-02D-A12Z-10 TCGA-BC-4073-01B-02D-A132-05 TCGA-BC-A10Q-01 TCGA-BC-A10Q-01 TCGA-BC-A10Q TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO 72 3.5 4.1 5.0 TCGA-BC-A10Q-F9852 TCGA-BC-A10Q TCGA-BC-A10Q-01A .5 1 0.7 1.1 0.6 -26400 4437 1135 0 340 2011-4-1 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 340 NO Intrahepatic Recurrence No NO YES false No MX NX T2 TCGA-BC-A10Q.10117C34-85C2-49DE-B2AD-F8D0D4570DA9.pdf A10Q WITH TUMOR 287000 150 440 YES YES 0.9 NO YES R1 Primary Tumor 01 Extended Lobectomy 5th NO YES BC Liver None A DECEASED 1998 TCGA-BC-A10Q-01A-11D-A12Y-01 TCGA-BC-A10Q-01A-11D-A12Y-01 TCGA-BC-A10Q-01A-11D-A12Z-10 TCGA-BC-A10Q-01 TCGA-BC-A10Q-01 A21E10AF-3D45-45A0-B2E4-14BC5FA33FA5 19c97e3d-f5af-4301-92f4-be8ac9e27427 TCGA-BC-A10Q-01A-11D-A12Z-10 TCGA-BC-A10Q-01 TCGA-BC-A10Q-01 19c97e3d-f5af-4301-92f4-be8ac9e27427 TCGA-BC-A10Q-01A-11D-A12Z-10 19c97e3d-f5af-4301-92f4-be8ac9e27427 19c97e3d-f5af-4301-92f4-be8ac9e27427 TCGA-BC-A10Q-01A-11D-A12Z-10 TCGA-BC-A10Q-01A-11D-A132-05 TCGA-BC-A10Q-11 TCGA-BC-A10Q-11 TCGA-BC-A10Q TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO 72 3.5 4.1 5.0 TCGA-BC-A10Q-F9852 TCGA-BC-A10Q TCGA-BC-A10Q-11A .5 1 0.7 1.1 0.6 -26400 4437 1135 0 340 2011-4-1 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 340 NO Intrahepatic Recurrence No NO YES false No MX NX T2 A10Q WITH TUMOR 287000 150 440 YES YES 0.9 NO YES R1 Solid Tissue Normal 11 Extended Lobectomy 5th NO YES BC Liver None A DECEASED 1998 TCGA-BC-A10Q-11 469f052a-477e-498a-ba3b-f288dcbc306f TCGA-BC-A10Q-11 469f052a-477e-498a-ba3b-f288dcbc306f 469f052a-477e-498a-ba3b-f288dcbc306f 469f052a-477e-498a-ba3b-f288dcbc306f TCGA-BC-A10Q-11A-11D-A132-05 TCGA-BC-A10R-01 TCGA-BC-A10R-01 TCGA-BC-A10R TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Mild 66 4.0 TCGA-BC-A10R-F9867 TCGA-BC-A10R TCGA-BC-A10R-01A 1 0.7 1.1 0.7 -24274 4316 308 0 199 27 2011-4-1 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 180 NO G2 Intrahepatic Recurrence Yes NO YES No false No MX NX T3 TCGA-BC-A10R.65BE2C95-CADA-44FC-9313-14529AFF773E.pdf A10R WITH TUMOR 209000 150 440 NO NO 0.9 NO YES R0 Primary Tumor 01 Lobectomy 5th NO YES BC Liver Micro A DECEASED 1999 TCGA-BC-A10R-01A-11D-A12Y-01 TCGA-BC-A10R-01A-11D-A12Y-01 TCGA-BC-A10R-01A-11D-A12Z-10 TCGA-BC-A10R-01 TCGA-BC-A10R-01 E9E08287-5807-4E84-B5A8-59DE0295A4E2 d6cb14d4-1ee1-4d83-ad3f-efa19969c00f TCGA-BC-A10R-01A-11D-A12Z-10 TCGA-BC-A10R-01 TCGA-BC-A10R-01 d6cb14d4-1ee1-4d83-ad3f-efa19969c00f TCGA-BC-A10R-01A-11D-A12Z-10 d6cb14d4-1ee1-4d83-ad3f-efa19969c00f d6cb14d4-1ee1-4d83-ad3f-efa19969c00f TCGA-BC-A10R-01A-11D-A12Z-10 TCGA-BC-A10R-01A-11D-A132-05 TCGA-BC-A10R-11 TCGA-BC-A10R-11 TCGA-BC-A10R TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Mild 66 4.0 TCGA-BC-A10R-F9867 TCGA-BC-A10R TCGA-BC-A10R-11A 1 0.7 1.1 0.7 -24274 4316 308 0 199 27 2011-4-1 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1620 NO G2 Intrahepatic Recurrence Yes NO YES No false No MX NX T3 A10R WITH TUMOR 209000 150 440 NO NO 0.9 NO YES R0 Solid Tissue Normal 11 Lobectomy 5th NO YES BC Liver Micro A DECEASED 1999 TCGA-BC-A10R-11 4d49b039-f1fa-4892-8439-4155e72dd7c5 TCGA-BC-A10R-11 4d49b039-f1fa-4892-8439-4155e72dd7c5 4d49b039-f1fa-4892-8439-4155e72dd7c5 4d49b039-f1fa-4892-8439-4155e72dd7c5 TCGA-BC-A10R-11A-11D-A132-05 TCGA-BC-A10S-01 TCGA-BC-A10S-01 TCGA-BC-A10S TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 81 3.6 TCGA-BC-A10S-F9875 TCGA-BC-A10S TCGA-BC-A10S-01A 0.6 -29842 4284 1423 0 1130 2011-4-1 MALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 550 NO G1 Intrahepatic Recurrence No NO YES No false No MX NX T3 TCGA-BC-A10S.A0F69833-CBDD-492D-9564-AE8FB2F9CE3B.pdf A10S WITH TUMOR 217000 150 440 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 5th NO YES BC Liver Micro A DECEASED 74 1999 TCGA-BC-A10S-01A-22D-A12Y-01 TCGA-BC-A10S-01A-22D-A12Y-01 TCGA-BC-A10S-01 TCGA-BC-A10S-01 C13F11E1-2E92-4548-B41E-EA189E440DDE 68f75980-9246-46b2-82d2-41abd9a72998 TCGA-BC-A10S-01A-22D-A12Z-10 TCGA-BC-A10S-01 TCGA-BC-A10S-01 68f75980-9246-46b2-82d2-41abd9a72998 TCGA-BC-A10S-01A-22D-A12Z-10 68f75980-9246-46b2-82d2-41abd9a72998 68f75980-9246-46b2-82d2-41abd9a72998 TCGA-BC-A10S-01A-22D-A12Z-10 TCGA-BC-A10S-01A-22D-A132-05 TCGA-BC-A10S-11 TCGA-BC-A10S-11 TCGA-BC-A10S TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 81 3.6 TCGA-BC-A10S-F9875 TCGA-BC-A10S TCGA-BC-A10S-11A 0.6 -29842 4284 1423 0 1130 2011-4-1 MALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 680 NO G1 Intrahepatic Recurrence No NO YES No false No MX NX T3 A10S WITH TUMOR 217000 150 440 NO NO 1.1 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 5th NO YES BC Liver Micro A DECEASED 74 1999 TCGA-BC-A10S-11A-11D-A132-05 TCGA-BC-A10T-01 TCGA-BC-A10T-01 TCGA-BC-A10T TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 76 3.0 TCGA-BC-A10T-F9882 TCGA-BC-A10T TCGA-BC-A10T-01A 0.7 1.2 -27944 3660 837 0 598 1,2 - Portal Fibrosis 2011-4-1 MALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1000 NO G1 Pulmonary Extrahepatic Recurrence No NO YES No false No MX NX T4 TCGA-BC-A10T.D8103C33-F303-4D97-81AF-CC3D06E79285.pdf A10T WITH TUMOR 450000 150 440 NO NO 1.1 NO NO R1 Primary Tumor 01 Other (specify) 5th NO YES BC Liver None A DECEASED 86 2000 TCGA-BC-A10T-01A-11D-A12Y-01 TCGA-BC-A10T-01A-11D-A12Y-01 TCGA-BC-A10T-01A-11D-A12Z-10 TCGA-BC-A10T-01 TCGA-BC-A10T-01 52FB12B7-8108-4EE8-AA7A-409225D0702A a4afd001-11fa-4bce-8766-b60b54566fcd TCGA-BC-A10T-01A-11D-A12Z-10 TCGA-BC-A10T-01 TCGA-BC-A10T-01 a4afd001-11fa-4bce-8766-b60b54566fcd TCGA-BC-A10T-01A-11D-A12Z-10 a4afd001-11fa-4bce-8766-b60b54566fcd a4afd001-11fa-4bce-8766-b60b54566fcd TCGA-BC-A10T-01A-11D-A12Z-10 TCGA-BC-A10T-01A-11D-A132-05 TCGA-BC-A10T-11 TCGA-BC-A10T-11 TCGA-BC-A10T TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 76 3.0 TCGA-BC-A10T-F9882 TCGA-BC-A10T TCGA-BC-A10T-11A 0.7 1.2 -27944 3660 837 0 598 1,2 - Portal Fibrosis 2011-4-1 MALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 480 NO G1 Pulmonary Extrahepatic Recurrence No NO YES No false No MX NX T4 A10T WITH TUMOR 450000 150 440 NO NO 1.1 NO NO R1 Solid Tissue Normal 11 Other (specify) 5th NO YES BC Liver None A DECEASED 86 2000 TCGA-BC-A10T-11 3497c0d8-c7b0-43ca-92a2-30ea6cd61bde TCGA-BC-A10T-11 3497c0d8-c7b0-43ca-92a2-30ea6cd61bde 3497c0d8-c7b0-43ca-92a2-30ea6cd61bde 3497c0d8-c7b0-43ca-92a2-30ea6cd61bde TCGA-BC-A10T-11A-11D-A132-05 TCGA-BC-A10U-01 TCGA-BC-A10U-01 TCGA-BC-A10U TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 69 3.5 4.3 5.0 TCGA-BC-A10U-F9923 TCGA-BC-A10U TCGA-BC-A10U-01A 0.0 0.4 4 0.8 1.4 0.9 -25305 3645 837 0 586 38 2011-4-4 MALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 510 NO G2 Intrahepatic Recurrence Yes NO YES No false No MX NX T2 TCGA-BC-A10U.57EB75F3-6F48-4CFB-86CF-F694C390C86A.pdf A10U WITH TUMOR 204000 150 440 NO NO 1.1 NO YES R1 Primary Tumor 01 Lobectomy 5th NO YES BC 1.2 Liver A DECEASED 2000 TCGA-BC-A10U-01A-11D-A12Y-01 TCGA-BC-A10U-01A-11D-A12Y-01 TCGA-BC-A10U-01A-11D-A12Z-10 TCGA-BC-A10U-01 TCGA-BC-A10U-01 DFCC1105-AC9E-4DD6-944A-CB6F4FE4EA3C 45684bfb-a8c1-4224-a632-a93aa7f70b47 TCGA-BC-A10U-01A-11D-A12Z-10 TCGA-BC-A10U-01 TCGA-BC-A10U-01 45684bfb-a8c1-4224-a632-a93aa7f70b47 TCGA-BC-A10U-01A-11D-A12Z-10 45684bfb-a8c1-4224-a632-a93aa7f70b47 45684bfb-a8c1-4224-a632-a93aa7f70b47 TCGA-BC-A10U-01A-11D-A12Z-10 TCGA-BC-A10U-01A-11D-A132-05 TCGA-BC-A10U-11 TCGA-BC-A10U-11 TCGA-BC-A10U TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 69 3.5 4.3 5.0 TCGA-BC-A10U-F9923 TCGA-BC-A10U TCGA-BC-A10U-11A 0.0 0.4 4 0.8 1.4 0.9 -25305 3645 837 0 586 38 2011-4-4 MALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1130 NO G2 Intrahepatic Recurrence Yes NO YES No false No MX NX T2 A10U WITH TUMOR 204000 150 440 NO NO 1.1 NO YES R1 Solid Tissue Normal 11 Lobectomy 5th NO YES BC 1.2 Liver A DECEASED 2000 TCGA-BC-A10U-11 1c2972fc-456c-4567-be96-bde9d39a0b76 TCGA-BC-A10U-11 1c2972fc-456c-4567-be96-bde9d39a0b76 1c2972fc-456c-4567-be96-bde9d39a0b76 1c2972fc-456c-4567-be96-bde9d39a0b76 TCGA-BC-A10U-11A-11D-A132-05 TCGA-BC-A10W-01 TCGA-BC-A10W-01 TCGA-BC-A10W TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 50 3.5 2.8 5.0 TCGA-BC-A10W-F9925 TCGA-BC-A10W TCGA-BC-A10W-01A 0.0 1.4 1 0.8 1.4 0.8 -18562 3100 91 0 79 2011-4-4 MALE Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 460 NO G3 No New Tumor Event NO false No MX NX T4 TCGA-BC-A10W.A7F79765-5038-47AA-87B0-40E2D802E535.pdf A10W WITH TUMOR 401 150 440 NO YES 0.9 NO YES R1 Primary Tumor 01 Lobectomy 5th NO YES BC 1.2 Liver A Hepatitis B Surface Antigen DECEASED 71 2002 TCGA-BC-A10W-01A-11D-A12Y-01 TCGA-BC-A10W-01A-11D-A12Y-01 TCGA-BC-A10W-01A-11D-A12Z-10 TCGA-BC-A10W-01 TCGA-BC-A10W-01 2F3ED728-EF5C-4987-A0FA-052947A658D3 affaf79d-f5a4-45a3-9cbf-181c473a8b2a TCGA-BC-A10W-01A-11D-A12Z-10 TCGA-BC-A10W-01 TCGA-BC-A10W-01 affaf79d-f5a4-45a3-9cbf-181c473a8b2a TCGA-BC-A10W-01A-11D-A12Z-10 affaf79d-f5a4-45a3-9cbf-181c473a8b2a affaf79d-f5a4-45a3-9cbf-181c473a8b2a TCGA-BC-A10W-01A-11D-A12Z-10 TCGA-BC-A10W-01A-11D-A132-05 TCGA-BC-A10W-11 TCGA-BC-A10W-11 TCGA-BC-A10W TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 50 3.5 2.8 5.0 TCGA-BC-A10W-F9925 TCGA-BC-A10W TCGA-BC-A10W-11A 0.0 1.4 1 0.8 1.4 0.8 -18562 3100 91 0 79 2011-4-4 MALE Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 390 NO G3 No New Tumor Event NO false No MX NX T4 A10W WITH TUMOR 401 150 440 NO YES 0.9 NO YES R1 Solid Tissue Normal 11 Lobectomy 5th NO YES BC 1.2 Liver A Hepatitis B Surface Antigen DECEASED 71 2002 TCGA-BC-A10W-11 2436079d-3e40-4c50-9f99-85d4a8c2ddac TCGA-BC-A10W-11 2436079d-3e40-4c50-9f99-85d4a8c2ddac 2436079d-3e40-4c50-9f99-85d4a8c2ddac 2436079d-3e40-4c50-9f99-85d4a8c2ddac TCGA-BC-A10W-11A-11D-A132-05 TCGA-BC-A10X-01 TCGA-BC-A10X-01 TCGA-BC-A10X TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 52 3.5 3.6 5.0 TCGA-BC-A10X-F9946 TCGA-BC-A10X TCGA-BC-A10X-01A 0.0 0.3 2 0.7 1.1 0.7 -19140 3080 770 0 264 2011-4-4 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 520 NO G2 No New Tumor Event NO false No MX N0 T3a Stage IIIA TCGA-BC-A10X.671F5D97-36F3-40BA-9E28-1B65B21EF3D4.pdf A10X TUMOR FREE 602 150 440 NO NO 1.0 NO YES R0 Primary Tumor 01 Lobectomy 5th NO YES BC 1.2 Liver Micro A DECEASED 65 2002 TCGA-BC-A10X-01A-11D-A12Y-01 TCGA-BC-A10X-01A-11D-A12Y-01 TCGA-BC-A10X-01A-11D-A12Z-10 TCGA-BC-A10X-01 TCGA-BC-A10X-01 586E5071-D93B-4D0D-B732-999FC8995A4A 92c0e4e0-e7a5-486b-82f9-ba7621a10b83 TCGA-BC-A10X-01A-11D-A12Z-10 TCGA-BC-A10X-01 TCGA-BC-A10X-01 92c0e4e0-e7a5-486b-82f9-ba7621a10b83 TCGA-BC-A10X-01A-11D-A12Z-10 92c0e4e0-e7a5-486b-82f9-ba7621a10b83 92c0e4e0-e7a5-486b-82f9-ba7621a10b83 TCGA-BC-A10X-01A-11D-A12Z-10 TCGA-BC-A10X-01A-11D-A132-05 TCGA-BC-A10X-11 TCGA-BC-A10X-11 TCGA-BC-A10X TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 52 3.5 3.6 5.0 TCGA-BC-A10X-F9946 TCGA-BC-A10X TCGA-BC-A10X-11A 0.0 0.3 2 0.7 1.1 0.7 -19140 3080 770 0 264 2011-4-4 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 430 NO G2 No New Tumor Event NO false No MX N0 T3a Stage IIIA A10X TUMOR FREE 602 150 440 NO NO 1.0 NO YES R0 Solid Tissue Normal 11 Lobectomy 5th NO YES BC 1.2 Liver Micro A DECEASED 65 2002 TCGA-BC-A10X-11 608bf540-a094-441e-9329-9e759ff5d84d TCGA-BC-A10X-11 608bf540-a094-441e-9329-9e759ff5d84d 608bf540-a094-441e-9329-9e759ff5d84d 608bf540-a094-441e-9329-9e759ff5d84d TCGA-BC-A10X-11A-11D-A132-05 TCGA-BC-A10Y-01 TCGA-BC-A10Y-01 TCGA-BC-A10Y TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 76 3.5 4.0 5.0 TCGA-BC-A10Y-F9958 TCGA-BC-A10Y TCGA-BC-A10Y-01A 0.0 0.5 0.9 1.4 1.0 -28049 2961 711 0 400 0 10 10575 2011-4-4 MALE 175 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 340 NO G3 Intrahepatic Recurrence Yes NO YES No false No MX NX T4 TCGA-BC-A10Y.20CD1D6D-C4ED-43AD-9FCD-0A683FD96C6E.pdf A10Y WITH TUMOR 239 150 440 YES NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 5th NO YES BC 1.2 Liver Micro A DECEASED 77 2002 TCGA-BC-A10Y-01A-11D-A12Y-01 TCGA-BC-A10Y-01A-11D-A12Y-01 TCGA-BC-A10Y-01A-11D-A12Z-10 TCGA-BC-A10Y-01 TCGA-BC-A10Y-01 89EA706C-7252-4E64-9A4E-97F2E6744EE4 dd37c309-81f0-4d3d-863d-a16aa505e346 TCGA-BC-A10Y-01A-11D-A12Z-10 TCGA-BC-A10Y-01 TCGA-BC-A10Y-01 dd37c309-81f0-4d3d-863d-a16aa505e346 TCGA-BC-A10Y-01A-11D-A12Z-10 dd37c309-81f0-4d3d-863d-a16aa505e346 dd37c309-81f0-4d3d-863d-a16aa505e346 TCGA-BC-A10Y-01A-11D-A12Z-10 TCGA-BC-A10Y-01A-11D-A132-05 TCGA-BC-A10Y-11 TCGA-BC-A10Y-11 TCGA-BC-A10Y TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 76 3.5 4.0 5.0 TCGA-BC-A10Y-F9958 TCGA-BC-A10Y 0.0 0.5 0.9 1.4 1.0 -28049 711 0 400 0 10 10575 2011-4-4 MALE 175 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES G3 Intrahepatic Recurrence Yes NO YES No No MX NX T4 A10Y WITH TUMOR 239 150 440 YES NO 1.0 NO NO R0 Solid Tissue Normal 11 Lobectomy 5th NO YES BC 1.2 Liver Micro DECEASED 77 2002 TCGA-BC-A10Y-11 b8e62048-d0a6-4b0f-8e57-e406b783f698 TCGA-BC-A10Y-11 b8e62048-d0a6-4b0f-8e57-e406b783f698 b8e62048-d0a6-4b0f-8e57-e406b783f698 b8e62048-d0a6-4b0f-8e57-e406b783f698 TCGA-BC-A10Y-11A-11D-A132-05 TCGA-BC-A10Z-01 TCGA-BC-A10Z-01 TCGA-BC-A10Z TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 62 3.5 3.1 5.0 TCGA-BC-A10Z-F9962 TCGA-BC-A10Z TCGA-BC-A10Z-01A 0.0 0.6 1 0.7 1.1 1.2 -22913 2652 34 0 0 10 779 2011-4-4 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 NO G2 No New Tumor Event NO false No MX N0 T1 Stage I TCGA-BC-A10Z.427BA175-823D-4C68-B659-D53CFEB5EA45.pdf A10Z TUMOR FREE 260 150 440 NO NO 0.9 NO YES R0 Primary Tumor 01 Extended Lobectomy 6th NO YES BC 1.2 Liver None A DECEASED 79 2003 TCGA-BC-A10Z-01A-11D-A12Y-01 TCGA-BC-A10Z-01A-11D-A12Y-01 TCGA-BC-A10Z-01A-11D-A12Z-10 TCGA-BC-A10Z-01 TCGA-BC-A10Z-01 9E0546BB-8A10-4B59-8083-5CD4F3FD6072 388a996e-0fb1-4274-905d-074ff0058d80 TCGA-BC-A10Z-01A-11D-A12Z-10 TCGA-BC-A10Z-01 TCGA-BC-A10Z-01 388a996e-0fb1-4274-905d-074ff0058d80 TCGA-BC-A10Z-01A-11D-A12Z-10 388a996e-0fb1-4274-905d-074ff0058d80 388a996e-0fb1-4274-905d-074ff0058d80 TCGA-BC-A10Z-01A-11D-A12Z-10 TCGA-BC-A10Z-01A-11D-A132-05 TCGA-BC-A10Z-11 TCGA-BC-A10Z-11 TCGA-BC-A10Z TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 62 3.5 3.1 5.0 TCGA-BC-A10Z-F9962 TCGA-BC-A10Z TCGA-BC-A10Z-11A 0.0 0.6 1 0.7 1.1 1.2 -22913 2652 34 0 0 10 779 2011-4-4 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 NO G2 No New Tumor Event NO false No MX N0 T1 Stage I A10Z TUMOR FREE 260 150 440 NO NO 0.9 NO YES R0 Solid Tissue Normal 11 Extended Lobectomy 6th NO YES BC 1.2 Liver None A DECEASED 79 2003 TCGA-BC-A10Z-11 07653b81-7194-4348-8ef9-1a7660c95376 TCGA-BC-A10Z-11 07653b81-7194-4348-8ef9-1a7660c95376 07653b81-7194-4348-8ef9-1a7660c95376 07653b81-7194-4348-8ef9-1a7660c95376 TCGA-BC-A10Z-11A-11D-A132-05 TCGA-BC-A110-01 TCGA-BC-A110-01 TCGA-BC-A110 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 51 3.5 3.7 5.0 TCGA-BC-A110-F9979 TCGA-BC-A110 TCGA-BC-A110-01A 0.0 0.3 2 0.7 1.1 3.5 -18951 2629 2116 0 2057 0 10 2011-4-4 FEMALE 155 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 280 NO G1 Other, specify Extrahepatic Recurrence spleen No NO YES No false Yes MX NX T1 TCGA-BC-A110.DCC8DAE3-E0AF-4B37-8E5F-A2004ACA1F9B.pdf A110 WITH TUMOR 288 150 440 NO YES 0.9 NO YES R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES BC 1.2 Liver None A DECEASED 91 2003 TCGA-BC-A110-01A-11D-A12Y-01 TCGA-BC-A110-01A-11D-A12Y-01 TCGA-BC-A110-01A-11D-A12Z-10 TCGA-BC-A110-01 TCGA-BC-A110-01 202A1EE8-759B-4A19-BC8E-FEDD6EF80192 3f4ab9a7-3a43-4601-a21f-2ee63b10efee TCGA-BC-A110-01A-11D-A12Z-10 TCGA-BC-A110-01 TCGA-BC-A110-01 3f4ab9a7-3a43-4601-a21f-2ee63b10efee TCGA-BC-A110-01A-11D-A12Z-10 3f4ab9a7-3a43-4601-a21f-2ee63b10efee 3f4ab9a7-3a43-4601-a21f-2ee63b10efee TCGA-BC-A110-01A-11D-A12Z-10 TCGA-BC-A110-01A-11D-A132-05 TCGA-BC-A110-11 TCGA-BC-A110-11 TCGA-BC-A110 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 51 3.5 3.7 5.0 TCGA-BC-A110-F9979 TCGA-BC-A110 0.0 0.3 2 0.7 1.1 3.5 -18951 2116 0 2057 0 10 2011-4-4 FEMALE 155 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES G1 Other, specify Extrahepatic Recurrence spleen No NO YES No Yes MX NX T1 A110 WITH TUMOR 288 150 440 NO YES 0.9 NO YES R0 Solid Tissue Normal 11 Segmentectomy, Single 6th NO YES BC 1.2 Liver None DECEASED 91 2003 TCGA-BC-A110-11 edcc32ad-1375-4502-822e-defcea52b943 TCGA-BC-A110-11 edcc32ad-1375-4502-822e-defcea52b943 edcc32ad-1375-4502-822e-defcea52b943 edcc32ad-1375-4502-822e-defcea52b943 TCGA-BC-A110-11A-11D-A132-05 TCGA-BC-A112-01 TCGA-BC-A112-01 TCGA-BC-A112 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 80 3.5 4.1 5.0 TCGA-BC-A112-F9980 TCGA-BC-A112 0.0 0.3 0.7 1.3 2.1 -29511 153 0 0 10 233 0 - No Fibrosis 2011-4-4 MALE 165 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES G2 No New Tumor Event NO Yes MX NX T3 A112 TUMOR FREE 218 150 440 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES BC 1.2 Liver None DECEASED 97 2009 TCGA-BC-A112-01A-11D-A12Y-01 TCGA-BC-A112-01A-11D-A12Y-01 TCGA-BC-A112-01A-11D-A12Z-10 TCGA-BC-A112-01 TCGA-BC-A112-01 f2b83833-c94a-4fc1-ae6a-7caf4f3a1353 TCGA-BC-A112-01A-11D-A12Z-10 TCGA-BC-A112-01 TCGA-BC-A112-01 f2b83833-c94a-4fc1-ae6a-7caf4f3a1353 TCGA-BC-A112-01A-11D-A12Z-10 f2b83833-c94a-4fc1-ae6a-7caf4f3a1353 f2b83833-c94a-4fc1-ae6a-7caf4f3a1353 TCGA-BC-A112-01A-11D-A12Z-10 TCGA-BC-A112-01A-11D-A132-05 TCGA-BC-A112-11 TCGA-BC-A112-11 TCGA-BC-A112 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 80 3.5 4.1 5.0 TCGA-BC-A112-F9980 TCGA-BC-A112 TCGA-BC-A112-11A 0.0 0.3 0.7 1.3 2.1 -29511 538 153 0 0 10 233 0 - No Fibrosis 2011-4-4 MALE 165 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 NO G2 No New Tumor Event NO false Yes MX NX T3 A112 TUMOR FREE 218 150 440 NO NO 1.1 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES BC 1.2 Liver None A DECEASED 97 2009 TCGA-BC-A112-11A-11D-A132-05 TCGA-BC-A216-01 TCGA-BC-A216-01 TCGA-BC-A216 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 62 3.5 3.4 5.0 TCGA-BC-A216-F22055 TCGA-BC-A216 TCGA-BC-A216-01A 0.0 0.6 2 0.5 1.5 0.9 -22968 1052 0 1351 0 8 831 0 - No Fibrosis Scheduled Follow-up Submission 2012-2-23 FEMALE 164 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 NO G2 NO false No M0 NX T3 Stage IIIA TCGA-BC-A216.28CDABB8-3172-4676-8F4A-8B91F2B8D85F.pdf A216 TUMOR FREE 211000 140000 440000 NO NO 1.4 NO YES R0 Primary Tumor 01 Extended Lobectomy 6th NO YES BC 1.5 Liver None A LIVING 151 2008 TCGA-BC-A216-01A-11D-A151-01 TCGA-BC-A216-01A-11D-A151-01 TCGA-BC-A216-01A-11D-A152-10 TCGA-BC-A216-01 TCGA-BC-A216-01 DA2496AC-30CA-4682-BEF4-B37CD691156E 2da5bdd2-23ba-4f3f-93f6-90951a889955 TCGA-BC-A216-01A-11D-A152-10 TCGA-BC-A216-01 TCGA-BC-A216-01 2da5bdd2-23ba-4f3f-93f6-90951a889955 TCGA-BC-A216-01A-11D-A152-10 2da5bdd2-23ba-4f3f-93f6-90951a889955 2da5bdd2-23ba-4f3f-93f6-90951a889955 TCGA-BC-A216-01A-11D-A152-10 TCGA-BC-A216-01A-11D-A153-05 TCGA-BC-A216-11 TCGA-BC-A216-11 TCGA-BC-A216 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 62 3.5 3.4 5.0 TCGA-BC-A216-F22055 TCGA-BC-A216 TCGA-BC-A216-11A 0.0 0.6 2 0.5 1.5 0.9 -22968 1052 0 1351 0 8 831 0 - No Fibrosis Scheduled Follow-up Submission 2012-2-23 FEMALE 164 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 NO G2 NO false No M0 NX T3 Stage IIIA A216 TUMOR FREE 211000 140000 440000 NO NO 1.4 NO YES R0 Solid Tissue Normal 11 Extended Lobectomy 6th NO YES BC 1.5 Liver None A LIVING 151 2008 TCGA-BC-A216-11 1ec66ae2-e78a-4eb8-891a-7f8b6b061dca TCGA-BC-A216-11 1ec66ae2-e78a-4eb8-891a-7f8b6b061dca 1ec66ae2-e78a-4eb8-891a-7f8b6b061dca 1ec66ae2-e78a-4eb8-891a-7f8b6b061dca TCGA-BC-A216-11A-11D-A153-05 TCGA-BC-A217-01 TCGA-BC-A217-01 TCGA-BC-A217 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 75 3.5 4.4 5.0 TCGA-BC-A217-F70242 TCGA-BC-A217 TCGA-BC-A217-01A 0.0 0.2 0.6 1.0 0.8 -27411 408 1397 0 421 0 10 28 0 - No Fibrosis 2015-2-2 FEMALE 163 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 NO NO G3 NO false No M0 NX T2 Stage II TCGA-BC-A217.FEA652A1-DD1E-4D78-87DF-FC2162267A96.pdf A217 TUMOR FREE 243000 150000 440000 NO NO 1.0 NO NO R0 Primary Tumor 01 7th YES NO BC 1.2 Liver Micro A DECEASED 81 2010 TCGA-BC-A217-01A-11D-A151-01 TCGA-BC-A217-01A-11D-A151-01 TCGA-BC-A217-01A-11D-A152-10 TCGA-BC-A217-01 TCGA-BC-A217-01 FAB6855B-0EB9-4C94-8D56-C2E357024779 84f24356-27a3-4321-a58d-f1f6b135c954 TCGA-BC-A217-01A-11D-A152-10 TCGA-BC-A217-01 TCGA-BC-A217-01 84f24356-27a3-4321-a58d-f1f6b135c954 TCGA-BC-A217-01A-11D-A152-10 84f24356-27a3-4321-a58d-f1f6b135c954 84f24356-27a3-4321-a58d-f1f6b135c954 TCGA-BC-A217-01A-11D-A152-10 TCGA-BC-A217-01A-11D-A153-05 TCGA-BC-A3KF-01 TCGA-BC-A3KF-01 TCGA-BC-A3KF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 66 TCGA-BC-A3KF-F38204 TCGA-BC-A3KF TCGA-BC-A3KF-01A 2 0.6 1.0 0.8 -24328 91 0 8 2012-12-11 FEMALE 173 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 340 NO YES G2 false No M0 NX T1 Stage I TCGA-BC-A3KF.AFBED89A-FA3F-45E9-9824-AEE5F891C5B2.pdf A3KF TUMOR FREE 171000 150000 440000 1.0 YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO BC Liver None A LIVING 58 2011 TCGA-BC-A3KF-01A-11D-A20V-01 TCGA-BC-A3KF-01A-11D-A20V-01 TCGA-BC-A3KF-01A-11D-A20W-10 TCGA-BC-A3KF-01 TCGA-BC-A3KF-01 6563285F-CE8B-40B7-AD37-7F1EC9704D87 82ac64bb-6cca-4f17-942a-3108995245a0 TCGA-BC-A3KF-01A-11D-A20W-10 TCGA-BC-A3KF-01 TCGA-BC-A3KF-01 82ac64bb-6cca-4f17-942a-3108995245a0 TCGA-BC-A3KF-01A-11D-A20W-10 82ac64bb-6cca-4f17-942a-3108995245a0 82ac64bb-6cca-4f17-942a-3108995245a0 TCGA-BC-A3KF-01A-11D-A20W-10 TCGA-BC-A3KF-01A-11D-A20Z-05 TCGA-BC-A3KG-01 TCGA-BC-A3KG-01 TCGA-BC-A3KG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES 68 3.5 3.6 5.0 TCGA-BC-A3KG-F38205 TCGA-BC-A3KG TCGA-BC-A3KG-01A 0.0 0.5 0.6 1.0 0.7 -25061 140 0 680 209 0 10 618 2013-6-27 FEMALE 159 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 790 NO NO G3 Liver Intrahepatic Recurrence NO YES No false No M0 N0 T2 Stage II TCGA-BC-A3KG.67A81454-06A8-451D-B855-F9D146CC0348.pdf A3KG WITH TUMOR 499000 150000 440000 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO BC 1.2 Liver Micro A LIVING 64 2011 TCGA-BC-A3KG-01A-11D-A20V-01 TCGA-BC-A3KG-01A-11D-A20V-01 TCGA-BC-A3KG-01A-11D-A20W-10 TCGA-BC-A3KG-01 TCGA-BC-A3KG-01 96E60A73-A334-453E-BB34-A1A3361E19A1 46deaeee-1e58-4eae-8aaf-94500ec4a6de TCGA-BC-A3KG-01A-11D-A20W-10 TCGA-BC-A3KG-01 TCGA-BC-A3KG-01 46deaeee-1e58-4eae-8aaf-94500ec4a6de TCGA-BC-A3KG-01A-11D-A20W-10 46deaeee-1e58-4eae-8aaf-94500ec4a6de 46deaeee-1e58-4eae-8aaf-94500ec4a6de TCGA-BC-A3KG-01A-11D-A20W-10 TCGA-BC-A3KG-01A-11D-A20Z-05 TCGA-BC-A5W4-01 TCGA-BC-A5W4-01 TCGA-BC-A5W4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 69 3.5 4.2 5.0 TCGA-BC-A5W4-F57584 TCGA-BC-A5W4 TCGA-BC-A5W4-01A 0.0 0.6 A 0.70 1.30 -25503 224 547 0 289 384 2014-3-17 MALE 183 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 540 9.9 13.0 NO NO G3 Locoregional Recurrence Yes NO YES No false Yes M0 NX T3a Stage IIIA TCGA-BC-A5W4.6BCF821F-1993-4BA9-A9D2-EB4DEACD402C.pdf A5W4 TUMOR FREE 102000 150000 440000 NO NO 12.9 NO NO R1 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO BC 1.2 Liver Micro A DECEASED 106 2012 TCGA-BC-A5W4-01A-11D-A28W-01 TCGA-BC-A5W4-01A-11D-A28W-01 TCGA-BC-A5W4-01A-11D-A28X-10 TCGA-BC-A5W4-01 TCGA-BC-A5W4-01 19439DF2-E133-4612-8AB5-F10CBA286F8C 440b70b1-0313-4c54-bfb4-e1f44a336aba TCGA-BC-A5W4-01A-11D-A28X-10 TCGA-BC-A5W4-01 TCGA-BC-A5W4-01 440b70b1-0313-4c54-bfb4-e1f44a336aba TCGA-BC-A5W4-01A-11D-A28X-10 440b70b1-0313-4c54-bfb4-e1f44a336aba 440b70b1-0313-4c54-bfb4-e1f44a336aba TCGA-BC-A5W4-01A-11D-A28X-10 TCGA-BC-A5W4-01A-11D-A28Y-05 TCGA-BC-A69H-01 TCGA-BC-A69H-01 TCGA-BC-A69H TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 64 3.6 4.3 4.8 TCGA-BC-A69H-F59404 TCGA-BC-A69H TCGA-BC-A69H-01A 0.0 0.4 A 0.8 1.3 0.8 -23380 94 0 444 1 0 103900 2014-5-12 MALE 173 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 610 9.1 12.0 NO NO G3 NO false No M0 NX T2 Stage II TCGA-BC-A69H.AE56DFF8-AF71-4217-A491-8F78543E186D.pdf A69H TUMOR FREE 194000 140000 440000 NO NO 10.7 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO BC 1.2 Liver Micro A LIVING 70 2013 TCGA-BC-A69H-01A-11D-A30U-01 TCGA-BC-A69H-01A-11D-A30U-01 TCGA-BC-A69H-01A-11D-A30V-10 TCGA-BC-A69H-01 TCGA-BC-A69H-01 9ECE0636-589F-4452-85F6-FF9EEC933374 d61e6c10-4515-4cd1-9bc7-884db524ebca TCGA-BC-A69H-01A-11D-A30V-10 TCGA-BC-A69H-01 TCGA-BC-A69H-01 d61e6c10-4515-4cd1-9bc7-884db524ebca TCGA-BC-A69H-01A-11D-A30V-10 d61e6c10-4515-4cd1-9bc7-884db524ebca d61e6c10-4515-4cd1-9bc7-884db524ebca TCGA-BC-A69H-01A-11D-A30V-10 TCGA-BC-A69H-01A-11D-A30Y-05 TCGA-BC-A69I-01 TCGA-BC-A69I-01 TCGA-BC-A69I TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 69 TCGA-BC-A69I-F59405 TCGA-BC-A69I TCGA-BC-A69I-01A 0.0 1.2 1 0.7 1.3 1.2 -25370 80 0 387 0 0 10 2 2014-5-12 MALE 180 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 500 9.9 13.0 NO NO G1 NO false No M0 N0 T1 Stage I TCGA-BC-A69I.94F0B317-494A-4467-94A2-5004010E133F.pdf A69I TUMOR FREE 171000 150000 440000 NO NO 10.4 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO BC 1.2 Liver None A LIVING 95 2013 TCGA-BC-A69I-01A-11D-A30U-01 TCGA-BC-A69I-01A-11D-A30U-01 TCGA-BC-A69I-01 TCGA-BC-A69I-01 545DE8B9-4DE8-484B-A8A6-986E674473A6 7f765ffb-6d9d-4cfe-a5b6-8a83d8839d42 TCGA-BC-A69I-01A-11D-A30V-10 TCGA-BC-A69I-01 TCGA-BC-A69I-01 7f765ffb-6d9d-4cfe-a5b6-8a83d8839d42 TCGA-BC-A69I-01A-11D-A30V-10 7f765ffb-6d9d-4cfe-a5b6-8a83d8839d42 7f765ffb-6d9d-4cfe-a5b6-8a83d8839d42 TCGA-BC-A69I-01A-11D-A30V-10 TCGA-BC-A69I-01A-11D-A30Y-05 TCGA-BC-A8YO-01 TCGA-BC-A8YO-01 TCGA-BC-A8YO TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 66 3.5 4.3 5.0 TCGA-BC-A8YO-F70635 TCGA-BC-A8YO TCGA-BC-A8YO-01A 0.0 0.3 3 0.6 1.0 0.8 -24189 141 0 562 2015-2-26 FEMALE 170 Alcohol consumption|Other Chronic hepatitis, either viral or autoimmune Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 680 NO NO G3 YES false No M0 N0 T4 Stage IIIC TCGA-BC-A8YO.BF3E21AE-D9DC-4011-908A-32C6C1FE10FB.pdf A8YO WITH TUMOR 441000 150000 440000 NO YES 1.0 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO BC 1.2 Liver Macro A LIVING 74 2013 TCGA-BC-A8YO-01A-11D-A36W-01 TCGA-BC-A8YO-01A-11D-A36W-01 TCGA-BC-A8YO-01A-11D-A36X-10 TCGA-BC-A8YO-01 TCGA-BC-A8YO-01 AC4E92CC-7921-4165-A7A7-30C29F8BB86F c10552f3-93ad-4f50-a420-3b5277416aef TCGA-BC-A8YO-01 TCGA-BC-A8YO-01 c10552f3-93ad-4f50-a420-3b5277416aef c10552f3-93ad-4f50-a420-3b5277416aef c10552f3-93ad-4f50-a420-3b5277416aef TCGA-BC-A8YO-01A-11D-A36Y-05 TCGA-BD-A2L6-01 TCGA-BD-A2L6-01 TCGA-BD-A2L6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 69 3.4 3.7 5.0 TCGA-BD-A2L6-F34562 TCGA-BD-A2L6 TCGA-BD-A2L6-01A 0.3 0.9 A 0.5 1.4 1.2 -25489 148 0 1363 415 1 0 20 53 3,4 - Fibrous Speta 2012-8-23 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 480 0.8 1.2 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No MX NX T2 TCGA-BD-A2L6.6E795E68-4CFC-4DC9-A072-9A78C59CE10A.pdf A2L6 WITH TUMOR 222 156 369 NO NO 1.0 NO R0 Primary Tumor 01 Lobectomy 7th YES NO BD 1.5 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 110 2011 TCGA-BD-A2L6-01A-11D-A20V-01 TCGA-BD-A2L6-01A-11D-A20V-01 TCGA-BD-A2L6-01A-11D-A20W-10 TCGA-BD-A2L6-01 TCGA-BD-A2L6-01 895D7028-99A7-4CC8-B3E0-A1E4601A4AE2 887e3dc8-2c4b-4b56-b43a-fc2b0ba4e478 TCGA-BD-A2L6-01A-11D-A20W-10 TCGA-BD-A2L6-01 TCGA-BD-A2L6-01 887e3dc8-2c4b-4b56-b43a-fc2b0ba4e478 TCGA-BD-A2L6-01A-11D-A20W-10 887e3dc8-2c4b-4b56-b43a-fc2b0ba4e478 887e3dc8-2c4b-4b56-b43a-fc2b0ba4e478 TCGA-BD-A2L6-01A-11D-A20W-10 TCGA-BD-A2L6-01A-11D-A20Z-05 TCGA-BD-A2L6-11 TCGA-BD-A2L6-11 TCGA-BD-A2L6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 69 3.4 3.7 5.0 TCGA-BD-A2L6-F34562 TCGA-BD-A2L6 TCGA-BD-A2L6-11A 0.3 0.9 A 0.5 1.4 1.2 -25489 148 0 1363 415 1 0 20 53 3,4 - Fibrous Speta 2012-8-23 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 310 0.8 1.2 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No MX NX T2 A2L6 WITH TUMOR 222 156 369 NO NO 1.0 NO R0 Solid Tissue Normal 11 Lobectomy 7th YES NO BD 1.5 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 110 2011 TCGA-BD-A2L6-11 66811a13-8463-429b-87ae-298455ee961a TCGA-BD-A2L6-11 66811a13-8463-429b-87ae-298455ee961a 66811a13-8463-429b-87ae-298455ee961a 66811a13-8463-429b-87ae-298455ee961a TCGA-BD-A2L6-11A-21D-A20Z-05 TCGA-BD-A3EP-01 TCGA-BD-A3EP-01 TCGA-BD-A3EP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 75 3.4 3.8 5.0 TCGA-BD-A3EP-F68680 TCGA-BD-A3EP TCGA-BD-A3EP-01A 0.3 0.6 0 A 0.5 1.4 1.1 -27756 398 0 409 1 0 20 17 1,2 - Portal Fibrosis 2014-12-10 FEMALE 168 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 0.8 1.2 NO YES G2 NO true No M0 N0 T1 Stage I TCGA-BD-A3EP.4560D451-6F7E-4F3F-8AF7-F393DB000ABD.pdf A3EP TUMOR FREE 333 156 369 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO BD 1.5 Liver None A LIVING 71 2010 TCGA-BD-A3EP-01A-11D-A22E-01 TCGA-BD-A3EP-01A-11D-A22E-01 TCGA-BD-A3EP-01A-11D-A22F-10 TCGA-BD-A3EP-01 TCGA-BD-A3EP-01 3AB8FEB7-1994-4767-8649-B594C45B352F 22142880-0e1a-4e12-98b1-2597e9d14def TCGA-BD-A3EP-01A-11D-A22F-10 TCGA-BD-A3EP-01 TCGA-BD-A3EP-01 22142880-0e1a-4e12-98b1-2597e9d14def TCGA-BD-A3EP-01A-11D-A22F-10 22142880-0e1a-4e12-98b1-2597e9d14def 22142880-0e1a-4e12-98b1-2597e9d14def TCGA-BD-A3EP-01A-11D-A22F-10 TCGA-BD-A3EP-01A-11D-A22H-05 TCGA-BD-A3EP-11 TCGA-BD-A3EP-11 TCGA-BD-A3EP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 75 3.4 3.8 5.0 TCGA-BD-A3EP-F68680 TCGA-BD-A3EP TCGA-BD-A3EP-11A 0.3 0.6 0 A 0.5 1.4 1.1 -27756 398 0 409 1 0 20 17 1,2 - Portal Fibrosis 2014-12-10 FEMALE 168 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 0.8 1.2 NO YES G2 NO true No M0 N0 T1 Stage I A3EP TUMOR FREE 333 156 369 NO NO 1.0 NO NO R0 Solid Tissue Normal 11 Lobectomy 7th YES NO BD 1.5 Liver None A LIVING 71 2010 TCGA-BD-A3EP-11 58067780-a21b-4eeb-b061-caef50ea0650 TCGA-BD-A3EP-11 58067780-a21b-4eeb-b061-caef50ea0650 58067780-a21b-4eeb-b061-caef50ea0650 58067780-a21b-4eeb-b061-caef50ea0650 TCGA-BD-A3EP-11A-12D-A22H-05 TCGA-BD-A3ER-01 TCGA-BD-A3ER-01 TCGA-BD-A3ER TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 62 3.4 3.9 5.0 TCGA-BD-A3ER-F68681 TCGA-BD-A3ER TCGA-BD-A3ER-01A 0.3 0.7 0 A 0.5 1.4 0.9 -22657 23 0 1115 226 0 0 20 5 6 - Established Cirrhosis 2014-12-10 MALE 188 Hemochromatosis Alcohol Consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 90 0.8 1.2 NO NO G2 Liver Locoregional Recurrence Yes NO YES No true Yes MX NX T2 Stage II TCGA-BD-A3ER.2CD158D7-48E7-43D6-8E0F-2D56FC6F5256.pdf A3ER WITH TUMOR 208 156 369 NO NO 1.2 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO BD 1.5 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 111 2011 TCGA-BD-A3ER-01A-11D-A20V-01 TCGA-BD-A3ER-01A-11D-A20V-01 TCGA-BD-A3ER-01A-11D-A20W-10 TCGA-BD-A3ER-01 22616236-E7D6-4905-A80C-4D3776310CCB 459ab827-f9c7-4b30-9b6a-86bee706c6e0 TCGA-BD-A3ER-01A-11D-A20W-10 TCGA-BD-A3ER-01 459ab827-f9c7-4b30-9b6a-86bee706c6e0 TCGA-BD-A3ER-01A-11D-A20W-10 459ab827-f9c7-4b30-9b6a-86bee706c6e0 459ab827-f9c7-4b30-9b6a-86bee706c6e0 TCGA-BD-A3ER-01A-11D-A20W-10 TCGA-BD-A3ER-01A-11D-A20Z-05 TCGA-BW-A5NO-01 TCGA-BW-A5NO-01 TCGA-BW-A5NO TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 50 TCGA-BW-A5NO TCGA-BW-A5NO-01A -18510 840 0 20 1 3,4 - Fibrous Speta 2014-3-26 MALE Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 NO G2 NO false No MX NX T3a Stage IIIA TCGA-BW-A5NO.39E090EF-9EA0-4362-BB47-432DE5AA1393.pdf A5NO TUMOR FREE NO NO NO RX Primary Tumor 01 Lobectomy 7th YES NO BW Liver None A LIVING 2010 TCGA-BW-A5NO-01A-11D-A27H-01 TCGA-BW-A5NO-01A-11D-A27H-01 TCGA-BW-A5NO-01A-11D-A27I-10 TCGA-BW-A5NO-01 TCGA-BW-A5NO-01 3520231E-6D3B-4514-AA06-E73D1BEAAF53 38bb0662-ec22-4b4f-9264-69957e582b33 TCGA-BW-A5NO-01A-11D-A27I-10 TCGA-BW-A5NO-01 TCGA-BW-A5NO-01 38bb0662-ec22-4b4f-9264-69957e582b33 TCGA-BW-A5NO-01A-11D-A27I-10 38bb0662-ec22-4b4f-9264-69957e582b33 38bb0662-ec22-4b4f-9264-69957e582b33 TCGA-BW-A5NO-01A-11D-A27I-10 TCGA-BW-A5NO-01A-11D-A27W-05 TCGA-BW-A5NP-01 TCGA-BW-A5NP-01 TCGA-BW-A5NP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 26 TCGA-BW-A5NP TCGA-BW-A5NP-01A -9809 1057 0 0 2 143684 3,4 - Fibrous Speta 2014-3-26 FEMALE Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 290 NO G3 YES false No M1 N0 T2 Stage IV TCGA-BW-A5NP.D13029B5-B160-48FC-A556-9FBF8CAF4EDB.pdf A5NP WITH TUMOR NO YES NO RX Primary Tumor 01 7th YES NO BW Liver Micro A LIVING 2010 TCGA-BW-A5NP-01A-11D-A27H-01 TCGA-BW-A5NP-01A-11D-A27H-01 TCGA-BW-A5NP-01A-11D-A27I-10 TCGA-BW-A5NP-01 TCGA-BW-A5NP-01 E66505C6-DD0D-4EC9-BA9F-21968A5747F6 d2b612ea-bc88-4b16-971d-6f0141bed0b9 TCGA-BW-A5NP-01A-11D-A27I-10 TCGA-BW-A5NP-01 TCGA-BW-A5NP-01 d2b612ea-bc88-4b16-971d-6f0141bed0b9 TCGA-BW-A5NP-01A-11D-A27I-10 d2b612ea-bc88-4b16-971d-6f0141bed0b9 d2b612ea-bc88-4b16-971d-6f0141bed0b9 TCGA-BW-A5NP-01A-11D-A27I-10 TCGA-BW-A5NP-01A-11D-A27W-05 TCGA-BW-A5NQ-01 TCGA-BW-A5NQ-01 TCGA-BW-A5NQ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 63 TCGA-BW-A5NQ TCGA-BW-A5NQ-01A -23353 1022 0 0 6 - Established Cirrhosis 2014-3-26 MALE Alcohol consumption|Other cirrhosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 NO G3 false Yes MX NX T1 Stage I TCGA-BW-A5NQ.D56121DE-22A7-44D8-97EF-E33D395ABAF9.pdf A5NQ TUMOR FREE RX Primary Tumor 01 Segmentectomy, Multiple 7th YES NO BW Liver None A LIVING 2010 TCGA-BW-A5NQ-01A-11D-A27H-01 TCGA-BW-A5NQ-01A-11D-A27H-01 TCGA-BW-A5NQ-01A-11D-A27I-10 TCGA-BW-A5NQ-01 TCGA-BW-A5NQ-01 48D0CECD-3B95-44BD-A5B0-9F56216B17F3 818ed3ec-2c9c-41cc-8c01-18c9a95e9a02 TCGA-BW-A5NQ-01A-11D-A27I-10 TCGA-BW-A5NQ-01 TCGA-BW-A5NQ-01 818ed3ec-2c9c-41cc-8c01-18c9a95e9a02 TCGA-BW-A5NQ-01A-11D-A27I-10 818ed3ec-2c9c-41cc-8c01-18c9a95e9a02 818ed3ec-2c9c-41cc-8c01-18c9a95e9a02 TCGA-BW-A5NQ-01A-11D-A27I-10 TCGA-BW-A5NQ-01A-11D-A27W-05 TCGA-CC-5258-01 TCGA-CC-5258-01 TCGA-CC-5258 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 48 TCGA-CC-5258-F20327 TCGA-CC-5258 TCGA-CC-5258-01A -17586 147 129 0 0 3 Scheduled Follow-up Submission 2012-1-9 MALE Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1700 NO G2 NO true No M0 N0 T2 Stage II TCGA-CC-5258.F63EEB94-37AE-43FC-97B9-8EBF328C2134.pdf 5258 TUMOR FREE NO NO NO NO RX Primary Tumor 01 Other (specify) 6th YES NO CC Liver None A Hepatitis C Antibody|HBV Surface Antibody DECEASED 55 2010 TCGA-CC-5258-01A-01D-A12Y-01 TCGA-CC-5258-01A-01D-A12Y-01 TCGA-CC-5258-01A-01D-A12Z-10 TCGA-CC-5258-01 TCGA-CC-5258-01 3E1812C6-00C2-437C-8BA6-39A2B0C610EC 54315bb5-c78e-4b9c-b9c1-8d0a944a854f TCGA-CC-5258-01A-01D-A12Z-10 TCGA-CC-5258-01 TCGA-CC-5258-01 54315bb5-c78e-4b9c-b9c1-8d0a944a854f TCGA-CC-5258-01A-01D-A12Z-10 54315bb5-c78e-4b9c-b9c1-8d0a944a854f 54315bb5-c78e-4b9c-b9c1-8d0a944a854f TCGA-CC-5258-01A-01D-A12Z-10 TCGA-CC-5258-01A-01D-A132-05 TCGA-CC-5259-01 TCGA-CC-5259-01 TCGA-CC-5259 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 60 TCGA-CC-5259-F70915 TCGA-CC-5259 -21946 0 250 180 2015-3-10 FEMALE 153 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G2 Liver Locoregional Recurrence No NO YES No No M0 N0 T4 Stage IIIC 5259 WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO CC Liver Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 49 2010 TCGA-CC-5259-01A-31D-A20W-10 TCGA-CC-5259-01 TCGA-CC-5259-01 e39040d8-cdb2-4ead-9e93-224ba7c37dbc TCGA-CC-5259-01A-31D-A20W-10 TCGA-CC-5259-01 e39040d8-cdb2-4ead-9e93-224ba7c37dbc TCGA-CC-5259-01A-31D-A20W-10 e39040d8-cdb2-4ead-9e93-224ba7c37dbc e39040d8-cdb2-4ead-9e93-224ba7c37dbc TCGA-CC-5259-01A-31D-A20W-10 TCGA-CC-5259-01A-31D-A20Z-05 TCGA-CC-5260-01 TCGA-CC-5260-01 TCGA-CC-5260 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 61 TCGA-CC-5260-F20330 TCGA-CC-5260 TCGA-CC-5260-01A -22345 105 87 0 0 Scheduled Follow-up Submission 2012-1-9 FEMALE 153 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 600 NO G1 NO true No M0 N0 T4 Stage IIIC TCGA-CC-5260.2E6A53F8-D019-4B4A-894F-CF21BEE91EDD.pdf 5260 TUMOR FREE NO NO NO NO RX Primary Tumor 01 Other (specify) 7th YES NO CC Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 46 2010 TCGA-CC-5260-01A-01D-A12Y-01 TCGA-CC-5260-01A-01D-A12Y-01 TCGA-CC-5260-01A-01D-A12Z-10 TCGA-CC-5260-01 TCGA-CC-5260-01 254C5E95-8AE2-44E6-89BF-56DB0E056A71 108f1509-bd7e-4a10-8989-f20f7b45bb09 TCGA-CC-5260-01A-01D-A12Z-10 TCGA-CC-5260-01 TCGA-CC-5260-01 108f1509-bd7e-4a10-8989-f20f7b45bb09 TCGA-CC-5260-01A-01D-A12Z-10 108f1509-bd7e-4a10-8989-f20f7b45bb09 108f1509-bd7e-4a10-8989-f20f7b45bb09 TCGA-CC-5260-01A-01D-A12Z-10 TCGA-CC-5260-01A-01D-A132-05 TCGA-CC-5261-01 TCGA-CC-5261-01 TCGA-CC-5261 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 44 TCGA-CC-5261-F20332 TCGA-CC-5261 TCGA-CC-5261-01A -16373 110 97 0 12 Scheduled Follow-up Submission 2012-1-9 MALE 175 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 450 NO G2 NO true No M0 N0 T2 Stage II TCGA-CC-5261.30B90892-0231-450E-8A93-28F387047463.pdf 5261 TUMOR FREE NO NO NO RX Primary Tumor 01 Other (specify) 7th YES NO CC Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 58 2010 TCGA-CC-5261-01A-01D-A12Y-01 TCGA-CC-5261-01A-01D-A12Y-01 TCGA-CC-5261-01A-01D-A12Z-10 TCGA-CC-5261-01 TCGA-CC-5261-01 76CB0776-E9E6-475F-9C3D-C8E60205528F 04beffef-0cd3-4935-8f2e-9e11c5638973 TCGA-CC-5261-01A-01D-A12Z-10 TCGA-CC-5261-01 TCGA-CC-5261-01 04beffef-0cd3-4935-8f2e-9e11c5638973 TCGA-CC-5261-01A-01D-A12Z-10 04beffef-0cd3-4935-8f2e-9e11c5638973 04beffef-0cd3-4935-8f2e-9e11c5638973 TCGA-CC-5261-01A-01D-A12Z-10 TCGA-CC-5261-01A-01D-A132-05 TCGA-CC-5262-01 TCGA-CC-5262-01 TCGA-CC-5262 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 67 TCGA-CC-5262-F20334 TCGA-CC-5262 TCGA-CC-5262-01A -24787 97 103 0 0 Scheduled Follow-up Submission 2012-1-9 MALE 170 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 800 NO G1 NO true No M0 N0 T4 Stage IIIC TCGA-CC-5262.B09509A2-A902-4298-AEDF-66BA21C584BB.pdf 5262 TUMOR FREE NO NO NO NO Primary Tumor 01 Other (specify) 7th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 62 2010 TCGA-CC-5262-01A-01D-A12Y-01 TCGA-CC-5262-01A-01D-A12Y-01 TCGA-CC-5262-01A-01D-A12Z-10 TCGA-CC-5262-01 TCGA-CC-5262-01 6AF7DF38-5308-4618-90F5-44A6882CD6DD 5b1b9e38-e00a-462b-976a-c540c13718ca TCGA-CC-5262-01A-01D-A12Z-10 TCGA-CC-5262-01 TCGA-CC-5262-01 5b1b9e38-e00a-462b-976a-c540c13718ca TCGA-CC-5262-01A-01D-A12Z-10 5b1b9e38-e00a-462b-976a-c540c13718ca 5b1b9e38-e00a-462b-976a-c540c13718ca TCGA-CC-5262-01A-01D-A12Z-10 TCGA-CC-5262-01A-01D-A132-05 TCGA-CC-5263-01 TCGA-CC-5263-01 TCGA-CC-5263 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 35 TCGA-CC-5263-F20328 TCGA-CC-5263 TCGA-CC-5263-01A -12863 91 129 0 Scheduled Follow-up Submission 2012-1-9 MALE 163 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 900 NO G1 NO true No M0 N0 T3 Stage IIIA TCGA-CC-5263.3136CA38-995E-4B6B-97F2-D37AF68EFA4C.pdf 5263 TUMOR FREE NO NO NO NO RX Primary Tumor 01 Other (specify) 6th YES NO CC Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 59 2010 TCGA-CC-5263-01A-01D-A12Y-01 TCGA-CC-5263-01A-01D-A12Y-01 TCGA-CC-5263-01A-01D-A12Z-10 TCGA-CC-5263-01 TCGA-CC-5263-01 6B4F8CDA-B879-4BF0-9AD5-317CEB6AA090 038e0d7b-8f46-40fb-bfec-74dab7a6fe59 TCGA-CC-5263-01A-01D-A12Z-10 TCGA-CC-5263-01 TCGA-CC-5263-01 038e0d7b-8f46-40fb-bfec-74dab7a6fe59 TCGA-CC-5263-01A-01D-A12Z-10 038e0d7b-8f46-40fb-bfec-74dab7a6fe59 038e0d7b-8f46-40fb-bfec-74dab7a6fe59 TCGA-CC-5263-01A-01D-A12Z-10 TCGA-CC-5263-01A-01D-A132-05 TCGA-CC-5264-01 TCGA-CC-5264-01 TCGA-CC-5264 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 71 TCGA-CC-5264-F20329 TCGA-CC-5264 TCGA-CC-5264-01A -25979 84 102 0 0 Scheduled Follow-up Submission 2012-1-9 MALE 160 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 550 NO G2 NO true No M0 N0 T3 Stage IIIA TCGA-CC-5264.4D5CD8E8-DAD7-4392-A44C-BBDF3DAD872F.pdf 5264 TUMOR FREE NO NO NO RX Primary Tumor 01 Other (specify) 6th YES NO CC Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 52 2010 TCGA-CC-5264-01A-01D-A12Y-01 TCGA-CC-5264-01A-01D-A12Y-01 TCGA-CC-5264-01A-01D-A12Z-10 TCGA-CC-5264-01 TCGA-CC-5264-01 D7CA2572-EA6A-4E9E-8E11-43FF0976EA17 06a52d13-3cb4-4d5f-94ef-55d980562486 TCGA-CC-5264-01A-01D-A12Z-10 TCGA-CC-5264-01 TCGA-CC-5264-01 06a52d13-3cb4-4d5f-94ef-55d980562486 TCGA-CC-5264-01A-01D-A12Z-10 06a52d13-3cb4-4d5f-94ef-55d980562486 06a52d13-3cb4-4d5f-94ef-55d980562486 TCGA-CC-5264-01A-01D-A12Z-10 TCGA-CC-5264-01A-01D-A132-05 TCGA-CC-A123-01 TCGA-CC-A123-01 TCGA-CC-A123 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 24 TCGA-CC-A123-F70913 TCGA-CC-A123 TCGA-CC-A123-01A -9107 49 0 219 145 3 2015-3-10 FEMALE Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 280 NO NO G1 Lung New Primary Tumor No NO YES true No M0 N0 T3 Stage IIIA TCGA-CC-A123.65D669CE-291F-489A-9B25-AD619B906900.pdf A123 WITH TUMOR NO NO NO RX Primary Tumor 01 Other (specify) 6th YES NO CC Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 2010 TCGA-CC-A123-01A-11D-A12Z-10 TCGA-CC-A123-01 TCGA-CC-A123-01 BB3F83AE-BA9B-44B2-998F-2D184242DD98 3e205fbf-b9e5-470d-9c6f-68ff88640c45 TCGA-CC-A123-01A-11D-A12Z-10 TCGA-CC-A123-01 3e205fbf-b9e5-470d-9c6f-68ff88640c45 TCGA-CC-A123-01A-11D-A12Z-10 3e205fbf-b9e5-470d-9c6f-68ff88640c45 3e205fbf-b9e5-470d-9c6f-68ff88640c45 TCGA-CC-A123-01A-11D-A12Z-10 TCGA-CC-A123-01A-11D-A132-05 TCGA-CC-A1HT-01 TCGA-CC-A1HT-01 TCGA-CC-A1HT TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 50 TCGA-CC-A1HT-F20333 TCGA-CC-A1HT TCGA-CC-A1HT-01A -18553 86 101 0 0 4 Scheduled Follow-up Submission 2012-1-9 MALE 163 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 470 NO G3 NO true No M0 N0 T3 Stage IIIA TCGA-CC-A1HT.81F0F911-C2C1-48AD-A67F-FD455503CB46.pdf A1HT TUMOR FREE NO NO NO NO Primary Tumor 01 Other (specify) 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 54 2010 TCGA-CC-A1HT-01A-11D-A12Y-01 TCGA-CC-A1HT-01A-11D-A12Y-01 TCGA-CC-A1HT-01A-11D-A12Z-10 TCGA-CC-A1HT-01 TCGA-CC-A1HT-01 C7A6791C-7141-42F9-8AFA-5083CCE10124 63a48c81-2b6c-4f68-a76b-69ff2fc449ed TCGA-CC-A1HT-01A-11D-A12Z-10 TCGA-CC-A1HT-01 TCGA-CC-A1HT-01 63a48c81-2b6c-4f68-a76b-69ff2fc449ed TCGA-CC-A1HT-01A-11D-A12Z-10 63a48c81-2b6c-4f68-a76b-69ff2fc449ed 63a48c81-2b6c-4f68-a76b-69ff2fc449ed TCGA-CC-A1HT-01A-11D-A12Z-10 TCGA-CC-A1HT-01A-11D-A132-05 TCGA-CC-A3M9-01 TCGA-CC-A3M9-01 TCGA-CC-A3M9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 45 TCGA-CC-A3M9-F70909 TCGA-CC-A3M9 TCGA-CC-A3M9-01A -16460 226 300 0 3 219 2 2015-3-10 MALE 174 Alcohol consumption Hepatocellular Carcinoma No C22.0 8173/3 C22.0 YES 200 NO NO G3 Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A3M9.9529CF47-D435-4CA9-B8B4-069CA2FCD3CD.pdf A3M9 WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 61 2011 TCGA-CC-A3M9-01A-11D-A20V-01 TCGA-CC-A3M9-01A-11D-A20V-01 TCGA-CC-A3M9-01A-11D-A20W-10 TCGA-CC-A3M9-01 TCGA-CC-A3M9-01 4A85474C-9DD3-4576-BC28-53D26AB6E49B faec0e24-6bcd-4388-b227-b8d4b73bb110 TCGA-CC-A3M9-01A-11D-A20W-10 TCGA-CC-A3M9-01 TCGA-CC-A3M9-01 faec0e24-6bcd-4388-b227-b8d4b73bb110 TCGA-CC-A3M9-01A-11D-A20W-10 faec0e24-6bcd-4388-b227-b8d4b73bb110 faec0e24-6bcd-4388-b227-b8d4b73bb110 TCGA-CC-A3M9-01A-11D-A20W-10 TCGA-CC-A3M9-01A-11D-A20Z-05 TCGA-CC-A3MA-01 TCGA-CC-A3MA-01 TCGA-CC-A3MA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 61 TCGA-CC-A3MA-F70907 TCGA-CC-A3MA TCGA-CC-A3MA-01A -22375 177 303 0 2 261 3 2015-3-10 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 530 NO NO G2 Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A3MA.B631A61B-4550-47DE-9240-0FCFAEF47BC6.pdf A3MA WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 66 2011 TCGA-CC-A3MA-01A-11D-A20V-01 TCGA-CC-A3MA-01A-11D-A20V-01 TCGA-CC-A3MA-01A-11D-A20W-10 TCGA-CC-A3MA-01 TCGA-CC-A3MA-01 9DC784BA-8DD4-4B84-9D5B-D0288C2312AE 86cde8fe-ca8b-47f6-b121-df5a05d3ec4c TCGA-CC-A3MA-01A-11D-A20W-10 TCGA-CC-A3MA-01 TCGA-CC-A3MA-01 86cde8fe-ca8b-47f6-b121-df5a05d3ec4c TCGA-CC-A3MA-01A-11D-A20W-10 86cde8fe-ca8b-47f6-b121-df5a05d3ec4c 86cde8fe-ca8b-47f6-b121-df5a05d3ec4c TCGA-CC-A3MA-01A-11D-A20W-10 TCGA-CC-A3MA-01A-11D-A20Z-05 TCGA-CC-A3MB-01 TCGA-CC-A3MB-01 TCGA-CC-A3MB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 36 TCGA-CC-A3MB-F70908 TCGA-CC-A3MB TCGA-CC-A3MB-01A -13255 205 315 0 3 260 3 2015-3-10 MALE 176 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 460 NO NO G1 Lung New Primary Tumor No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A3MB.62A01956-C6F4-4FCB-AC43-052EEC8AE7AE.pdf A3MB WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 58 2011 TCGA-CC-A3MB-01A-11D-A20V-01 TCGA-CC-A3MB-01A-11D-A20V-01 TCGA-CC-A3MB-01A-11D-A20W-10 TCGA-CC-A3MB-01 TCGA-CC-A3MB-01 7E1DF0FD-6902-42B5-B4CE-BC7D69F5CC3C 97a9402f-537a-4767-bee3-72e1bebcdd97 TCGA-CC-A3MB-01A-11D-A20W-10 TCGA-CC-A3MB-01 TCGA-CC-A3MB-01 97a9402f-537a-4767-bee3-72e1bebcdd97 TCGA-CC-A3MB-01A-11D-A20W-10 97a9402f-537a-4767-bee3-72e1bebcdd97 97a9402f-537a-4767-bee3-72e1bebcdd97 TCGA-CC-A3MB-01A-11D-A20W-10 TCGA-CC-A3MB-01A-11D-A20Z-05 TCGA-CC-A3MC-01 TCGA-CC-A3MC-01 TCGA-CC-A3MC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 54 TCGA-CC-A3MC-F70912 TCGA-CC-A3MC TCGA-CC-A3MC-01A -20067 268 0 363 297 3 2015-3-10 MALE 163 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 400 NO NO G2 Liver Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A3MC.3D0D4B1A-1340-488C-B231-F18CC1BC3783.pdf A3MC WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 52 2011 TCGA-CC-A3MC-01A-11D-A22E-01 TCGA-CC-A3MC-01A-11D-A22E-01 TCGA-CC-A3MC-01A-11D-A22F-10 TCGA-CC-A3MC-01 TCGA-CC-A3MC-01 F0DE71AB-1E83-49F4-9335-7601B45D2FE1 19377cf4-aafe-449a-b10b-f637b4eef29f TCGA-CC-A3MC-01A-11D-A22F-10 TCGA-CC-A3MC-01 TCGA-CC-A3MC-01 19377cf4-aafe-449a-b10b-f637b4eef29f TCGA-CC-A3MC-01A-11D-A22F-10 19377cf4-aafe-449a-b10b-f637b4eef29f 19377cf4-aafe-449a-b10b-f637b4eef29f TCGA-CC-A3MC-01A-11D-A22F-10 TCGA-CC-A3MC-01A-11D-A22H-05 TCGA-CC-A5UC-01 TCGA-CC-A5UC-01 TCGA-CC-A5UC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 63 TCGA-CC-A5UC-F69917 TCGA-CC-A5UC TCGA-CC-A5UC-01A -23156 99 347 0 0 312 2 2015-1-22 MALE 165 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 210 NO NO G3 Lung New Primary Tumor No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A5UC.21B4A68D-F76C-49BB-81D7-423E957852E1.pdf A5UC WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 57 2012 TCGA-CC-A5UC-01A-11D-A28W-01 TCGA-CC-A5UC-01A-11D-A28W-01 TCGA-CC-A5UC-01A-11D-A28X-10 TCGA-CC-A5UC-01 TCGA-CC-A5UC-01 D2A8F8C2-65A2-4CF1-9635-CEB3AC787FFF 04ecdbec-f452-4bff-986c-23b414d92252 TCGA-CC-A5UC-01A-11D-A28X-10 TCGA-CC-A5UC-01 TCGA-CC-A5UC-01 04ecdbec-f452-4bff-986c-23b414d92252 TCGA-CC-A5UC-01A-11D-A28X-10 04ecdbec-f452-4bff-986c-23b414d92252 04ecdbec-f452-4bff-986c-23b414d92252 TCGA-CC-A5UC-01A-11D-A28X-10 TCGA-CC-A5UC-01A-11D-A28Y-05 TCGA-CC-A5UD-01 TCGA-CC-A5UD-01 TCGA-CC-A5UD TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 45 TCGA-CC-A5UD-F69700 TCGA-CC-A5UD TCGA-CC-A5UD-01A -16702 92 304 0 0 182 1 2015-1-16 MALE 170 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 310 NO NO G2 Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A5UD.77BF208C-F5ED-4A05-BFDE-36063F43E022.pdf A5UD WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 62 2012 TCGA-CC-A5UD-01A-11D-A28W-01 TCGA-CC-A5UD-01A-11D-A28W-01 TCGA-CC-A5UD-01A-11D-A28X-10 TCGA-CC-A5UD-01 TCGA-CC-A5UD-01 EDBB5D86-ACB6-4404-993E-CA4B015846B1 cdb1c4a5-5d21-4ab7-aeb3-e65dc5d739c6 TCGA-CC-A5UD-01A-11D-A28X-10 TCGA-CC-A5UD-01 TCGA-CC-A5UD-01 cdb1c4a5-5d21-4ab7-aeb3-e65dc5d739c6 TCGA-CC-A5UD-01A-11D-A28X-10 cdb1c4a5-5d21-4ab7-aeb3-e65dc5d739c6 cdb1c4a5-5d21-4ab7-aeb3-e65dc5d739c6 TCGA-CC-A5UD-01A-11D-A28X-10 TCGA-CC-A5UD-01A-11D-A28Y-05 TCGA-CC-A5UE-01 TCGA-CC-A5UE-01 TCGA-CC-A5UE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 48 TCGA-CC-A5UE-F69701 TCGA-CC-A5UE TCGA-CC-A5UE-01A -17805 85 272 0 0 175 3 2015-1-16 MALE 175 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 300 NO NO G2 Locoregional Recurrence No NO YES No true No M0 N0 T4 Stage IIIB TCGA-CC-A5UE.3D729315-DE44-441D-9CB2-3CFB827C2808.pdf A5UE WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 65 2012 TCGA-CC-A5UE-01A-11D-A28W-01 TCGA-CC-A5UE-01A-11D-A28W-01 TCGA-CC-A5UE-01A-11D-A28X-10 TCGA-CC-A5UE-01 TCGA-CC-A5UE-01 04DD2C1C-27F8-4CF7-B2E0-28FAF54A3A83 dff668bd-b423-4ab8-961c-93c0bc093763 TCGA-CC-A5UE-01A-11D-A28X-10 TCGA-CC-A5UE-01 TCGA-CC-A5UE-01 dff668bd-b423-4ab8-961c-93c0bc093763 TCGA-CC-A5UE-01A-11D-A28X-10 dff668bd-b423-4ab8-961c-93c0bc093763 dff668bd-b423-4ab8-961c-93c0bc093763 TCGA-CC-A5UE-01A-11D-A28X-10 TCGA-CC-A5UE-01A-11D-A28Y-05 TCGA-CC-A7IE-01 TCGA-CC-A7IE-01 TCGA-CC-A7IE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 57 TCGA-CC-A7IE-F69923 TCGA-CC-A7IE -20985 217 0 0 169 3 2015-1-22 MALE 172 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G2 Lung New Primary Tumor No NO YES No No M0 N0 T3 Stage IIIA A7IE WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 62 2012 TCGA-CC-A7IE-01A-21D-A381-01 TCGA-CC-A7IE-01A-21D-A381-01 TCGA-CC-A7IE-01A-21D-A382-10 TCGA-CC-A7IE-01 TCGA-CC-A7IE-01 b4e476f1-17f7-4af3-9076-8bcd783324a7 TCGA-CC-A7IE-01 TCGA-CC-A7IE-01 b4e476f1-17f7-4af3-9076-8bcd783324a7 b4e476f1-17f7-4af3-9076-8bcd783324a7 b4e476f1-17f7-4af3-9076-8bcd783324a7 TCGA-CC-A7IE-01A-21D-A383-05 TCGA-CC-A7IF-01 TCGA-CC-A7IF-01 TCGA-CC-A7IF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 59 TCGA-CC-A7IF-F69922 TCGA-CC-A7IF TCGA-CC-A7IF-01A -21845 236 649 0 0 254 3 2015-1-22 MALE 169 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 380 NO NO G1 Lung New Primary Tumor No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A7IF.4CD1A49C-2243-4F21-BF19-EB6F069D431E.pdf A7IF WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 58 2013 TCGA-CC-A7IF-01A-11D-A33B-01 TCGA-CC-A7IF-01A-11D-A33B-01 TCGA-CC-A7IF-01A-11D-A33K-10 TCGA-CC-A7IF-01 TCGA-CC-A7IF-01 0CC0E36D-2924-43A0-BE95-40D8B37E6D94 cb8ca883-8695-48c3-9ab4-2f3a84e562ef TCGA-CC-A7IF-01A-11D-A33K-10 TCGA-CC-A7IF-01 TCGA-CC-A7IF-01 cb8ca883-8695-48c3-9ab4-2f3a84e562ef TCGA-CC-A7IF-01A-11D-A33K-10 cb8ca883-8695-48c3-9ab4-2f3a84e562ef cb8ca883-8695-48c3-9ab4-2f3a84e562ef TCGA-CC-A7IF-01A-11D-A33K-10 TCGA-CC-A7IF-01A-11D-A33L-05 TCGA-CC-A7IG-01 TCGA-CC-A7IG-01 TCGA-CC-A7IG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 47 TCGA-CC-A7IG-F69702 TCGA-CC-A7IG TCGA-CC-A7IG-01A -17453 239 299 0 0 195 2 2015-1-16 MALE 174 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 210 NO NO G2 Locoregional Recurrence No NO YES No true No M0 N0 T2 Stage II TCGA-CC-A7IG.FF015D7F-02CD-485E-83B6-8C533DE83B2A.pdf A7IG WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 62 2013 TCGA-CC-A7IG-01A-11D-A33B-01 TCGA-CC-A7IG-01A-11D-A33B-01 TCGA-CC-A7IG-01A-11D-A33K-10 TCGA-CC-A7IG-01 TCGA-CC-A7IG-01 7567BCA8-9934-401C-A0C2-F835EB05C5B8 0caa8897-d988-4898-8c6a-c706598b9b94 TCGA-CC-A7IG-01A-11D-A33K-10 TCGA-CC-A7IG-01 TCGA-CC-A7IG-01 0caa8897-d988-4898-8c6a-c706598b9b94 TCGA-CC-A7IG-01A-11D-A33K-10 0caa8897-d988-4898-8c6a-c706598b9b94 0caa8897-d988-4898-8c6a-c706598b9b94 TCGA-CC-A7IG-01A-11D-A33K-10 TCGA-CC-A7IG-01A-11D-A33L-05 TCGA-CC-A7IH-01 TCGA-CC-A7IH-01 TCGA-CC-A7IH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 58 TCGA-CC-A7IH-F69920 TCGA-CC-A7IH TCGA-CC-A7IH-01A -21381 181 0 365 3 2015-1-22 MALE 175 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 190 NO NO G1 NO true No M0 N0 T3 Stage IIIA TCGA-CC-A7IH.643C84D1-C247-4CA6-84C3-38ED99E886F6.pdf A7IH TUMOR FREE NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 56 2013 TCGA-CC-A7IH-01A-11D-A33B-01 TCGA-CC-A7IH-01A-11D-A33B-01 TCGA-CC-A7IH-01A-11D-A33K-10 TCGA-CC-A7IH-01 TCGA-CC-A7IH-01 0012F1FF-DA7A-46FD-895D-6AFE2F19CF89 8d017f32-1008-4312-b94e-a98be428973f TCGA-CC-A7IH-01A-11D-A33K-10 TCGA-CC-A7IH-01 TCGA-CC-A7IH-01 8d017f32-1008-4312-b94e-a98be428973f TCGA-CC-A7IH-01A-11D-A33K-10 8d017f32-1008-4312-b94e-a98be428973f 8d017f32-1008-4312-b94e-a98be428973f TCGA-CC-A7IH-01A-11D-A33K-10 TCGA-CC-A7IH-01A-11D-A33L-05 TCGA-CC-A7II-01 TCGA-CC-A7II-01 TCGA-CC-A7II TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 54 TCGA-CC-A7II-F69918 TCGA-CC-A7II TCGA-CC-A7II-01A -20079 169 0 399 278 2 2015-1-22 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 400 NO NO G3 Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A7II.A5E3C73D-B84B-4D1C-858F-4B4392341610.pdf A7II WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 52 2013 TCGA-CC-A7II-01A-11D-A33B-01 TCGA-CC-A7II-01A-11D-A33B-01 TCGA-CC-A7II-01A-11D-A33K-10 TCGA-CC-A7II-01 TCGA-CC-A7II-01 7BBE03C6-0221-4D78-829D-75FE8E98D5C0 097f54ce-6270-4e1f-bd7a-f55ed185bead TCGA-CC-A7II-01A-11D-A33K-10 TCGA-CC-A7II-01 TCGA-CC-A7II-01 097f54ce-6270-4e1f-bd7a-f55ed185bead TCGA-CC-A7II-01A-11D-A33K-10 097f54ce-6270-4e1f-bd7a-f55ed185bead 097f54ce-6270-4e1f-bd7a-f55ed185bead TCGA-CC-A7II-01A-11D-A33K-10 TCGA-CC-A7II-01A-11D-A33L-05 TCGA-CC-A7IJ-01 TCGA-CC-A7IJ-01 TCGA-CC-A7IJ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 56 TCGA-CC-A7IJ-F69704 TCGA-CC-A7IJ TCGA-CC-A7IJ-01A -20751 168 0 382 2 2015-1-16 MALE 165 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 270 NO NO G3 NO true No M0 N0 T2 Stage II TCGA-CC-A7IJ.0FF7D013-EAEC-4406-B314-0ECEA7B59E69.pdf A7IJ TUMOR FREE NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 54 2013 TCGA-CC-A7IJ-01A-11D-A33P-01 TCGA-CC-A7IJ-01A-11D-A33P-01 TCGA-CC-A7IJ-01A-11D-A33Q-10 TCGA-CC-A7IJ-01 TCGA-CC-A7IJ-01 3C457C98-F4B2-4C93-8127-0CCC18DC0600 96863e50-5c9b-4bee-8870-8c938aa66633 TCGA-CC-A7IJ-01A-11D-A33Q-10 TCGA-CC-A7IJ-01 TCGA-CC-A7IJ-01 96863e50-5c9b-4bee-8870-8c938aa66633 TCGA-CC-A7IJ-01A-11D-A33Q-10 96863e50-5c9b-4bee-8870-8c938aa66633 96863e50-5c9b-4bee-8870-8c938aa66633 TCGA-CC-A7IJ-01A-11D-A33Q-10 TCGA-CC-A7IJ-01A-11D-A341-05 TCGA-CC-A7IK-01 TCGA-CC-A7IK-01 TCGA-CC-A7IK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 59 TCGA-CC-A7IK-F69705 TCGA-CC-A7IK TCGA-CC-A7IK-01A -21552 163 262 0 0 150 2 2015-1-16 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 470 NO NO G3 Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A7IK.6944ABF0-8C64-48D5-920A-6FA6DAC8A57B.pdf A7IK WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 57 2013 TCGA-CC-A7IK-01A-12D-A33P-01 TCGA-CC-A7IK-01A-12D-A33P-01 TCGA-CC-A7IK-01A-12D-A33Q-10 TCGA-CC-A7IK-01 TCGA-CC-A7IK-01 E37E4FA6-4FFA-439E-9AC5-973B0B09546E acaa569c-eed9-471d-8eb2-4723eb07c00b TCGA-CC-A7IK-01A-12D-A33Q-10 TCGA-CC-A7IK-01 TCGA-CC-A7IK-01 acaa569c-eed9-471d-8eb2-4723eb07c00b TCGA-CC-A7IK-01A-12D-A33Q-10 acaa569c-eed9-471d-8eb2-4723eb07c00b acaa569c-eed9-471d-8eb2-4723eb07c00b TCGA-CC-A7IK-01A-12D-A33Q-10 TCGA-CC-A7IK-01A-12D-A341-05 TCGA-CC-A7IL-01 TCGA-CC-A7IL-01 TCGA-CC-A7IL TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 61 TCGA-CC-A7IL-F69706 TCGA-CC-A7IL TCGA-CC-A7IL-01A -22319 161 278 0 0 179 2 2015-1-16 MALE 174 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 230 NO NO G1 Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A7IL.2C629C1E-6849-47F6-B9B4-A97BC0453EFF.pdf A7IL WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 63 2013 TCGA-CC-A7IL-01A-11D-A33P-01 TCGA-CC-A7IL-01A-11D-A33P-01 TCGA-CC-A7IL-01A-11D-A33Q-10 TCGA-CC-A7IL-01 TCGA-CC-A7IL-01 89E30AE9-EC3D-41A9-B00C-AAC64C23348D e198c43b-5d3f-4fe6-8f3c-09642a2b4995 TCGA-CC-A7IL-01A-11D-A33Q-10 TCGA-CC-A7IL-01 TCGA-CC-A7IL-01 e198c43b-5d3f-4fe6-8f3c-09642a2b4995 TCGA-CC-A7IL-01A-11D-A33Q-10 e198c43b-5d3f-4fe6-8f3c-09642a2b4995 e198c43b-5d3f-4fe6-8f3c-09642a2b4995 TCGA-CC-A7IL-01A-11D-A33Q-10 TCGA-CC-A7IL-01A-11D-A341-05 TCGA-CC-A8HS-01 TCGA-CC-A8HS-01 TCGA-CC-A8HS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 18 TCGA-CC-A8HS-F69707 TCGA-CC-A8HS TCGA-CC-A8HS-01A -6617 223 300 0 0 201 3 2015-1-16 MALE 172 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 NO NO G1 Locoregional Recurrence No NO YES No true No M0 N1 T3 Stage IIIC TCGA-CC-A8HS.D7967904-FE4B-4BB5-92B2-5354404AC939.pdf A8HS WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 62 2013 TCGA-CC-A8HS-01A-11D-A35Z-10 TCGA-CC-A8HS-01 TCGA-CC-A8HS-01 5FDE4663-91E1-4017-ABF8-9B5A895A772D c8c2f5d3-a744-4bff-acdb-ada38d8dd074 TCGA-CC-A8HS-01 c8c2f5d3-a744-4bff-acdb-ada38d8dd074 c8c2f5d3-a744-4bff-acdb-ada38d8dd074 c8c2f5d3-a744-4bff-acdb-ada38d8dd074 TCGA-CC-A8HS-01A-11D-A369-05 TCGA-CC-A8HT-01 TCGA-CC-A8HT-01 TCGA-CC-A8HT TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 74 TCGA-CC-A8HT-F69842 TCGA-CC-A8HT TCGA-CC-A8HT-01A -27334 197 140 0 0 83 4 2015-1-21 MALE 159 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 NO NO G2 Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A8HT.0D2B4676-F045-4259-A18C-47EA5DF8E7A2.pdf A8HT WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 48 2013 TCGA-CC-A8HT-01A-11D-A35Y-01 TCGA-CC-A8HT-01A-11D-A35Y-01 TCGA-CC-A8HT-01A-11D-A35Z-10 TCGA-CC-A8HT-01 TCGA-CC-A8HT-01 F16A4EEA-9AE9-4C17-AE6E-4FEA4F3A6611 33b64021-96cf-4916-92db-948b9a767d1b TCGA-CC-A8HT-01 TCGA-CC-A8HT-01 33b64021-96cf-4916-92db-948b9a767d1b 33b64021-96cf-4916-92db-948b9a767d1b 33b64021-96cf-4916-92db-948b9a767d1b TCGA-CC-A8HT-01A-11D-A369-05 TCGA-CC-A8HU-01 TCGA-CC-A8HU-01 TCGA-CC-A8HU TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 39 TCGA-CC-A8HU-F69708 TCGA-CC-A8HU TCGA-CC-A8HU-01A -14367 141 344 0 0 301 3 2015-1-16 FEMALE 163 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 360 NO NO G3 Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A8HU.CBCE823C-E6F5-4718-97F0-2705BE3C855A.pdf A8HU WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 42 2013 TCGA-CC-A8HU-01A-11D-A35Y-01 TCGA-CC-A8HU-01A-11D-A35Y-01 TCGA-CC-A8HU-01A-11D-A35Z-10 TCGA-CC-A8HU-01 TCGA-CC-A8HU-01 55506EEF-798F-408E-96D6-E687AB8C340B 81b1e9c2-4184-42bd-86ac-a8452d7ca9ec TCGA-CC-A8HU-01 TCGA-CC-A8HU-01 81b1e9c2-4184-42bd-86ac-a8452d7ca9ec 81b1e9c2-4184-42bd-86ac-a8452d7ca9ec 81b1e9c2-4184-42bd-86ac-a8452d7ca9ec TCGA-CC-A8HU-01A-11D-A369-05 TCGA-CC-A8HV-01 TCGA-CC-A8HV-01 TCGA-CC-A8HV TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO 51 TCGA-CC-A8HV-F69784 TCGA-CC-A8HV TCGA-CC-A8HV-01A -18935 140 279 0 0 149 2 2015-1-19 FEMALE 159 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 230 NO NO G2 Locoregional Recurrence No NO YES No true No M0 N0 T2 Stage II TCGA-CC-A8HV.8C178CD4-7D29-4584-B41B-BAE67890DBEB.pdf A8HV WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 51 2013 TCGA-CC-A8HV-01A-11D-A40C-01 TCGA-CC-A8HV-01A-11D-A40C-01 TCGA-CC-A8HV-01A-11D-A35Z-10 TCGA-CC-A8HV-01 TCGA-CC-A8HV-01 B4CB08BD-E5B7-4266-B8DC-AF5DBA49E929 2eabe1cd-7b0a-4a9f-a26b-c43dd0f61e44 TCGA-CC-A8HV-01 TCGA-CC-A8HV-01 2eabe1cd-7b0a-4a9f-a26b-c43dd0f61e44 2eabe1cd-7b0a-4a9f-a26b-c43dd0f61e44 2eabe1cd-7b0a-4a9f-a26b-c43dd0f61e44 TCGA-CC-A8HV-01A-11D-A369-05 TCGA-CC-A9FS-01 TCGA-CC-A9FS-01 TCGA-CC-A9FS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 55 TCGA-CC-A9FS-F69914 TCGA-CC-A9FS -20157 0 211 109 2 2015-1-22 MALE 174 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G2 Lung New Primary Tumor No NO YES No No M0 N0 T2 Stage II A9FS WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 72 2013 TCGA-CC-A9FS-01A-11D-A36W-01 TCGA-CC-A9FS-01A-11D-A36W-01 TCGA-CC-A9FS-01A-11D-A36X-10 TCGA-CC-A9FS-01 TCGA-CC-A9FS-01 cebcb67f-7a10-479f-a49a-b60030e0cc11 TCGA-CC-A9FS-01 TCGA-CC-A9FS-01 cebcb67f-7a10-479f-a49a-b60030e0cc11 cebcb67f-7a10-479f-a49a-b60030e0cc11 cebcb67f-7a10-479f-a49a-b60030e0cc11 TCGA-CC-A9FS-01A-11D-A36Y-05 TCGA-CC-A9FU-01 TCGA-CC-A9FU-01 TCGA-CC-A9FU TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 52 TCGA-CC-A9FU TCGA-CC-A9FU-01A -19326 205 0 0 2014-8-22 FEMALE 153 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 220 NO G2 NO true No M0 N0 T3a Stage IIIA TCGA-CC-A9FU.95F22F75-89A6-4B67-BDF2-A357825453EF.pdf A9FU TUMOR FREE NO R0 Primary Tumor 01 Lobectomy 7th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 48 2013 TCGA-CC-A9FU-01A-11D-A36W-01 TCGA-CC-A9FU-01A-11D-A36W-01 TCGA-CC-A9FU-01A-11D-A36X-10 TCGA-CC-A9FU-01 TCGA-CC-A9FU-01 654a532f-71be-4ce2-9102-e73dde083ab1 TCGA-CC-A9FU-01 TCGA-CC-A9FU-01 654a532f-71be-4ce2-9102-e73dde083ab1 654a532f-71be-4ce2-9102-e73dde083ab1 654a532f-71be-4ce2-9102-e73dde083ab1 TCGA-CC-A9FU-01A-11D-A36Y-05 TCGA-CC-A9FV-01 TCGA-CC-A9FV-01 TCGA-CC-A9FV TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 57 TCGA-CC-A9FV TCGA-CC-A9FV-01A -21044 184 0 0 2014-8-22 MALE 165 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 420 NO G2 NO true No M0 N0 T3 Stage IIIA TCGA-CC-A9FV.01A31339-0FAD-4D49-ACD1-E357D32C887B.pdf A9FV TUMOR FREE NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 59 2013 TCGA-CC-A9FV-01A-11D-A36W-01 TCGA-CC-A9FV-01A-11D-A36W-01 TCGA-CC-A9FV-01A-11D-A36X-10 TCGA-CC-A9FV-01 TCGA-CC-A9FV-01 6fdf4f1c-5fac-46b4-bb5c-c23dae9bf215 TCGA-CC-A9FV-01 TCGA-CC-A9FV-01 6fdf4f1c-5fac-46b4-bb5c-c23dae9bf215 6fdf4f1c-5fac-46b4-bb5c-c23dae9bf215 6fdf4f1c-5fac-46b4-bb5c-c23dae9bf215 TCGA-CC-A9FV-01A-11D-A36Y-05 TCGA-CC-A9FW-01 TCGA-CC-A9FW-01 TCGA-CC-A9FW TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 68 TCGA-CC-A9FW-F69912 TCGA-CC-A9FW -24891 0 248 153 3 2015-1-22 MALE 175 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G2 Locoregional Recurrence No NO YES No No M0 N0 T3 Stage IIIA A9FW WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 67 2013 TCGA-CC-A9FW-01A-11D-A36W-01 TCGA-CC-A9FW-01A-11D-A36W-01 TCGA-CC-A9FW-01A-11D-A36X-10 TCGA-CC-A9FW-01 TCGA-CC-A9FW-01 c05ba7f7-a80f-4cea-ac20-5935edc5c4d1 TCGA-CC-A9FW-01 TCGA-CC-A9FW-01 c05ba7f7-a80f-4cea-ac20-5935edc5c4d1 c05ba7f7-a80f-4cea-ac20-5935edc5c4d1 c05ba7f7-a80f-4cea-ac20-5935edc5c4d1 TCGA-CC-A9FW-01A-11D-A36Y-05 TCGA-DD-A113-01 TCGA-DD-A113-01 TCGA-DD-A113 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 55 3.5 4.3 5.0 TCGA-DD-A113-F38777 TCGA-DD-A113 TCGA-DD-A113-01A 0.1 0.5 A 0.7 1.2 0.8 -20188 1650 0 2425 1678 1676 1 0 6 133 0 - No Fibrosis 2012-12-21 FEMALE 154 Other Smoking Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 0.9 1.2 NO NO G3 Liver Intrahepatic Recurrence Yes YES YES No false No M0 N0 T2 Stage II TCGA-DD-A113.F0D7BCB4-D3C3-491A-BDE2-8E77E77F1655.pdf A113 WITH TUMOR 365 150 450 NO NO 0.9 NO R0 R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 56 2006 TCGA-DD-A113-01A-11D-A12Y-01 TCGA-DD-A113-01A-11D-A12Y-01 TCGA-DD-A113-01A-11D-A12Z-10 TCGA-DD-A113-01 TCGA-DD-A113-01 32faf34e-96a7-4668-9edb-a9addeceda95 TCGA-DD-A113-01A-11D-A12Z-10 TCGA-DD-A113-01 TCGA-DD-A113-01 32faf34e-96a7-4668-9edb-a9addeceda95 TCGA-DD-A113-01A-11D-A12Z-10 32faf34e-96a7-4668-9edb-a9addeceda95 32faf34e-96a7-4668-9edb-a9addeceda95 TCGA-DD-A113-01A-11D-A12Z-10 TCGA-DD-A113-01A-11D-A132-05 TCGA-DD-A113-11 TCGA-DD-A113-11 TCGA-DD-A113 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 55 3.5 4.3 5.0 TCGA-DD-A113-F38777 TCGA-DD-A113 0.1 0.5 A 0.7 1.2 0.8 -20188 0 2425 1678 1676 1 0 6 133 0 - No Fibrosis 2012-12-21 FEMALE 154 Other Smoking Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.2 NO G3 Liver Intrahepatic Recurrence Yes YES YES No No M0 N0 T2 Stage II A113 WITH TUMOR 365 150 450 NO NO 0.9 NO R0 R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver Micro Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 56 2006 TCGA-DD-A113-11 c6842e1d-4f63-458c-9287-0326c03a69c9 TCGA-DD-A113-11 c6842e1d-4f63-458c-9287-0326c03a69c9 c6842e1d-4f63-458c-9287-0326c03a69c9 c6842e1d-4f63-458c-9287-0326c03a69c9 TCGA-DD-A113-11A-12D-A132-05 TCGA-DD-A114-01 TCGA-DD-A114-01 TCGA-DD-A114 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 42 3.5 3.5 5.0 TCGA-DD-A114-F38779 TCGA-DD-A114 TCGA-DD-A114-01A 0.1 2.5 A 0.9 1.4 1.2 -15410 2063 1149 0 1 0 6 21 5 - Nodular Formation and Incomplete Cirrhosis 2012-12-21 MALE 173 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 0.9 1.2 NO NO G3 NO false No M0 T2 Stage II TCGA-DD-A114.BACAFF9B-FAC1-49A8-8C56-A0A26794AA1E.pdf A114 TUMOR FREE 185 150 450 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver Micro A Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 74 2005 TCGA-DD-A114-01A-11D-A12Y-01 TCGA-DD-A114-01A-11D-A12Y-01 TCGA-DD-A114-01A-11D-A12Z-10 TCGA-DD-A114-01 TCGA-DD-A114-01 63446327-F5E2-4CEA-909A-0E67787B85F0 6cff6851-4d3c-479d-a83a-e579953f6b18 TCGA-DD-A114-01A-11D-A12Z-10 TCGA-DD-A114-01 TCGA-DD-A114-01 6cff6851-4d3c-479d-a83a-e579953f6b18 TCGA-DD-A114-01A-11D-A12Z-10 6cff6851-4d3c-479d-a83a-e579953f6b18 6cff6851-4d3c-479d-a83a-e579953f6b18 TCGA-DD-A114-01A-11D-A12Z-10 TCGA-DD-A114-01A-11D-A132-05 TCGA-DD-A114-11 TCGA-DD-A114-11 TCGA-DD-A114 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 42 3.5 3.5 5.0 TCGA-DD-A114-F38779 TCGA-DD-A114 0.1 2.5 A 0.9 1.4 1.2 -15410 1149 0 1 0 6 21 5 - Nodular Formation and Incomplete Cirrhosis 2012-12-21 MALE 173 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.2 NO G3 NO No M0 T2 Stage II A114 TUMOR FREE 185 150 450 NO NO 1.0 NO NO R0 Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver Micro Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 74 2005 TCGA-DD-A114-11 fbeec4cf-0ad3-4e9e-bfc1-d112b1e51b3a TCGA-DD-A114-11 fbeec4cf-0ad3-4e9e-bfc1-d112b1e51b3a fbeec4cf-0ad3-4e9e-bfc1-d112b1e51b3a fbeec4cf-0ad3-4e9e-bfc1-d112b1e51b3a TCGA-DD-A114-11A-12D-A132-05 TCGA-DD-A115-01 TCGA-DD-A115-01 TCGA-DD-A115 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 53 3.5 4.1 5.0 TCGA-DD-A115-F38780 TCGA-DD-A115 TCGA-DD-A115-01A 0.1 0.6 A 0.1 1.2 1.1 -19697 3198 2542 0 469 0 0 6 10 0 - No Fibrosis 2012-12-21 MALE 168 Alcohol consumption Smoking Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 230 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 N0 T3 Stage IIIA TCGA-DD-A115.C0EAB9A6-AAA3-48D5-AE3F-A428D828D63C.pdf A115 WITH TUMOR 337 150 450 NO NO 1.0 NO NO R0 Primary Tumor 01 Extended Lobectomy 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 79 2002 TCGA-DD-A115-01A-11D-A12Y-01 TCGA-DD-A115-01A-11D-A12Y-01 TCGA-DD-A115-01A-11D-A12Z-10 TCGA-DD-A115-01 TCGA-DD-A115-01 BD79C5A6-BBA6-424B-BFB8-9F4D495E31F4 bb55462c-2475-4a92-98e4-9119b26c0c82 TCGA-DD-A115-01A-11D-A12Z-10 TCGA-DD-A115-01 TCGA-DD-A115-01 bb55462c-2475-4a92-98e4-9119b26c0c82 TCGA-DD-A115-01A-11D-A12Z-10 bb55462c-2475-4a92-98e4-9119b26c0c82 bb55462c-2475-4a92-98e4-9119b26c0c82 TCGA-DD-A115-01A-11D-A12Z-10 TCGA-DD-A115-01A-11D-A132-05 TCGA-DD-A115-11 TCGA-DD-A115-11 TCGA-DD-A115 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 53 3.5 4.1 5.0 TCGA-DD-A115-F38780 TCGA-DD-A115 TCGA-DD-A115-11A 0.1 0.6 A 0.1 1.2 1.1 -19697 3198 2542 0 469 0 0 6 10 0 - No Fibrosis 2012-12-21 MALE 168 Alcohol consumption Smoking Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 N0 T3 Stage IIIA A115 WITH TUMOR 337 150 450 NO NO 1.0 NO NO R0 Solid Tissue Normal 11 Extended Lobectomy 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 79 2002 TCGA-DD-A115-11A-12D-A132-05 TCGA-DD-A116-01 TCGA-DD-A116-01 TCGA-DD-A116 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES 68 3.5 4.1 5.0 TCGA-DD-A116-F38781 TCGA-DD-A116 TCGA-DD-A116-01A 0.1 1.1 0 A 0.8 1.4 1.1 -24934 3208 1622 0 1023 828 1 0 6 24 3,4 - Fibrous Speta 2012-12-21 MALE 175 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 NO NO G3 Other, specify Extrahepatic Recurrence sternum No YES YES No false No M0 N0 T3 Stage IIIA TCGA-DD-A116.0914680E-B846-4370-920D-FEB06F609EE5.pdf A116 TUMOR FREE 157 150 450 NO NO 1.0 YES NO R0 R0 Primary Tumor 01 Segmentectomy, Multiple 5th NO YES DD 1.0 Liver A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 73 2002 TCGA-DD-A116-01A-11D-A12Y-01 TCGA-DD-A116-01A-11D-A12Y-01 TCGA-DD-A116-01A-11D-A12Z-10 TCGA-DD-A116-01 TCGA-DD-A116-01 A1871661-C3B8-42AA-B48F-765AD96F0ADB 6dcfd83a-74cb-447c-ab0d-40894fa9d359 TCGA-DD-A116-01A-11D-A12Z-10 TCGA-DD-A116-01 TCGA-DD-A116-01 6dcfd83a-74cb-447c-ab0d-40894fa9d359 TCGA-DD-A116-01A-11D-A12Z-10 6dcfd83a-74cb-447c-ab0d-40894fa9d359 6dcfd83a-74cb-447c-ab0d-40894fa9d359 TCGA-DD-A116-01A-11D-A12Z-10 TCGA-DD-A116-01A-11D-A132-05 TCGA-DD-A116-11 TCGA-DD-A116-11 TCGA-DD-A116 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES 68 3.5 4.1 5.0 TCGA-DD-A116-F38781 TCGA-DD-A116 TCGA-DD-A116-11A 0.1 1.1 0 A 0.8 1.4 1.1 -24934 3208 1622 0 1023 828 1 0 6 24 3,4 - Fibrous Speta 2012-12-21 MALE 175 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 NO NO G3 Other, specify Extrahepatic Recurrence sternum No YES YES No false No M0 N0 T3 Stage IIIA A116 TUMOR FREE 157 150 450 NO NO 1.0 YES NO R0 R0 Solid Tissue Normal 11 Segmentectomy, Multiple 5th NO YES DD 1.0 Liver A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 73 2002 f099f7fb-f07a-4529-83dc-e7023c52a999 f099f7fb-f07a-4529-83dc-e7023c52a999 f099f7fb-f07a-4529-83dc-e7023c52a999 f099f7fb-f07a-4529-83dc-e7023c52a999 TCGA-DD-A116-11A-11D-A132-05 TCGA-DD-A118-01 TCGA-DD-A118-01 TCGA-DD-A118 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 77 3.4 3.4 4.8 TCGA-DD-A118-F38782 TCGA-DD-A118 TCGA-DD-A118-01A 0.1 0.5 A 0.7 1.2 0.9 -28406 2854 0 3437 659 658 1 0 6 85150 0 - No Fibrosis 2012-12-21 FEMALE 169 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 NO NO G2 Other, specify Extrahepatic Recurrence lateral to the C-loop of the duodenum, anterior to the right kidney No YES YES No false No M0 N0 T2 Stage II TCGA-DD-A118.74D4EB64-F12B-470D-8A7C-EDD24CD1448D.pdf A118 381 150 450 NO NO 1.0 NO NO R0 R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 75 2003 TCGA-DD-A118-01A-11D-A12Y-01 TCGA-DD-A118-01A-11D-A12Y-01 TCGA-DD-A118-01A-11D-A12Z-10 TCGA-DD-A118-01 TCGA-DD-A118-01 443B7BF5-9A6A-43F6-BCD9-DDF6498FEF31 20d6834b-5766-4f4a-b30d-8c14195ec7ed TCGA-DD-A118-01A-11D-A12Z-10 TCGA-DD-A118-01 TCGA-DD-A118-01 20d6834b-5766-4f4a-b30d-8c14195ec7ed TCGA-DD-A118-01A-11D-A12Z-10 20d6834b-5766-4f4a-b30d-8c14195ec7ed 20d6834b-5766-4f4a-b30d-8c14195ec7ed TCGA-DD-A118-01A-11D-A12Z-10 TCGA-DD-A118-01A-11D-A132-05 TCGA-DD-A118-11 TCGA-DD-A118-11 TCGA-DD-A118 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 77 3.4 3.4 4.8 TCGA-DD-A118-F38782 TCGA-DD-A118 TCGA-DD-A118-11A 0.1 0.5 A 0.7 1.2 0.9 -28406 2854 0 3437 659 658 1 0 6 85150 0 - No Fibrosis 2012-12-21 FEMALE 169 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 60 NO NO G2 Other, specify Extrahepatic Recurrence lateral to the C-loop of the duodenum, anterior to the right kidney No YES YES No false No M0 N0 T2 Stage II A118 381 150 450 NO NO 1.0 NO NO R0 R0 Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 75 2003 TCGA-DD-A118-11 485b184d-15f1-4858-9e06-330d5258cfff TCGA-DD-A118-11 485b184d-15f1-4858-9e06-330d5258cfff 485b184d-15f1-4858-9e06-330d5258cfff 485b184d-15f1-4858-9e06-330d5258cfff TCGA-DD-A118-11A-11D-A132-05 TCGA-DD-A119-01 TCGA-DD-A119-01 TCGA-DD-A119 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 40 3.5 3.9 5.0 TCGA-DD-A119-F38783 TCGA-DD-A119 TCGA-DD-A119-01A 0.1 1.6 2 A 0.9 1.4 1.3 -14613 2738 223 0 1 0 6 1836 0 - No Fibrosis 2012-12-21 MALE 160 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 NO NO G3 false No M1 N0 T3a Stage IV TCGA-DD-A119.F8B8C948-933A-4B28-A0D1-98166C9B16EF.pdf A119 572 150 450 1.0 YES R2 Primary Tumor 01 Extended Lobectomy 6th NO YES DD 1.0 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 58 2003 TCGA-DD-A119-01A-11D-A12Y-01 TCGA-DD-A119-01A-11D-A12Y-01 TCGA-DD-A119-01A-11D-A12Z-10 TCGA-DD-A119-01 TCGA-DD-A119-01 7E545BB7-0EB0-4AC5-AC91-9B50DFA1A13B 3d0d0f6b-4caa-4c53-b971-17466f076e95 TCGA-DD-A119-01A-11D-A12Z-10 TCGA-DD-A119-01 TCGA-DD-A119-01 3d0d0f6b-4caa-4c53-b971-17466f076e95 TCGA-DD-A119-01A-11D-A12Z-10 3d0d0f6b-4caa-4c53-b971-17466f076e95 3d0d0f6b-4caa-4c53-b971-17466f076e95 TCGA-DD-A119-01A-11D-A12Z-10 TCGA-DD-A119-01A-11D-A132-05 TCGA-DD-A119-11 TCGA-DD-A119-11 TCGA-DD-A119 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 40 3.5 3.9 5.0 TCGA-DD-A119-F38783 TCGA-DD-A119 0.1 1.6 2 A 0.9 1.4 1.3 -14613 223 0 1 0 6 1836 0 - No Fibrosis 2012-12-21 MALE 160 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G3 No M1 N0 T3a Stage IV A119 572 150 450 1.0 YES R2 Solid Tissue Normal 11 Extended Lobectomy 6th NO YES DD 1.0 Liver Micro Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 58 2003 TCGA-DD-A119-11 d5e600a3-d273-4879-ac33-1a72a02073e5 TCGA-DD-A119-11 d5e600a3-d273-4879-ac33-1a72a02073e5 d5e600a3-d273-4879-ac33-1a72a02073e5 d5e600a3-d273-4879-ac33-1a72a02073e5 TCGA-DD-A119-11A-11D-A132-05 TCGA-DD-A11A-01 TCGA-DD-A11A-01 TCGA-DD-A11A TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 67 TCGA-DD-A11A-F38784 TCGA-DD-A11A TCGA-DD-A11A-01A 0.1 3.6 0.9 1.4 1.1 -24646 2184 0 79 0 0 6 223 0 - No Fibrosis 2012-12-21 MALE 156 Other HBcAB total (+), HBsAg (-), HBcIgm Ab (-) Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 260 NO YES G3 false No M0 N0 T1 Stage I TCGA-DD-A11A.E1571DB1-B1B2-4B0E-9A0A-01A4470353DF.pdf A11A 513 150 450 1.0 NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Core Antibody LIVING 67 2004 TCGA-DD-A11A-01A-11D-A12Y-01 TCGA-DD-A11A-01A-11D-A12Y-01 TCGA-DD-A11A-01A-11D-A12Z-10 TCGA-DD-A11A-01 TCGA-DD-A11A-01 789AC9AF-D425-4708-98CF-E6656BE1CCCB 2e96d65b-0247-40fc-a0e3-90fcb6feac3d TCGA-DD-A11A-01A-11D-A12Z-10 TCGA-DD-A11A-01 TCGA-DD-A11A-01 2e96d65b-0247-40fc-a0e3-90fcb6feac3d TCGA-DD-A11A-01A-11D-A12Z-10 2e96d65b-0247-40fc-a0e3-90fcb6feac3d 2e96d65b-0247-40fc-a0e3-90fcb6feac3d TCGA-DD-A11A-01A-11D-A12Z-10 TCGA-DD-A11A-01A-11D-A132-05 TCGA-DD-A11A-11 TCGA-DD-A11A-11 TCGA-DD-A11A TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 67 TCGA-DD-A11A-F38784 TCGA-DD-A11A TCGA-DD-A11A-11A 0.1 3.6 0.9 1.4 1.1 -24646 2184 0 79 0 0 6 223 0 - No Fibrosis 2012-12-21 MALE 156 Other HBcAB total (+), HBsAg (-), HBcIgm Ab (-) Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 NO YES G3 false No M0 N0 T1 Stage I A11A 513 150 450 1.0 NO R0 Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Core Antibody LIVING 67 2004 TCGA-DD-A11A-11 1f1a8329-397c-4ec8-a7cc-46ec9c48fa42 TCGA-DD-A11A-11 1f1a8329-397c-4ec8-a7cc-46ec9c48fa42 1f1a8329-397c-4ec8-a7cc-46ec9c48fa42 1f1a8329-397c-4ec8-a7cc-46ec9c48fa42 TCGA-DD-A11A-11A-11D-A132-05 TCGA-DD-A11B-01 TCGA-DD-A11B-01 TCGA-DD-A11B TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 73 3.5 3.9 5.0 TCGA-DD-A11B-F38785 TCGA-DD-A11B TCGA-DD-A11B-01A 0.1 1.6 A 0.9 1.4 1.0 -26857 1975 14 0 1 0 6 15 6 - Established Cirrhosis 2012-12-21 MALE 181 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 280 8.4 12.0 NO NO G2 NO false No M0 N0 T1 Stage I TCGA-DD-A11B.B53C4282-5266-43FE-A958-19097FD20290.pdf A11B TUMOR FREE 90 150 450 NO NO 10.2 NO NO RX Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 134 2005 TCGA-DD-A11B-01A-11D-A12Y-01 TCGA-DD-A11B-01A-11D-A12Y-01 TCGA-DD-A11B-01A-11D-A12Z-10 TCGA-DD-A11B-01 TCGA-DD-A11B-01 76061131-4963-4848-8B8D-771C892D21D9 92802474-4e5b-46c9-a000-a4451ad43582 TCGA-DD-A11B-01A-11D-A12Z-10 TCGA-DD-A11B-01 TCGA-DD-A11B-01 92802474-4e5b-46c9-a000-a4451ad43582 TCGA-DD-A11B-01A-11D-A12Z-10 92802474-4e5b-46c9-a000-a4451ad43582 92802474-4e5b-46c9-a000-a4451ad43582 TCGA-DD-A11B-01A-11D-A12Z-10 TCGA-DD-A11B-01A-11D-A132-05 TCGA-DD-A11B-11 TCGA-DD-A11B-11 TCGA-DD-A11B TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 73 3.5 3.9 5.0 TCGA-DD-A11B-F38785 TCGA-DD-A11B TCGA-DD-A11B-11A 0.1 1.6 A 0.9 1.4 1.0 -26857 1975 14 0 1 0 6 15 6 - Established Cirrhosis 2012-12-21 MALE 181 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 320 8.4 12.0 NO NO G2 NO false No M0 N0 T1 Stage I A11B TUMOR FREE 90 150 450 NO NO 10.2 NO NO RX Solid Tissue Normal 11 Segmentectomy, Single 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 134 2005 TCGA-DD-A11B-11 5b37433a-6415-497f-bf36-0f0b5c2ad21e TCGA-DD-A11B-11 5b37433a-6415-497f-bf36-0f0b5c2ad21e 5b37433a-6415-497f-bf36-0f0b5c2ad21e 5b37433a-6415-497f-bf36-0f0b5c2ad21e TCGA-DD-A11B-11A-11D-A132-05 TCGA-DD-A11C-01 TCGA-DD-A11C-01 TCGA-DD-A11C TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 69 3.5 3.6 5.0 TCGA-DD-A11C-F38786 TCGA-DD-A11C TCGA-DD-A11C-01A 0.1 2.3 1 A 0.9 1.4 0.9 -25403 1703 0 662 1 0 6 11 0 - No Fibrosis 2012-12-21 MALE 186 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 220 NO YES G3 NO false No M0 N0 T1 Stage I TCGA-DD-A11C.35CD5B20-BF61-4D28-AC7F-2CDC959382CD.pdf A11C TUMOR FREE 391 150 450 NO NO 1.0 NO YES RX Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 123 2006 TCGA-DD-A11C-01A-11D-A12Y-01 TCGA-DD-A11C-01A-11D-A12Y-01 TCGA-DD-A11C-01A-11D-A12Z-10 TCGA-DD-A11C-01 TCGA-DD-A11C-01 76C64559-2722-42D3-9C42-1734DB8DEF08 edc609e1-c791-4d5f-8ca1-272ce9b34289 TCGA-DD-A11C-01A-11D-A12Z-10 TCGA-DD-A11C-01 TCGA-DD-A11C-01 edc609e1-c791-4d5f-8ca1-272ce9b34289 TCGA-DD-A11C-01A-11D-A12Z-10 edc609e1-c791-4d5f-8ca1-272ce9b34289 edc609e1-c791-4d5f-8ca1-272ce9b34289 TCGA-DD-A11C-01A-11D-A12Z-10 TCGA-DD-A11C-01A-11D-A132-05 TCGA-DD-A11C-11 TCGA-DD-A11C-11 TCGA-DD-A11C TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 69 3.5 3.6 5.0 TCGA-DD-A11C-F38786 TCGA-DD-A11C 0.1 2.3 1 A 0.9 1.4 0.9 -25403 0 662 1 0 6 11 0 - No Fibrosis 2012-12-21 MALE 186 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES YES G3 NO No M0 N0 T1 Stage I A11C TUMOR FREE 391 150 450 NO NO 1.0 NO YES RX Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver None Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 123 2006 TCGA-DD-A11C-11 ba72262f-9361-4d4c-8fa0-cc44e26320f6 TCGA-DD-A11C-11 ba72262f-9361-4d4c-8fa0-cc44e26320f6 ba72262f-9361-4d4c-8fa0-cc44e26320f6 ba72262f-9361-4d4c-8fa0-cc44e26320f6 TCGA-DD-A11C-11A-11D-A132-05 TCGA-DD-A11D-01 TCGA-DD-A11D-01 TCGA-DD-A11D TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 57 3.5 4.5 5.0 TCGA-DD-A11D-F38787 TCGA-DD-A11D TCGA-DD-A11D-01A 0.1 0.5 2 A 0.6 1.1 1.1 -21003 1731 1560 0 498 1 0 6 8 6 - Established Cirrhosis 2012-12-21 FEMALE 163 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 300 0.9 1.2 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 N0 T1 Stage I TCGA-DD-A11D.8D1A74F7-E6C3-4557-917A-CA7273929ADF.pdf A11D WITH TUMOR 249 150 450 NO NO 0.9 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A DECEASED 73 2006 TCGA-DD-A11D-01A-11D-A12Y-01 TCGA-DD-A11D-01A-11D-A12Y-01 TCGA-DD-A11D-01A-11D-A12Z-10 TCGA-DD-A11D-01 TCGA-DD-A11D-01 808949E2-ABA5-44F8-A479-D21599DEC5AB 62a6d38d-34a2-4d06-962f-95cc89d582d4 TCGA-DD-A11D-01A-11D-A12Z-10 TCGA-DD-A11D-01 TCGA-DD-A11D-01 62a6d38d-34a2-4d06-962f-95cc89d582d4 TCGA-DD-A11D-01A-11D-A12Z-10 62a6d38d-34a2-4d06-962f-95cc89d582d4 62a6d38d-34a2-4d06-962f-95cc89d582d4 TCGA-DD-A11D-01A-11D-A12Z-10 TCGA-DD-A11D-01A-11D-A132-05 TCGA-DD-A11D-11 TCGA-DD-A11D-11 TCGA-DD-A11D TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 57 3.5 4.5 5.0 TCGA-DD-A11D-F38787 TCGA-DD-A11D TCGA-DD-A11D-11A 0.1 0.5 2 A 0.6 1.1 1.1 -21003 1731 1560 0 498 1 0 6 8 6 - Established Cirrhosis 2012-12-21 FEMALE 163 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 0.9 1.2 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 N0 T1 Stage I A11D WITH TUMOR 249 150 450 NO NO 0.9 NO YES R0 Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver None A DECEASED 73 2006 TCGA-DD-A11D-11 8e70d12c-38fd-4da2-ad1e-b7f860959aa2 TCGA-DD-A11D-11 8e70d12c-38fd-4da2-ad1e-b7f860959aa2 8e70d12c-38fd-4da2-ad1e-b7f860959aa2 8e70d12c-38fd-4da2-ad1e-b7f860959aa2 TCGA-DD-A11D-11A-12D-A132-05 TCGA-DD-A1E9-01 TCGA-DD-A1E9-01 TCGA-DD-A1E9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 70 3.5 4.1 5.0 TCGA-DD-A1E9-F42012 TCGA-DD-A1E9 TCGA-DD-A1E9-01A 0.1 13 4 A 0.8 1.3 0.9 -25808 3234 2759 0 720 1 0 6 202 6 - Established Cirrhosis 2013-4-9 MALE 172 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 8.4 12.0 NO NO G2 Liver Intrahepatic Recurrence Yes NO NO No true No M0 N0 T1 Stage I TCGA-DD-A1E9.07CF8AAC-8A8A-4E4C-BBDA-EDCD78608723.pdf A1E9 110 150 450 NO NO 10.4 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 101 2002 TCGA-DD-A1E9-01A-21D-A151-01 TCGA-DD-A1E9-01A-21D-A151-01 TCGA-DD-A1E9-01A-21D-A152-10 D93BA981-49B7-4E84-82FE-5AAF95EAA05C TCGA-DD-A1E9-01A-21D-A152-10 TCGA-DD-A1E9-01A-21D-A152-10 TCGA-DD-A1E9-01A-21D-A152-10 TCGA-DD-A1E9-01A-21D-A153-05 TCGA-DD-A1E9-11 TCGA-DD-A1E9-11 TCGA-DD-A1E9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 70 3.5 4.1 5.0 TCGA-DD-A1E9-F42012 TCGA-DD-A1E9 TCGA-DD-A1E9-11A 0.1 13 4 A 0.8 1.3 0.9 -25808 3234 2759 0 720 1 0 6 202 6 - Established Cirrhosis 2013-4-9 MALE 172 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 8.4 12.0 NO NO G2 Liver Intrahepatic Recurrence Yes NO NO No true No M0 N0 T1 Stage I A1E9 110 150 450 NO NO 10.4 NO YES R0 Solid Tissue Normal 11 Segmentectomy, Multiple 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 101 2002 TCGA-DD-A1E9-11A-11D-A153-05 TCGA-DD-A1EA-01 TCGA-DD-A1EA-01 TCGA-DD-A1EA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 68 3.5 3.3 5.0 TCGA-DD-A1EA-F42204 TCGA-DD-A1EA TCGA-DD-A1EA-01A 0.1 0.9 1 A 0.8 1.3 1.2 -24925 3298 0 2415 754 0 0 6 3 1,2 - Portal Fibrosis 2013-4-15 MALE 168 Hepatitis B smoking Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 8.3 10.8 NO NO G2 Liver Locoregional Recurrence Yes NO YES No true No M0 N0 T2 Stage II TCGA-DD-A1EA.0B2D3D3C-78CC-4DB7-9A8C-92BF05CFB68B.pdf A1EA WITH TUMOR 209 150 450 NO NO 10.2 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 5th NO YES DD 1.0 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV D LIVING 94 2002 TCGA-DD-A1EA-01A-11D-A12Y-01 TCGA-DD-A1EA-01A-11D-A12Y-01 TCGA-DD-A1EA-01A-11D-A12Z-10 TCGA-DD-A1EA-01 TCGA-DD-A1EA-01 4e8c2054-b8f7-4754-b42d-4714edcee3c7 TCGA-DD-A1EA-01A-11D-A12Z-10 TCGA-DD-A1EA-01 TCGA-DD-A1EA-01 4e8c2054-b8f7-4754-b42d-4714edcee3c7 TCGA-DD-A1EA-01A-11D-A12Z-10 4e8c2054-b8f7-4754-b42d-4714edcee3c7 4e8c2054-b8f7-4754-b42d-4714edcee3c7 TCGA-DD-A1EA-01A-11D-A12Z-10 TCGA-DD-A1EA-01A-11D-A132-05 TCGA-DD-A1EB-01 TCGA-DD-A1EB-01 TCGA-DD-A1EB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 72 3.5 3.7 5.0 TCGA-DD-A1EB-F42225 TCGA-DD-A1EB TCGA-DD-A1EB-01A 0.1 0.3 1 B 0.6 1.1 1.3 -26471 3538 0 2017 505 1 0 6 7 0 - No Fibrosis 2013-4-15 FEMALE 164 Other smoking Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 180 8.4 12.0 NO YES G2 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T1 Stage I TCGA-DD-A1EB.40ABAF02-60C0-4997-AB0F-2B9A90F1FE3B.pdf A1EB TUMOR FREE 204 150 450 NO NO 8.7 NO YES R0 Primary Tumor 01 Lobectomy 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 57 2001 TCGA-DD-A1EB-01A-11D-A12Y-01 TCGA-DD-A1EB-01A-11D-A12Y-01 TCGA-DD-A1EB-01A-11D-A12Z-10 TCGA-DD-A1EB-01 TCGA-DD-A1EB-01 17D465CF-A283-416B-B948-91BFE18168C2 bb931f9d-802e-4e02-b503-a637aa369e8b TCGA-DD-A1EB-01A-11D-A12Z-10 TCGA-DD-A1EB-01 TCGA-DD-A1EB-01 bb931f9d-802e-4e02-b503-a637aa369e8b TCGA-DD-A1EB-01A-11D-A12Z-10 bb931f9d-802e-4e02-b503-a637aa369e8b bb931f9d-802e-4e02-b503-a637aa369e8b TCGA-DD-A1EB-01A-11D-A12Z-10 TCGA-DD-A1EB-01A-11D-A132-05 TCGA-DD-A1EB-11 TCGA-DD-A1EB-11 TCGA-DD-A1EB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 72 3.5 3.7 5.0 TCGA-DD-A1EB-F42225 TCGA-DD-A1EB 0.1 0.3 1 B 0.6 1.1 1.3 -26471 0 2017 505 1 0 6 7 0 - No Fibrosis 2013-4-15 FEMALE 164 Other smoking Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.4 12.0 YES G2 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T1 Stage I A1EB TUMOR FREE 204 150 450 NO NO 8.7 NO YES R0 Solid Tissue Normal 11 Lobectomy 5th NO YES DD 1.0 Liver None Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 57 2001 TCGA-DD-A1EB-11 e55a12d6-3ec4-4346-8849-cf7525fff740 TCGA-DD-A1EB-11 e55a12d6-3ec4-4346-8849-cf7525fff740 e55a12d6-3ec4-4346-8849-cf7525fff740 e55a12d6-3ec4-4346-8849-cf7525fff740 TCGA-DD-A1EB-11A-11D-A132-05 TCGA-DD-A1EC-01 TCGA-DD-A1EC-01 TCGA-DD-A1EC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 20 3.5 3.2 5.0 TCGA-DD-A1EC-F42201 TCGA-DD-A1EC TCGA-DD-A1EC-01A 0.1 0.4 A 0.7 1.2 0.8 -7363 2254 0 602 299 1 0 6 2 0 - No Fibrosis 2013-4-15 FEMALE 157 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 8.4 12.0 NO YES G3 Other, specify Extrahepatic Recurrence peritoneal No NO YES No true No M0 N0 T1 Stage I TCGA-DD-A1EC.7CF5361C-34F3-496F-A7FC-AF4E9F2BD859.pdf A1EC 556 150 450 NO NO 11.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A LIVING 50 2004 TCGA-DD-A1EC-01A-21D-A12Y-01 TCGA-DD-A1EC-01A-21D-A12Y-01 TCGA-DD-A1EC-01A-21D-A12Z-10 TCGA-DD-A1EC-01 TCGA-DD-A1EC-01 E364D0C2-AC0F-47AD-A720-ED09E8270F5E 7d73dcf5-7ddc-4df8-82f8-19fbb1f719ed TCGA-DD-A1EC-01A-21D-A12Z-10 TCGA-DD-A1EC-01 TCGA-DD-A1EC-01 7d73dcf5-7ddc-4df8-82f8-19fbb1f719ed TCGA-DD-A1EC-01A-21D-A12Z-10 7d73dcf5-7ddc-4df8-82f8-19fbb1f719ed 7d73dcf5-7ddc-4df8-82f8-19fbb1f719ed TCGA-DD-A1EC-01A-21D-A12Z-10 TCGA-DD-A1EC-01A-21D-A132-05 TCGA-DD-A1EC-11 TCGA-DD-A1EC-11 TCGA-DD-A1EC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 20 3.5 3.2 5.0 TCGA-DD-A1EC-F42201 TCGA-DD-A1EC 0.1 0.4 A 0.7 1.2 0.8 -7363 0 602 299 1 0 6 2 0 - No Fibrosis 2013-4-15 FEMALE 157 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.4 12.0 YES G3 Other, specify Extrahepatic Recurrence peritoneal No NO YES No No M0 N0 T1 Stage I A1EC 556 150 450 NO NO 11.0 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None LIVING 50 2004 TCGA-DD-A1EC-11 d3041275-6a41-4974-a082-9b261b65c81f TCGA-DD-A1EC-11 d3041275-6a41-4974-a082-9b261b65c81f d3041275-6a41-4974-a082-9b261b65c81f d3041275-6a41-4974-a082-9b261b65c81f TCGA-DD-A1EC-11A-11D-A132-05 TCGA-DD-A1ED-01 TCGA-DD-A1ED-01 TCGA-DD-A1ED TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 68 3.5 4.2 5.0 TCGA-DD-A1ED-F42202 TCGA-DD-A1ED TCGA-DD-A1ED-01A 0.1 0.8 A 0.8 1.3 1.3 -25039 1525 0 2301 1 0 6 3 0 - No Fibrosis 2013-4-15 MALE 168 Alcohol consumption tattoos Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 60 8.4 12.0 NO NO G1 NO true No M0 N0 T1 Stage I TCGA-DD-A1ED.6C4C27E3-EB96-48E4-BDF8-6E93C1557707.pdf A1ED TUMOR FREE 219 150 450 NO NO 8.9 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 85 2006 TCGA-DD-A1ED-01A-11D-A151-01 TCGA-DD-A1ED-01A-11D-A151-01 TCGA-DD-A1ED-01A-11D-A152-10 TCGA-DD-A1ED-01 TCGA-DD-A1ED-01 37114D9C-9279-40B4-B2CE-513F96895267 24f42719-6ad5-48fb-b27d-5812c3447b46 TCGA-DD-A1ED-01A-11D-A152-10 TCGA-DD-A1ED-01 TCGA-DD-A1ED-01 24f42719-6ad5-48fb-b27d-5812c3447b46 TCGA-DD-A1ED-01A-11D-A152-10 24f42719-6ad5-48fb-b27d-5812c3447b46 24f42719-6ad5-48fb-b27d-5812c3447b46 TCGA-DD-A1ED-01A-11D-A152-10 TCGA-DD-A1ED-01A-11D-A153-05 TCGA-DD-A1ED-11 TCGA-DD-A1ED-11 TCGA-DD-A1ED TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 68 3.5 4.2 5.0 TCGA-DD-A1ED-F42202 TCGA-DD-A1ED TCGA-DD-A1ED-11A 0.1 0.8 A 0.8 1.3 1.3 -25039 1525 0 2301 1 0 6 3 0 - No Fibrosis 2013-4-15 MALE 168 Alcohol consumption tattoos Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 8.4 12.0 NO NO G1 NO true No M0 N0 T1 Stage I A1ED TUMOR FREE 219 150 450 NO NO 8.9 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 85 2006 TCGA-DD-A1ED-11A-11D-A153-05 TCGA-DD-A1EE-01 TCGA-DD-A1EE-01 TCGA-DD-A1EE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 73 3.5 2.7 5.0 TCGA-DD-A1EE-F42208 TCGA-DD-A1EE TCGA-DD-A1EE-01A 0.1 0.5 B 0.8 1.3 1.2 -26858 1521 349 0 204 44 2 0 6 3 6 - Established Cirrhosis 2013-4-15 MALE 175 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 8.4 12.0 NO NO G3 Liver Intrahepatic Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-DD-A1EE.EC55BB6D-4704-48D6-9C37-E82AADE685F7.pdf A1EE WITH TUMOR 208 150 450 NO NO 14.3 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 77 2006 TCGA-DD-A1EE-01A-11D-A12Y-01 TCGA-DD-A1EE-01A-11D-A12Y-01 TCGA-DD-A1EE-01A-11D-A12Z-10 TCGA-DD-A1EE-01 TCGA-DD-A1EE-01 4D09C18B-8451-4B2D-BB83-7688A4B19389 b5ef133a-86de-4cd1-9ff2-52e6cbbeaae8 TCGA-DD-A1EE-01 TCGA-DD-A1EE-01 b5ef133a-86de-4cd1-9ff2-52e6cbbeaae8 b5ef133a-86de-4cd1-9ff2-52e6cbbeaae8 b5ef133a-86de-4cd1-9ff2-52e6cbbeaae8 TCGA-DD-A1EE-01A-11D-A132-05 TCGA-DD-A1EE-11 TCGA-DD-A1EE-11 TCGA-DD-A1EE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 73 3.5 2.7 5.0 TCGA-DD-A1EE-F42208 TCGA-DD-A1EE TCGA-DD-A1EE-11A 0.1 0.5 B 0.8 1.3 1.2 -26858 1521 349 0 204 44 2 0 6 3 6 - Established Cirrhosis 2013-4-15 MALE 175 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 190 8.4 12.0 NO NO G3 Liver Intrahepatic Recurrence No NO YES No true No M0 N0 T3 Stage IIIA A1EE WITH TUMOR 208 150 450 NO NO 14.3 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 77 2006 TCGA-DD-A1EE-11 78eb93c7-0300-4f16-ab32-7489715e3353 TCGA-DD-A1EE-11 78eb93c7-0300-4f16-ab32-7489715e3353 78eb93c7-0300-4f16-ab32-7489715e3353 78eb93c7-0300-4f16-ab32-7489715e3353 TCGA-DD-A1EE-11A-11D-A132-05 TCGA-DD-A1EF-01 TCGA-DD-A1EF-01 TCGA-DD-A1EF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 57 3.5 4.5 5.0 TCGA-DD-A1EF-F42200 TCGA-DD-A1EF TCGA-DD-A1EF-01A 0.1 1.0 9 B 0.6 1.1 0.9 -21165 1382 394 0 2 0 6 16211 3,4 - Fibrous Speta 2013-4-15 FEMALE 164 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 190 8.4 12.0 NO NO G3 true No M0 N0 T1 Stage I TCGA-DD-A1EF.002B24F9-22DB-4504-A048-BF9790A4837E.pdf A1EF WITH TUMOR 337 150 450 8.5 YES R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 81 2007 TCGA-DD-A1EF-01A-11D-A12Y-01 TCGA-DD-A1EF-01A-11D-A12Y-01 TCGA-DD-A1EF-01A-11D-A12Z-10 TCGA-DD-A1EF-01 TCGA-DD-A1EF-01 062D49C8-C170-4837-9CC6-13C6D665122D 5da8b83f-c43b-46c3-9667-022d7e0a6f2b TCGA-DD-A1EF-01A-11D-A12Z-10 TCGA-DD-A1EF-01 TCGA-DD-A1EF-01 5da8b83f-c43b-46c3-9667-022d7e0a6f2b TCGA-DD-A1EF-01A-11D-A12Z-10 5da8b83f-c43b-46c3-9667-022d7e0a6f2b 5da8b83f-c43b-46c3-9667-022d7e0a6f2b TCGA-DD-A1EF-01A-11D-A12Z-10 TCGA-DD-A1EF-01A-11D-A132-05 TCGA-DD-A1EF-11 TCGA-DD-A1EF-11 TCGA-DD-A1EF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 57 3.5 4.5 5.0 TCGA-DD-A1EF-F42200 TCGA-DD-A1EF TCGA-DD-A1EF-11A 0.1 1.0 9 B 0.6 1.1 0.9 -21165 1382 394 0 2 0 6 16211 3,4 - Fibrous Speta 2013-4-15 FEMALE 164 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 8.4 12.0 NO NO G3 true No M0 N0 T1 Stage I A1EF WITH TUMOR 337 150 450 8.5 YES R0 Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 81 2007 TCGA-DD-A1EF-11A-11D-A132-05 TCGA-DD-A1EG-01 TCGA-DD-A1EG-01 TCGA-DD-A1EG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 76 3.5 4.2 5.0 TCGA-DD-A1EG-F42003 TCGA-DD-A1EG 0.1 0.7 1 A 0.8 1.3 0.6 -28108 1372 0 880 875 0 0 6 16 1,2 - Portal Fibrosis 2013-4-9 MALE 168 Alcohol consumption|Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.4 12.0 NO G3 Liver Intrahepatic Recurrence No YES YES No No M0 N0 T1 Stage I A1EG WITH TUMOR 146 150 450 YES YES 9.1 NO YES R0 R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.0 Liver None Hepatitis B Surface Antigen DECEASED 82 2007 TCGA-DD-A1EG-01A-11D-A20V-01 TCGA-DD-A1EG-01A-11D-A20V-01 TCGA-DD-A1EG-01A-11D-A20W-10 TCGA-DD-A1EG-01 TCGA-DD-A1EG-01 caf05305-45bc-4858-b8b5-21fe37061a5c TCGA-DD-A1EG-01A-11D-A20W-10 TCGA-DD-A1EG-01 TCGA-DD-A1EG-01 caf05305-45bc-4858-b8b5-21fe37061a5c TCGA-DD-A1EG-01A-11D-A20W-10 caf05305-45bc-4858-b8b5-21fe37061a5c caf05305-45bc-4858-b8b5-21fe37061a5c TCGA-DD-A1EG-01A-11D-A20W-10 TCGA-DD-A1EG-01A-11D-A20Z-05 TCGA-DD-A1EG-11 TCGA-DD-A1EG-11 TCGA-DD-A1EG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 76 3.5 4.2 5.0 TCGA-DD-A1EG-F42003 TCGA-DD-A1EG 0.1 0.7 1 A 0.8 1.3 0.6 -28108 1372 0 880 875 0 0 6 16 1,2 - Portal Fibrosis 2013-4-9 MALE 168 Alcohol consumption|Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.4 12.0 NO G3 Liver Intrahepatic Recurrence No YES YES No No M0 N0 T1 Stage I A1EG WITH TUMOR 146 150 450 YES YES 9.1 NO YES R0 R0 Solid Tissue Normal 11 Lobectomy 7th NO YES DD 1.0 Liver None Hepatitis B Surface Antigen DECEASED 82 2007 TCGA-DD-A1EG-11 b80a257d-9c8b-4c49-87bc-30f74ff9cd3e TCGA-DD-A1EG-11 b80a257d-9c8b-4c49-87bc-30f74ff9cd3e b80a257d-9c8b-4c49-87bc-30f74ff9cd3e b80a257d-9c8b-4c49-87bc-30f74ff9cd3e TCGA-DD-A1EG-11A-11D-A20Z-05 TCGA-DD-A1EH-01 TCGA-DD-A1EH-01 TCGA-DD-A1EH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 23 3.5 4.7 5.0 TCGA-DD-A1EH-F42567 TCGA-DD-A1EH TCGA-DD-A1EH-01A 0.1 1.0 1 B 0.8 1.3 1.0 -8499 933 0 1495 120 1 0 6 94340 3,4 - Fibrous Speta 2013-4-24 MALE 179 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 220 9.5 13.8 NO NO G3 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T3 Stage III TCGA-DD-A1EH.951E7AFB-F380-4FA8-B213-CB766A60FF5B.pdf A1EH WITH TUMOR 212 150 450 YES YES 10.4 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver Macro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV D LIVING 70 2008 TCGA-DD-A1EH-01A-11D-A12Y-01 TCGA-DD-A1EH-01A-11D-A12Y-01 TCGA-DD-A1EH-01A-11D-A12Z-10 TCGA-DD-A1EH-01 TCGA-DD-A1EH-01 D64DEA8B-1FBC-463F-B634-BB8AD46FA286 0559ff1c-6aee-491f-9b58-747732a10755 TCGA-DD-A1EH-01A-11D-A12Z-10 TCGA-DD-A1EH-01 TCGA-DD-A1EH-01 0559ff1c-6aee-491f-9b58-747732a10755 TCGA-DD-A1EH-01A-11D-A12Z-10 0559ff1c-6aee-491f-9b58-747732a10755 0559ff1c-6aee-491f-9b58-747732a10755 TCGA-DD-A1EH-01A-11D-A12Z-10 TCGA-DD-A1EH-01A-11D-A132-05 TCGA-DD-A1EH-11 TCGA-DD-A1EH-11 TCGA-DD-A1EH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 23 3.5 4.7 5.0 TCGA-DD-A1EH-F42567 TCGA-DD-A1EH 0.1 1.0 1 B 0.8 1.3 1.0 -8499 0 1495 120 1 0 6 94340 3,4 - Fibrous Speta 2013-4-24 MALE 179 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 9.5 13.8 NO G3 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T3 Stage III A1EH WITH TUMOR 212 150 450 YES YES 10.4 NO YES R0 Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver Macro Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV D LIVING 70 2008 TCGA-DD-A1EH-11 ac77b52b-6f6c-41ec-b998-6d23250d0516 TCGA-DD-A1EH-11 ac77b52b-6f6c-41ec-b998-6d23250d0516 ac77b52b-6f6c-41ec-b998-6d23250d0516 ac77b52b-6f6c-41ec-b998-6d23250d0516 TCGA-DD-A1EH-11A-11D-A132-05 TCGA-DD-A1EI-01 TCGA-DD-A1EI-01 TCGA-DD-A1EI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 46 3.5 5.1 5.0 TCGA-DD-A1EI-F42222 TCGA-DD-A1EI TCGA-DD-A1EI-01A 0.1 0.7 0 B 0.8 1.3 0.9 -17097 926 0 183 2 0 6 24 6 - Established Cirrhosis 2013-4-15 MALE 175 Hepatitis B cirrhosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 8.3 10.8 NO YES G2 NO true No M0 N0 T1 Stage I TCGA-DD-A1EI.C253EB16-129F-4442-8C88-8A132E610E8C.pdf A1EI TUMOR FREE 148 150 450 10.9 NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV D LIVING 69 2008 TCGA-DD-A1EI-01A-11D-A12Y-01 TCGA-DD-A1EI-01A-11D-A12Y-01 TCGA-DD-A1EI-01A-11D-A12Z-10 TCGA-DD-A1EI-01 TCGA-DD-A1EI-01 95cdfdf7-26d2-41b6-bac7-a6305a91ec3c TCGA-DD-A1EI-01A-11D-A12Z-10 TCGA-DD-A1EI-01 TCGA-DD-A1EI-01 95cdfdf7-26d2-41b6-bac7-a6305a91ec3c TCGA-DD-A1EI-01A-11D-A12Z-10 95cdfdf7-26d2-41b6-bac7-a6305a91ec3c 95cdfdf7-26d2-41b6-bac7-a6305a91ec3c TCGA-DD-A1EI-01A-11D-A12Z-10 TCGA-DD-A1EI-01A-11D-A132-05 TCGA-DD-A1EI-11 TCGA-DD-A1EI-11 TCGA-DD-A1EI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 46 3.5 5.1 5.0 TCGA-DD-A1EI-F42222 TCGA-DD-A1EI TCGA-DD-A1EI-11A 0.1 0.7 0 B 0.8 1.3 0.9 -17097 926 0 183 2 0 6 24 6 - Established Cirrhosis 2013-4-15 MALE 175 Hepatitis B cirrhosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 190 8.3 10.8 NO YES G2 NO true No M0 N0 T1 Stage I A1EI TUMOR FREE 148 150 450 10.9 NO R0 Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV D LIVING 69 2008 TCGA-DD-A1EI-11 196f7a32-4d09-4e8b-9aa4-7964baf951d7 TCGA-DD-A1EI-11 196f7a32-4d09-4e8b-9aa4-7964baf951d7 196f7a32-4d09-4e8b-9aa4-7964baf951d7 196f7a32-4d09-4e8b-9aa4-7964baf951d7 TCGA-DD-A1EI-11A-11D-A132-05 TCGA-DD-A1EJ-01 TCGA-DD-A1EJ-01 TCGA-DD-A1EJ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Mild 71 3.2 3.5 5.0 TCGA-DD-A1EJ-F42209 TCGA-DD-A1EJ TCGA-DD-A1EJ-01A 0.1 0.7 1 B 0.6 1.1 0.6 -26009 909 1005 0 887 263 2 0 6 18840 0 - No Fibrosis 2013-4-15 FEMALE 154 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 290 8.3 10.8 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N1 T1 Stage IIIC TCGA-DD-A1EJ.A34C7F12-5EB1-4B7C-890C-FD2DFF41E85C.pdf A1EJ WITH TUMOR 608 150 450 NO NO 10.2 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 64 2008 TCGA-DD-A1EJ-01A-11D-A151-01 TCGA-DD-A1EJ-01A-11D-A151-01 TCGA-DD-A1EJ-01A-11D-A152-10 TCGA-DD-A1EJ-01 TCGA-DD-A1EJ-01 ECCFCC47-BC5E-437D-9AD7-BB7E39A6016B c8b3eddd-f3cf-42eb-bb30-ccc3943eadec TCGA-DD-A1EJ-01A-11D-A152-10 TCGA-DD-A1EJ-01 TCGA-DD-A1EJ-01 c8b3eddd-f3cf-42eb-bb30-ccc3943eadec TCGA-DD-A1EJ-01A-11D-A152-10 c8b3eddd-f3cf-42eb-bb30-ccc3943eadec c8b3eddd-f3cf-42eb-bb30-ccc3943eadec TCGA-DD-A1EJ-01A-11D-A152-10 TCGA-DD-A1EJ-01A-11D-A153-05 TCGA-DD-A1EJ-11 TCGA-DD-A1EJ-11 TCGA-DD-A1EJ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Mild 71 3.2 3.5 5.0 TCGA-DD-A1EJ-F42209 TCGA-DD-A1EJ TCGA-DD-A1EJ-11A 0.1 0.7 1 B 0.6 1.1 0.6 -26009 909 1005 0 887 263 2 0 6 18840 0 - No Fibrosis 2013-4-15 FEMALE 154 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 130 8.3 10.8 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N1 T1 Stage IIIC A1EJ WITH TUMOR 608 150 450 NO NO 10.2 NO YES R0 Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 64 2008 TCGA-DD-A1EJ-11 8e48cff2-5edd-4ce6-9531-5dc594ae78ff TCGA-DD-A1EJ-11 8e48cff2-5edd-4ce6-9531-5dc594ae78ff 8e48cff2-5edd-4ce6-9531-5dc594ae78ff 8e48cff2-5edd-4ce6-9531-5dc594ae78ff TCGA-DD-A1EJ-11A-11D-A153-05 TCGA-DD-A1EK-01 TCGA-DD-A1EK-01 TCGA-DD-A1EK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Mild 64 3.5 4.3 5.0 TCGA-DD-A1EK-F42001 TCGA-DD-A1EK TCGA-DD-A1EK-01A 0.1 0.5 1 A 0.6 1.1 0.7 -23437 819 558 0 167 0 0 6 19 0 - No Fibrosis 2013-4-9 FEMALE 159 Other tobacco, birth control bills Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 8.3 10.8 NO NO G2 Liver Locoregional Recurrence Yes NO YES No true No M1 N0 T4 Stage IVB TCGA-DD-A1EK.AE199A35-2585-4363-8896-9B55B12C1BDF.pdf A1EK WITH TUMOR 387 150 450 YES NO 10.3 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 97 2008 TCGA-DD-A1EK-01A-11D-A20V-01 TCGA-DD-A1EK-01A-11D-A20V-01 TCGA-DD-A1EK-01A-11D-A20W-10 TCGA-DD-A1EK-01 TCGA-DD-A1EK-01 24214ac8-46a2-44c2-9ce8-8514b9c61181 TCGA-DD-A1EK-01A-11D-A20W-10 TCGA-DD-A1EK-01 TCGA-DD-A1EK-01 24214ac8-46a2-44c2-9ce8-8514b9c61181 TCGA-DD-A1EK-01A-11D-A20W-10 24214ac8-46a2-44c2-9ce8-8514b9c61181 24214ac8-46a2-44c2-9ce8-8514b9c61181 TCGA-DD-A1EK-01A-11D-A20W-10 TCGA-DD-A1EK-01A-11D-A20Z-05 TCGA-DD-A1EL-01 TCGA-DD-A1EL-01 TCGA-DD-A1EL TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 23 3.5 4.4 5.0 TCGA-DD-A1EL-F42229 TCGA-DD-A1EL TCGA-DD-A1EL-01A 0.1 0.5 A 0.8 1.3 1.0 -8573 577 415 0 [Discrepancy] 0 0 6 5 0 - No Fibrosis 2013-4-15 MALE 182 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 130 8.3 10.8 NO NO G3 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T2 Stage II TCGA-DD-A1EL.C8A1098A-0717-4801-A3E5-C13C42C65936.pdf A1EL WITH TUMOR 153 150 450 YES NO 10.8 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV D DECEASED 54 2009 TCGA-DD-A1EL-01A-11D-A151-01 TCGA-DD-A1EL-01A-11D-A151-01 TCGA-DD-A1EL-01A-11D-A152-10 TCGA-DD-A1EL-01 TCGA-DD-A1EL-01 2FACE58F-5F20-4DDA-921C-E6DB5744DC09 4e27ce05-b76a-4d5a-b070-78c508f509a3 TCGA-DD-A1EL-01A-11D-A152-10 TCGA-DD-A1EL-01 TCGA-DD-A1EL-01 4e27ce05-b76a-4d5a-b070-78c508f509a3 TCGA-DD-A1EL-01A-11D-A152-10 4e27ce05-b76a-4d5a-b070-78c508f509a3 4e27ce05-b76a-4d5a-b070-78c508f509a3 TCGA-DD-A1EL-01A-11D-A152-10 TCGA-DD-A1EL-01A-11D-A153-05 TCGA-DD-A1EL-11 TCGA-DD-A1EL-11 TCGA-DD-A1EL TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 23 3.5 4.4 5.0 TCGA-DD-A1EL-F42229 TCGA-DD-A1EL 0.1 0.5 A 0.8 1.3 1.0 -8573 415 0 [Discrepancy] 0 0 6 5 0 - No Fibrosis 2013-4-15 MALE 182 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 10.8 NO G3 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T2 Stage II A1EL WITH TUMOR 153 150 450 YES NO 10.8 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV D DECEASED 54 2009 TCGA-DD-A1EL-11 ddd83e9a-35cb-4539-8141-7557eccd3b34 TCGA-DD-A1EL-11 ddd83e9a-35cb-4539-8141-7557eccd3b34 ddd83e9a-35cb-4539-8141-7557eccd3b34 ddd83e9a-35cb-4539-8141-7557eccd3b34 TCGA-DD-A1EL-11A-11D-A153-05 TCGA-DD-A39V-01 TCGA-DD-A39V-01 TCGA-DD-A39V TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES None 77 3.5 4.0 5.0 TCGA-DD-A39V-F42707 TCGA-DD-A39V TCGA-DD-A39V-01A 3 A 0.8 1.2 0.9 -28254 4180 643 0 455 1 0 - No Fibrosis 2013-4-27 MALE 174 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 180 8.4 12.0 NO NO G3 Other, specify Extrahepatic Recurrence second or third rib posteriorly No NO YES No false No M0 NX T2 Stage II TCGA-DD-A39V.AB7EF7A1-F8F1-404A-BF15-2CC53F63C033.pdf A39V WITH TUMOR 193 150 450 NO NO 11.4 YES YES R0 Primary Tumor 01 Lobectomy 5th NO YES DD Liver None A DECEASED 79 2000 TCGA-DD-A39V-01A-11D-A20V-01 TCGA-DD-A39V-01A-11D-A20V-01 TCGA-DD-A39V-01A-11D-A20W-10 TCGA-DD-A39V-01 TCGA-DD-A39V-01 97B93870-5348-422B-83D9-9A64A2EF3E30 f2a077e8-1dd2-4a7b-b832-0f7367818044 TCGA-DD-A39V-01A-11D-A20W-10 TCGA-DD-A39V-01 TCGA-DD-A39V-01 f2a077e8-1dd2-4a7b-b832-0f7367818044 TCGA-DD-A39V-01A-11D-A20W-10 f2a077e8-1dd2-4a7b-b832-0f7367818044 f2a077e8-1dd2-4a7b-b832-0f7367818044 TCGA-DD-A39V-01A-11D-A20W-10 TCGA-DD-A39V-01A-11D-A20Z-05 TCGA-DD-A39V-11 TCGA-DD-A39V-11 TCGA-DD-A39V TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES None 77 3.5 4.0 5.0 TCGA-DD-A39V-F42707 TCGA-DD-A39V TCGA-DD-A39V-11A 3 A 0.8 1.2 0.9 -28254 4180 643 0 455 1 0 - No Fibrosis 2013-4-27 MALE 174 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 8.4 12.0 NO NO G3 Other, specify Extrahepatic Recurrence second or third rib posteriorly No NO YES No false No M0 NX T2 Stage II A39V WITH TUMOR 193 150 450 NO NO 11.4 YES YES R0 Solid Tissue Normal 11 Lobectomy 5th NO YES DD Liver None A DECEASED 79 2000 TCGA-DD-A39V-11 9e3df1b0-dba1-4423-976e-99aab5b7d5e2 TCGA-DD-A39V-11 9e3df1b0-dba1-4423-976e-99aab5b7d5e2 9e3df1b0-dba1-4423-976e-99aab5b7d5e2 9e3df1b0-dba1-4423-976e-99aab5b7d5e2 TCGA-DD-A39V-11A-11D-A20Z-05 TCGA-DD-A39W-01 TCGA-DD-A39W-01 TCGA-DD-A39W TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 29 TCGA-DD-A39W-F42705 TCGA-DD-A39W TCGA-DD-A39W-01A -10699 6014 827 0 2013-5-8 FEMALE 177 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 180 NO NO G2 false No M0 N0 T3 Stage III TCGA-DD-A39W.3EE9248B-64B4-4B76-A427-73C254D6489D.pdf A39W R0 Primary Tumor 01 Segmentectomy, Multiple 4th NO YES DD Liver None A DECEASED 74 1995 TCGA-DD-A39W-01A-11D-A20V-01 TCGA-DD-A39W-01A-11D-A20V-01 TCGA-DD-A39W-01A-11D-A20W-10 TCGA-DD-A39W-01 TCGA-DD-A39W-01 95A7A30E-A9BC-4197-8142-4F4C70B041CE 6f393dc9-7002-4fa7-8d05-c390e95e81e0 TCGA-DD-A39W-01A-11D-A20W-10 TCGA-DD-A39W-01 TCGA-DD-A39W-01 6f393dc9-7002-4fa7-8d05-c390e95e81e0 TCGA-DD-A39W-01A-11D-A20W-10 6f393dc9-7002-4fa7-8d05-c390e95e81e0 6f393dc9-7002-4fa7-8d05-c390e95e81e0 TCGA-DD-A39W-01A-11D-A20W-10 TCGA-DD-A39W-01A-11D-A20Z-05 TCGA-DD-A39W-11 TCGA-DD-A39W-11 TCGA-DD-A39W TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 29 TCGA-DD-A39W-F42705 TCGA-DD-A39W -10699 827 0 2013-5-8 FEMALE 177 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G2 No M0 N0 T3 Stage III A39W R0 Solid Tissue Normal 11 Segmentectomy, Multiple 4th NO YES DD Liver None DECEASED 74 1995 TCGA-DD-A39W-11 e66b878f-0a33-4edf-ba17-e0ec9f41e589 TCGA-DD-A39W-11 e66b878f-0a33-4edf-ba17-e0ec9f41e589 e66b878f-0a33-4edf-ba17-e0ec9f41e589 e66b878f-0a33-4edf-ba17-e0ec9f41e589 TCGA-DD-A39W-11A-11D-A20Z-05 TCGA-DD-A39X-01 TCGA-DD-A39X-01 TCGA-DD-A39X TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 78 3.5 4.1 5.0 TCGA-DD-A39X-F42568 TCGA-DD-A39X TCGA-DD-A39X-01A 0.1 0.5 2 A 0.6 0.9 0.9 -28528 4705 1694 0 1032 1 0 6 10 0 - No Fibrosis 2013-4-24 FEMALE 152 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 8.4 12.0 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 NX T1 Stage I TCGA-DD-A39X.B9919D23-7D65-4295-84D5-6678B26BEA01.pdf A39X WITH TUMOR 180 150 450 YES NO 9.8 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody DECEASED 48 1998 TCGA-DD-A39X-01A-11D-A20V-01 TCGA-DD-A39X-01A-11D-A20V-01 TCGA-DD-A39X-01A-11D-A20W-10 TCGA-DD-A39X-01 TCGA-DD-A39X-01 5D51C3D9-4693-4108-B601-BCC8C59743A5 2a624b0d-4dc2-4c00-8984-b256a69643c7 TCGA-DD-A39X-01A-11D-A20W-10 TCGA-DD-A39X-01 TCGA-DD-A39X-01 2a624b0d-4dc2-4c00-8984-b256a69643c7 TCGA-DD-A39X-01A-11D-A20W-10 2a624b0d-4dc2-4c00-8984-b256a69643c7 2a624b0d-4dc2-4c00-8984-b256a69643c7 TCGA-DD-A39X-01A-11D-A20W-10 TCGA-DD-A39X-01A-11D-A20Z-05 TCGA-DD-A39X-11 TCGA-DD-A39X-11 TCGA-DD-A39X TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 78 3.5 4.1 5.0 TCGA-DD-A39X-F42568 TCGA-DD-A39X TCGA-DD-A39X-11A 0.1 0.5 2 A 0.6 0.9 0.9 -28528 4705 1694 0 1032 1 0 6 10 0 - No Fibrosis 2013-4-24 FEMALE 152 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 230 8.4 12.0 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 NX T1 Stage I A39X WITH TUMOR 180 150 450 YES NO 9.8 NO YES R0 Solid Tissue Normal 11 Segmentectomy, Multiple 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody DECEASED 48 1998 TCGA-DD-A39X-11 9815693f-418d-4517-9a7e-5c708c157b0c TCGA-DD-A39X-11 9815693f-418d-4517-9a7e-5c708c157b0c 9815693f-418d-4517-9a7e-5c708c157b0c 9815693f-418d-4517-9a7e-5c708c157b0c TCGA-DD-A39X-11A-11D-A20Z-05 TCGA-DD-A39Y-01 TCGA-DD-A39Y-01 TCGA-DD-A39Y TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 67 3.5 4.0 5.0 TCGA-DD-A39Y-F42701 TCGA-DD-A39Y TCGA-DD-A39Y-01A 0.1 1.1 A 1.2 12.0 0.8 -24769 3530 171 0 2 0 6 5600 0 - No Fibrosis 2013-4-27 MALE 176 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 220 8.4 12.0 NO NO G3 NO false No M0 NX T1 Stage I TCGA-DD-A39Y.2674265B-6B9D-49B3-9BD2-DF4E77AD4B26.pdf A39Y TUMOR FREE 243 150 450 NO NO 10.2 NO YES R0 Primary Tumor 01 Extended Lobectomy 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 85 2002 TCGA-DD-A39Y-01A-11D-A20V-01 TCGA-DD-A39Y-01A-11D-A20V-01 TCGA-DD-A39Y-01A-11D-A20W-10 TCGA-DD-A39Y-01 TCGA-DD-A39Y-01 2BEF3FF0-41EC-4939-AC16-6E32F2C94D1E 6a169722-0dcb-4df7-82c5-8f8b7a512d32 TCGA-DD-A39Y-01A-11D-A20W-10 TCGA-DD-A39Y-01 TCGA-DD-A39Y-01 6a169722-0dcb-4df7-82c5-8f8b7a512d32 TCGA-DD-A39Y-01A-11D-A20W-10 6a169722-0dcb-4df7-82c5-8f8b7a512d32 6a169722-0dcb-4df7-82c5-8f8b7a512d32 TCGA-DD-A39Y-01A-11D-A20W-10 TCGA-DD-A39Y-01A-11D-A20Z-05 TCGA-DD-A39Z-01 TCGA-DD-A39Z-01 TCGA-DD-A39Z TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 43 3.5 3.1 5.0 TCGA-DD-A39Z-F42006 TCGA-DD-A39Z TCGA-DD-A39Z-01A 0.1 1.2 1 B 0.6 0.9 0.7 -15930 5728 601 0 2 2013-4-24 FEMALE 165 Alcohol consumption extensive tobacco history Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 8.4 12.0 NO NO G2 false No M0 NX T2 Stage II TCGA-DD-A39Z.1976B0D8-E1F2-468F-9AB0-242E9507AB0D.pdf A39Z TUMOR FREE 437 150 450 12.6 YES R0 Primary Tumor 01 Segmentectomy, Single 4th NO YES DD 1.1 Liver None A DECEASED 61 1996 TCGA-DD-A39Z-01A-11D-A20V-01 TCGA-DD-A39Z-01A-11D-A20V-01 TCGA-DD-A39Z-01A-11D-A20W-10 TCGA-DD-A39Z-01 TCGA-DD-A39Z-01 A17BEA72-BD38-493A-98EA-C7768718E81D 2bbf9181-a71f-4714-b1b5-0d23a47d1306 TCGA-DD-A39Z-01A-11D-A20W-10 TCGA-DD-A39Z-01 TCGA-DD-A39Z-01 2bbf9181-a71f-4714-b1b5-0d23a47d1306 TCGA-DD-A39Z-01A-11D-A20W-10 2bbf9181-a71f-4714-b1b5-0d23a47d1306 2bbf9181-a71f-4714-b1b5-0d23a47d1306 TCGA-DD-A39Z-01A-11D-A20W-10 TCGA-DD-A39Z-01A-11D-A20Z-05 TCGA-DD-A39Z-11 TCGA-DD-A39Z-11 TCGA-DD-A39Z TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 43 3.5 3.1 5.0 TCGA-DD-A39Z-F42006 TCGA-DD-A39Z 0.1 1.2 1 B 0.6 0.9 0.7 -15930 601 0 2 2013-4-24 FEMALE 165 Alcohol consumption extensive tobacco history Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.4 12.0 NO G2 No M0 NX T2 Stage II A39Z TUMOR FREE 437 150 450 12.6 YES R0 Solid Tissue Normal 11 Segmentectomy, Single 4th NO YES DD 1.1 Liver None DECEASED 61 1996 TCGA-DD-A39Z-11 f847f8c8-7a39-4327-ad12-3aac2c331be8 TCGA-DD-A39Z-11 f847f8c8-7a39-4327-ad12-3aac2c331be8 f847f8c8-7a39-4327-ad12-3aac2c331be8 f847f8c8-7a39-4327-ad12-3aac2c331be8 TCGA-DD-A39Z-11A-21D-A20Z-05 TCGA-DD-A3A0-01 TCGA-DD-A3A0-01 TCGA-DD-A3A0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES None 70 3.5 3.3 5.0 TCGA-DD-A3A0-F42710 TCGA-DD-A3A0 TCGA-DD-A3A0-01A 0.1 1.4 A 0.8 1.2 2.7 -25889 3586 785 0 359 1 0 6 1 0 - No Fibrosis 2013-4-27 MALE 178 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 220 8.4 12.0 NO NO G2 New Primary Tumor No NO YES No false No M0 NX T1 Stage I TCGA-DD-A3A0.C9E146D4-77FF-4877-8DA6-2E5D912F33C6.pdf A3A0 WITH TUMOR 138 150 450 NO NO 13.2 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 88 2001 TCGA-DD-A3A0-01A-11D-A20V-01 TCGA-DD-A3A0-01A-11D-A20V-01 TCGA-DD-A3A0-01A-11D-A20W-10 TCGA-DD-A3A0-01 053627EF-A775-4F28-85F8-CDCFE4DCDDF7 TCGA-DD-A3A0-01A-11D-A20W-10 TCGA-DD-A3A0-01 TCGA-DD-A3A0-01A-11D-A20W-10 TCGA-DD-A3A0-01A-11D-A20W-10 TCGA-DD-A3A0-01A-11D-A20Z-05 TCGA-DD-A3A1-01 TCGA-DD-A3A1-01 TCGA-DD-A3A1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 65 3.5 3.8 5.0 TCGA-DD-A3A1-F42704 TCGA-DD-A3A1 TCGA-DD-A3A1-01A 0.1 0.8 1 A 0.8 1.2 1.1 -24046 3753 233 0 0 0 6 6 0 - No Fibrosis 2013-4-27 MALE 185 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 8.4 12.0 NO NO G2 false No M0 N0 T3b Stage IIIA TCGA-DD-A3A1.EAB38F5C-4399-48DE-A4F5-18B7CB982689.pdf A3A1 TUMOR FREE 178 150 450 NO NO 11.2 NO YES R0 Primary Tumor 01 Extended Lobectomy 5th NO YES DD 1.1 Liver Macro A DECEASED 78 2001 TCGA-DD-A3A1-01A-11D-A20V-01 TCGA-DD-A3A1-01A-11D-A20V-01 TCGA-DD-A3A1-01A-11D-A20W-10 TCGA-DD-A3A1-01 TCGA-DD-A3A1-01 8F14D825-2D09-4F5C-A2CD-0FAFC2104791 578e5ec2-7091-4f3e-a440-1fcd5585a704 TCGA-DD-A3A1-01A-11D-A20W-10 TCGA-DD-A3A1-01 TCGA-DD-A3A1-01 578e5ec2-7091-4f3e-a440-1fcd5585a704 TCGA-DD-A3A1-01A-11D-A20W-10 578e5ec2-7091-4f3e-a440-1fcd5585a704 578e5ec2-7091-4f3e-a440-1fcd5585a704 TCGA-DD-A3A1-01A-11D-A20W-10 TCGA-DD-A3A1-01A-11D-A20Z-05 TCGA-DD-A3A1-11 TCGA-DD-A3A1-11 TCGA-DD-A3A1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 65 3.5 3.8 5.0 TCGA-DD-A3A1-F42704 TCGA-DD-A3A1 TCGA-DD-A3A1-11A 0.1 0.8 1 A 0.8 1.2 1.1 -24046 3753 233 0 0 0 6 6 0 - No Fibrosis 2013-4-27 MALE 185 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 180 8.4 12.0 NO NO G2 false No M0 N0 T3b Stage IIIA A3A1 TUMOR FREE 178 150 450 NO NO 11.2 NO YES R0 Solid Tissue Normal 11 Extended Lobectomy 5th NO YES DD 1.1 Liver Macro A DECEASED 78 2001 TCGA-DD-A3A1-11 5573955b-f0ec-4cfe-ad02-4f9f91693770 TCGA-DD-A3A1-11 5573955b-f0ec-4cfe-ad02-4f9f91693770 5573955b-f0ec-4cfe-ad02-4f9f91693770 5573955b-f0ec-4cfe-ad02-4f9f91693770 TCGA-DD-A3A1-11A-11D-A20Z-05 TCGA-DD-A3A2-01 TCGA-DD-A3A2-01 TCGA-DD-A3A2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 76 3.5 4.2 5.0 TCGA-DD-A3A2-F42706 TCGA-DD-A3A2 TCGA-DD-A3A2-01A 0.1 0.5 A 0.6 0.9 0.8 -27930 4962 2131 0 0 0 - No Fibrosis 2013-4-27 FEMALE 178 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 8.4 12.0 NO NO G1 false No M0 N0 T1 Stage I TCGA-DD-A3A2.91B547FA-DAB2-4B65-9AC4-5151D4524001.pdf A3A2 TUMOR FREE 326 150 450 NO NO 8.8 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 5th NO YES DD 1.1 Liver None A DECEASED 85 1998 TCGA-DD-A3A2-01A-11D-A20V-01 TCGA-DD-A3A2-01A-11D-A20V-01 TCGA-DD-A3A2-01A-11D-A20W-10 TCGA-DD-A3A2-01 TCGA-DD-A3A2-01 694C11EB-8C14-41FF-AD29-B0029EE9A218 b532e040-8d89-458b-a13c-3da835918813 TCGA-DD-A3A2-01A-11D-A20W-10 TCGA-DD-A3A2-01 TCGA-DD-A3A2-01 b532e040-8d89-458b-a13c-3da835918813 TCGA-DD-A3A2-01A-11D-A20W-10 b532e040-8d89-458b-a13c-3da835918813 b532e040-8d89-458b-a13c-3da835918813 TCGA-DD-A3A2-01A-11D-A20W-10 TCGA-DD-A3A2-01A-11D-A20Z-05 TCGA-DD-A3A2-11 TCGA-DD-A3A2-11 TCGA-DD-A3A2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 76 3.5 4.2 5.0 TCGA-DD-A3A2-F42706 TCGA-DD-A3A2 TCGA-DD-A3A2-11A 0.1 0.5 A 0.6 0.9 0.8 -27930 4962 2131 0 0 0 - No Fibrosis 2013-4-27 FEMALE 178 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 8.4 12.0 NO NO G1 false No M0 N0 T1 Stage I A3A2 TUMOR FREE 326 150 450 NO NO 8.8 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 5th NO YES DD 1.1 Liver None A DECEASED 85 1998 TCGA-DD-A3A2-11 6d9b3d3a-2dd0-477e-aaf2-504ecd6c3de3 TCGA-DD-A3A2-11 6d9b3d3a-2dd0-477e-aaf2-504ecd6c3de3 6d9b3d3a-2dd0-477e-aaf2-504ecd6c3de3 6d9b3d3a-2dd0-477e-aaf2-504ecd6c3de3 TCGA-DD-A3A2-11A-11D-A20Z-05 TCGA-DD-A3A3-01 TCGA-DD-A3A3-01 TCGA-DD-A3A3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 45 TCGA-DD-A3A3-F42700 TCGA-DD-A3A3 TCGA-DD-A3A3-01A 0.1 0.9 B 0.8 1.2 1.2 -16708 4397 535 0 1 0 6 6 0 - No Fibrosis 2013-4-27 MALE 167 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 8.4 12.0 NO NO G2 false No M0 N0 T1 Stage I TCGA-DD-A3A3.A37A1F44-D2AD-457C-8292-3E7A6667268D.pdf A3A3 276 150 450 8.8 NO R0 Primary Tumor 01 Extended Lobectomy 5th NO YES DD 1.1 Liver Macro A DECEASED 71 1999 TCGA-DD-A3A3-01A-11D-A22E-01 TCGA-DD-A3A3-01A-11D-A22E-01 TCGA-DD-A3A3-01A-11D-A22F-10 TCGA-DD-A3A3-01 TCGA-DD-A3A3-01 12B1E429-5B1A-40A2-BEBD-65CAECD789C3 3d39e165-1def-4a5e-b011-b2ceb033d415 TCGA-DD-A3A3-01A-11D-A22F-10 TCGA-DD-A3A3-01 TCGA-DD-A3A3-01 3d39e165-1def-4a5e-b011-b2ceb033d415 TCGA-DD-A3A3-01A-11D-A22F-10 3d39e165-1def-4a5e-b011-b2ceb033d415 3d39e165-1def-4a5e-b011-b2ceb033d415 TCGA-DD-A3A3-01A-11D-A22F-10 TCGA-DD-A3A3-01A-11D-A22H-05 TCGA-DD-A3A3-11 TCGA-DD-A3A3-11 TCGA-DD-A3A3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 45 TCGA-DD-A3A3-F42700 TCGA-DD-A3A3 TCGA-DD-A3A3-11A 0.1 0.9 B 0.8 1.2 1.2 -16708 4397 535 0 1 0 6 6 0 - No Fibrosis 2013-4-27 MALE 167 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 190 8.4 12.0 NO NO G2 false No M0 N0 T1 Stage I A3A3 276 150 450 8.8 NO R0 Solid Tissue Normal 11 Extended Lobectomy 5th NO YES DD 1.1 Liver Macro A DECEASED 71 1999 TCGA-DD-A3A3-11 13d4c229-cf05-4fca-a52d-798dc7894ba1 TCGA-DD-A3A3-11 13d4c229-cf05-4fca-a52d-798dc7894ba1 13d4c229-cf05-4fca-a52d-798dc7894ba1 13d4c229-cf05-4fca-a52d-798dc7894ba1 TCGA-DD-A3A3-11A-11D-A22H-05 TCGA-DD-A3A4-01 TCGA-DD-A3A4-01 TCGA-DD-A3A4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 37 3.5 3.3 5.0 TCGA-DD-A3A4-F42697 TCGA-DD-A3A4 TCGA-DD-A3A4-01A 0.1 1.0 2 B 0.4 1.2 1.0 -13739 4776 612 0 87 0 0 - No Fibrosis 2013-4-27 MALE 189 Other Tobacco use Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 8.4 12.0 NO NO G3 Liver Intrahepatic Recurrence Yes NO YES No false No M0 N0 T3 Stage IIIA TCGA-DD-A3A4.C755324B-9B82-4319-BDD8-EB8A24107AAC.pdf A3A4 WITH TUMOR 283 150 450 YES NO 11.0 NO YES R0 Primary Tumor 01 Extended Lobectomy 5th NO YES DD 1.0 Liver None A DECEASED 65 1998 TCGA-DD-A3A4-01A-11D-A22E-01 TCGA-DD-A3A4-01A-11D-A22E-01 TCGA-DD-A3A4-01A-11D-A22F-10 TCGA-DD-A3A4-01 TCGA-DD-A3A4-01 953B1312-01CF-4CB4-8916-F3813C9FE832 3bf58509-d849-492e-85cc-665f1db2ccc7 TCGA-DD-A3A4-01A-11D-A22F-10 TCGA-DD-A3A4-01 TCGA-DD-A3A4-01 3bf58509-d849-492e-85cc-665f1db2ccc7 TCGA-DD-A3A4-01A-11D-A22F-10 3bf58509-d849-492e-85cc-665f1db2ccc7 3bf58509-d849-492e-85cc-665f1db2ccc7 TCGA-DD-A3A4-01A-11D-A22F-10 TCGA-DD-A3A4-01A-11D-A22H-05 TCGA-DD-A3A4-11 TCGA-DD-A3A4-11 TCGA-DD-A3A4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 37 3.5 3.3 5.0 TCGA-DD-A3A4-F42697 TCGA-DD-A3A4 0.1 1.0 2 B 0.4 1.2 1.0 -13739 612 0 87 0 0 - No Fibrosis 2013-4-27 MALE 189 Other Tobacco use Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.4 12.0 NO G3 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T3 Stage IIIA A3A4 WITH TUMOR 283 150 450 YES NO 11.0 NO YES R0 Solid Tissue Normal 11 Extended Lobectomy 5th NO YES DD 1.0 Liver None DECEASED 65 1998 TCGA-DD-A3A4-11 b706b36a-2bcf-405c-aa18-30cbb54fac73 TCGA-DD-A3A4-11 b706b36a-2bcf-405c-aa18-30cbb54fac73 b706b36a-2bcf-405c-aa18-30cbb54fac73 b706b36a-2bcf-405c-aa18-30cbb54fac73 TCGA-DD-A3A5-01 TCGA-DD-A3A5-01 TCGA-DD-A3A5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 66 3.5 4.2 5.0 TCGA-DD-A3A5-F42571 TCGA-DD-A3A5 TCGA-DD-A3A5-01A 0.1 0.8 A 0.6 0.9 0.7 -24288 5538 3125 0 84 1 0 6 55 0 - No Fibrosis 2013-4-24 FEMALE 170 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 8.4 12.0 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 N0 T3 Stage III TCGA-DD-A3A5.646F2FED-EA95-4758-B454-4B0E638553B4.pdf A3A5 WITH TUMOR 312 150 450 NO NO 8.7 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 4th NO YES DD 1.1 Liver None A DECEASED 58 1996 TCGA-DD-A3A5-01A-11D-A22E-01 TCGA-DD-A3A5-01A-11D-A22E-01 TCGA-DD-A3A5-01A-11D-A22F-10 TCGA-DD-A3A5-01 TCGA-DD-A3A5-01 EB836FD0-DB80-410C-8C1E-8F713772CE75 a2367aee-0cd5-473e-b799-77970c0ceea3 TCGA-DD-A3A5-01A-11D-A22F-10 TCGA-DD-A3A5-01 TCGA-DD-A3A5-01 a2367aee-0cd5-473e-b799-77970c0ceea3 TCGA-DD-A3A5-01A-11D-A22F-10 a2367aee-0cd5-473e-b799-77970c0ceea3 a2367aee-0cd5-473e-b799-77970c0ceea3 TCGA-DD-A3A5-01A-11D-A22F-10 TCGA-DD-A3A5-01A-11D-A22H-05 TCGA-DD-A3A5-11 TCGA-DD-A3A5-11 TCGA-DD-A3A5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 66 3.5 4.2 5.0 TCGA-DD-A3A5-F42571 TCGA-DD-A3A5 0.1 0.8 A 0.6 0.9 0.7 -24288 3125 0 84 1 0 6 55 0 - No Fibrosis 2013-4-24 FEMALE 170 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.4 12.0 NO G2 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T3 Stage III A3A5 WITH TUMOR 312 150 450 NO NO 8.7 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 4th NO YES DD 1.1 Liver None DECEASED 58 1996 TCGA-DD-A3A5-11 dfeaa69b-72ec-4a2e-8f26-7c4d826a1aa0 TCGA-DD-A3A5-11 dfeaa69b-72ec-4a2e-8f26-7c4d826a1aa0 dfeaa69b-72ec-4a2e-8f26-7c4d826a1aa0 dfeaa69b-72ec-4a2e-8f26-7c4d826a1aa0 TCGA-DD-A3A6-01 TCGA-DD-A3A6-01 TCGA-DD-A3A6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 72 3.5 4.3 5.0 TCGA-DD-A3A6-F42703 TCGA-DD-A3A6 TCGA-DD-A3A6-01A 0.1 0.4 A 0.6 0.9 1.0 -26319 5304 3258 0 0 0 - No Fibrosis 2013-4-27 FEMALE 175 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 150 8.4 12.0 NO NO G2 NO false No M0 N0 T2 Stage II TCGA-DD-A3A6.EEA9EFFB-B5F9-42D9-B452-E165E018C33C.pdf A3A6 TUMOR FREE 4 0 6 NO NO 9.3 NO NO R0 Primary Tumor 01 Extended Lobectomy 4th NO YES DD 1.1 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 52 1997 TCGA-DD-A3A6-01A-11D-A22E-01 TCGA-DD-A3A6-01A-11D-A22E-01 TCGA-DD-A3A6-01A-11D-A22F-10 TCGA-DD-A3A6-01 TCGA-DD-A3A6-01 BA568908-D423-4039-87E8-B5597CB65AB9 56e6f602-0afb-434e-b28e-665d923ad781 TCGA-DD-A3A6-01A-11D-A22F-10 TCGA-DD-A3A6-01 TCGA-DD-A3A6-01 56e6f602-0afb-434e-b28e-665d923ad781 TCGA-DD-A3A6-01A-11D-A22F-10 56e6f602-0afb-434e-b28e-665d923ad781 56e6f602-0afb-434e-b28e-665d923ad781 TCGA-DD-A3A6-01A-11D-A22F-10 TCGA-DD-A3A6-01A-11D-A22H-05 TCGA-DD-A3A6-11 TCGA-DD-A3A6-11 TCGA-DD-A3A6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 72 3.5 4.3 5.0 TCGA-DD-A3A6-F42703 TCGA-DD-A3A6 TCGA-DD-A3A6-11A 0.1 0.4 A 0.6 0.9 1.0 -26319 5304 3258 0 0 0 - No Fibrosis 2013-4-27 FEMALE 175 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 8.4 12.0 NO NO G2 NO false No M0 N0 T2 Stage II A3A6 TUMOR FREE 4 0 6 NO NO 9.3 NO NO R0 Solid Tissue Normal 11 Extended Lobectomy 4th NO YES DD 1.1 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 52 1997 TCGA-DD-A3A6-11 809db606-7929-48aa-ae6b-c2c9597a31c7 TCGA-DD-A3A6-11 809db606-7929-48aa-ae6b-c2c9597a31c7 809db606-7929-48aa-ae6b-c2c9597a31c7 809db606-7929-48aa-ae6b-c2c9597a31c7 TCGA-DD-A3A7-01 TCGA-DD-A3A7-01 TCGA-DD-A3A7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Mild 67 TCGA-DD-A3A7-F42004 TCGA-DD-A3A7 TCGA-DD-A3A7-01A 0.1 0.8 4 0.8 1.2 1.4 -24599 4772 419 0 144 1 0 6 120 0 - No Fibrosis 2013-4-9 MALE 188 Alcohol consumption|Other tobacco Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 130 8.4 12.0 NO NO G3 Liver Intrahepatic Recurrence No NO YES No false No M0 N0 T3b Stage IIIB TCGA-DD-A3A7.B520F88D-4004-4DFA-BF8D-7CE96777C5A3.pdf A3A7 WITH TUMOR 562 150 450 NO NO 10.6 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.1 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 80 1998 TCGA-DD-A3A7-01A-11D-A22E-01 TCGA-DD-A3A7-01A-11D-A22E-01 TCGA-DD-A3A7-01A-11D-A22F-10 TCGA-DD-A3A7-01 TCGA-DD-A3A7-01 DC935FAC-6F3A-4861-A820-4F0A5D7D8CEA 5bd6ca42-16ca-484f-877f-cda4fb3f93a8 TCGA-DD-A3A7-01A-11D-A22F-10 TCGA-DD-A3A7-01 TCGA-DD-A3A7-01 5bd6ca42-16ca-484f-877f-cda4fb3f93a8 TCGA-DD-A3A7-01A-11D-A22F-10 5bd6ca42-16ca-484f-877f-cda4fb3f93a8 5bd6ca42-16ca-484f-877f-cda4fb3f93a8 TCGA-DD-A3A7-01A-11D-A22F-10 TCGA-DD-A3A7-01A-11D-A22H-05 TCGA-DD-A3A8-01 TCGA-DD-A3A8-01 TCGA-DD-A3A8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 75 TCGA-DD-A3A8-F42570 TCGA-DD-A3A8 TCGA-DD-A3A8-01A 0.1 1.0 3 A 0.8 1.2 0.9 -27524 3708 11 0 1 0 6 4 0 - No Fibrosis 2013-4-24 MALE 177 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 290 NO NO G2 NO false Yes M0 N0 T2 Stage II TCGA-DD-A3A8.5D143B3D-AC64-4C1C-A276-D12111750C67.pdf A3A8 TUMOR FREE 251 150 450 NO NO NO YES R0 Primary Tumor 01 Lobectomy 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 99 2001 TCGA-DD-A3A8-01A-11D-A22E-01 TCGA-DD-A3A8-01A-11D-A22E-01 TCGA-DD-A3A8-01A-11D-A22F-10 TCGA-DD-A3A8-01 TCGA-DD-A3A8-01 D0C214D0-9A29-41AE-9FC4-1FE0D7B5428A 41e90e6f-0afe-433e-a13d-cc5fc758c55b TCGA-DD-A3A8-01A-11D-A22F-10 TCGA-DD-A3A8-01 TCGA-DD-A3A8-01 41e90e6f-0afe-433e-a13d-cc5fc758c55b TCGA-DD-A3A8-01A-11D-A22F-10 41e90e6f-0afe-433e-a13d-cc5fc758c55b 41e90e6f-0afe-433e-a13d-cc5fc758c55b TCGA-DD-A3A8-01A-11D-A22F-10 TCGA-DD-A3A8-01A-11D-A22H-05 TCGA-DD-A3A8-11 TCGA-DD-A3A8-11 TCGA-DD-A3A8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 75 TCGA-DD-A3A8-F42570 TCGA-DD-A3A8 0.1 1.0 3 A 0.8 1.2 0.9 -27524 11 0 1 0 6 4 0 - No Fibrosis 2013-4-24 MALE 177 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G2 NO Yes M0 N0 T2 Stage II A3A8 TUMOR FREE 251 150 450 NO NO NO YES R0 Solid Tissue Normal 11 Lobectomy 5th NO YES DD 1.0 Liver None Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 99 2001 TCGA-DD-A3A8-11 cf95e020-748c-474d-baba-68ca888d2f4f TCGA-DD-A3A8-11 cf95e020-748c-474d-baba-68ca888d2f4f cf95e020-748c-474d-baba-68ca888d2f4f cf95e020-748c-474d-baba-68ca888d2f4f TCGA-DD-A3A9-01 TCGA-DD-A3A9-01 TCGA-DD-A3A9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 64 3.5 4.0 5.0 TCGA-DD-A3A9-F42709 TCGA-DD-A3A9 TCGA-DD-A3A9-01A 0.1 0.3 A 0.6 0.9 0.9 -23526 3584 931 0 289 1 0 6 19930 0 - No Fibrosis 2013-4-27 FEMALE 168 Other smoker Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 230 8.4 12.0 NO NO G2 Lung Extrahepatic Recurrence NO YES false No M1 N0 T4 Stage IVB TCGA-DD-A3A9.59B64E76-42CB-421D-B8A7-36F7050BA5E5.pdf A3A9 WITH TUMOR 317 150 450 9.3 NO R0 Primary Tumor 01 Lobectomy 5th NO YES DD 1.0 Liver None A DECEASED 62 2001 TCGA-DD-A3A9-01A-11D-A25U-01 TCGA-DD-A3A9-01A-11D-A25U-01 TCGA-DD-A3A9-01A-11D-A25V-10 TCGA-DD-A3A9-01 TCGA-DD-A3A9-01 8021FC77-6677-4784-83FA-19CF2ECBDC1F e53f26c4-eb37-4a21-823e-98000f26309d TCGA-DD-A3A9-01A-11D-A25V-10 TCGA-DD-A3A9-01 TCGA-DD-A3A9-01 e53f26c4-eb37-4a21-823e-98000f26309d TCGA-DD-A3A9-01A-11D-A25V-10 e53f26c4-eb37-4a21-823e-98000f26309d e53f26c4-eb37-4a21-823e-98000f26309d TCGA-DD-A3A9-01A-11D-A25V-10 TCGA-DD-A3A9-01A-11D-A264-05 TCGA-DD-A4NA-01 TCGA-DD-A4NA-01 TCGA-DD-A4NA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 67 TCGA-DD-A4-F49640 TCGA-DD-A4 TCGA-DD-A4-01A 2 0.6 1.1 0.8 -24603 1198 0 1008 0 0 6 3 5 - Nodular Formation and Incomplete Cirrhosis 2013-10-7 FEMALE 166 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 8.3 10.8 NO YES G3 NO true No M0 N1 T2 Stage IIIC TCGA-DD-A4.48C11C04-947E-4954-9687-DF275D897F79.pdf A4 TUMOR FREE 332 150 450 NO NO 9.6 NO YES R0 Primary Tumor 01 Extended Lobectomy 6th NO YES DD Liver A Hepatitis B Surface Antigen|HBV Surface Antibody LIVING 93 2009 TCGA-DD-A4NA-01A-11D-A25U-01 TCGA-DD-A4NA-01A-11D-A25U-01 TCGA-DD-A4NA-01A-11D-A25V-10 TCGA-DD-A4NA-01 TCGA-DD-A4NA-01 C7C5E4DB-1B88-4A44-8048-7E87E1540459 59b320d5-a277-4723-b9f0-d1e7fe2a20af TCGA-DD-A4NA-01A-11D-A25V-10 TCGA-DD-A4NA-01 TCGA-DD-A4NA-01 59b320d5-a277-4723-b9f0-d1e7fe2a20af TCGA-DD-A4NA-01A-11D-A25V-10 59b320d5-a277-4723-b9f0-d1e7fe2a20af 59b320d5-a277-4723-b9f0-d1e7fe2a20af TCGA-DD-A4NA-01A-11D-A25V-10 TCGA-DD-A4NA-01A-11D-A264-05 TCGA-DD-A4NB-01 TCGA-DD-A4NB-01 TCGA-DD-A4NB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 25 TCGA-DD-A4NB-F59448 TCGA-DD-A4NB TCGA-DD-A4NB-01A 0.1 1.0 2 0.8 1.3 0.8 -9426 464 0 989 913 912 1 0 6 3 2014-5-13 MALE 185 No History of Primary Risk Factors Fibrolamellar Carcinoma No C22.0 8171/3 C22.0 YES 180 9.5 13.8 NO NO G2 Other, specify Extrahepatic Recurrence retroperitoneal lymph nodes No YES YES No true No M0 N0 T1 Stage I TCGA-DD-A4NB.963CA9F8-DA47-4E2E-892E-14E7AB0EB76E.pdf A4NB TUMOR FREE 296 150 450 NO NO 13.9 NO YES R0 R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.0 Liver None A LIVING 69 2011 TCGA-DD-A4NB-01A-12D-A25U-01 TCGA-DD-A4NB-01A-12D-A25U-01 TCGA-DD-A4NB-01A-12D-A25V-10 TCGA-DD-A4NB-01 TCGA-DD-A4NB-01 45787358-74F0-4C4F-85E9-984864B87439 173a2cc4-0d27-4a27-857f-97a0e53fa8d1 TCGA-DD-A4NB-01A-12D-A25V-10 TCGA-DD-A4NB-01 TCGA-DD-A4NB-01 173a2cc4-0d27-4a27-857f-97a0e53fa8d1 TCGA-DD-A4NB-01A-12D-A25V-10 173a2cc4-0d27-4a27-857f-97a0e53fa8d1 173a2cc4-0d27-4a27-857f-97a0e53fa8d1 TCGA-DD-A4NB-01A-12D-A25V-10 TCGA-DD-A4NB-01A-12D-A264-05 TCGA-DD-A4ND-01 TCGA-DD-A4ND-01 TCGA-DD-A4ND TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 56 3.5 3.9 5 TCGA-DD-A4ND-F43021 TCGA-DD-A4ND TCGA-DD-A4ND-01A 0.1 0.5 3 A 0.6 1.1 0.7 -20782 2088 0 2746 20 1 0 - No Fibrosis 2014-10-21 FEMALE 162 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 8.4 12 NO NO G3 Other, specify New Primary Tumor stage IV breast carcinoma No NO NO No true Yes M0 N0 T1 Stage I TCGA-DD-A4ND.64D878AE-DEEA-4C56-854C-3774038E2914.pdf A4ND TUMOR FREE NO NO 8.8 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1 Liver None A LIVING 89 2007 TCGA-DD-A4ND-01A-11D-A25U-01 TCGA-DD-A4ND-01A-11D-A25U-01 TCGA-DD-A4ND-01A-11D-A25V-10 TCGA-DD-A4ND-01 TCGA-DD-A4ND-01 BED220BC-C4F4-407D-A237-BB3ADCAB45CB b3d02a68-fde3-42cd-8ca2-7e3565f85632 TCGA-DD-A4ND-01A-11D-A25V-10 TCGA-DD-A4ND-01 TCGA-DD-A4ND-01 b3d02a68-fde3-42cd-8ca2-7e3565f85632 TCGA-DD-A4ND-01A-11D-A25V-10 b3d02a68-fde3-42cd-8ca2-7e3565f85632 b3d02a68-fde3-42cd-8ca2-7e3565f85632 TCGA-DD-A4ND-01A-11D-A25V-10 TCGA-DD-A4ND-01A-11D-A264-05 TCGA-DD-A4NE-01 TCGA-DD-A4NE-01 TCGA-DD-A4NE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 75 3.5 4.2 5.0 TCGA-DD-A4NE-F49644 TCGA-DD-A4NE TCGA-DD-A4NE-01A 0.1 0.9 3 A 0.6 1.0 0.8 -27549 631 660 0 190 0 0 6 28 0 - No Fibrosis 2013-10-7 FEMALE 170 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 200 8.3 10.8 NO NO G3 Liver Locoregional Recurrence No NO YES No true No M0 N0 T3a Stage IIIA TCGA-DD-A4NE.8E3E5E19-6A21-44B1-B000-F90EA27F6EE0.pdf A4NE WITH TUMOR 348 150 450 NO NO 10.2 NO YES R0 Primary Tumor 01 Extended Lobectomy 7th NO YES DD 1.0 Liver None A Hepatitis C Virus R|Hepatitis B Surface Antigen|HBV Core Antibody DECEASED 79 2011 TCGA-DD-A4NE-01A-11D-A27I-10 TCGA-DD-A4NE-01 TCGA-DD-A4NE-01 A13ADCC3-E48C-4BFA-8AC2-654490756B65 050080ae-44db-4056-8df1-eae4d9014ac9 TCGA-DD-A4NE-01A-11D-A27I-10 TCGA-DD-A4NE-01 050080ae-44db-4056-8df1-eae4d9014ac9 TCGA-DD-A4NE-01A-11D-A27I-10 050080ae-44db-4056-8df1-eae4d9014ac9 050080ae-44db-4056-8df1-eae4d9014ac9 TCGA-DD-A4NE-01A-11D-A27I-10 TCGA-DD-A4NE-01A-11D-A27W-05 TCGA-DD-A4NF-01 TCGA-DD-A4NF-01 TCGA-DD-A4NF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES Mild 72 3.5 4 5.0 TCGA-DD-A4NF-F59456 TCGA-DD-A4NF TCGA-DD-A4NF-01A 0.1 0.5 A 0.8 1.3 0.9 -26330 364 0 942 656 0 0 6 6 6 - Established Cirrhosis 2014-5-13 MALE 173 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 200 9.5 13.8 NO NO G2 Bone Extrahepatic Recurrence No NO YES No true No M0 N0 T1 Stage I TCGA-DD-A4NF.7381633C-866A-4440-93B1-BC7102B59C93.pdf A4NF WITH TUMOR 97 150 450 NO NO 12.7 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.0 Liver None A Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 86 2011 TCGA-DD-A4NF-01A-11D-A27H-01 TCGA-DD-A4NF-01A-11D-A27H-01 TCGA-DD-A4NF-01A-11D-A27I-10 TCGA-DD-A4NF-01 TCGA-DD-A4NF-01 F89D6497-C924-4C3A-953D-6DCA31C8764A 23ac1fcb-a802-468b-8a25-639f2b221aba TCGA-DD-A4NF-01A-11D-A27I-10 TCGA-DD-A4NF-01 TCGA-DD-A4NF-01 23ac1fcb-a802-468b-8a25-639f2b221aba TCGA-DD-A4NF-01A-11D-A27I-10 23ac1fcb-a802-468b-8a25-639f2b221aba 23ac1fcb-a802-468b-8a25-639f2b221aba TCGA-DD-A4NF-01A-11D-A27I-10 TCGA-DD-A4NF-01A-11D-A27W-05 TCGA-DD-A4NG-01 TCGA-DD-A4NG-01 TCGA-DD-A4NG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 77 3.5 4.5 5.0 TCGA-DD-A4NG-F49648 TCGA-DD-A4NG TCGA-DD-A4NG-01A 0.1 0.5 1 A 0.8 1.3 0.9 -28234 629 802 0 445 430 1 0 6 3 2013-10-7 MALE 164 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 280 8.3 10.8 NO NO G2 Liver Locoregional Recurrence NO YES No true No M0 NX T3a Stage IIIA TCGA-DD-A4NG.4E4F148F-7C70-43DE-802E-271078BDFB4F.pdf A4NG WITH TUMOR 220 150 450 NO NO 10.6 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.0 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 94 2011 TCGA-DD-A4NG-01A-11D-A27I-10 TCGA-DD-A4NG-01 TCGA-DD-A4NG-01 43087284-F231-4802-AA2D-34B8622D1846 0fd0cbba-815e-4087-aa44-39c4b271ff49 TCGA-DD-A4NG-01A-11D-A27I-10 TCGA-DD-A4NG-01 0fd0cbba-815e-4087-aa44-39c4b271ff49 TCGA-DD-A4NG-01A-11D-A27I-10 0fd0cbba-815e-4087-aa44-39c4b271ff49 0fd0cbba-815e-4087-aa44-39c4b271ff49 TCGA-DD-A4NG-01A-11D-A27I-10 TCGA-DD-A4NG-01A-11D-A27W-05 TCGA-DD-A4NH-01 TCGA-DD-A4NH-01 TCGA-DD-A4NH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 65 3.5 4.0 5.0 TCGA-DD-A4NH-F59474 TCGA-DD-A4NH TCGA-DD-A4NH-01A 0.1 0.6 1 A 0.6 1.1 0.8 -23865 335 0 917 161 0 0 6 92889 1,2 - Portal Fibrosis 2014-5-13 FEMALE 157 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 270 9.5 13.8 NO NO G3 Lung Extrahepatic Recurrence No NO YES No true No M0 N0 T3b Stage IIIB TCGA-DD-A4NH.C9179EC7-2990-4581-B652-60289CC895F5.pdf A4NH WITH TUMOR 226 150 450 NO NO 11.8 NO YES R0 Primary Tumor 01 Extended Lobectomy 7th NO YES DD 1.0 Liver Macro A Hepatitis B Surface Antigen LIVING 81 2011 TCGA-DD-A4NH-01A-11D-A27H-01 TCGA-DD-A4NH-01A-11D-A27H-01 TCGA-DD-A4NH-01A-11D-A27I-10 TCGA-DD-A4NH-01 TCGA-DD-A4NH-01 DAC12730-5AF5-47EB-9DC6-008E0D3C2CD6 8d1c5ea4-08dd-4f4f-9876-ca5316e233b5 TCGA-DD-A4NH-01A-11D-A27I-10 TCGA-DD-A4NH-01 TCGA-DD-A4NH-01 8d1c5ea4-08dd-4f4f-9876-ca5316e233b5 TCGA-DD-A4NH-01A-11D-A27I-10 8d1c5ea4-08dd-4f4f-9876-ca5316e233b5 8d1c5ea4-08dd-4f4f-9876-ca5316e233b5 TCGA-DD-A4NH-01A-11D-A27I-10 TCGA-DD-A4NH-01A-11D-A27W-05 TCGA-DD-A4NI-01 TCGA-DD-A4NI-01 TCGA-DD-A4NI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 67 3.5 4.4 5.0 TCGA-DD-A4NI-F59476 TCGA-DD-A4NI TCGA-DD-A4NI-01A 0.1 0.6 6 A 0.8 1.3 1.1 -24516 357 0 816 0 0 6 6 0 - No Fibrosis 2014-5-13 MALE 172 Alcohol consumption|Non-Alcoholic Fatty Liver Disease tobacco Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 130 9.5 13.8 NO YES G2 NO true Yes M0 NX T2 Stage II TCGA-DD-A4NI.7D4F801A-187C-4B20-96B3-98313D5252E3.pdf A4NI TUMOR FREE 187 150 450 NO NO 12.4 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 99 2011 TCGA-DD-A4NI-01A-11D-A27H-01 TCGA-DD-A4NI-01A-11D-A27H-01 TCGA-DD-A4NI-01A-11D-A27I-10 TCGA-DD-A4NI-01 TCGA-DD-A4NI-01 C8A5BC94-6611-4B36-918E-0D26304CFCBA 49d9e652-b4e1-4858-b21e-256c17623f50 TCGA-DD-A4NI-01A-11D-A27I-10 TCGA-DD-A4NI-01 TCGA-DD-A4NI-01 49d9e652-b4e1-4858-b21e-256c17623f50 TCGA-DD-A4NI-01A-11D-A27I-10 49d9e652-b4e1-4858-b21e-256c17623f50 49d9e652-b4e1-4858-b21e-256c17623f50 TCGA-DD-A4NI-01A-11D-A27I-10 TCGA-DD-A4NI-01A-11D-A27W-05 TCGA-DD-A4NJ-01 TCGA-DD-A4NJ-01 TCGA-DD-A4NJ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 54 3.5 4.7 5.0 TCGA-DD-A4NJ-F59477 TCGA-DD-A4NJ TCGA-DD-A4NJ-01A 0.1 0.4 1 A 0.6 1.1 0.7 -19964 416 0 928 549 0 0 6 5 1,2 - Portal Fibrosis 2014-5-13 FEMALE 164 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 9.5 13.8 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T2 Stage II TCGA-DD-A4NJ.36C3150D-343E-4B3F-A5D7-1AE978246648.pdf A4NJ WITH TUMOR 303 150 450 NO NO 11.5 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 88 2011 TCGA-DD-A4NJ-01A-11D-A27H-01 TCGA-DD-A4NJ-01A-11D-A27H-01 TCGA-DD-A4NJ-01A-11D-A27I-10 TCGA-DD-A4NJ-01 DCF080D8-9F50-4DB3-B327-0C52F23FCE8D 1dc20bf4-f17d-4b26-88c0-86aff9ddfc7a TCGA-DD-A4NJ-01A-11D-A27I-10 TCGA-DD-A4NJ-01 1dc20bf4-f17d-4b26-88c0-86aff9ddfc7a TCGA-DD-A4NJ-01A-11D-A27I-10 1dc20bf4-f17d-4b26-88c0-86aff9ddfc7a 1dc20bf4-f17d-4b26-88c0-86aff9ddfc7a TCGA-DD-A4NJ-01A-11D-A27I-10 TCGA-DD-A4NJ-01A-11D-A27W-05 TCGA-DD-A4NK-01 TCGA-DD-A4NK-01 TCGA-DD-A4NK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 80 3.5 4.1 5.0 TCGA-DD-A4NK-F49654 TCGA-DD-A4NK TCGA-DD-A4NK-01A 0.1 0.5 3 A 0.7 1.2 1.1 -29244 3143 1210 0 89 0 0 6 3 0 - No Fibrosis 2013-10-7 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 130 8.4 12.0 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T3 Stage IIIA TCGA-DD-A4NK.0521278C-B2AC-4D7D-BC1F-5003B630808E.pdf A4NK WITH TUMOR 372 150 450 YES NO 8.7 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen DECEASED 84 2004 TCGA-DD-A4NK-01A-11D-A28W-01 TCGA-DD-A4NK-01A-11D-A28W-01 TCGA-DD-A4NK-01A-11D-A28X-10 TCGA-DD-A4NK-01 65645058-B639-4FBA-9204-6CC07D139290 28e2f8ef-14bf-4965-82a5-1d2e33a19af3 TCGA-DD-A4NK-01A-11D-A28X-10 TCGA-DD-A4NK-01 28e2f8ef-14bf-4965-82a5-1d2e33a19af3 TCGA-DD-A4NK-01A-11D-A28X-10 28e2f8ef-14bf-4965-82a5-1d2e33a19af3 28e2f8ef-14bf-4965-82a5-1d2e33a19af3 TCGA-DD-A4NK-01A-11D-A28X-10 TCGA-DD-A4NK-01A-11D-A28Y-05 TCGA-DD-A4NL-01 TCGA-DD-A4NL-01 TCGA-DD-A4NL TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 46 3.5 4.4 5.0 TCGA-DD-A4NL-F59645 TCGA-DD-A4NL TCGA-DD-A4NL-01A 0.1 0.3 0.8 1.3 1.0 -16874 1896 0 1711 1 0 6 2 0 - No Fibrosis 2014-5-17 MALE 173 Alcohol consumption|Other Tobacco use Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 NO YES G1 NO true No M0 N0 T1 Stage I TCGA-DD-A4NL.54C7EDE1-EDBE-44A4-A3BE-FD639D6891DA.pdf A4NL TUMOR FREE 266 150 450 NO NO NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 113 2007 TCGA-DD-A4NL-01A-11D-A28W-01 TCGA-DD-A4NL-01A-11D-A28W-01 TCGA-DD-A4NL-01A-11D-A28X-10 TCGA-DD-A4NL-01 TCGA-DD-A4NL-01 90779b87-ec28-4c54-b98e-3d70e132b7b3 TCGA-DD-A4NL-01A-11D-A28X-10 TCGA-DD-A4NL-01 TCGA-DD-A4NL-01 90779b87-ec28-4c54-b98e-3d70e132b7b3 TCGA-DD-A4NL-01A-11D-A28X-10 90779b87-ec28-4c54-b98e-3d70e132b7b3 90779b87-ec28-4c54-b98e-3d70e132b7b3 TCGA-DD-A4NL-01A-11D-A28X-10 TCGA-DD-A4NL-01A-11D-A28Y-05 TCGA-DD-A4NN-01 TCGA-DD-A4NN-01 TCGA-DD-A4NN TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 56 3.5 4.3 5.0 TCGA-DD-A4NN-F49659 TCGA-DD-A4NN TCGA-DD-A4NN-01A 0.1 0.5 1 A 0.7 1.2 0.9 -20548 3053 899 0 166 0 0 6 4223 0 - No Fibrosis 2013-10-7 FEMALE 163 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 8.0 12.0 NO NO G3 Lung Extrahepatic Recurrence No NO YES No true No M0 N0 T1 Stage I TCGA-DD-A4NN.16053CE8-B3B1-4925-AEAA-5B118E1C2E45.pdf A4NN WITH TUMOR 307 150 450 NO NO 8.8 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A DECEASED 59 2004 TCGA-DD-A4NN-01A-11D-A28W-01 TCGA-DD-A4NN-01A-11D-A28W-01 TCGA-DD-A4NN-01A-11D-A28X-10 TCGA-DD-A4NN-01 TCGA-DD-A4NN-01 9D74528E-5389-4281-B73A-894B9B356E0E 362c086d-ce73-408a-afcf-f129d54af1e9 TCGA-DD-A4NN-01A-11D-A28X-10 TCGA-DD-A4NN-01 TCGA-DD-A4NN-01 362c086d-ce73-408a-afcf-f129d54af1e9 TCGA-DD-A4NN-01A-11D-A28X-10 362c086d-ce73-408a-afcf-f129d54af1e9 362c086d-ce73-408a-afcf-f129d54af1e9 TCGA-DD-A4NN-01A-11D-A28X-10 TCGA-DD-A4NN-01A-11D-A28Y-05 TCGA-DD-A4NO-01 TCGA-DD-A4NO-01 TCGA-DD-A4NO TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 65 3.5 4.5 5.0 TCGA-DD-A4NO-F49662 TCGA-DD-A4NO TCGA-DD-A4NO-01A 0.1 0.4 A 0.8 1.3 1.6 -24090 1879 0 2245 990 0 0 6 3 0 - No Fibrosis 2013-10-7 MALE 176 Hepatitis C|Other Tobacco use Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 190 8.4 12.0 NO NO G1 Liver Locoregional Recurrence Yes NO YES No true No M0 N0 T1 Stage I TCGA-DD-A4NO.0B108361-E361-4A8B-9F5C-FC3ACB992DB9.pdf A4NO WITH TUMOR 201 150 450 NO NO 9.9 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A Hepatitis C Virus R|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 109 2007 TCGA-DD-A4NO-01A-11D-A28W-01 TCGA-DD-A4NO-01A-11D-A28W-01 TCGA-DD-A4NO-01A-11D-A28X-10 TCGA-DD-A4NO-01 TCGA-DD-A4NO-01 4382BDF1-B3AD-44F1-92B0-1C7DC3CD4CE2 830be6d6-82f7-4085-88a4-060f01c267fb TCGA-DD-A4NO-01A-11D-A28X-10 TCGA-DD-A4NO-01 TCGA-DD-A4NO-01 830be6d6-82f7-4085-88a4-060f01c267fb TCGA-DD-A4NO-01A-11D-A28X-10 830be6d6-82f7-4085-88a4-060f01c267fb 830be6d6-82f7-4085-88a4-060f01c267fb TCGA-DD-A4NO-01A-11D-A28X-10 TCGA-DD-A4NO-01A-11D-A28Y-05 TCGA-DD-A4NP-01 TCGA-DD-A4NP-01 TCGA-DD-A4NP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 32 3.5 2.4 5.0 TCGA-DD-A4NP-F59646 TCGA-DD-A4NP TCGA-DD-A4NP-01A 0.1 0.7 B 0.9 1.4 1.9 -11838 2736 0 3308 1286 0 0 6 2 0 - No Fibrosis 2014-5-17 MALE 177 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 8.4 12.0 NO NO G3 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T1 Stage I TCGA-DD-A4NP.6C7AE628-1BC9-453D-A1C2-5F2F63A295FC.pdf A4NP TUMOR FREE 348 150 450 NO NO 8.9 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 79 2005 TCGA-DD-A4NP-01A-11D-A28W-01 TCGA-DD-A4NP-01A-11D-A28W-01 TCGA-DD-A4NP-01A-11D-A28X-10 TCGA-DD-A4NP-01 TCGA-DD-A4NP-01 BCE78D42-7476-4889-B557-651EE0EBACA7 3101309f-f0e5-42d8-88ca-a44d37d240f0 TCGA-DD-A4NP-01A-11D-A28X-10 TCGA-DD-A4NP-01 TCGA-DD-A4NP-01 3101309f-f0e5-42d8-88ca-a44d37d240f0 TCGA-DD-A4NP-01A-11D-A28X-10 3101309f-f0e5-42d8-88ca-a44d37d240f0 3101309f-f0e5-42d8-88ca-a44d37d240f0 TCGA-DD-A4NP-01A-11D-A28X-10 TCGA-DD-A4NP-01A-11D-A28Y-05 TCGA-DD-A4NQ-01 TCGA-DD-A4NQ-01 TCGA-DD-A4NQ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Mild 60 3.5 4.4 5.0 TCGA-DD-A4NQ-F49669 TCGA-DD-A4NQ TCGA-DD-A4NQ-01A 0.1 0.7 1 A 0.8 1.3 0.8 -22111 2030 373 0 126 0 0 6 141 2013-10-7 MALE 159 Hepatitis B|Other tobacco Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 8.4 12.0 NO NO G3 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T2 Stage II TCGA-DD-A4NQ.D79DB738-2DA3-43F6-898C-4A212964FA03.pdf A4NQ WITH TUMOR 283 150 450 NO NO 10.1 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver Macro A Hepatitis C Virus R|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 75 2007 TCGA-DD-A4NQ-01A-21D-A28W-01 TCGA-DD-A4NQ-01A-21D-A28W-01 TCGA-DD-A4NQ-01A-21D-A28X-10 TCGA-DD-A4NQ-01 TCGA-DD-A4NQ-01 A206D8AA-F54A-47BB-B0DA-E8D95F719D63 15a72f2f-83c5-4264-8103-5c3e28445d12 TCGA-DD-A4NQ-01A-21D-A28X-10 TCGA-DD-A4NQ-01 TCGA-DD-A4NQ-01 15a72f2f-83c5-4264-8103-5c3e28445d12 TCGA-DD-A4NQ-01A-21D-A28X-10 15a72f2f-83c5-4264-8103-5c3e28445d12 15a72f2f-83c5-4264-8103-5c3e28445d12 TCGA-DD-A4NQ-01A-21D-A28X-10 TCGA-DD-A4NQ-01A-21D-A28Y-05 TCGA-DD-A4NR-01 TCGA-DD-A4NR-01 TCGA-DD-A4NR TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 85 3.5 3.1 5.0 TCGA-DD-A4NR-F49670 TCGA-DD-A4NR TCGA-DD-A4NR-01A 0.1 0.8 1 A 0.7 1.2 1.0 -31386 2652 9 0 0 0 6 40250 6 - Established Cirrhosis 2013-10-7 FEMALE 64 Other primary biliary cirrhosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 8.4 12.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-A4NR.93133C58-B1BF-4A5C-8EFC-AE17EC6A0B64.pdf A4NR TUMOR FREE 239 150 450 NO NO 9.3 NO YES R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 54 2005 TCGA-DD-A4NR-01A-11D-A30U-01 TCGA-DD-A4NR-01A-11D-A30U-01 TCGA-DD-A4NR-01A-11D-A30V-10 TCGA-DD-A4NR-01 TCGA-DD-A4NR-01 D99B1488-C4F1-46C5-BCEF-675E8FFB31D1 6af2d20a-bab8-4f0c-ac22-c1454619ef46 TCGA-DD-A4NR-01A-11D-A30V-10 TCGA-DD-A4NR-01 TCGA-DD-A4NR-01 6af2d20a-bab8-4f0c-ac22-c1454619ef46 TCGA-DD-A4NR-01A-11D-A30V-10 6af2d20a-bab8-4f0c-ac22-c1454619ef46 6af2d20a-bab8-4f0c-ac22-c1454619ef46 TCGA-DD-A4NR-01A-11D-A30V-10 TCGA-DD-A4NR-01A-11D-A30Y-05 TCGA-DD-A4NS-01 TCGA-DD-A4NS-01 TCGA-DD-A4NS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 61 TCGA-DD-A4NS-F49671 TCGA-DD-A4NS TCGA-DD-A4NS-01A 0.1 0.9 2 0.7 1.2 1.1 -22638 2596 2456 0 913 893 0 0 6 2 0 - No Fibrosis 2013-10-7 FEMALE 167 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 8.4 12.0 NO NO G2 Bone Extrahepatic Recurrence No YES YES No true No M0 N0 T1 Stage I TCGA-DD-A4NS.97CA96D5-990E-41F9-949D-CCCCFFB78CBD.pdf A4NS WITH TUMOR 270 150 450 NO NO 8.8 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 58 2005 TCGA-DD-A4NS-01A-11D-A30U-01 TCGA-DD-A4NS-01A-11D-A30U-01 TCGA-DD-A4NS-01A-11D-A30V-10 TCGA-DD-A4NS-01 TCGA-DD-A4NS-01 75C04C4C-1A60-4B07-B987-76598237D3E0 c3b5e80e-398b-4390-ae78-4f2cb9be4497 TCGA-DD-A4NS-01A-11D-A30V-10 TCGA-DD-A4NS-01 TCGA-DD-A4NS-01 c3b5e80e-398b-4390-ae78-4f2cb9be4497 TCGA-DD-A4NS-01A-11D-A30V-10 c3b5e80e-398b-4390-ae78-4f2cb9be4497 c3b5e80e-398b-4390-ae78-4f2cb9be4497 TCGA-DD-A4NS-01A-11D-A30V-10 TCGA-DD-A4NS-01A-11D-A30Y-05 TCGA-DD-A4NV-01 TCGA-DD-A4NV-01 TCGA-DD-A4NV TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 61 3.5 3.9 5.0 TCGA-DD-A4NV-F59879 TCGA-DD-A4NV 0.1 0.5 1 A 0.8 1.3 0.8 -22438 0 2398 1 0 6 3 0 - No Fibrosis 2014-5-22 MALE 179 Non-Alcoholic Fatty Liver Disease|Other morbid obesity, tobacco use Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.4 12.0 NO G1 NO No M0 N0 T3 Stage IIIA A4NV TUMOR FREE 240 150 450 NO NO 9.0 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 129 2007 TCGA-DD-A4NV-01A-11D-A30U-01 TCGA-DD-A4NV-01A-11D-A30U-01 TCGA-DD-A4NV-01A-11D-A30V-10 TCGA-DD-A4NV-01 TCGA-DD-A4NV-01 cabf0153-dac2-48ae-a225-19147772ddfe TCGA-DD-A4NV-01A-11D-A30V-10 TCGA-DD-A4NV-01 TCGA-DD-A4NV-01 cabf0153-dac2-48ae-a225-19147772ddfe TCGA-DD-A4NV-01A-11D-A30V-10 cabf0153-dac2-48ae-a225-19147772ddfe cabf0153-dac2-48ae-a225-19147772ddfe TCGA-DD-A4NV-01A-11D-A30V-10 TCGA-DD-A4NV-01A-11D-A30Y-05 TCGA-DD-A73A-01 TCGA-DD-A73A-01 TCGA-DD-A73A TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 71 3.5 4.4 5.0 TCGA-DD-A73A-F66593 TCGA-DD-A73A 0.1 1.2 A 0.8 1.3 1.4 -26136 0 728 1 0 6 4 3,4 - Fibrous Speta 2014-10-21 MALE 174 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 9.5 13.8 NO G2 NO No M0 N0 T1 Stage I A73A TUMOR FREE 89 150 450 NO NO 12.8 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.0 Liver None Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 102 2012 TCGA-DD-A73A-01A-12D-A32F-01 TCGA-DD-A73A-01A-12D-A32F-01 TCGA-DD-A73A-01A-12D-A32G-10 TCGA-DD-A73A-01 TCGA-DD-A73A-01 b2ae2c3b-87c2-47e1-9d66-ae23a3f83919 TCGA-DD-A73A-01A-12D-A32G-10 TCGA-DD-A73A-01 TCGA-DD-A73A-01 b2ae2c3b-87c2-47e1-9d66-ae23a3f83919 TCGA-DD-A73A-01A-12D-A32G-10 b2ae2c3b-87c2-47e1-9d66-ae23a3f83919 b2ae2c3b-87c2-47e1-9d66-ae23a3f83919 TCGA-DD-A73A-01A-12D-A32G-10 TCGA-DD-A73A-01A-12D-A32R-05 TCGA-DD-A73B-01 TCGA-DD-A73B-01 TCGA-DD-A73B TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 72 3.5 3.5 5.0 TCGA-DD-A73B TCGA-DD-A73B-01A 0.1 2.1 1 B 0.6 1.1 0.9 -26390 345 283 0 0 0 6 30 6 - Established Cirrhosis 2013-9-30 FEMALE 154 Alpha-1 Antitrypsin Deficiency|Other Gilberts syndrome. Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 150 0.8 1.2 NO G2 YES false No M0 N0 T1 Stage I TCGA-DD-A73B.B1C57A75-7C86-49D9-B143-09E60824F508.pdf A73B WITH TUMOR 88 150 450 NO NO 1.1 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen DECEASED 74 2012 TCGA-DD-A73B-01A-12D-A32F-01 TCGA-DD-A73B-01A-12D-A32F-01 TCGA-DD-A73B-01A-12D-A32G-10 TCGA-DD-A73B-01 TCGA-DD-A73B-01 9C91FA76-A8F5-499C-9D32-2D8B107013D7 4ed5467c-be43-4125-a6c4-7b7aad6ea5f6 TCGA-DD-A73B-01A-12D-A32G-10 TCGA-DD-A73B-01 TCGA-DD-A73B-01 4ed5467c-be43-4125-a6c4-7b7aad6ea5f6 TCGA-DD-A73B-01A-12D-A32G-10 4ed5467c-be43-4125-a6c4-7b7aad6ea5f6 4ed5467c-be43-4125-a6c4-7b7aad6ea5f6 TCGA-DD-A73B-01A-12D-A32G-10 TCGA-DD-A73B-01A-12D-A32R-05 TCGA-DD-A73C-01 TCGA-DD-A73C-01 TCGA-DD-A73C TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 65 3.5 4.9 5.0 TCGA-DD-A73C-F66595 TCGA-DD-A73C TCGA-DD-A73C-01A 0.1 0.7 1 A 0.6 1.1 0.8 -23782 288 0 701 566 0 0 6 3 0 - No Fibrosis 2014-10-21 FEMALE 159 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 9.5 13.8 NO NO G1 Liver Locoregional Recurrence No YES No false No M0 N0 T3a Stage IIIA TCGA-DD-A73C.FE051CD7-9C34-4A45-934C-DD8BB00C717A.pdf A73C WITH TUMOR 247 150 450 NO NO 11.7 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 49 2012 TCGA-DD-A73C-01A-12D-A33B-01 TCGA-DD-A73C-01A-12D-A33B-01 TCGA-DD-A73C-01A-12D-A33K-10 TCGA-DD-A73C-01 TCGA-DD-A73C-01 35C56771-BADA-4231-99BB-BA79C363A7B6 b518428e-84c5-4dbe-a608-c7d55e35067a TCGA-DD-A73C-01A-12D-A33K-10 TCGA-DD-A73C-01 TCGA-DD-A73C-01 b518428e-84c5-4dbe-a608-c7d55e35067a TCGA-DD-A73C-01A-12D-A33K-10 b518428e-84c5-4dbe-a608-c7d55e35067a b518428e-84c5-4dbe-a608-c7d55e35067a TCGA-DD-A73C-01A-12D-A33K-10 TCGA-DD-A73C-01A-12D-A33L-05 TCGA-DD-A73D-01 TCGA-DD-A73D-01 TCGA-DD-A73D TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 68 3.5 4.5 5.0 TCGA-DD-A73D-F66596 TCGA-DD-A73D TCGA-DD-A73D-01A 0.1 0.3 1 A 0.6 1.1 0.8 -24941 313 0 693 592 0 0 6 4 6 - Established Cirrhosis 2014-10-21 FEMALE 170 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 9.5 13.8 NO NO G1 Liver Intrahepatic Recurrence Yes YES No false No MX NX T2 Stage II TCGA-DD-A73D.6C9BA4B3-78FD-4D16-A420-5C98BCEFD55D.pdf A73D WITH TUMOR 214 150 450 NO NO 12.5 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.0 Liver Micro A Hepatitis C Virus R|Hepatitis B Surface Antigen LIVING 102 2012 TCGA-DD-A73D-01A-12D-A32F-01 TCGA-DD-A73D-01A-12D-A32F-01 TCGA-DD-A73D-01A-12D-A32G-10 TCGA-DD-A73D-01 TCGA-DD-A73D-01 E2A3DCDC-788C-4A4E-BA7B-4E77BA910ED6 3470b46c-4f18-47fe-a18f-f98c97e8996a TCGA-DD-A73D-01A-12D-A32G-10 TCGA-DD-A73D-01 TCGA-DD-A73D-01 3470b46c-4f18-47fe-a18f-f98c97e8996a TCGA-DD-A73D-01A-12D-A32G-10 3470b46c-4f18-47fe-a18f-f98c97e8996a 3470b46c-4f18-47fe-a18f-f98c97e8996a TCGA-DD-A73D-01A-12D-A32G-10 TCGA-DD-A73D-01A-12D-A32R-05 TCGA-DD-A73E-01 TCGA-DD-A73E-01 TCGA-DD-A73E TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 66 3.5 4.7 5.0 TCGA-DD-A73E-F66598 TCGA-DD-A73E TCGA-DD-A73E-01A 0.1 0.4 2 A 0.8 1.3 1.2 -24377 336 0 44 0 0 6 1 0 - No Fibrosis 2014-10-21 MALE 172 Alcohol consumption|Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 9.5 13.8 NO YES G1 NO false No M0 N0 T1 Stage I TCGA-DD-A73E.10881D8D-1C62-4F3D-ACF6-36AD1F23B0A9.pdf A73E TUMOR FREE 190 150 450 NO NO 11.5 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody LIVING 108 2012 TCGA-DD-A73E-01A-12D-A32F-01 TCGA-DD-A73E-01A-12D-A32F-01 TCGA-DD-A73E-01A-12D-A32G-10 TCGA-DD-A73E-01 TCGA-DD-A73E-01 3E71F43C-97E0-417A-855A-8280181B8197 c5adfcce-a4a4-47bc-8b9e-7e81819b80a1 TCGA-DD-A73E-01A-12D-A32G-10 TCGA-DD-A73E-01 TCGA-DD-A73E-01 c5adfcce-a4a4-47bc-8b9e-7e81819b80a1 TCGA-DD-A73E-01A-12D-A32G-10 c5adfcce-a4a4-47bc-8b9e-7e81819b80a1 c5adfcce-a4a4-47bc-8b9e-7e81819b80a1 TCGA-DD-A73E-01A-12D-A32G-10 TCGA-DD-A73E-01A-12D-A32R-05 TCGA-DD-A73F-01 TCGA-DD-A73F-01 TCGA-DD-A73F TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 77 3.5 4.6 5.0 TCGA-DD-A73F-F71152 TCGA-DD-A73F TCGA-DD-A73F-01A 0.1 0.5 1 A 0.6 1.1 1.0 -28234 975 0 1085 1 0 6 283 0 - No Fibrosis 2015-3-18 FEMALE 164 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 9.5 13.8 NO YES G1 NO false No M0 N0 T1 Stage I TCGA-DD-A73F.2FCC867C-91AD-40B3-8046-FFB84BDD2EA7.pdf A73F TUMOR FREE 243 150 450 NO NO 10.9 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.0 Liver None A LIVING 69 2010 TCGA-DD-A73F-01A-11D-A32F-01 TCGA-DD-A73F-01A-11D-A32F-01 TCGA-DD-A73F-01A-11D-A32G-10 TCGA-DD-A73F-01 TCGA-DD-A73F-01 D6B6C02A-C3BB-400A-91F6-ACA8D71A8E25 ea6f7f61-d66c-47c9-a67a-e0d65af36815 TCGA-DD-A73F-01A-11D-A32G-10 TCGA-DD-A73F-01 TCGA-DD-A73F-01 ea6f7f61-d66c-47c9-a67a-e0d65af36815 TCGA-DD-A73F-01A-11D-A32G-10 ea6f7f61-d66c-47c9-a67a-e0d65af36815 ea6f7f61-d66c-47c9-a67a-e0d65af36815 TCGA-DD-A73F-01A-11D-A32G-10 TCGA-DD-A73F-01A-11D-A32R-05 TCGA-DD-A73G-01 TCGA-DD-A73G-01 TCGA-DD-A73G TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 73 3.5 3.2 5.0 TCGA-DD-A73G-F66600 TCGA-DD-A73G TCGA-DD-A73G-01A 0.1 0.5 1 A 0.7 1.2 0.7 -26949 3045 0 3478 0 0 6 2035400 0 - No Fibrosis 2014-10-21 FEMALE 155 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 8.4 12.0 NO NO G3 NO false No M0 N0 T1 Stage I TCGA-DD-A73G.C7A70BE1-34F6-4500-8C6C-A0D4FBBBD251.pdf A73G TUMOR FREE 460 150 450 NO NO 11.7 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 44 2005 TCGA-DD-A73G-01A-22D-A32F-01 TCGA-DD-A73G-01A-22D-A32F-01 TCGA-DD-A73G-01A-22D-A32G-10 TCGA-DD-A73G-01 TCGA-DD-A73G-01 77B45158-4306-4D86-9FE3-E1068745AC41 b44b63e6-5163-4df8-b82b-80401b703167 TCGA-DD-A73G-01A-22D-A32G-10 TCGA-DD-A73G-01 TCGA-DD-A73G-01 b44b63e6-5163-4df8-b82b-80401b703167 TCGA-DD-A73G-01A-22D-A32G-10 b44b63e6-5163-4df8-b82b-80401b703167 b44b63e6-5163-4df8-b82b-80401b703167 TCGA-DD-A73G-01A-22D-A32G-10 TCGA-DD-A73G-01A-22D-A32R-05 TCGA-DD-AA3A-01 TCGA-DD-AA3A-01 TCGA-DD-AA3A TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 81 3.5 4.9 5.0 TCGA-DD-AA3A TCGA-DD-AA3A-01A 0.1 0.8 1 A 0.6 1.1 0.7 -29712 1559 410 0 1 0 8 1 0 - No Fibrosis 2014-5-27 FEMALE 151 No History of Primary Risk Factors Hepatocholangiocarcinoma (Mixed) No C22.0 8180/3 C22.0 YES 100 0.9 1.2 NO G4 true No MX N0 T1 Stage I TCGA-DD-AA3A.F1055545-91C4-4397-BD34-FE995A3E9B05.pdf AA3A TUMOR FREE 256 150 450 NO NO 1.1 NO YES R0 Primary Tumor 01 Extended Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 60 2009 TCGA-DD-AA3A-01A-11D-A36W-01 TCGA-DD-AA3A-01A-11D-A36W-01 TCGA-DD-AA3A-01A-11D-A36X-10 TCGA-DD-AA3A-01 TCGA-DD-AA3A-01 8AB78FE1-CF2C-4A91-A1BE-4C038A0E2A8E 99fb714e-01a3-4aa0-8792-39df3be95a1d TCGA-DD-AA3A-01 TCGA-DD-AA3A-01 99fb714e-01a3-4aa0-8792-39df3be95a1d 99fb714e-01a3-4aa0-8792-39df3be95a1d 99fb714e-01a3-4aa0-8792-39df3be95a1d TCGA-DD-AA3A-01A-11D-A36Y-05 TCGA-DD-AAC8-01 TCGA-DD-AAC8-01 TCGA-DD-AAC8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 72 3.8 4.3 5.3 TCGA-DD-AAC8 TCGA-DD-AAC8-01A 0.2 0.6 A 0.7 1.5 1.1 -26322 2080 16 0 0 0 8 1 1,2 - Portal Fibrosis 2014-6-28 MALE 156 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 570 1.0 1.0 NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AAC8.2751F570-A1CE-4F6A-98CD-56C8B31AB0FF.pdf AAC8 TUMOR FREE 177 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver Micro A DECEASED 57 2008 TCGA-DD-AAC8-01A-11D-A40Q-01 TCGA-DD-AAC8-01A-11D-A40Q-01 TCGA-DD-AAC8-01A-11D-A40R-10 TCGA-DD-AAC8-01 TCGA-DD-AAC8-01 3c6ca697-64ab-43d8-99ab-10ecbc0e8313 TCGA-DD-AAC8-01 TCGA-DD-AAC8-01 3c6ca697-64ab-43d8-99ab-10ecbc0e8313 3c6ca697-64ab-43d8-99ab-10ecbc0e8313 3c6ca697-64ab-43d8-99ab-10ecbc0e8313 TCGA-DD-AAC8-01A-11D-A40S-05 TCGA-DD-AAC9-01 TCGA-DD-AAC9-01 TCGA-DD-AAC9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 51 3.8 4.2 5.3 TCGA-DD-AAC9-F68363 TCGA-DD-AAC9 TCGA-DD-AAC9-01A 0.2 0.7 A 0.7 1.5 1.3 -18911 2069 0 347 0 0 8 5 6 - Established Cirrhosis 2014-11-17 MALE 174 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 130 1.0 1.0 NO YES G2 NO true No M0 N0 T1 Stage I TCGA-DD-AAC9.A993CEA3-6AA2-4CE7-A9EC-8318B1377E99.pdf AAC9 TUMOR FREE 149 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None A LIVING 81 2008 TCGA-DD-AAC9-01A-11D-A40Q-01 TCGA-DD-AAC9-01A-11D-A40Q-01 TCGA-DD-AAC9-01A-11D-A40R-10 TCGA-DD-AAC9-01 TCGA-DD-AAC9-01 49d7b78f-7841-4969-b063-5bc57099283c TCGA-DD-AAC9-01 TCGA-DD-AAC9-01 49d7b78f-7841-4969-b063-5bc57099283c 49d7b78f-7841-4969-b063-5bc57099283c 49d7b78f-7841-4969-b063-5bc57099283c TCGA-DD-AAC9-01A-11D-A40S-05 TCGA-DD-AACA-01 TCGA-DD-AACA-01 TCGA-DD-AACA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 65 3.8 3.7 5.3 TCGA-DD-AACA-F68364 TCGA-DD-AACA TCGA-DD-AACA-01A 0.2 0.7 A 0.7 1.5 1.2 -23973 2057 0 2301 797 776 0 0 8 7 6 - Established Cirrhosis 2014-11-17 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 1.0 1.0 NO NO G3 Liver Locoregional Recurrence No YES YES No true No M0 N0 T1 Stage I TCGA-DD-AACA.6600D758-13D7-4925-BC34-F2A90EE0CFE5.pdf AACA WITH TUMOR 136 130 400 NO NO 0.9 NO NO R0 R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None A LIVING 70 2008 TCGA-DD-AACA-01A-11D-A40Q-01 TCGA-DD-AACA-01A-11D-A40Q-01 TCGA-DD-AACA-01A-11D-A40R-10 TCGA-DD-AACA-01 TCGA-DD-AACA-01 57f193de-ae4f-4ac9-aab2-a5e275b3501e TCGA-DD-AACA-01 TCGA-DD-AACA-01 57f193de-ae4f-4ac9-aab2-a5e275b3501e 57f193de-ae4f-4ac9-aab2-a5e275b3501e 57f193de-ae4f-4ac9-aab2-a5e275b3501e TCGA-DD-AACA-01A-11D-A40S-05 TCGA-DD-AACA-02 TCGA-DD-AACA-02 TCGA-DD-AACA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 65 3.8 3.7 5.3 TCGA-DD-AACA-F68364 TCGA-DD-AACA TCGA-DD-AACA-02A 0.2 0.7 A 0.7 1.5 1.2 -23973 2057 0 2301 797 776 0 0 8 7 6 - Established Cirrhosis 2014-11-17 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G3 Liver Locoregional Recurrence No YES YES No true No M0 N0 T1 Stage I TCGA-DD-AACA.C4260237-1E27-45C7-ADE8-41939D1324A8.pdf AACA WITH TUMOR 136 130 400 NO NO 0.9 NO NO R0 R0 Recurrent Tumor 02 Segmentectomy, Single 6th NO YES DD 1.2 Liver None A LIVING 70 2008 TCGA-DD-AACA-02 3f1addce-3a5a-4b68-ae77-df6191c9ba57,b1bab5f2-614b-436b-b53f-b2910b70c487 TCGA-DD-AACA-02 3f1addce-3a5a-4b68-ae77-df6191c9ba57,b1bab5f2-614b-436b-b53f-b2910b70c487 3f1addce-3a5a-4b68-ae77-df6191c9ba57,b1bab5f2-614b-436b-b53f-b2910b70c487 3f1addce-3a5a-4b68-ae77-df6191c9ba57,b1bab5f2-614b-436b-b53f-b2910b70c487 TCGA-DD-AACA-02A-11D-A40S-05,TCGA-DD-AACA-02B-11D-A40S-05 TCGA-DD-AACB-01 TCGA-DD-AACB-01 TCGA-DD-AACB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 74 3.8 4.1 5.3 TCGA-DD-AACB-F68365 TCGA-DD-AACB TCGA-DD-AACB-01A 0.2 0.8 A 0.7 1.5 1.1 -27103 2045 0 2324 0 0 8 1902 6 - Established Cirrhosis 2014-11-17 FEMALE 156 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 410 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AACB.40E83F82-43B5-426D-A120-2F2F597332C6.pdf AACB TUMOR FREE 179 130 400 NO NO 0.8 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver Micro A LIVING 72 2008 TCGA-DD-AACB-01A-11D-A40Q-01 TCGA-DD-AACB-01A-11D-A40Q-01 TCGA-DD-AACB-01A-11D-A40R-10 TCGA-DD-AACB-01 TCGA-DD-AACB-01 09c2a2ad-2174-4ebc-b356-628af5e05799 TCGA-DD-AACB-01 TCGA-DD-AACB-01 09c2a2ad-2174-4ebc-b356-628af5e05799 09c2a2ad-2174-4ebc-b356-628af5e05799 09c2a2ad-2174-4ebc-b356-628af5e05799 TCGA-DD-AACB-01A-11D-A40S-05 TCGA-DD-AACC-01 TCGA-DD-AACC-01 TCGA-DD-AACC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 61 3.8 3.9 5.3 TCGA-DD-AACC 0.2 0.5 A 0.7 1.5 1.3 -22499 1685 0 0 0 8 24 6 - Established Cirrhosis 2014-6-28 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8180/3 C22.0 YES 1.0 1.0 G2 YES No M0 N0 T1 Stage I AACC WITH TUMOR 208 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None DECEASED 61 2008 TCGA-DD-AACC-01A-11D-A40Q-01 TCGA-DD-AACC-01A-11D-A40Q-01 TCGA-DD-AACC-01A-11D-A40R-10 TCGA-DD-AACC-01 TCGA-DD-AACC-01 bffa7652-8069-4a46-9796-26be43eb1d54 TCGA-DD-AACC-01 TCGA-DD-AACC-01 bffa7652-8069-4a46-9796-26be43eb1d54 bffa7652-8069-4a46-9796-26be43eb1d54 bffa7652-8069-4a46-9796-26be43eb1d54 TCGA-DD-AACC-01A-11D-A40S-05 TCGA-DD-AACD-01 TCGA-DD-AACD-01 TCGA-DD-AACD TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 48 3.8 3.9 5.3 TCGA-DD-AACD TCGA-DD-AACD-01A 0.2 0.3 3 A 0.7 1.5 1.0 -17828 2015 381 0 1 0 8 2 1,2 - Portal Fibrosis 2014-6-28 MALE 182 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 230 1.0 1.0 NO G4 YES true No M0 N0 T1 Stage I TCGA-DD-AACD.0494EF97-6D76-4DC7-8642-880C889C2C24.pdf AACD WITH TUMOR 268 130 400 NO NO 6.9 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver Micro A DECEASED 66 2008 TCGA-DD-AACD-01A-11D-A40Q-01 TCGA-DD-AACD-01A-11D-A40Q-01 TCGA-DD-AACD-01A-11D-A40R-10 TCGA-DD-AACD-01 TCGA-DD-AACD-01 84d26646-771b-4d61-95a1-61c695c9f6fc TCGA-DD-AACD-01 TCGA-DD-AACD-01 84d26646-771b-4d61-95a1-61c695c9f6fc 84d26646-771b-4d61-95a1-61c695c9f6fc 84d26646-771b-4d61-95a1-61c695c9f6fc TCGA-DD-AACD-01A-11D-A40S-05 TCGA-DD-AACE-01 TCGA-DD-AACE-01 TCGA-DD-AACE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 62 3.8 4.4 5.3 TCGA-DD-AACE-F68366 TCGA-DD-AACE TCGA-DD-AACE-01A 0.2 0.9 A 0.7 1.5 1.2 -22727 1973 0 2184 1279 0 0 8 2 6 - Established Cirrhosis 2014-12-30 MALE 162 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 1.0 1.0 NO NO G3 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T1 Stage I TCGA-DD-AACE.63AE7F04-F180-486A-89FB-6E509AF91E0B.pdf AACE TUMOR FREE 175 130 400 [Discrepancy] NO 0.9 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None A LIVING 62 2008 TCGA-DD-AACE-01A-11D-A40Q-01 TCGA-DD-AACE-01A-11D-A40Q-01 TCGA-DD-AACE-01A-11D-A40R-10 TCGA-DD-AACE-01 TCGA-DD-AACE-01 087f71fd-fbd5-47c6-92ed-23286b2ed945 TCGA-DD-AACE-01 TCGA-DD-AACE-01 087f71fd-fbd5-47c6-92ed-23286b2ed945 087f71fd-fbd5-47c6-92ed-23286b2ed945 087f71fd-fbd5-47c6-92ed-23286b2ed945 TCGA-DD-AACE-01A-11D-A40S-05 TCGA-DD-AACF-01 TCGA-DD-AACF-01 TCGA-DD-AACF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 68 3.8 3.5 5.3 TCGA-DD-AACF 0.2 0.5 A 0.7 1.5 1.1 -25172 365 0 0 0 8 16 6 - Established Cirrhosis 2014-6-28 MALE 168 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 G3 YES No M0 N0 T1 Stage I AACF WITH TUMOR 99 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver None DECEASED 60 2008 TCGA-DD-AACF-01A-11D-A40Q-01 TCGA-DD-AACF-01A-11D-A40Q-01 TCGA-DD-AACF-01A-11D-A40R-10 TCGA-DD-AACF-01 TCGA-DD-AACF-01 be1c653d-1f9a-41fd-b53c-024216355721 TCGA-DD-AACF-01 TCGA-DD-AACF-01 be1c653d-1f9a-41fd-b53c-024216355721 be1c653d-1f9a-41fd-b53c-024216355721 be1c653d-1f9a-41fd-b53c-024216355721 TCGA-DD-AACF-01A-11D-A40S-05 TCGA-DD-AACG-01 TCGA-DD-AACG-01 TCGA-DD-AACG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 52 3.8 3.6 5.3 TCGA-DD-AACG TCGA-DD-AACG-01A 0.2 1.0 A 0.7 1.5 1.5 -19174 1931 469 0 0 0 8 11718 6 - Established Cirrhosis 2014-6-28 MALE 168 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 280 1.0 1.0 NO G4 YES true No M0 N0 T2 Stage II TCGA-DD-AACG.8B0FA2B9-F484-4D9C-AFAE-BDD90DA6A7A8.pdf AACG WITH TUMOR 196 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver Micro A DECEASED 65 2008 TCGA-DD-AACG-01A-11D-A40Q-01 TCGA-DD-AACG-01A-11D-A40Q-01 TCGA-DD-AACG-01A-11D-A40R-10 TCGA-DD-AACG-01 TCGA-DD-AACG-01 73815125-e38b-4244-99f0-e630c6ea5fff TCGA-DD-AACG-01 TCGA-DD-AACG-01 73815125-e38b-4244-99f0-e630c6ea5fff 73815125-e38b-4244-99f0-e630c6ea5fff 73815125-e38b-4244-99f0-e630c6ea5fff TCGA-DD-AACG-01A-11D-A40S-05 TCGA-DD-AACH-01 TCGA-DD-AACH-01 TCGA-DD-AACH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 69 3.8 4.3 5.3 TCGA-DD-AACH 0.2 1.5 A 0.7 15 1.2 -25544 195 0 0 0 8 7 6 - Established Cirrhosis 2014-6-28 MALE 160 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 G3 YES No M0 N0 T2 Stage II AACH TUMOR FREE 290 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver Micro DECEASED 53 2008 TCGA-DD-AACH-01A-11D-A40Q-01 TCGA-DD-AACH-01A-11D-A40Q-01 TCGA-DD-AACH-01A-11D-A40R-10 TCGA-DD-AACH-01 TCGA-DD-AACH-01 e23ff6ac-2fdf-4838-aaa3-27e012bbf6ed TCGA-DD-AACH-01 TCGA-DD-AACH-01 e23ff6ac-2fdf-4838-aaa3-27e012bbf6ed e23ff6ac-2fdf-4838-aaa3-27e012bbf6ed e23ff6ac-2fdf-4838-aaa3-27e012bbf6ed TCGA-DD-AACH-01A-11D-A40S-05 TCGA-DD-AACI-01 TCGA-DD-AACI-01 TCGA-DD-AACI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 69 3.8 3.6 5.3 TCGA-DD-AACI-F68367 TCGA-DD-AACI TCGA-DD-AACI-01A 0.2 0.5 A 0.7 1.5 1.0 -25236 1870 0 1618 1432 1 0 8 1 5 - Nodular Formation and Incomplete Cirrhosis 2014-11-17 MALE 155 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 320 1.0 1.0 NO NO G3 Liver Intrahepatic Recurrence No NO YES No true No M0 N0 T2 Stage II TCGA-DD-AACI.54CDEB1D-8CF9-4723-9A7D-CD9DFEDFD659.pdf AACI WITH TUMOR 106 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None A LIVING 48 2008 TCGA-DD-AACI-01A-11D-A40Q-01 TCGA-DD-AACI-01A-11D-A40Q-01 TCGA-DD-AACI-01A-11D-A40R-10 TCGA-DD-AACI-01 TCGA-DD-AACI-01 6cf6f149-a805-4f83-90cc-a3cf6eee7317 TCGA-DD-AACI-01 TCGA-DD-AACI-01 6cf6f149-a805-4f83-90cc-a3cf6eee7317 6cf6f149-a805-4f83-90cc-a3cf6eee7317 6cf6f149-a805-4f83-90cc-a3cf6eee7317 TCGA-DD-AACI-01A-11D-A40S-05 TCGA-DD-AACJ-01 TCGA-DD-AACJ-01 TCGA-DD-AACJ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 75 3.8 3.6 5.3 TCGA-DD-AACJ-F68368 TCGA-DD-AACJ TCGA-DD-AACJ-01A 0.2 1.0 A 0.7 1.5 1.0 -27528 1835 0 2102 100 2 0 8 25 2014-11-17 MALE 159 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 380 1.0 1.0 NO NO G2 Liver Locoregional Recurrence No NO YES No true No M0 N0 T2 Stage II TCGA-DD-AACJ.2CD482F0-0882-4A61-9B40-1D7B3DBC625E.pdf AACJ WITH TUMOR 213 130 400 NO NO 0.8 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver Micro A LIVING 73 2008 TCGA-DD-AACJ-01A-11D-A40Q-01 TCGA-DD-AACJ-01A-11D-A40Q-01 TCGA-DD-AACJ-01A-11D-A40R-10 TCGA-DD-AACJ-01 TCGA-DD-AACJ-01 9db8d89d-ef37-49a5-81ed-3ae95aa3c920 TCGA-DD-AACJ-01 TCGA-DD-AACJ-01 9db8d89d-ef37-49a5-81ed-3ae95aa3c920 9db8d89d-ef37-49a5-81ed-3ae95aa3c920 9db8d89d-ef37-49a5-81ed-3ae95aa3c920 TCGA-DD-AACJ-01A-11D-A40S-05 TCGA-DD-AACK-01 TCGA-DD-AACK-01 TCGA-DD-AACK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 70 3.8 4.6 5.3 TCGA-DD-AACK-F68369 TCGA-DD-AACK TCGA-DD-AACK-01A 0.2 0.9 A 0.7 1.5 1.3 -25796 1828 0 9 2 0 8 5 6 - Established Cirrhosis 2014-11-17 MALE 172 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 1.0 1.0 NO YES G2 NO true No M0 N0 T1 Stage I TCGA-DD-AACK.B41B7C44-ED04-46EB-AD41-271456ECA762.pdf AACK TUMOR FREE 98 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver Micro A LIVING 68 2008 TCGA-DD-AACK-01A-11D-A40Q-01 TCGA-DD-AACK-01A-11D-A40Q-01 TCGA-DD-AACK-01A-11D-A40R-10 TCGA-DD-AACK-01 TCGA-DD-AACK-01 1eb7d71a-045d-4c79-8375-100de27caafd TCGA-DD-AACK-01 TCGA-DD-AACK-01 1eb7d71a-045d-4c79-8375-100de27caafd 1eb7d71a-045d-4c79-8375-100de27caafd 1eb7d71a-045d-4c79-8375-100de27caafd TCGA-DD-AACK-01A-11D-A40S-05 TCGA-DD-AACL-01 TCGA-DD-AACL-01 TCGA-DD-AACL TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 66 3.8 3.3 5.3 TCGA-DD-AACL-F68370 TCGA-DD-AACL 0.2 0.7 A 0.7 1.5 1.0 -24355 107 0 58 1 0 8 1368 2014-11-17 FEMALE 150 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 No M0 N0 T1 Stage I AACL 99 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None DECEASED 69 2008 TCGA-DD-AACL-01A-11D-A40Q-01 TCGA-DD-AACL-01A-11D-A40Q-01 TCGA-DD-AACL-01A-11D-A40R-10 TCGA-DD-AACL-01 TCGA-DD-AACL-01 ece2a45a-7c07-44a2-baca-4a62aa38592f TCGA-DD-AACL-01 TCGA-DD-AACL-01 ece2a45a-7c07-44a2-baca-4a62aa38592f ece2a45a-7c07-44a2-baca-4a62aa38592f ece2a45a-7c07-44a2-baca-4a62aa38592f TCGA-DD-AACL-01A-11D-A40S-05 TCGA-DD-AACM-01 TCGA-DD-AACM-01 TCGA-DD-AACM TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 48 3.8 4.2 5.3 TCGA-DD-AACM-F68371 TCGA-DD-AACM 0.2 1.6 A 0.7 1.5 1.2 -17590 0 1769 1126 1097 0 0 8 2 3,4 - Fibrous Speta 2014-11-17 MALE 177 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 Lung Extrahepatic Recurrence No YES YES No No M0 N0 T2 Stage II AACM WITH TUMOR 113 130 400 NO NO 0.9 NO NO R0 R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver None LIVING 68 2009 TCGA-DD-AACM-01A-11D-A40Q-01 TCGA-DD-AACM-01A-11D-A40Q-01 TCGA-DD-AACM-01A-11D-A40R-10 TCGA-DD-AACM-01 TCGA-DD-AACM-01 TCGA-DD-AACM-01A-11D-A40S-05 TCGA-DD-AACN-01 TCGA-DD-AACN-01 TCGA-DD-AACN TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 32 3.8 3.9 5.3 TCGA-DD-AACN-F68372 TCGA-DD-AACN 0.2 2.2 A 0.7 1.5 1.5 -12007 0 1302 357 0 0 9 699 2014-11-17 MALE 171 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T1 Stage I AACN WITH TUMOR 185 130 400 YES NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver None LIVING 70 2009 TCGA-DD-AACN-01A-11D-A40Q-01 TCGA-DD-AACN-01A-11D-A40Q-01 TCGA-DD-AACN-01A-11D-A40R-10 TCGA-DD-AACN-01 TCGA-DD-AACN-01 d3633d63-7cbe-4014-b051-211240a29ac8 TCGA-DD-AACN-01 TCGA-DD-AACN-01 d3633d63-7cbe-4014-b051-211240a29ac8 d3633d63-7cbe-4014-b051-211240a29ac8 d3633d63-7cbe-4014-b051-211240a29ac8 TCGA-DD-AACN-01A-11D-A40S-05 TCGA-DD-AACO-01 TCGA-DD-AACO-01 TCGA-DD-AACO TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 40 3.8 3.7 5.3 TCGA-DD-AACO-F68373 TCGA-DD-AACO TCGA-DD-AACO-01A 0.2 0.6 A 0.7 1.5 1.4 -14796 1637 0 1876 479 0 0 9 5 6 - Established Cirrhosis 2014-11-17 MALE 164 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 1.0 1.0 NO NO G3 Liver Intrahepatic Recurrence No NO YES No true No M0 N0 T1 Stage I TCGA-DD-AACO.B5BE83AC-C974-422B-91E7-A69057BA26C9.pdf AACO WITH TUMOR 88 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None A LIVING 43 2009 TCGA-DD-AACO-01A-11D-A40Q-01 TCGA-DD-AACO-01A-11D-A40Q-01 TCGA-DD-AACO-01A-11D-A40R-10 TCGA-DD-AACO-01 TCGA-DD-AACO-01 032ec32d-66ca-4792-9132-2e61d918c3c2 TCGA-DD-AACO-01 TCGA-DD-AACO-01 032ec32d-66ca-4792-9132-2e61d918c3c2 032ec32d-66ca-4792-9132-2e61d918c3c2 032ec32d-66ca-4792-9132-2e61d918c3c2 TCGA-DD-AACO-01A-11D-A40S-05 TCGA-DD-AACP-01 TCGA-DD-AACP-01 TCGA-DD-AACP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 64 3.8 4.1 5.3 TCGA-DD-AACP-F68374 TCGA-DD-AACP TCGA-DD-AACP-01A 0.2 1.1 A 0.7 1.5 1.1 -23728 1625 0 415 0 0 8 227 2014-11-17 MALE 155 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AACP.7FDD120A-A5AD-4209-B167-34BA2289A784.pdf AACP 151 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None A LIVING 62 2009 TCGA-DD-AACP-01A-11D-A40Q-01 TCGA-DD-AACP-01A-11D-A40Q-01 TCGA-DD-AACP-01A-11D-A40R-10 TCGA-DD-AACP-01 TCGA-DD-AACP-01 6aafc1f6-257e-4105-b032-457bcc52dc1b TCGA-DD-AACP-01 TCGA-DD-AACP-01 6aafc1f6-257e-4105-b032-457bcc52dc1b 6aafc1f6-257e-4105-b032-457bcc52dc1b 6aafc1f6-257e-4105-b032-457bcc52dc1b TCGA-DD-AACP-01A-11D-A40S-05 TCGA-DD-AACQ-01 TCGA-DD-AACQ-01 TCGA-DD-AACQ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 50 3.8 4.2 5.3 TCGA-DD-AACQ-F68375 TCGA-DD-AACQ TCGA-DD-AACQ-01A 0.2 0.8 A 0.7 1.5 1.3 -18429 1665 432 0 429 105 0 0 8 7 2014-11-17 MALE 169 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 1.0 1.0 NO NO G3 Liver Locoregional Recurrence Yes NO YES No true No M0 N0 T2 Stage II TCGA-DD-AACQ.3BBE2BEA-D346-4EA8-82CB-9305EC49A331.pdf AACQ WITH TUMOR 157 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver None A DECEASED 64 2009 TCGA-DD-AACQ-01A-11D-A40Q-01 TCGA-DD-AACQ-01A-11D-A40Q-01 TCGA-DD-AACQ-01A-11D-A40R-10 TCGA-DD-AACQ-01 TCGA-DD-AACQ-01 3e6d35a3-3a10-4629-a316-8df8cc951678 TCGA-DD-AACQ-01 TCGA-DD-AACQ-01 3e6d35a3-3a10-4629-a316-8df8cc951678 3e6d35a3-3a10-4629-a316-8df8cc951678 3e6d35a3-3a10-4629-a316-8df8cc951678 TCGA-DD-AACQ-01A-11D-A40S-05 TCGA-DD-AACS-01 TCGA-DD-AACS-01 TCGA-DD-AACS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 39 3.8 4.3 5.3 TCGA-DD-AACS-F68376 TCGA-DD-AACS TCGA-DD-AACS-01A 0.2 1.0 A 0.7 1.5 1.1 -14473 1532 0 1804 0 0 8 1 2014-11-17 MALE 172 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AACS.EA952B6F-851C-4675-A933-80325945E7EC.pdf AACS TUMOR FREE 223 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None A LIVING 80 2009 TCGA-DD-AACS-01A-11D-A40Q-01 TCGA-DD-AACS-01A-11D-A40Q-01 TCGA-DD-AACS-01A-11D-A40R-10 TCGA-DD-AACS-01 TCGA-DD-AACS-01 078cb900-3686-4894-9e1f-cc4bb1e39eae TCGA-DD-AACS-01 TCGA-DD-AACS-01 078cb900-3686-4894-9e1f-cc4bb1e39eae 078cb900-3686-4894-9e1f-cc4bb1e39eae 078cb900-3686-4894-9e1f-cc4bb1e39eae TCGA-DD-AACS-01A-11D-A40S-05 TCGA-DD-AACT-01 TCGA-DD-AACT-01 TCGA-DD-AACT TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 69 3.8 4.4 5.3 TCGA-DD-AACT-F68377 TCGA-DD-AACT TCGA-DD-AACT-01A 0.2 0.8 A 0.7 1.5 0.7 -25292 1317 0 1562 0 0 8 4 2014-11-17 FEMALE 158 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 60 1.0 1.0 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-DD-AACT.0A9193A6-4600-44F8-88AD-264F8F2D7B4E.pdf AACT TUMOR FREE 213 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None A LIVING 62 2010 TCGA-DD-AACT-01A-11D-A40Q-01 TCGA-DD-AACT-01A-11D-A40Q-01 TCGA-DD-AACT-01A-11D-A40R-10 TCGA-DD-AACT-01 TCGA-DD-AACT-01 0e370e53-c3cc-4191-a6f5-68c932ee7641 TCGA-DD-AACT-01 TCGA-DD-AACT-01 0e370e53-c3cc-4191-a6f5-68c932ee7641 0e370e53-c3cc-4191-a6f5-68c932ee7641 0e370e53-c3cc-4191-a6f5-68c932ee7641 TCGA-DD-AACT-01A-11D-A40S-05 TCGA-DD-AACU-01 TCGA-DD-AACU-01 TCGA-DD-AACU TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 59 3.8 4.4 5.3 TCGA-DD-AACU-F68378 TCGA-DD-AACU TCGA-DD-AACU-01A 0.2 0.3 A 0.7 1.5 1.1 -21606 1272 0 1567 0 0 8 22 2014-11-17 MALE 166 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AACU.3CA9651B-35BE-4D1E-9C91-BF3029931F32.pdf AACU TUMOR FREE 166 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None A LIVING 67 2010 TCGA-DD-AACU-01A-11D-A40Q-01 TCGA-DD-AACU-01A-11D-A40Q-01 TCGA-DD-AACU-01A-11D-A40R-10 TCGA-DD-AACU-01 TCGA-DD-AACU-01 3fea9924-e623-43ef-a003-0821bf2e3013 TCGA-DD-AACU-01 TCGA-DD-AACU-01 3fea9924-e623-43ef-a003-0821bf2e3013 3fea9924-e623-43ef-a003-0821bf2e3013 3fea9924-e623-43ef-a003-0821bf2e3013 TCGA-DD-AACU-01A-11D-A40S-05 TCGA-DD-AACV-01 TCGA-DD-AACV-01 TCGA-DD-AACV TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 53 3.8 4.3 5.3 TCGA-DD-AACV-F68379 TCGA-DD-AACV 0.2 0.6 A 0.7 1.5 1.2 -19660 0 1531 344 0 0 8 9 2014-11-17 MALE 169 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T1 Stage I AACV WITH TUMOR 164 130 400 YES NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver Micro LIVING 70 2010 TCGA-DD-AACV-01A-11D-A40Q-01 TCGA-DD-AACV-01A-11D-A40Q-01 TCGA-DD-AACV-01A-11D-A40R-10 TCGA-DD-AACV-01 TCGA-DD-AACV-01 cd9bf80a-84dc-4ffa-8b82-6d298d9931e7 TCGA-DD-AACV-01 TCGA-DD-AACV-01 cd9bf80a-84dc-4ffa-8b82-6d298d9931e7 cd9bf80a-84dc-4ffa-8b82-6d298d9931e7 cd9bf80a-84dc-4ffa-8b82-6d298d9931e7 TCGA-DD-AACV-01A-11D-A40S-05 TCGA-DD-AACW-01 TCGA-DD-AACW-01 TCGA-DD-AACW TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 43 3.8 4.0 5.3 TCGA-DD-AACW-F68380 TCGA-DD-AACW TCGA-DD-AACW-01A 0.2 0.6 A 0.7 1.5 1.0 -15872 1184 0 1424 0 0 8 1726 2014-11-17 MALE 166 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AACW.04474C44-102B-4514-BC48-468B9ED478A2.pdf AACW TUMOR FREE 137 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None A LIVING 65 2010 TCGA-DD-AACW-01A-11D-A40Q-01 TCGA-DD-AACW-01A-11D-A40Q-01 TCGA-DD-AACW-01A-11D-A40R-10 TCGA-DD-AACW-01 TCGA-DD-AACW-01 6dd11614-cfb8-46ae-ad65-75fb407306e4 TCGA-DD-AACW-01 TCGA-DD-AACW-01 6dd11614-cfb8-46ae-ad65-75fb407306e4 6dd11614-cfb8-46ae-ad65-75fb407306e4 6dd11614-cfb8-46ae-ad65-75fb407306e4 TCGA-DD-AACW-01A-11D-A40S-05 TCGA-DD-AACX-01 TCGA-DD-AACX-01 TCGA-DD-AACX TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Mild 66 3.8 4.2 5.3 TCGA-DD-AACX-F68381 TCGA-DD-AACX 0.2 0.5 A 0.7 1.5 0.8 -24329 0 170 42 1 0 8 3 3,4 - Fibrous Speta 2014-11-17 MALE 155 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 Other, specify Extrahepatic Recurrence lymph node No NO YES No No M0 N0 T2 Stage II AACX WITH TUMOR 179 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 53 2010 TCGA-DD-AACX-01A-11D-A40Q-01 TCGA-DD-AACX-01A-11D-A40Q-01 TCGA-DD-AACX-01A-11D-A40R-10 TCGA-DD-AACX-01 TCGA-DD-AACX-01 be86bc67-ccbb-4565-adc3-4577b8067a33 TCGA-DD-AACX-01 TCGA-DD-AACX-01 be86bc67-ccbb-4565-adc3-4577b8067a33 be86bc67-ccbb-4565-adc3-4577b8067a33 be86bc67-ccbb-4565-adc3-4577b8067a33 TCGA-DD-AACX-01A-11D-A40S-05 TCGA-DD-AACY-01 TCGA-DD-AACY-01 TCGA-DD-AACY TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 61 3.8 3.1 5.3 TCGA-DD-AACY-F68382 TCGA-DD-AACY 0.2 1.3 A 0.7 1.5 0.6 -22332 0 1450 776 0 0 8 290 3,4 - Fibrous Speta 2014-11-17 MALE 162 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 Liver Intrahepatic Recurrence No NO YES No No M0 N0 T1 Stage I AACY WITH TUMOR 114 130 400 YES NO 1.1 NO NO R0 Primary Tumor 01 Extended Lobectomy 7th NO YES DD 1.2 Liver None LIVING 62 2010 TCGA-DD-AACY-01A-11D-A40Q-01 TCGA-DD-AACY-01A-11D-A40Q-01 TCGA-DD-AACY-01A-11D-A40R-10 TCGA-DD-AACY-01 TCGA-DD-AACY-01 c9dcf079-d32b-47d6-807f-988628c13c92 TCGA-DD-AACY-01 TCGA-DD-AACY-01 c9dcf079-d32b-47d6-807f-988628c13c92 c9dcf079-d32b-47d6-807f-988628c13c92 c9dcf079-d32b-47d6-807f-988628c13c92 TCGA-DD-AACY-01A-11D-A40S-05 TCGA-DD-AACZ-01 TCGA-DD-AACZ-01 TCGA-DD-AACZ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 63 3.8 4.5 5.3 TCGA-DD-AACZ 0.2 0.4 A 0.7 1.5 0.6 -23230 171 0 1 0 8 25 2014-6-29 FEMALE 149 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 G4 YES No M0 N0 T1 Stage I AACZ TUMOR FREE 412 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Extended Lobectomy 7th NO YES DD 1.2 Liver Macro DECEASED 52 2010 TCGA-DD-AACZ-01A-11D-A40Q-01 TCGA-DD-AACZ-01A-11D-A40Q-01 TCGA-DD-AACZ-01A-11D-A40R-10 TCGA-DD-AACZ-01 TCGA-DD-AACZ-01 c037b79c-c02f-474e-be9d-6c9ca4cfd633 TCGA-DD-AACZ-01 TCGA-DD-AACZ-01 c037b79c-c02f-474e-be9d-6c9ca4cfd633 c037b79c-c02f-474e-be9d-6c9ca4cfd633 c037b79c-c02f-474e-be9d-6c9ca4cfd633 TCGA-DD-AACZ-01A-11D-A40S-05 TCGA-DD-AAD0-01 TCGA-DD-AAD0-01 TCGA-DD-AAD0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 73 3.8 3.4 5.3 TCGA-DD-AAD0-F68383 TCGA-DD-AAD0 0.2 0.8 A 0.7 1.5 0.5 -26781 0 137 47 0 0 8 4 2014-11-17 FEMALE 150 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 YES G2 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T1 Stage I AAD0 WITH TUMOR 86 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 54 2010 TCGA-DD-AAD0-01A-11D-A40Q-01 TCGA-DD-AAD0-01A-11D-A40Q-01 TCGA-DD-AAD0-01A-11D-A40R-10 TCGA-DD-AAD0-01 TCGA-DD-AAD0-01 d9971596-7f19-4d41-ad23-688e1051c85c TCGA-DD-AAD0-01 TCGA-DD-AAD0-01 d9971596-7f19-4d41-ad23-688e1051c85c d9971596-7f19-4d41-ad23-688e1051c85c d9971596-7f19-4d41-ad23-688e1051c85c TCGA-DD-AAD0-01A-11D-A40S-05 TCGA-DD-AAD1-01 TCGA-DD-AAD1-01 TCGA-DD-AAD1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 51 3.8 4.5 5.3 TCGA-DD-AAD1-F68384 TCGA-DD-AAD1 0.2 0.6 A 0.7 1.5 0.5 -18794 0 564 127 1 0 8 451 2014-12-21 FEMALE 161 Hepatitis B|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G4 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T1 Stage I AAD1 WITH TUMOR 157 130 400 NO NO 0.9 NO NO R1 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None LIVING 44 2010 TCGA-DD-AAD1-01A-11D-A40Q-01 TCGA-DD-AAD1-01A-11D-A40Q-01 TCGA-DD-AAD1-01A-11D-A40R-10 TCGA-DD-AAD1-01 TCGA-DD-AAD1-01 d416dda9-edc6-4dae-b563-23a546e70b8a TCGA-DD-AAD1-01 TCGA-DD-AAD1-01 d416dda9-edc6-4dae-b563-23a546e70b8a d416dda9-edc6-4dae-b563-23a546e70b8a d416dda9-edc6-4dae-b563-23a546e70b8a TCGA-DD-AAD1-01A-11D-A40S-05 TCGA-DD-AAD2-01 TCGA-DD-AAD2-01 TCGA-DD-AAD2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 66 3.8 3.5 5.3 TCGA-DD-AAD2-F68385 TCGA-DD-AAD2 TCGA-DD-AAD2-01A 0.2 0.3 A 0.7 1.5 0.8 -24221 1105 0 658 0 0 8 25 1,2 - Portal Fibrosis 2014-11-17 MALE 156 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 1.0 1.0 NO YES G2 NO true No M0 N0 T1 Stage I TCGA-DD-AAD2.3F50DE59-F830-4D51-90C6-7B275AF0876F.pdf AAD2 TUMOR FREE 172 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver Micro A LIVING 52 2010 TCGA-DD-AAD2-01A-11D-A40Q-01 TCGA-DD-AAD2-01A-11D-A40Q-01 TCGA-DD-AAD2-01A-11D-A40R-10 TCGA-DD-AAD2-01 TCGA-DD-AAD2-01 2c10e17e-58c2-445c-9306-ca22625bdc38 TCGA-DD-AAD2-01 TCGA-DD-AAD2-01 2c10e17e-58c2-445c-9306-ca22625bdc38 2c10e17e-58c2-445c-9306-ca22625bdc38 2c10e17e-58c2-445c-9306-ca22625bdc38 TCGA-DD-AAD2-01A-11D-A40S-05 TCGA-DD-AAD3-01 TCGA-DD-AAD3-01 TCGA-DD-AAD3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 43 3.8 3.9 5.3 TCGA-DD-AAD3-F68386 TCGA-DD-AAD3 TCGA-DD-AAD3-01A 0.2 0.4 A 0.7 1.5 0.8 -15706 1072 0 1295 0 1,2 - Portal Fibrosis 2014-11-17 MALE 178 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-DD-AAD3.03056B3E-B81F-44C0-B21E-6C850D67DB43.pdf AAD3 TUMOR FREE 181 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.2 Liver None A LIVING 77 2011 TCGA-DD-AAD3-01A-11D-A40Q-01 TCGA-DD-AAD3-01A-11D-A40Q-01 TCGA-DD-AAD3-01A-11D-A40R-10 TCGA-DD-AAD3-01 TCGA-DD-AAD3-01 9aa788e8-ff29-49a1-bec4-282c728de83e TCGA-DD-AAD3-01 TCGA-DD-AAD3-01 9aa788e8-ff29-49a1-bec4-282c728de83e 9aa788e8-ff29-49a1-bec4-282c728de83e 9aa788e8-ff29-49a1-bec4-282c728de83e TCGA-DD-AAD3-01A-11D-A40S-05 TCGA-DD-AAD5-01 TCGA-DD-AAD5-01 TCGA-DD-AAD5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 54 3.8 3.7 5.3 TCGA-DD-AAD5-F68387 TCGA-DD-AAD5 TCGA-DD-AAD5-01A 0.2 0.6 A 0.7 1.5 0.6 -19748 1058 0 1345 130 0 0 8 73 3,4 - Fibrous Speta 2014-11-17 MALE 170 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 1.0 1.0 NO NO G3 Liver Intrahepatic Recurrence No NO YES No true No M0 N0 T1 Stage I TCGA-DD-AAD5.7F74E08A-C14B-413E-9D75-FCDBFC2F67C5.pdf AAD5 WITH TUMOR 349 130 400 NO NO 1.2 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 70 2011 TCGA-DD-AAD5-01A-11D-A40Q-01 TCGA-DD-AAD5-01A-11D-A40Q-01 TCGA-DD-AAD5-01A-11D-A40R-10 TCGA-DD-AAD5-01 TCGA-DD-AAD5-01 6b62b19f-8a09-4042-83e9-f86399aac7d1 TCGA-DD-AAD5-01 TCGA-DD-AAD5-01 6b62b19f-8a09-4042-83e9-f86399aac7d1 6b62b19f-8a09-4042-83e9-f86399aac7d1 6b62b19f-8a09-4042-83e9-f86399aac7d1 TCGA-DD-AAD5-01A-11D-A40S-05 TCGA-DD-AAD6-01 TCGA-DD-AAD6-01 TCGA-DD-AAD6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 66 3.8 2.7 5.3 TCGA-DD-AAD6-F68388 TCGA-DD-AAD6 TCGA-DD-AAD6-01A 0.2 0.6 A 0.7 1.5 1.1 -24185 1035 0 672 50 1 2014-11-17 MALE 167 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 1.0 1.0 NO NO G3 Liver Locoregional Recurrence Yes NO YES No true No M0 N0 T3a Stage IIIA TCGA-DD-AAD6.B246AEB4-8035-4114-9F1E-3E076809A896.pdf AAD6 TUMOR FREE 185 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None A LIVING 93 2011 TCGA-DD-AAD6-01A-11D-A40Q-01 TCGA-DD-AAD6-01A-11D-A40Q-01 TCGA-DD-AAD6-01A-11D-A40R-10 TCGA-DD-AAD6-01 TCGA-DD-AAD6-01 14edee70-32c0-41f3-a8f1-1b641ab548cb TCGA-DD-AAD6-01 TCGA-DD-AAD6-01 14edee70-32c0-41f3-a8f1-1b641ab548cb 14edee70-32c0-41f3-a8f1-1b641ab548cb 14edee70-32c0-41f3-a8f1-1b641ab548cb TCGA-DD-AAD6-01A-11D-A40S-05 TCGA-DD-AAD8-01 TCGA-DD-AAD8-01 TCGA-DD-AAD8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 73 3.8 4.3 5.3 TCGA-DD-AAD8-F68389 TCGA-DD-AAD8 TCGA-DD-AAD8-01A 0.2 0.3 A 0.7 1.5 0.6 -26781 981 0 1219 0 0 8 4 1,2 - Portal Fibrosis 2014-11-17 FEMALE 152 Hepatitis B|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 1.0 1.0 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-DD-AAD8.5536ED7C-6CC3-442D-A8FD-5EE91C98F358.pdf AAD8 TUMOR FREE 130 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None A LIVING 57 2011 TCGA-DD-AAD8-01A-11D-A40Q-01 TCGA-DD-AAD8-01A-11D-A40Q-01 TCGA-DD-AAD8-01A-11D-A40R-10 TCGA-DD-AAD8-01 TCGA-DD-AAD8-01 6c2960e2-ad7a-4c08-a453-1bf747483d42 TCGA-DD-AAD8-01 TCGA-DD-AAD8-01 6c2960e2-ad7a-4c08-a453-1bf747483d42 6c2960e2-ad7a-4c08-a453-1bf747483d42 6c2960e2-ad7a-4c08-a453-1bf747483d42 TCGA-DD-AAD8-01A-11D-A40S-05 TCGA-DD-AADA-01 TCGA-DD-AADA-01 TCGA-DD-AADA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 66 3.8 4.1 5.3 TCGA-DD-AADA-F68390 TCGA-DD-AADA TCGA-DD-AADA-01A 0.2 0.5 A 0.7 1.5 0.6 -24288 959 0 1233 0 0 8 8698 2014-11-17 FEMALE 147 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AADA.624DA15E-ADC6-4F09-9DCB-3B4C42F3B453.pdf AADA TUMOR FREE 173 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver Macro A LIVING 59 2011 TCGA-DD-AADA-01A-11D-A40Q-01 TCGA-DD-AADA-01A-11D-A40Q-01 TCGA-DD-AADA-01A-11D-A40R-10 TCGA-DD-AADA-01 TCGA-DD-AADA-01 392aa482-9a49-403c-817e-7b429e1d82f9 TCGA-DD-AADA-01 TCGA-DD-AADA-01 392aa482-9a49-403c-817e-7b429e1d82f9 392aa482-9a49-403c-817e-7b429e1d82f9 392aa482-9a49-403c-817e-7b429e1d82f9 TCGA-DD-AADA-01A-11D-A40S-05 TCGA-DD-AADB-01 TCGA-DD-AADB-01 TCGA-DD-AADB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 51 3.8 4.5 5.3 TCGA-DD-AADB-F68391 TCGA-DD-AADB TCGA-DD-AADB-01A 0.2 1.5 A 0.7 1.5 0.8 -18728 946 0 1242 0 0 8 419 2014-11-17 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G4 NO true No M0 N0 T1 Stage I TCGA-DD-AADB.3963D999-C204-45C2-8515-B922BEBA7C9D.pdf AADB TUMOR FREE 180 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None A LIVING 68 2011 TCGA-DD-AADB-01A-11D-A40Q-01 TCGA-DD-AADB-01A-11D-A40Q-01 TCGA-DD-AADB-01A-11D-A40R-10 TCGA-DD-AADB-01 TCGA-DD-AADB-01 89ad7202-565f-4459-a1ca-946dd27d07b7 TCGA-DD-AADB-01 TCGA-DD-AADB-01 89ad7202-565f-4459-a1ca-946dd27d07b7 89ad7202-565f-4459-a1ca-946dd27d07b7 89ad7202-565f-4459-a1ca-946dd27d07b7 TCGA-DD-AADB-01A-11D-A40S-05 TCGA-DD-AADC-01 TCGA-DD-AADC-01 TCGA-DD-AADC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 53 3.8 3.8 5.3 TCGA-DD-AADC TCGA-DD-AADC-01A 0.2 0.7 A 0.7 1.5 0.8 -19527 945 425 0 0 0 8 36 2014-7-7 MALE 176 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 1.0 1.0 NO G3 YES true No M0 N0 T1 Stage I TCGA-DD-AADC.2A33A2FB-4491-43AA-8C6D-8173FB1D2179.pdf AADC WITH TUMOR 212 130 400 NO NO 1.2 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.2 Liver Macro A DECEASED 81 2011 TCGA-DD-AADC-01A-11D-A40Q-01 TCGA-DD-AADC-01A-11D-A40Q-01 TCGA-DD-AADC-01A-11D-A40R-10 TCGA-DD-AADC-01 TCGA-DD-AADC-01 577cf129-d44e-4dda-bc23-bcbe2c55cfcc TCGA-DD-AADC-01 TCGA-DD-AADC-01 577cf129-d44e-4dda-bc23-bcbe2c55cfcc 577cf129-d44e-4dda-bc23-bcbe2c55cfcc 577cf129-d44e-4dda-bc23-bcbe2c55cfcc TCGA-DD-AADC-01A-11D-A40S-05 TCGA-DD-AADD-01 TCGA-DD-AADD-01 TCGA-DD-AADD TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 51 3.8 4.1 5.3 TCGA-DD-AADD-F68392 TCGA-DD-AADD TCGA-DD-AADD-01A 0.2 0.4 A 0.7 1.5 0.9 -18752 931 0 1231 1 0 8 9804 2014-11-17 MALE 168 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 1.0 1.0 NO NO G4 NO true No M0 N0 T1 Stage I TCGA-DD-AADD.DCDE4D46-AB4E-4C21-9F01-35A304FFF8D5.pdf AADD TUMOR FREE 299 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.2 Liver None A LIVING 68 2011 TCGA-DD-AADD-01A-11D-A40Q-01 TCGA-DD-AADD-01A-11D-A40Q-01 TCGA-DD-AADD-01A-11D-A40R-10 TCGA-DD-AADD-01 TCGA-DD-AADD-01 439c718c-5d13-4516-9343-0a0b8c5869c4 TCGA-DD-AADD-01 TCGA-DD-AADD-01 439c718c-5d13-4516-9343-0a0b8c5869c4 439c718c-5d13-4516-9343-0a0b8c5869c4 439c718c-5d13-4516-9343-0a0b8c5869c4 TCGA-DD-AADD-01A-11D-A40S-05 TCGA-DD-AADE-01 TCGA-DD-AADE-01 TCGA-DD-AADE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 50 3.8 3.9 5.3 TCGA-DD-AADE-F68393 TCGA-DD-AADE 0.2 0.5 A 0.7 1.5 1.1 -18482 0 1202 168 0 0 8 7 3,4 - Fibrous Speta 2014-11-17 MALE 166 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G4 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T1 Stage I AADE WITH TUMOR 148 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver Micro LIVING 63 2011 TCGA-DD-AADE-01A-11D-A40Q-01 TCGA-DD-AADE-01A-11D-A40Q-01 TCGA-DD-AADE-01A-11D-A40R-10 TCGA-DD-AADE-01 TCGA-DD-AADE-01 TCGA-DD-AADE-01A-11D-A40S-05 TCGA-DD-AADF-01 TCGA-DD-AADF-01 TCGA-DD-AADF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 64 3.8 3.5 5.3 TCGA-DD-AADF TCGA-DD-AADF-01A 0.2 1.1 A 0.7 1.5 0.6 -23614 865 115 0 1 0 8 725 2014-7-7 FEMALE 145 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 1.0 1.0 NO G4 NO true No M0 N0 T1 Stage I TCGA-DD-AADF.046D3A59-FFB8-40B1-8ED2-6853F42CF611.pdf AADF TUMOR FREE 174 130 400 NO NO 1.2 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.2 Liver None A DECEASED 55 2011 TCGA-DD-AADF-01A-11D-A40Q-01 TCGA-DD-AADF-01A-11D-A40Q-01 TCGA-DD-AADF-01A-11D-A40R-10 TCGA-DD-AADF-01 TCGA-DD-AADF-01 3213d854-0c94-4958-94e6-d3ada06b0ed2 TCGA-DD-AADF-01 TCGA-DD-AADF-01 3213d854-0c94-4958-94e6-d3ada06b0ed2 3213d854-0c94-4958-94e6-d3ada06b0ed2 3213d854-0c94-4958-94e6-d3ada06b0ed2 TCGA-DD-AADF-01A-11D-A40S-05 TCGA-DD-AADG-01 TCGA-DD-AADG-01 TCGA-DD-AADG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 70 3.8 4.2 5.3 TCGA-DD-AADG-F68394 TCGA-DD-AADG TCGA-DD-AADG-01A 0.2 0.9 A 0.7 1.5 1.0 -25887 862 0 1145 386 270 0 0 8 2256 3,4 - Fibrous Speta 2014-11-17 MALE 160 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 1.0 1.0 NO NO G3 Liver Intrahepatic Recurrence No YES YES No true No M0 N0 T3a Stage IIIA TCGA-DD-AADG.E6130559-E3EA-4010-9031-071D55816383.pdf AADG TUMOR FREE 170 130 400 NO NO 1.0 NO NO R0 R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 61 2011 TCGA-DD-AADG-01A-11D-A40Q-01 TCGA-DD-AADG-01A-11D-A40Q-01 TCGA-DD-AADG-01A-11D-A40R-10 TCGA-DD-AADG-01 TCGA-DD-AADG-01 8f27c933-b86c-4d95-8d17-75f0861ecc10 TCGA-DD-AADG-01 TCGA-DD-AADG-01 8f27c933-b86c-4d95-8d17-75f0861ecc10 8f27c933-b86c-4d95-8d17-75f0861ecc10 8f27c933-b86c-4d95-8d17-75f0861ecc10 TCGA-DD-AADG-01A-11D-A40S-05 TCGA-DD-AADI-01 TCGA-DD-AADI-01 TCGA-DD-AADI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 43 3.8 3.8 5.3 TCGA-DD-AADI-F68395 TCGA-DD-AADI 0.2 0.5 A 0.7 1.5 0.8 -15928 0 1085 0 0 8 27 2014-11-17 FEMALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 NO No M0 N0 T1 Stage I AADI TUMOR FREE 141 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None LIVING 64 2011 TCGA-DD-AADI-01A-11D-A40Q-01 TCGA-DD-AADI-01A-11D-A40Q-01 TCGA-DD-AADI-01A-11D-A40R-10 TCGA-DD-AADI-01 TCGA-DD-AADI-01 e4311714-b7a4-47b2-81a2-bddd0775f1e6 TCGA-DD-AADI-01 TCGA-DD-AADI-01 e4311714-b7a4-47b2-81a2-bddd0775f1e6 e4311714-b7a4-47b2-81a2-bddd0775f1e6 e4311714-b7a4-47b2-81a2-bddd0775f1e6 TCGA-DD-AADI-01A-11D-A40S-05 TCGA-DD-AADJ-01 TCGA-DD-AADJ-01 TCGA-DD-AADJ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 70 3.8 4.2 5.3 TCGA-DD-AADJ-F68396 TCGA-DD-AADJ 0.2 0.6 A 0.7 1.5 0.6 -25863 0 1066 0 0 8 708 2014-11-17 FEMALE 154 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 NO No M0 N0 T1 Stage I AADJ TUMOR FREE 203 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 59 2011 TCGA-DD-AADJ-01A-11D-A40Q-01 TCGA-DD-AADJ-01A-11D-A40Q-01 TCGA-DD-AADJ-01A-11D-A40R-10 TCGA-DD-AADJ-01 TCGA-DD-AADJ-01 d3582fe8-0633-449d-969d-8e0e4c06bfd8 TCGA-DD-AADJ-01 TCGA-DD-AADJ-01 d3582fe8-0633-449d-969d-8e0e4c06bfd8 d3582fe8-0633-449d-969d-8e0e4c06bfd8 d3582fe8-0633-449d-969d-8e0e4c06bfd8 TCGA-DD-AADJ-01A-11D-A40S-05 TCGA-DD-AADK-01 TCGA-DD-AADK-01 TCGA-DD-AADK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 68 3.8 4.4 5.3 TCGA-DD-AADK-F68397 TCGA-DD-AADK 0.2 0.5 A 0.7 1.5 1.2 -25046 0 1049 0 0 8 236 6 - Established Cirrhosis 2014-11-17 FEMALE 150 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 NO No M0 N0 T2 Stage II AADK TUMOR FREE 197 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.2 Liver Micro LIVING 51 2011 TCGA-DD-AADK-01A-11D-A40Q-01 TCGA-DD-AADK-01A-11D-A40Q-01 TCGA-DD-AADK-01A-11D-A40R-10 TCGA-DD-AADK-01 TCGA-DD-AADK-01 b57c62f8-10b1-47cc-af66-9ba1d281661f TCGA-DD-AADK-01 TCGA-DD-AADK-01 b57c62f8-10b1-47cc-af66-9ba1d281661f b57c62f8-10b1-47cc-af66-9ba1d281661f b57c62f8-10b1-47cc-af66-9ba1d281661f TCGA-DD-AADK-01A-11D-A40S-05 TCGA-DD-AADL-01 TCGA-DD-AADL-01 TCGA-DD-AADL TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 58 3.8 3.5 5.3 TCGA-DD-AADL-F68398 TCGA-DD-AADL TCGA-DD-AADL-01A 0.2 0.5 2 A 0.7 1.5 0.5 -21512 720 0 636 0 0 8 14 2014-11-17 MALE 159 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G4 NO true No M0 N0 T1 Stage I TCGA-DD-AADL.248AF6DC-85A7-4334-B282-B7B0102C4596.pdf AADL TUMOR FREE 204 130 400 NO NO 0.9 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver Micro A LIVING 53 2012 TCGA-DD-AADL-01A-11D-A40Q-01 TCGA-DD-AADL-01A-11D-A40Q-01 TCGA-DD-AADL-01A-11D-A40R-10 TCGA-DD-AADL-01 TCGA-DD-AADL-01 5381c623-bc22-4f71-8ce1-4f8a4d354826 TCGA-DD-AADL-01 TCGA-DD-AADL-01 5381c623-bc22-4f71-8ce1-4f8a4d354826 5381c623-bc22-4f71-8ce1-4f8a4d354826 5381c623-bc22-4f71-8ce1-4f8a4d354826 TCGA-DD-AADL-01A-11D-A40S-05 TCGA-DD-AADM-01 TCGA-DD-AADM-01 TCGA-DD-AADM TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 58 3.8 4.1 5.3 TCGA-DD-AADM TCGA-DD-AADM-01A 0.2 0.5 A 0.7 1.5 0.8 -21349 704 12 0 0 0 8 112 2014-7-7 MALE 159 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO G3 NO true No M0 N0 T2 Stage II TCGA-DD-AADM.36839A87-47E6-4E63-8683-A1549549AECE.pdf AADM TUMOR FREE 126 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.2 Liver None A DECEASED 55 2012 TCGA-DD-AADM-01A-11D-A40Q-01 TCGA-DD-AADM-01A-11D-A40Q-01 TCGA-DD-AADM-01A-11D-A40R-10 TCGA-DD-AADM-01 TCGA-DD-AADM-01 377c868a-4176-4c2b-b1bb-9f97b8d85739 TCGA-DD-AADM-01 TCGA-DD-AADM-01 377c868a-4176-4c2b-b1bb-9f97b8d85739 377c868a-4176-4c2b-b1bb-9f97b8d85739 377c868a-4176-4c2b-b1bb-9f97b8d85739 TCGA-DD-AADM-01A-11D-A40S-05 TCGA-DD-AADN-01 TCGA-DD-AADN-01 TCGA-DD-AADN TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 59 3.8 3.5 5.3 TCGA-DD-AADN-F68400 TCGA-DD-AADN TCGA-DD-AADN-01A 0.2 1.1 A 0.7 1.5 0.8 -21632 602 0 898 0 0 8 151367 2014-11-17 MALE 160 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 1.0 1.0 NO NO G4 NO true No MX NX T1 Stage I TCGA-DD-AADN.043E7A50-2122-42D4-BB6F-9AAC61FE8CBE.pdf AADN TUMOR FREE 176 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver Micro A LIVING 62 2012 TCGA-DD-AADN-01A-11D-A40Q-01 TCGA-DD-AADN-01A-11D-A40Q-01 TCGA-DD-AADN-01A-11D-A40R-10 TCGA-DD-AADN-01 TCGA-DD-AADN-01 972a081e-7a07-4b85-93d9-b58ad38229f7 TCGA-DD-AADN-01 TCGA-DD-AADN-01 972a081e-7a07-4b85-93d9-b58ad38229f7 972a081e-7a07-4b85-93d9-b58ad38229f7 972a081e-7a07-4b85-93d9-b58ad38229f7 TCGA-DD-AADN-01A-11D-A40S-05 TCGA-DD-AADO-01 TCGA-DD-AADO-01 TCGA-DD-AADO TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 55 3.8 4.5 5.3 TCGA-DD-AADO-F68401 TCGA-DD-AADO 0.2 0.4 A 0.7 1.5 0.6 -20139 0 453 0 0 8 176037 2014-11-17 MALE 168 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 NO No M0 N0 T1 Stage I AADO TUMOR FREE 180 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver Micro LIVING 58 2013 TCGA-DD-AADO-01A-11D-A40Q-01 TCGA-DD-AADO-01A-11D-A40Q-01 TCGA-DD-AADO-01A-11D-A40R-10 TCGA-DD-AADO-01 TCGA-DD-AADO-01 dc8b6cb8-c320-4f72-8e12-0177cecffc87 TCGA-DD-AADO-01 TCGA-DD-AADO-01 dc8b6cb8-c320-4f72-8e12-0177cecffc87 dc8b6cb8-c320-4f72-8e12-0177cecffc87 dc8b6cb8-c320-4f72-8e12-0177cecffc87 TCGA-DD-AADO-01A-11D-A40S-05 TCGA-DD-AADP-01 TCGA-DD-AADP-01 TCGA-DD-AADP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 45 3.8 3.7 5.3 TCGA-DD-AADP-F68402 TCGA-DD-AADP TCGA-DD-AADP-01A 0.2 0.6 A 0.7 1.5 0.5 -16760 161 0 458 0 0 8 9 2014-11-17 MALE 167 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AADP.11B44F97-2332-4CB7-B57C-063B1C6127EF.pdf AADP TUMOR FREE 102 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver Micro A LIVING 67 2013 TCGA-DD-AADP-01A-11D-A38W-01 TCGA-DD-AADP-01A-11D-A38W-01 TCGA-DD-AADP-01A-11D-A38X-10 TCGA-DD-AADP-01 TCGA-DD-AADP-01 6b57a5b6-2306-493a-aecf-0de8d2f098a8 TCGA-DD-AADP-01 TCGA-DD-AADP-01 6b57a5b6-2306-493a-aecf-0de8d2f098a8 6b57a5b6-2306-493a-aecf-0de8d2f098a8 6b57a5b6-2306-493a-aecf-0de8d2f098a8 TCGA-DD-AADP-01A-11D-A39G-05 TCGA-DD-AADQ-01 TCGA-DD-AADQ-01 TCGA-DD-AADQ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 59 3.8 4.4 5.3 TCGA-DD-AADQ-F68403 TCGA-DD-AADQ 0.2 0.3 A 0.7 1.5 0.7 -21756 0 436 0 0 8 7 2014-11-17 MALE 165 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 NO No M0 N0 T2 Stage II AADQ TUMOR FREE 163 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 64 2013 TCGA-DD-AADQ-01A-11D-A40Q-01 TCGA-DD-AADQ-01A-11D-A40Q-01 TCGA-DD-AADQ-01A-11D-A40R-10 TCGA-DD-AADQ-01 TCGA-DD-AADQ-01 c623f952-e487-4d8d-a5c3-eef8bac53a05 TCGA-DD-AADQ-01 TCGA-DD-AADQ-01 c623f952-e487-4d8d-a5c3-eef8bac53a05 c623f952-e487-4d8d-a5c3-eef8bac53a05 c623f952-e487-4d8d-a5c3-eef8bac53a05 TCGA-DD-AADQ-01A-11D-A40S-05 TCGA-DD-AADR-01 TCGA-DD-AADR-01 TCGA-DD-AADR TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 58 3.8 4.4 5.3 TCGA-DD-AADR-F68404 TCGA-DD-AADR 0.2 0.9 A 0.7 1.5 1.0 -21217 0 2028 2028 0 0 8 3 6 - Established Cirrhosis 2014-11-17 MALE 170 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 Liver Intrahepatic Recurrence No NO YES No No M0 N0 T1 Stage I AADR TUMOR FREE 75 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None LIVING 75 2009 TCGA-DD-AADR-01A-11D-A40Q-01 TCGA-DD-AADR-01A-11D-A40Q-01 TCGA-DD-AADR-01A-11D-A40R-10 TCGA-DD-AADR-01 TCGA-DD-AADR-01 fcea51b1-3899-4c1d-bcc1-b0fbefe01661 TCGA-DD-AADR-01 TCGA-DD-AADR-01 fcea51b1-3899-4c1d-bcc1-b0fbefe01661 fcea51b1-3899-4c1d-bcc1-b0fbefe01661 fcea51b1-3899-4c1d-bcc1-b0fbefe01661 TCGA-DD-AADR-01A-11D-A40S-05 TCGA-DD-AADS-01 TCGA-DD-AADS-01 TCGA-DD-AADS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 63 3.8 3.7 5.3 TCGA-DD-AADS-F68405 TCGA-DD-AADS 0.2 0.7 1 A 0.7 1.5 0.9 -23227 0 474 0 0 8 11 2014-11-17 MALE 164 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G2 NO No M0 N0 T1 Stage I AADS TUMOR FREE 120 130 400 NO NO 1.2 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 53 2013 TCGA-DD-AADS-01A-11D-A40Q-01 TCGA-DD-AADS-01A-11D-A40Q-01 TCGA-DD-AADS-01A-11D-A40R-10 TCGA-DD-AADS-01 TCGA-DD-AADS-01 b05b2c69-27f3-46db-891a-9d2f8b0d8b97 TCGA-DD-AADS-01 TCGA-DD-AADS-01 b05b2c69-27f3-46db-891a-9d2f8b0d8b97 b05b2c69-27f3-46db-891a-9d2f8b0d8b97 b05b2c69-27f3-46db-891a-9d2f8b0d8b97 TCGA-DD-AADS-01A-11D-A40S-05 TCGA-DD-AADU-01 TCGA-DD-AADU-01 TCGA-DD-AADU TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 60 3.8 4.3 5.3 TCGA-DD-AADU-F68406 TCGA-DD-AADU 0.2 1.8 A 0.7 1.5 0.8 -21940 0 554 0 0 8 52 3,4 - Fibrous Speta 2014-11-17 MALE 166 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 NO No M0 N0 T2 Stage II AADU TUMOR FREE 223 130 400 NO NO 1.0 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver Micro LIVING 73 2013 TCGA-DD-AADU-01A-11D-A40Q-01 TCGA-DD-AADU-01A-11D-A40Q-01 TCGA-DD-AADU-01A-11D-A40R-10 TCGA-DD-AADU-01 TCGA-DD-AADU-01 e0178b54-86f9-45e7-949d-2c4132ac9822 TCGA-DD-AADU-01 TCGA-DD-AADU-01 e0178b54-86f9-45e7-949d-2c4132ac9822 e0178b54-86f9-45e7-949d-2c4132ac9822 e0178b54-86f9-45e7-949d-2c4132ac9822 TCGA-DD-AADU-01A-11D-A40S-05 TCGA-DD-AADV-01 TCGA-DD-AADV-01 TCGA-DD-AADV TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 50 3.8 3.8 5.3 TCGA-DD-AADV-F68407 TCGA-DD-AADV TCGA-DD-AADV-01A 0.2 0.8 A 0.7 1.5 0.9 -18300 286 0 574 0 0 8 11 6 - Established Cirrhosis 2014-11-17 MALE 176 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G3 NO true Yes M0 N0 T1 Stage I TCGA-DD-AADV.750CC634-8874-488C-B20D-6B636978156A.pdf AADV TUMOR FREE 187 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.2 Liver None A LIVING 64 2013 TCGA-DD-AADV-01A-11D-A38W-01 TCGA-DD-AADV-01A-11D-A38W-01 TCGA-DD-AADV-01A-11D-A38X-10 TCGA-DD-AADV-01 TCGA-DD-AADV-01 31ca8dd5-ebff-496f-b9ea-e62a96449238 TCGA-DD-AADV-01 TCGA-DD-AADV-01 31ca8dd5-ebff-496f-b9ea-e62a96449238 31ca8dd5-ebff-496f-b9ea-e62a96449238 31ca8dd5-ebff-496f-b9ea-e62a96449238 TCGA-DD-AADV-01A-11D-A39G-05 TCGA-DD-AADW-01 TCGA-DD-AADW-01 TCGA-DD-AADW TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES None 48 3.8 4.3 4.3 TCGA-DD-AADW-F68408 TCGA-DD-AADW TCGA-DD-AADW-01A 0.2 1.0 A 0.7 1.5 0.8 -17781 287 0 587 386 1 0 8 250 6 - Established Cirrhosis 2014-11-17 MALE 163 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 1.0 1.0 NO NO G3 Liver Locoregional Recurrence No NO YES No true No M0 N0 T1 Stage I TCGA-DD-AADW.18DA1A83-81E4-462C-AA58-FBB1298F86F9.pdf AADW TUMOR FREE 102 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 49 2013 TCGA-DD-AADW-01A-11D-A38W-01 TCGA-DD-AADW-01A-11D-A38W-01 TCGA-DD-AADW-01A-11D-A38X-10 TCGA-DD-AADW-01 TCGA-DD-AADW-01 64842a3f-2584-4d55-9e6c-bb976485476a TCGA-DD-AADW-01 TCGA-DD-AADW-01 64842a3f-2584-4d55-9e6c-bb976485476a 64842a3f-2584-4d55-9e6c-bb976485476a 64842a3f-2584-4d55-9e6c-bb976485476a TCGA-DD-AADW-01A-11D-A39G-05 TCGA-DD-AADY-01 TCGA-DD-AADY-01 TCGA-DD-AADY TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 55 3.8 3.5 5.3 TCGA-DD-AADY-F68409 TCGA-DD-AADY 0.2 0.8 A 0.7 1.5 0.6 -20233 0 555 0 0 8 9 6 - Established Cirrhosis 2014-11-17 FEMALE 161 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G2 NO No M0 N0 T1 Stage I AADY TUMOR FREE 159 130 400 NO NO 1.3 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 55 2013 TCGA-DD-AADY-01A-11D-A40Q-01 TCGA-DD-AADY-01A-11D-A40Q-01 TCGA-DD-AADY-01A-11D-A40R-10 TCGA-DD-AADY-01 TCGA-DD-AADY-01 a7a49062-5a0f-4a5f-bcac-9673538f975d TCGA-DD-AADY-01 TCGA-DD-AADY-01 a7a49062-5a0f-4a5f-bcac-9673538f975d a7a49062-5a0f-4a5f-bcac-9673538f975d a7a49062-5a0f-4a5f-bcac-9673538f975d TCGA-DD-AADY-01A-11D-A40S-05 TCGA-DD-AAE0-01 TCGA-DD-AAE0-01 TCGA-DD-AAE0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 45 3.8 4.8 5.3 TCGA-DD-AAE0-F68410 TCGA-DD-AAE0 TCGA-DD-AAE0-01A 0.2 0.9 A 0.7 1.5 0.5 -16732 314 0 555 0 0 8 8751 3,4 - Fibrous Speta 2014-11-17 FEMALE 159 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 1.0 1.0 NO NO G4 NO true No M0 N0 T3a Stage IIIA TCGA-DD-AAE0.C8EB705D-E9F9-4101-9B7F-EE4968CA5781.pdf AAE0 TUMOR FREE 226 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 56 2013 TCGA-DD-AAE0-01A-11D-A40Q-01 TCGA-DD-AAE0-01A-11D-A40Q-01 TCGA-DD-AAE0-01A-11D-A40R-10 TCGA-DD-AAE0-01 TCGA-DD-AAE0-01 848b19c6-7761-48b9-9f22-ab31d5aadba1 TCGA-DD-AAE0-01 TCGA-DD-AAE0-01 848b19c6-7761-48b9-9f22-ab31d5aadba1 848b19c6-7761-48b9-9f22-ab31d5aadba1 848b19c6-7761-48b9-9f22-ab31d5aadba1 TCGA-DD-AAE0-01A-11D-A40S-05 TCGA-DD-AAE1-01 TCGA-DD-AAE1-01 TCGA-DD-AAE1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 52 3.8 4.1 5.3 TCGA-DD-AAE1-F68411 TCGA-DD-AAE1 0.2 0.4 A 0.7 1.5 0.8 -19073 0 552 0 0 8 2693 6 - Established Cirrhosis 2014-11-17 MALE 169 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 NO No M0 N0 T1 Stage I AAE1 TUMOR FREE 102 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 62 2013 TCGA-DD-AAE1-01A-11D-A40Q-01 TCGA-DD-AAE1-01A-11D-A40Q-01 TCGA-DD-AAE1-01A-11D-A40R-10 TCGA-DD-AAE1-01 TCGA-DD-AAE1-01 ba7eaaac-b25a-4f83-b8f8-885b172ac44c TCGA-DD-AAE1-01 TCGA-DD-AAE1-01 ba7eaaac-b25a-4f83-b8f8-885b172ac44c ba7eaaac-b25a-4f83-b8f8-885b172ac44c ba7eaaac-b25a-4f83-b8f8-885b172ac44c TCGA-DD-AAE1-01A-11D-A40S-05 TCGA-DD-AAE2-01 TCGA-DD-AAE2-01 TCGA-DD-AAE2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 51 3.8 4.4 5.3 TCGA-DD-AAE2-F68412 TCGA-DD-AAE2 TCGA-DD-AAE2-01A 0.2 0.4 A 0.7 1.5 0.8 -18695 337 0 638 0 0 8 41 6 - Established Cirrhosis 2014-11-17 MALE 174 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AAE2.C70F898B-E3C1-42C1-BF50-38E126A5B708.pdf AAE2 TUMOR FREE 238 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 82 2013 TCGA-DD-AAE2-01A-11D-A40Q-01 TCGA-DD-AAE2-01A-11D-A40Q-01 TCGA-DD-AAE2-01A-11D-A40R-10 TCGA-DD-AAE2-01 TCGA-DD-AAE2-01 1ee97326-1e6c-4c92-ab9f-c4eb6aeb5c46 TCGA-DD-AAE2-01 TCGA-DD-AAE2-01 1ee97326-1e6c-4c92-ab9f-c4eb6aeb5c46 1ee97326-1e6c-4c92-ab9f-c4eb6aeb5c46 1ee97326-1e6c-4c92-ab9f-c4eb6aeb5c46 TCGA-DD-AAE2-01A-11D-A40S-05 TCGA-DD-AAE3-01 TCGA-DD-AAE3-01 TCGA-DD-AAE3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 50 3.8 4.7 5.3 TCGA-DD-AAE3-F68413 TCGA-DD-AAE3 TCGA-DD-AAE3-01A 0.2 1.1 A 0.7 1.5 0.8 -18271 342 0 566 0 0 8 2 1,2 - Portal Fibrosis 2014-11-17 MALE 165 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 1.0 1.0 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-DD-AAE3.FED7CE87-1B13-4035-A76B-CEC1045B93C4.pdf AAE3 TUMOR FREE 180 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 73 2013 TCGA-DD-AAE3-01A-11D-A40Q-01 TCGA-DD-AAE3-01A-11D-A40Q-01 TCGA-DD-AAE3-01A-11D-A40R-10 TCGA-DD-AAE3-01 TCGA-DD-AAE3-01 5b1caa21-6281-47b4-b11f-fbe5458f1ffb TCGA-DD-AAE3-01 TCGA-DD-AAE3-01 5b1caa21-6281-47b4-b11f-fbe5458f1ffb 5b1caa21-6281-47b4-b11f-fbe5458f1ffb 5b1caa21-6281-47b4-b11f-fbe5458f1ffb TCGA-DD-AAE3-01A-11D-A40S-05 TCGA-DD-AAE4-01 TCGA-DD-AAE4-01 TCGA-DD-AAE4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 49 3.8 4.0 5.3 TCGA-DD-AAE4-F68414 TCGA-DD-AAE4 0.2 0.8 A 0.7 1.5 0.5 -18009 0 608 111 0 0 8 7 6 - Established Cirrhosis 2014-11-17 FEMALE 157 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G1 Liver Locoregional Recurrence Yes NO YES No No M0 N0 T1 Stage I AAE4 WITH TUMOR 113 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 62 2013 TCGA-DD-AAE4-01A-11D-A40Q-01 TCGA-DD-AAE4-01A-11D-A40Q-01 TCGA-DD-AAE4-01A-11D-A40R-10 TCGA-DD-AAE4-01 TCGA-DD-AAE4-01 e1aa2737-5bf3-4348-b3bf-07d881e71e6e TCGA-DD-AAE4-01 TCGA-DD-AAE4-01 e1aa2737-5bf3-4348-b3bf-07d881e71e6e e1aa2737-5bf3-4348-b3bf-07d881e71e6e e1aa2737-5bf3-4348-b3bf-07d881e71e6e TCGA-DD-AAE4-01A-11D-A40S-05 TCGA-DD-AAE6-01 TCGA-DD-AAE6-01 TCGA-DD-AAE6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 59 3.8 4.4 5.3 TCGA-DD-AAE6-F68416 TCGA-DD-AAE6 TCGA-DD-AAE6-01A 0.2 0.9 A 0.7 1.5 0.8 -21764 399 0 141 105 0 0 8 113 6 - Established Cirrhosis 2014-11-17 FEMALE 159 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 1.0 1.0 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T1 Stage I TCGA-DD-AAE6.1B3F62E9-8E87-43FA-AEA8-00C89D678F8F.pdf AAE6 WITH TUMOR 209 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver Micro A LIVING 46 2012 TCGA-DD-AAE6-01A-11D-A40Q-01 TCGA-DD-AAE6-01A-11D-A40Q-01 TCGA-DD-AAE6-01A-11D-A40R-10 TCGA-DD-AAE6-01 TCGA-DD-AAE6-01 8d639a44-445c-440c-8452-bafba2df33fc TCGA-DD-AAE6-01 TCGA-DD-AAE6-01 8d639a44-445c-440c-8452-bafba2df33fc 8d639a44-445c-440c-8452-bafba2df33fc 8d639a44-445c-440c-8452-bafba2df33fc TCGA-DD-AAE6-01A-11D-A40S-05 TCGA-DD-AAE7-01 TCGA-DD-AAE7-01 TCGA-DD-AAE7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Severe 72 3.8 4.7 5.3 TCGA-DD-AAE7-F68418 TCGA-DD-AAE7 TCGA-DD-AAE7-01A 0.2 1.1 A 0.7 1.5 0.9 -26568 410 0 644 0 0 8 1 3,4 - Fibrous Speta 2014-11-17 MALE 172 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G2 NO true Yes M0 N0 T1 Stage I TCGA-DD-AAE7.1861F2A9-334D-4C4E-A7D0-D010712D6096.pdf AAE7 TUMOR FREE 188 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 74 2012 TCGA-DD-AAE7-01A-11D-A40Q-01 TCGA-DD-AAE7-01A-11D-A40Q-01 TCGA-DD-AAE7-01A-11D-A40R-10 TCGA-DD-AAE7-01 TCGA-DD-AAE7-01 2c7587fc-5549-4888-abe9-b989e216e9c4 TCGA-DD-AAE7-01 TCGA-DD-AAE7-01 2c7587fc-5549-4888-abe9-b989e216e9c4 2c7587fc-5549-4888-abe9-b989e216e9c4 2c7587fc-5549-4888-abe9-b989e216e9c4 TCGA-DD-AAE7-01A-11D-A40S-05 TCGA-DD-AAE8-01 TCGA-DD-AAE8-01 TCGA-DD-AAE8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 45 3.8 4.3 5.3 TCGA-DD-AAE8-F68419 TCGA-DD-AAE8 0.2 3.0 A 0.7 1.5 0.6 -16549 0 664 113 0 0 8 3 6 - Established Cirrhosis 2014-11-17 MALE 170 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 Liver Intrahepatic Recurrence Yes NO YES No Yes M0 N0 T1 Stage I AAE8 TUMOR FREE 125 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 78 2012 TCGA-DD-AAE8-01A-11D-A40Q-01 TCGA-DD-AAE8-01A-11D-A40Q-01 TCGA-DD-AAE8-01A-11D-A40R-10 TCGA-DD-AAE8-01 TCGA-DD-AAE8-01 TCGA-DD-AAE8-01A-11D-A40S-05 TCGA-DD-AAE9-01 TCGA-DD-AAE9-01 TCGA-DD-AAE9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 69 3.8 4.1 5.3 TCGA-DD-AAE9-F68857 TCGA-DD-AAE9 TCGA-DD-AAE9-01A 0.2 0.7 A 0.7 1.5 0.9 -25451 419 0 722 0 0 8 3 1,2 - Portal Fibrosis 2014-12-21 MALE 165 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AAE9.64700E97-F031-49DE-83F0-8CCDBDEE23AF.pdf AAE9 TUMOR FREE 138 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 63 2012 TCGA-DD-AAE9-01A-11D-A40Q-01 TCGA-DD-AAE9-01A-11D-A40Q-01 TCGA-DD-AAE9-01A-11D-A40R-10 TCGA-DD-AAE9-01 TCGA-DD-AAE9-01 134b8660-251e-428f-9057-b385b122c5ec TCGA-DD-AAE9-01 TCGA-DD-AAE9-01 134b8660-251e-428f-9057-b385b122c5ec 134b8660-251e-428f-9057-b385b122c5ec 134b8660-251e-428f-9057-b385b122c5ec TCGA-DD-AAE9-01A-11D-A40S-05 TCGA-DD-AAEA-01 TCGA-DD-AAEA-01 TCGA-DD-AAEA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 65 3.8 4.5 5.3 TCGA-DD-AAEA-F68421 TCGA-DD-AAEA 0.2 0.6 A 0.7 1.5 0.9 -24027 0 575 0 0 8 2 1,2 - Portal Fibrosis 2014-11-17 MALE 163 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 NO Yes M0 N0 T1 Stage I AAEA TUMOR FREE 255 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None LIVING 66 2012 TCGA-DD-AAEA-01A-11D-A40Q-01 TCGA-DD-AAEA-01A-11D-A40Q-01 TCGA-DD-AAEA-01A-11D-A40R-10 TCGA-DD-AAEA-01 TCGA-DD-AAEA-01 c23a2426-2763-4088-b85b-e9cfcfc7959d TCGA-DD-AAEA-01 TCGA-DD-AAEA-01 c23a2426-2763-4088-b85b-e9cfcfc7959d c23a2426-2763-4088-b85b-e9cfcfc7959d c23a2426-2763-4088-b85b-e9cfcfc7959d TCGA-DD-AAEA-01A-11D-A40S-05 TCGA-DD-AAEB-01 TCGA-DD-AAEB-01 TCGA-DD-AAEB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 60 3.8 4.1 5.3 TCGA-DD-AAEB-F68423 TCGA-DD-AAEB TCGA-DD-AAEB-01A 0.2 0.3 A 0.7 1.5 0.6 -22121 468 0 478 1 0 8 1 2014-11-17 MALE 161 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 1.0 1.0 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-DD-AAEB.E991576A-60BD-4C11-9B4E-EA43F19D06C3.pdf AAEB TUMOR FREE 270 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 75 2012 TCGA-DD-AAEB-01A-11D-A40Q-01 TCGA-DD-AAEB-01A-11D-A40Q-01 TCGA-DD-AAEB-01A-11D-A40R-10 TCGA-DD-AAEB-01 TCGA-DD-AAEB-01 34dd06ab-c00e-4e24-8c92-eae9c430216a TCGA-DD-AAEB-01 TCGA-DD-AAEB-01 34dd06ab-c00e-4e24-8c92-eae9c430216a 34dd06ab-c00e-4e24-8c92-eae9c430216a 34dd06ab-c00e-4e24-8c92-eae9c430216a TCGA-DD-AAEB-01A-11D-A40S-05 TCGA-DD-AAED-01 TCGA-DD-AAED-01 TCGA-DD-AAED TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 51 3.8 4.0 5.3 TCGA-DD-AAED-F68424 TCGA-DD-AAED 0.2 0.6 A 0.7 1.5 0.5 -18722 0 763 198 0 0 8 2405 1,2 - Portal Fibrosis 2014-11-17 MALE 166 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T1 Stage I AAED WITH TUMOR 211 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 69 2012 TCGA-DD-AAED-01A-12D-A40Q-01 TCGA-DD-AAED-01A-12D-A40Q-01 TCGA-DD-AAED-01A-12D-A40R-10 TCGA-DD-AAED-01 TCGA-DD-AAED-01 ccf74279-b0d5-45ca-9a90-fd7d3d2fa630 TCGA-DD-AAED-01 TCGA-DD-AAED-01 ccf74279-b0d5-45ca-9a90-fd7d3d2fa630 ccf74279-b0d5-45ca-9a90-fd7d3d2fa630 ccf74279-b0d5-45ca-9a90-fd7d3d2fa630 TCGA-DD-AAED-01A-12D-A40S-05 TCGA-DD-AAEE-01 TCGA-DD-AAEE-01 TCGA-DD-AAEE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 55 3.8 4.7 5.3 TCGA-DD-AAEE-F68427 TCGA-DD-AAEE TCGA-DD-AAEE-01A 0.2 0.8 A 0.7 1.5 0.9 -20396 509 0 810 298 224 0 0 8 3 6 - Established Cirrhosis 2014-11-17 MALE 160 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 1.0 1.0 NO NO G4 Liver Intrahepatic Recurrence Yes YES YES No true No M0 N0 T1 Stage I TCGA-DD-AAEE.D857BF5A-E2C6-4A6E-88CA-E8707E6FF3D9.pdf AAEE WITH TUMOR 221 130 400 NO NO 1.0 NO NO RX R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 58 2012 TCGA-DD-AAEE-01A-11D-A40Q-01 TCGA-DD-AAEE-01A-11D-A40Q-01 TCGA-DD-AAEE-01A-11D-A40R-10 TCGA-DD-AAEE-01 TCGA-DD-AAEE-01 6624447f-0954-4488-b8f7-2e73162ef22b TCGA-DD-AAEE-01 TCGA-DD-AAEE-01 6624447f-0954-4488-b8f7-2e73162ef22b 6624447f-0954-4488-b8f7-2e73162ef22b 6624447f-0954-4488-b8f7-2e73162ef22b TCGA-DD-AAEE-01A-11D-A40S-05 TCGA-DD-AAEG-01 TCGA-DD-AAEG-01 TCGA-DD-AAEG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 59 3.8 3.0 5.3 TCGA-DD-AAEG-F68430 TCGA-DD-AAEG TCGA-DD-AAEG-01A 0.2 0.6 A 0.7 1.5 0.6 -21853 529 0 719 0 0 8 1 6 - Established Cirrhosis 2014-11-17 FEMALE 149 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G3 NO true Yes M0 N0 T1 Stage I TCGA-DD-AAEG.B48B65B0-92F9-4B49-B8A8-563EA5AF70F1.pdf AAEG TUMOR FREE 69 130 400 NO NO 1.3 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None A LIVING 40 2012 TCGA-DD-AAEG-01A-11D-A38W-01 TCGA-DD-AAEG-01A-11D-A38W-01 TCGA-DD-AAEG-01A-11D-A38X-10 TCGA-DD-AAEG-01 TCGA-DD-AAEG-01 700bf3b6-dff8-4de7-877f-1c742620f896 TCGA-DD-AAEG-01 TCGA-DD-AAEG-01 700bf3b6-dff8-4de7-877f-1c742620f896 700bf3b6-dff8-4de7-877f-1c742620f896 700bf3b6-dff8-4de7-877f-1c742620f896 TCGA-DD-AAEG-01A-11D-A39G-05 TCGA-DD-AAEH-01 TCGA-DD-AAEH-01 TCGA-DD-AAEH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 73 3.8 2.9 5.3 TCGA-DD-AAEH-F68431 TCGA-DD-AAEH TCGA-DD-AAEH-01A 0.2 0.9 A 0.7 1.5 0.6 -26894 553 0 784 660 644 2 1,2 - Portal Fibrosis 2014-11-17 MALE 163 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 10 1.0 1.0 NO NO G2 Bone Extrahepatic Recurrence No YES YES No true No M0 N0 T1 Stage I TCGA-DD-AAEH.D6F3E1F8-27F3-47F9-88CC-F4145C983073.pdf AAEH TUMOR FREE 223 130 400 NO NO 1.1 NO NO RX R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver Micro A LIVING 62 2012 TCGA-DD-AAEH-01A-11D-A40Q-01 TCGA-DD-AAEH-01A-11D-A40Q-01 TCGA-DD-AAEH-01A-11D-A40R-10 TCGA-DD-AAEH-01 TCGA-DD-AAEH-01 5be075bb-9fa0-4821-8e61-672f28e2b833 TCGA-DD-AAEH-01 TCGA-DD-AAEH-01 5be075bb-9fa0-4821-8e61-672f28e2b833 5be075bb-9fa0-4821-8e61-672f28e2b833 5be075bb-9fa0-4821-8e61-672f28e2b833 TCGA-DD-AAEH-01A-11D-A40S-05 TCGA-DD-AAEI-01 TCGA-DD-AAEI-01 TCGA-DD-AAEI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES None 72 3.8 3.6 5.3 TCGA-DD-AAEI-F68433 TCGA-DD-AAEI 0.2 0.5 A 0.7 1.5 0.9 -26465 0 1531 491 0 0 8 24 6 - Established Cirrhosis 2014-11-17 MALE 166 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G2 Bone Extrahepatic Recurrence No NO YES No No M0 N0 T1 Stage I AAEI WITH TUMOR 161 130 400 YES NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None LIVING 79 2010 TCGA-DD-AAEI-01A-11D-A40Q-01 TCGA-DD-AAEI-01A-11D-A40Q-01 TCGA-DD-AAEI-01A-11D-A40R-10 TCGA-DD-AAEI-01 TCGA-DD-AAEI-01 ab0da649-e0c0-497a-a20b-4d1a618dba72 TCGA-DD-AAEI-01 TCGA-DD-AAEI-01 ab0da649-e0c0-497a-a20b-4d1a618dba72 ab0da649-e0c0-497a-a20b-4d1a618dba72 ab0da649-e0c0-497a-a20b-4d1a618dba72 TCGA-DD-AAEI-01A-11D-A40S-05 TCGA-DD-AAEK-01 TCGA-DD-AAEK-01 TCGA-DD-AAEK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 51 3.8 4.1 5.3 TCGA-DD-AAEK-F68434 TCGA-DD-AAEK TCGA-DD-AAEK-01A 0.2 1.0 A 0.7 1.5 0.7 -18757 1162 0 1067 0 0 8 5166 6 - Established Cirrhosis 2014-11-17 MALE 169 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 10 1.0 1.0 NO YES G3 NO true No M0 N0 T2 Stage II TCGA-DD-AAEK.C174382E-E3FB-456E-B5B7-1949B3086967.pdf AAEK TUMOR FREE 202 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.2 Liver None A LIVING 64 2010 TCGA-DD-AAEK-01A-11D-A40Q-01 TCGA-DD-AAEK-01A-11D-A40Q-01 TCGA-DD-AAEK-01A-11D-A40R-10 TCGA-DD-AAEK-01 TCGA-DD-AAEK-01 099fe601-12b3-4e3d-8d01-322ef9ac9e5a TCGA-DD-AAEK-01 TCGA-DD-AAEK-01 099fe601-12b3-4e3d-8d01-322ef9ac9e5a 099fe601-12b3-4e3d-8d01-322ef9ac9e5a 099fe601-12b3-4e3d-8d01-322ef9ac9e5a TCGA-DD-AAEK-01A-11D-A40S-05 TCGA-DD-AAVP-01 TCGA-DD-AAVP-01 TCGA-DD-AAVP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 48 3.3 4.3 5.0 TCGA-DD-AAVP-F67571 TCGA-DD-AAVP TCGA-DD-AAVP-01A 0.2 1.1 1 A 0.7 1.4 1.2 -17833 2467 0 2752 903 0 0 15 2 6 - Established Cirrhosis 2014-11-6 MALE 167 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 0.8 1.2 NO NO G1 Liver Locoregional Recurrence Yes NO YES Yes true No M0 N0 T1 Stage I TCGA-DD-AAVP.E930F87E-767F-4413-909E-97F7ABAD3D51.pdf AAVP TUMOR FREE 189 130 400 YES NO 1 NO YES RX R0 Primary Tumor 01 Extended Lobectomy 6th NO YES DD 1.2 Liver None A LIVING 62 2007 TCGA-DD-AAVP-01A-11D-A40Q-01 TCGA-DD-AAVP-01A-11D-A40Q-01 TCGA-DD-AAVP-01A-11D-A40R-10 TCGA-DD-AAVP-01 TCGA-DD-AAVP-01 6c3a4f09-1862-4fed-9977-759ec00a5aeb TCGA-DD-AAVP-01 TCGA-DD-AAVP-01 6c3a4f09-1862-4fed-9977-759ec00a5aeb 6c3a4f09-1862-4fed-9977-759ec00a5aeb 6c3a4f09-1862-4fed-9977-759ec00a5aeb TCGA-DD-AAVP-01A-11D-A40S-05 TCGA-DD-AAVQ-01 TCGA-DD-AAVQ-01 TCGA-DD-AAVQ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 38 3.3 3.0 5.2 TCGA-DD-AAVQ-F67572 TCGA-DD-AAVQ 0.2 1.0 A 0.7 1.4 1.1 -13911 0 2728 1509 1 0 15 1456 6 - Established Cirrhosis 2014-11-6 MALE 171 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.2 NO G2 Liver Locoregional Recurrence Yes NO YES Yes No M0 N0 T1 Stage I AAVQ TUMOR FREE 128 130 400 YES NO 1.2 NO NO RX R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None LIVING 72 2007 TCGA-DD-AAVQ-01A-11D-A40Q-01 TCGA-DD-AAVQ-01A-11D-A40Q-01 TCGA-DD-AAVQ-01A-11D-A40R-10 TCGA-DD-AAVQ-01 TCGA-DD-AAVQ-01 d01e30b3-9f94-47f6-8a4e-0b4f84ad5eb2 TCGA-DD-AAVQ-01 TCGA-DD-AAVQ-01 d01e30b3-9f94-47f6-8a4e-0b4f84ad5eb2 d01e30b3-9f94-47f6-8a4e-0b4f84ad5eb2 d01e30b3-9f94-47f6-8a4e-0b4f84ad5eb2 TCGA-DD-AAVQ-01A-11D-A40S-05 TCGA-DD-AAVR-01 TCGA-DD-AAVR-01 TCGA-DD-AAVR TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 44 3.3 3.6 5.2 TCGA-DD-AAVR-F67574 TCGA-DD-AAVR 0.2 1.2 1 A 0.0 1.4 1.1 -16157 0 2513 1 0 15 36 6 - Established Cirrhosis 2014-11-6 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.2 NO G2 NO No M0 N0 T1 Stage I AAVR TUMOR FREE 174 130 400 NO NO 1.0 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver None LIVING 69 2007 TCGA-DD-AAVR-01A-11D-A40Q-01 TCGA-DD-AAVR-01A-11D-A40Q-01 TCGA-DD-AAVR-01A-11D-A40R-10 TCGA-DD-AAVR-01 TCGA-DD-AAVR-01 c0c50e3a-973e-429d-b93f-dd7ff2aebbcc TCGA-DD-AAVR-01 TCGA-DD-AAVR-01 c0c50e3a-973e-429d-b93f-dd7ff2aebbcc c0c50e3a-973e-429d-b93f-dd7ff2aebbcc c0c50e3a-973e-429d-b93f-dd7ff2aebbcc TCGA-DD-AAVR-01A-11D-A40S-05 TCGA-DD-AAVS-01 TCGA-DD-AAVS-01 TCGA-DD-AAVS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 56 3.3 3.0 5.2 TCGA-DD-AAVS-F67576 TCGA-DD-AAVS 0.2 1.0 A 0 1.4 1.0 -20586 0 1823 1 0 15 50149 3,4 - Fibrous Speta 2014-11-6 MALE 169 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.2 NO G2 NO No M0 N0 T1 Stage I AAVS TUMOR FREE 281 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver None LIVING 72 2007 TCGA-DD-AAVS-01A-11D-A40Q-01 TCGA-DD-AAVS-01A-11D-A40Q-01 TCGA-DD-AAVS-01A-11D-A40R-10 TCGA-DD-AAVS-01 TCGA-DD-AAVS-01 b510c5b5-c31a-4d90-9674-994fd9c50ff1 TCGA-DD-AAVS-01 TCGA-DD-AAVS-01 b510c5b5-c31a-4d90-9674-994fd9c50ff1 b510c5b5-c31a-4d90-9674-994fd9c50ff1 b510c5b5-c31a-4d90-9674-994fd9c50ff1 TCGA-DD-AAVS-01A-11D-A40S-05 TCGA-DD-AAVU-01 TCGA-DD-AAVU-01 TCGA-DD-AAVU TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 46 3.3 4.6 5.2 TCGA-DD-AAVU-F67577 TCGA-DD-AAVU 0.2 0.6 A 0 1.4 1.2 -16889 0 2202 1630 1 0 15 2 3,4 - Fibrous Speta 2014-11-6 MALE 160 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.2 NO G2 Liver Intrahepatic Recurrence No NO YES Yes No M0 N0 T2 Stage II AAVU TUMOR FREE 166 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver Micro LIVING 88 2008 TCGA-DD-AAVU-01A-11D-A40Q-01 TCGA-DD-AAVU-01A-11D-A40Q-01 TCGA-DD-AAVU-01A-11D-A40R-10 TCGA-DD-AAVU-01 TCGA-DD-AAVU-01 ef6ecdbb-20df-4c7b-bb47-5f14af908008 TCGA-DD-AAVU-01 TCGA-DD-AAVU-01 ef6ecdbb-20df-4c7b-bb47-5f14af908008 ef6ecdbb-20df-4c7b-bb47-5f14af908008 ef6ecdbb-20df-4c7b-bb47-5f14af908008 TCGA-DD-AAVU-01A-11D-A40S-05 TCGA-DD-AAVV-01 TCGA-DD-AAVV-01 TCGA-DD-AAVV TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 56 3.3 4.6 5.2 TCGA-DD-AAVV-F68858 TCGA-DD-AAVV TCGA-DD-AAVV-01A 0.2 0.9 A 0 1.4 1.3 -20751 2513 0 2455 1 0 15 7 3,4 - Fibrous Speta 2014-12-21 MALE 158 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 0.8 1.2 NO YES G3 NO true No M0 N0 T2 Stage II TCGA-DD-AAVV.5F24D049-6BE5-403B-9E5A-399921814C68.pdf AAVV TUMOR FREE 244 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver Micro A LIVING 71 2007 TCGA-DD-AAVV-01A-11D-A40Q-01 TCGA-DD-AAVV-01A-11D-A40Q-01 TCGA-DD-AAVV-01A-11D-A40R-10 TCGA-DD-AAVV-01 TCGA-DD-AAVV-01 45baf47b-b48d-44b4-b97d-1e2955a91f1c TCGA-DD-AAVV-01 TCGA-DD-AAVV-01 45baf47b-b48d-44b4-b97d-1e2955a91f1c 45baf47b-b48d-44b4-b97d-1e2955a91f1c 45baf47b-b48d-44b4-b97d-1e2955a91f1c TCGA-DD-AAVV-01A-11D-A40S-05 TCGA-DD-AAVW-01 TCGA-DD-AAVW-01 TCGA-DD-AAVW TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 35 3.3 4.6 5.2 TCGA-DD-AAVW-F67582 TCGA-DD-AAVW TCGA-DD-AAVW-01A 0.2 1.4 A 0.7 1.4 1.1 -12986 2156 0 2317 0 0 15 927 6 - Established Cirrhosis 2014-11-6 MALE 162 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 0.8 1.2 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-DD-AAVW.922707E9-9F68-458F-B1FC-E95CA2876420.pdf AAVW TUMOR FREE 212 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver None A LIVING 62 2008 TCGA-DD-AAVW-01A-11D-A40Q-01 TCGA-DD-AAVW-01A-11D-A40Q-01 TCGA-DD-AAVW-01A-11D-A40R-10 TCGA-DD-AAVW-01 TCGA-DD-AAVW-01 931985c4-6972-4fa5-9890-ba58b4ab3b6a TCGA-DD-AAVW-01 TCGA-DD-AAVW-01 931985c4-6972-4fa5-9890-ba58b4ab3b6a 931985c4-6972-4fa5-9890-ba58b4ab3b6a 931985c4-6972-4fa5-9890-ba58b4ab3b6a TCGA-DD-AAVW-01A-11D-A40S-05 TCGA-DD-AAVX-01 TCGA-DD-AAVX-01 TCGA-DD-AAVX TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Severe 38 3.3 3.9 5.2 TCGA-DD-AAVX-F67583 TCGA-DD-AAVX TCGA-DD-AAVX-01A 0.2 1.1 2 A 0.7 1.4 1.0 -14016 2039 0 1570 393 0 0 15 1 6 - Established Cirrhosis 2014-12-30 MALE 178 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 50 0.8 1.2 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T2 Stage II TCGA-DD-AAVX.C62E123A-5AFC-47FA-AE6A-E16C22ACD374.pdf AAVX WITH TUMOR 186 130 400 YES YES 1.0 YES YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver Micro A LIVING 65 2008 TCGA-DD-AAVX-01A-11D-A40Q-01 TCGA-DD-AAVX-01A-11D-A40Q-01 TCGA-DD-AAVX-01A-11D-A40R-10 TCGA-DD-AAVX-01 TCGA-DD-AAVX-01 7ac6a0a3-3c2a-4e47-a248-690ac73d4593 TCGA-DD-AAVX-01 TCGA-DD-AAVX-01 7ac6a0a3-3c2a-4e47-a248-690ac73d4593 7ac6a0a3-3c2a-4e47-a248-690ac73d4593 7ac6a0a3-3c2a-4e47-a248-690ac73d4593 TCGA-DD-AAVX-01A-11D-A40S-05 TCGA-DD-AAVY-01 TCGA-DD-AAVY-01 TCGA-DD-AAVY TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 56 3.3 3.0 5.2 TCGA-DD-AAVY-F67586 TCGA-DD-AAVY TCGA-DD-AAVY-01A 0.2 1.0 2 A 0.7 1.4 1.2 -20709 1826 0 1970 0 0 15 11 0 - No Fibrosis 2014-11-6 MALE 161 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 0.8 1.2 NO NO G2 NO true No M0 N0 T3 Stage IIIA TCGA-DD-AAVY.ADDCC231-66AE-4136-AAEC-DCA3DA1C4159.pdf AAVY TUMOR FREE 210 130 400 NO NO 1.0 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver Micro A LIVING 63 2009 TCGA-DD-AAVY-01A-11D-A40Q-01 TCGA-DD-AAVY-01A-11D-A40Q-01 TCGA-DD-AAVY-01A-11D-A40R-10 TCGA-DD-AAVY-01 TCGA-DD-AAVY-01 1e91fe2c-87a8-44b1-ba40-f8d92d470a40 TCGA-DD-AAVY-01 TCGA-DD-AAVY-01 1e91fe2c-87a8-44b1-ba40-f8d92d470a40 1e91fe2c-87a8-44b1-ba40-f8d92d470a40 1e91fe2c-87a8-44b1-ba40-f8d92d470a40 TCGA-DD-AAVY-01A-11D-A40S-05 TCGA-DD-AAVZ-01 TCGA-DD-AAVZ-01 TCGA-DD-AAVZ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 38 3.3 3.8 5.2 TCGA-DD-AAVZ-F67588 TCGA-DD-AAVZ 0.2 1.0 1 A 0.7 1.4 1.2 -14005 0 1900 0 0 15 945 6 - Established Cirrhosis 2014-11-6 MALE 171 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.2 NO G2 NO No M0 N0 T1 Stage I AAVZ TUMOR FREE 98 130 400 NO NO 1.2 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver None LIVING 62 2009 TCGA-DD-AAVZ-01A-11D-A40Q-01 TCGA-DD-AAVZ-01A-11D-A40Q-01 TCGA-DD-AAVZ-01A-11D-A40R-10 TCGA-DD-AAVZ-01 TCGA-DD-AAVZ-01 ab1ad0d6-3d4e-463c-9ff2-c355602506c5 TCGA-DD-AAVZ-01 TCGA-DD-AAVZ-01 ab1ad0d6-3d4e-463c-9ff2-c355602506c5 ab1ad0d6-3d4e-463c-9ff2-c355602506c5 ab1ad0d6-3d4e-463c-9ff2-c355602506c5 TCGA-DD-AAVZ-01A-11D-A40S-05 TCGA-DD-AAW0-01 TCGA-DD-AAW0-01 TCGA-DD-AAW0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 54 3.3 4.6 5.2 TCGA-DD-AAW0-F67590 TCGA-DD-AAW0 TCGA-DD-AAW0-01A 0.2 0.2 A 0.7 1.4 1.3 -19981 1737 0 2015 0 0 15 3 3,4 - Fibrous Speta 2014-11-6 MALE 172 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 0.8 1.2 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-DD-AAW0.75F8B93A-4839-4A9B-92CD-98147D025D31.pdf AAW0 TUMOR FREE 183 130 400 NO NO 1.0 NO YES R0 Primary Tumor 01 Total Hepatectomy with Transplant 6th NO YES DD 1.2 Liver None A LIVING 75 2009 TCGA-DD-AAW0-01A-11D-A40Q-01 TCGA-DD-AAW0-01A-11D-A40Q-01 TCGA-DD-AAW0-01A-11D-A40R-10 TCGA-DD-AAW0-01 TCGA-DD-AAW0-01 7095ba1c-4133-4612-86bf-c3b4dea188ba TCGA-DD-AAW0-01 TCGA-DD-AAW0-01 7095ba1c-4133-4612-86bf-c3b4dea188ba 7095ba1c-4133-4612-86bf-c3b4dea188ba 7095ba1c-4133-4612-86bf-c3b4dea188ba TCGA-DD-AAW0-01A-11D-A40S-05 TCGA-DD-AAW1-01 TCGA-DD-AAW1-01 TCGA-DD-AAW1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Severe 55 3.3 4.0 5.3 TCGA-DD-AAW1-F67591 TCGA-DD-AAW1 TCGA-DD-AAW1-01A 0.2 0.7 A 0.7 1.4 1.2 -20288 1703 0 1989 0 0 15 4 6 - Established Cirrhosis 2014-11-6 MALE 167 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 0.8 1.2 NO NO G2 NO true No M0 N0 T3 Stage IIIA TCGA-DD-AAW1.3ED5891B-FD39-4F88-94AA-D040867A51B5.pdf AAW1 TUMOR FREE 126 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver Micro A LIVING 60 2009 TCGA-DD-AAW1-01A-11D-A40O-01 TCGA-DD-AAW1-01A-11D-A40O-01 TCGA-DD-AAW1-01A-11D-A40P-10 TCGA-DD-AAW1-01 TCGA-DD-AAW1-01 898a30f1-75df-4503-a586-c2cb43fe1db9 TCGA-DD-AAW1-01 TCGA-DD-AAW1-01 898a30f1-75df-4503-a586-c2cb43fe1db9 898a30f1-75df-4503-a586-c2cb43fe1db9 898a30f1-75df-4503-a586-c2cb43fe1db9 TCGA-DD-AAW1-01A-11D-A40X-05 TCGA-DD-AAW2-01 TCGA-DD-AAW2-01 TCGA-DD-AAW2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 69 3.3 4.0 5.2 TCGA-DD-AAW2-F67592 TCGA-DD-AAW2 TCGA-DD-AAW2-01A 0.2 0.4 1 A 0.7 1.4 1.1 -25420 1575 0 1855 391 1 0 15 3 6 - Established Cirrhosis 2014-12-30 MALE 156 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 0.8 1.2 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T1 Stage I TCGA-DD-AAW2.74C2D5FA-1FDF-424A-BEE2-DE602A4F6DA7.pdf AAW2 WITH TUMOR 164 130 400 [Discrepancy] YES 1.0 [Discrepancy] YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver None A LIVING 50 2009 TCGA-DD-AAW2-01A-11D-A40O-01 TCGA-DD-AAW2-01A-11D-A40O-01 TCGA-DD-AAW2-01A-11D-A40P-10 TCGA-DD-AAW2-01 TCGA-DD-AAW2-01 3c1b3db3-89b5-479d-8ddf-4765b46934f4 TCGA-DD-AAW2-01 TCGA-DD-AAW2-01 3c1b3db3-89b5-479d-8ddf-4765b46934f4 3c1b3db3-89b5-479d-8ddf-4765b46934f4 3c1b3db3-89b5-479d-8ddf-4765b46934f4 TCGA-DD-AAW2-01A-11D-A40X-05 TCGA-DD-AAW3-01 TCGA-DD-AAW3-01 TCGA-DD-AAW3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 69 3.3 4.1 5.2 TCGA-DD-AAW3-F67593 TCGA-DD-AAW3 0.2 0.6 1 0.0 1.4 1.0 -25254 0 1633 0 0 15 3 0 - No Fibrosis 2014-11-6 MALE 162 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G2 NO No M0 N0 T1 Stage I AAW3 TUMOR FREE 241 130 400 NO NO NO YES R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None LIVING 64 2009 TCGA-DD-AAW3-01A-11D-A40O-01 TCGA-DD-AAW3-01A-11D-A40O-01 TCGA-DD-AAW3-01A-11D-A40P-10 TCGA-DD-AAW3-01 TCGA-DD-AAW3-01 e08177f4-46ff-4f46-94bc-e58870fdfc23 TCGA-DD-AAW3-01 TCGA-DD-AAW3-01 e08177f4-46ff-4f46-94bc-e58870fdfc23 e08177f4-46ff-4f46-94bc-e58870fdfc23 e08177f4-46ff-4f46-94bc-e58870fdfc23 TCGA-DD-AAW3-01A-11D-A40X-05 TCGA-ED-A459-01 TCGA-ED-A459-01 TCGA-ED-A459 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 47 3800 5200 5100 TCGA-ED-A459-F68559 TCGA-ED-A459 TCGA-ED-A459-01A .3 1.4 .7 1.1 1.1 -17402 87 0 910 0 20 267 2014-11-26 MALE 167 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1800 .9 1.3 NO NO G2 NO true No M0 N0 T2 Stage II TCGA-ED-A459.289EC60C-0AAB-4E61-A8AB-A199D4663AE6.pdf A459 TUMOR FREE 200 150 400 NO YES .9 YES NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.2 Liver Micro A Hepatitis B Surface Antigen LIVING 51 2012 TCGA-ED-A459-01A-11D-A25U-01 TCGA-ED-A459-01A-11D-A25U-01 TCGA-ED-A459-01A-11D-A25V-10 TCGA-ED-A459-01 TCGA-ED-A459-01 1FC886B4-8512-4C36-A4AE-280B704566C4 31c9c8be-6cde-4db6-b9fd-6173b41bedc8 TCGA-ED-A459-01A-11D-A25V-10 TCGA-ED-A459-01 TCGA-ED-A459-01 31c9c8be-6cde-4db6-b9fd-6173b41bedc8 TCGA-ED-A459-01A-11D-A25V-10 31c9c8be-6cde-4db6-b9fd-6173b41bedc8 31c9c8be-6cde-4db6-b9fd-6173b41bedc8 TCGA-ED-A459-01A-11D-A25V-10 TCGA-ED-A459-01A-11D-A264-05 TCGA-ED-A4XI-01 TCGA-ED-A4XI-01 TCGA-ED-A4XI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 58 3.8 2.9 5.1 TCGA-ED-A4XI-F68085 TCGA-ED-A4XI TCGA-ED-A4XI-01A 0.1 1.3 4.1 5.9 54 -21497 70 0 819 0 20 573 2014-11-13 MALE 170 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 2000 0.3 1.3 NO NO G3 NO true No M0 N0 T2 Stage II TCGA-ED-A4XI.40130FAC-455F-49B7-A97E-CFFED2202925.pdf A4XI TUMOR FREE 276 150 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen LIVING 55 2012 TCGA-ED-A4XI-01A-11D-A25U-01 TCGA-ED-A4XI-01A-11D-A25U-01 TCGA-ED-A4XI-01A-11D-A25V-10 TCGA-ED-A4XI-01 TCGA-ED-A4XI-01 DEFFD9B3-D2EB-424A-A537-732A89EA4EC0 0baf2ded-0f46-4e37-83ae-9e0b99af41c9 TCGA-ED-A4XI-01A-11D-A25V-10 TCGA-ED-A4XI-01 TCGA-ED-A4XI-01 0baf2ded-0f46-4e37-83ae-9e0b99af41c9 TCGA-ED-A4XI-01A-11D-A25V-10 0baf2ded-0f46-4e37-83ae-9e0b99af41c9 0baf2ded-0f46-4e37-83ae-9e0b99af41c9 TCGA-ED-A4XI-01A-11D-A25V-10 TCGA-ED-A4XI-01A-11D-A264-05 TCGA-ED-A5KG-01 TCGA-ED-A5KG-01 TCGA-ED-A5KG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 60 3.8 6.0 5.1 TCGA-ED-A5KG-F56100 TCGA-ED-A5KG TCGA-ED-A5KG-01A 0.1 0.4 4.1 5.8 3.9 -22258 112 0 854 110 0 20 3177 2015-3-30 FEMALE 160 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1810 0.3 1.3 NO NO G2 Other, specify New Primary Tumor Kidney No NO NO No true No M0 N0 T2 Stage II TCGA-ED-A5KG.87394A2B-7AF7-49E0-9ED0-6FFCC899EC38.pdf A5KG WITH TUMOR 147 150 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen LIVING 61 2012 TCGA-ED-A5KG-01A-11D-A27H-01 TCGA-ED-A5KG-01A-11D-A27H-01 TCGA-ED-A5KG-01A-11D-A27I-10 TCGA-ED-A5KG-01 TCGA-ED-A5KG-01 ED389F30-65B0-49AA-B262-4F4DA5FE2B78 658b2281-9818-48dc-846d-8cad2bae42f0 TCGA-ED-A5KG-01A-11D-A27I-10 TCGA-ED-A5KG-01 TCGA-ED-A5KG-01 658b2281-9818-48dc-846d-8cad2bae42f0 TCGA-ED-A5KG-01A-11D-A27I-10 658b2281-9818-48dc-846d-8cad2bae42f0 658b2281-9818-48dc-846d-8cad2bae42f0 TCGA-ED-A5KG-01A-11D-A27I-10 TCGA-ED-A5KG-01A-11D-A27W-05 TCGA-ED-A627-01 TCGA-ED-A627-01 TCGA-ED-A627 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 74 TCGA-ED-A627-F55716 TCGA-ED-A627 TCGA-ED-A627-01A -27303 157 0 423 2 2014-1-14 MALE 176 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1140 NO NO G2 NO true No M0 NX T1 Stage I TCGA-ED-A627.104D5D1C-E6E3-4806-9E6C-4C949865F713.pdf A627 TUMOR FREE NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 74 2012 TCGA-ED-A627-01A-12D-A30U-01 TCGA-ED-A627-01A-12D-A30U-01 TCGA-ED-A627-01A-12D-A30V-10 TCGA-ED-A627-01 TCGA-ED-A627-01 6DC93090-A39B-4360-9B6D-46E0F2888801 bd4be8e6-c06f-493f-84f4-e434be3a24d4 TCGA-ED-A627-01A-12D-A30V-10 TCGA-ED-A627-01 TCGA-ED-A627-01 bd4be8e6-c06f-493f-84f4-e434be3a24d4 TCGA-ED-A627-01A-12D-A30V-10 bd4be8e6-c06f-493f-84f4-e434be3a24d4 bd4be8e6-c06f-493f-84f4-e434be3a24d4 TCGA-ED-A627-01A-12D-A30V-10 TCGA-ED-A627-01A-12D-A30Y-05 TCGA-ED-A66X-01 TCGA-ED-A66X-01 TCGA-ED-A66X TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO Mild 35 3.8 4.7 5.1 TCGA-ED-A66X-F56838 TCGA-ED-A66X TCGA-ED-A66X-01A 0.1 9 4.1 5.6 4.5 -12947 89 0 406 124 124 0 20 5840 2014-2-24 MALE 170 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 2190 0.3 1.3 NO NO G3 Liver Intrahepatic Recurrence No YES YES No true No M0 N0 T3a Stage IIIA TCGA-ED-A66X.F83A9A75-387A-4A66-9817-084A8E633E37.pdf A66X TUMOR FREE 268 150 400 NO NO 1 NO NO R0 R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen LIVING 61 2013 TCGA-ED-A66X-01A-11D-A30U-01 TCGA-ED-A66X-01A-11D-A30U-01 TCGA-ED-A66X-01A-11D-A30V-10 TCGA-ED-A66X-01 TCGA-ED-A66X-01 3C51801A-12EB-499D-8D7B-05DDE844A1C5 9c49cf78-bf9b-4562-a8c1-9e8e4203b548 TCGA-ED-A66X-01A-11D-A30V-10 TCGA-ED-A66X-01 TCGA-ED-A66X-01 9c49cf78-bf9b-4562-a8c1-9e8e4203b548 TCGA-ED-A66X-01A-11D-A30V-10 9c49cf78-bf9b-4562-a8c1-9e8e4203b548 9c49cf78-bf9b-4562-a8c1-9e8e4203b548 TCGA-ED-A66X-01A-11D-A30V-10 TCGA-ED-A66X-01A-11D-A30Y-05 TCGA-ED-A66Y-01 TCGA-ED-A66Y-01 TCGA-ED-A66Y TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 51 3.8 6 5.1 TCGA-ED-A66Y-F56839 TCGA-ED-A66Y TCGA-ED-A66Y-01A 0.1 1 4.1 5.9 4.4 -18797 75 296 0 7 0 20 12100 2014-2-24 FEMALE 160 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1670 0.3 1.3 NO NO G3 NO true No M0 N0 T3a Stage IIIA TCGA-ED-A66Y.14F29317-F7B9-49D4-B215-EF489A4283CA.pdf A66Y TUMOR FREE 289 150 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen DECEASED 59 2013 TCGA-ED-A66Y-01A-11D-A30U-01 TCGA-ED-A66Y-01A-11D-A30U-01 TCGA-ED-A66Y-01A-11D-A30V-10 TCGA-ED-A66Y-01 TCGA-ED-A66Y-01 098B1DB6-9847-438F-9541-0FD535A43F1E 920735ec-0932-408d-8132-8a30ba8aa160 TCGA-ED-A66Y-01A-11D-A30V-10 TCGA-ED-A66Y-01 TCGA-ED-A66Y-01 920735ec-0932-408d-8132-8a30ba8aa160 TCGA-ED-A66Y-01A-11D-A30V-10 920735ec-0932-408d-8132-8a30ba8aa160 920735ec-0932-408d-8132-8a30ba8aa160 TCGA-ED-A66Y-01A-11D-A30V-10 TCGA-ED-A66Y-01A-11D-A30Y-05 TCGA-ED-A7PX-01 TCGA-ED-A7PX-01 TCGA-ED-A7PX TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 48 TCGA-ED-A7PX-F62650 TCGA-ED-A7PX TCGA-ED-A7PX-01A 0.1 0.9 4.1 5.8 17.0 -17638 86 0 6 0 20 24 2014-9-30 FEMALE 161 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 830 NO YES G3 NO true No M0 NX T2 Stage II TCGA-ED-A7PX.AF42396C-2DC9-4885-B7B1-D59BA1D2949A.pdf A7PX TUMOR FREE 239 150 400 NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen LIVING 43 2013 TCGA-ED-A7PX-01A-51D-A34Y-01 TCGA-ED-A7PX-01A-51D-A34Y-01 TCGA-ED-A7PX-01A-51D-A34Z-10 TCGA-ED-A7PX-01 TCGA-ED-A7PX-01 DC921D8F-D56C-4CAB-B842-6FA7E8164347 cb358266-8d3e-4089-88f1-25e8eaaf6d7c TCGA-ED-A7PX-01A-51D-A34Z-10 TCGA-ED-A7PX-01 TCGA-ED-A7PX-01 cb358266-8d3e-4089-88f1-25e8eaaf6d7c TCGA-ED-A7PX-01A-51D-A34Z-10 cb358266-8d3e-4089-88f1-25e8eaaf6d7c cb358266-8d3e-4089-88f1-25e8eaaf6d7c TCGA-ED-A7PX-01A-51D-A34Z-10 TCGA-ED-A7PX-01A-51D-A356-05 TCGA-ED-A7PY-01 TCGA-ED-A7PY-01 TCGA-ED-A7PY TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 20 TCGA-ED-A7PY-F62651 TCGA-ED-A7PY TCGA-ED-A7PY-01A 0.1 0.6 4.0 5.8 3.9 -7556 83 0 390 0 20 2 2014-7-23 FEMALE 156 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1380 0.3 1.3 NO NO G3 NO true No M0 NX T2 Stage II TCGA-ED-A7PY.B6D3F89E-C1A5-445A-B9BD-047B2FB92E4C.pdf A7PY TUMOR FREE 282 150 400 YES NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen LIVING 40 2013 TCGA-ED-A7PY-01A-11D-A33P-01 TCGA-ED-A7PY-01A-11D-A33P-01 TCGA-ED-A7PY-01A-11D-A33Q-10 TCGA-ED-A7PY-01 TCGA-ED-A7PY-01 D734D536-23CF-4054-A46E-4B6E29E72204 9800881e-b8ee-4e3f-83fc-f5d7d6b31259 TCGA-ED-A7PY-01A-11D-A33Q-10 TCGA-ED-A7PY-01 TCGA-ED-A7PY-01 9800881e-b8ee-4e3f-83fc-f5d7d6b31259 TCGA-ED-A7PY-01A-11D-A33Q-10 9800881e-b8ee-4e3f-83fc-f5d7d6b31259 9800881e-b8ee-4e3f-83fc-f5d7d6b31259 TCGA-ED-A7PY-01A-11D-A33Q-10 TCGA-ED-A7PY-01A-11D-A341-05 TCGA-ED-A7PZ-01 TCGA-ED-A7PZ-01 TCGA-ED-A7PZ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 61 3.8 4.2 5.1 TCGA-ED-A7PZ-F62652 TCGA-ED-A7PZ TCGA-ED-A7PZ-01A 0.1 0.9 4.0 5.8 7.0 -22601 78 0 6 0 20 2 2014-9-30 MALE 159 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1350 0.3 1.3 NO YES G2 NO true No M0 NX T2 Stage II TCGA-ED-A7PZ.85F0B753-BB67-4836-92DC-81F602C0CC8C.pdf A7PZ TUMOR FREE 289 150 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen LIVING 50 2013 TCGA-ED-A7PZ-01A-11D-A33P-01 TCGA-ED-A7PZ-01A-11D-A33P-01 TCGA-ED-A7PZ-01A-11D-A33Q-10 TCGA-ED-A7PZ-01 TCGA-ED-A7PZ-01 B3158C1C-6EBD-44FB-B18D-EC780AF191AE 847c0750-c025-4c3d-be34-3721eff0b1b7 TCGA-ED-A7PZ-01A-11D-A33Q-10 TCGA-ED-A7PZ-01 TCGA-ED-A7PZ-01 847c0750-c025-4c3d-be34-3721eff0b1b7 TCGA-ED-A7PZ-01A-11D-A33Q-10 847c0750-c025-4c3d-be34-3721eff0b1b7 847c0750-c025-4c3d-be34-3721eff0b1b7 TCGA-ED-A7PZ-01A-11D-A33Q-10 TCGA-ED-A7PZ-01A-11D-A341-05 TCGA-ED-A7XO-01 TCGA-ED-A7XO-01 TCGA-ED-A7XO TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO Mild 29 3.8 4.2 5.1 TCGA-ED-A7XO-F65727 TCGA-ED-A7XO TCGA-ED-A7XO-01A 0.1 0.6 4.1 5.9 4.9 -10828 77 0 427 262 0 4 2014-10-8 MALE 175 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1430 NO NO G2 Liver Locoregional Recurrence No NO YES No true No M0 N0 T3a Stage IIIA TCGA-ED-A7XO.3FC3BB34-8E4A-4422-BFEF-58B15947F032.pdf A7XO WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 64 2013 TCGA-ED-A7XO-01A-11D-A34Y-01 TCGA-ED-A7XO-01A-11D-A34Y-01 TCGA-ED-A7XO-01A-11D-A34Z-10 TCGA-ED-A7XO-01 TCGA-ED-A7XO-01 8AB5B223-7E37-42E0-AFF5-5FAA283348E6 22e11be6-f4ce-47a6-8c50-5eb957834906 TCGA-ED-A7XO-01A-11D-A34Z-10 TCGA-ED-A7XO-01 TCGA-ED-A7XO-01 22e11be6-f4ce-47a6-8c50-5eb957834906 TCGA-ED-A7XO-01A-11D-A34Z-10 22e11be6-f4ce-47a6-8c50-5eb957834906 22e11be6-f4ce-47a6-8c50-5eb957834906 TCGA-ED-A7XO-01A-11D-A34Z-10 TCGA-ED-A7XO-01A-11D-A356-05 TCGA-ED-A7XP-01 TCGA-ED-A7XP-01 TCGA-ED-A7XP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 53 3.8 6.9 5.1 TCGA-ED-A7XP-F65353 TCGA-ED-A7XP TCGA-ED-A7XP-01A 0.1 0.1 4.1 5.9 4.8 -19504 62 0 400 187 0 20 18 2014-9-22 FEMALE 157 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 780 0.3 1.3 NO NO G3 Liver Locoregional Recurrence Yes NO YES No true No M0 N0 T2 Stage II TCGA-ED-A7XP.70432A18-BDAF-465D-9311-66E37E3F941E.pdf A7XP WITH TUMOR 108 150 400 NO NO 1 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen LIVING 54 2013 TCGA-ED-A7XP-01A-11D-A34Y-01 TCGA-ED-A7XP-01A-11D-A34Y-01 TCGA-ED-A7XP-01A-11D-A34Z-10 TCGA-ED-A7XP-01 TCGA-ED-A7XP-01 61951975-5873-4365-B1DB-F64554C07D3A 932e8866-4903-4541-a239-8318abbca064 TCGA-ED-A7XP-01A-11D-A34Z-10 TCGA-ED-A7XP-01 TCGA-ED-A7XP-01 932e8866-4903-4541-a239-8318abbca064 TCGA-ED-A7XP-01A-11D-A34Z-10 932e8866-4903-4541-a239-8318abbca064 932e8866-4903-4541-a239-8318abbca064 TCGA-ED-A7XP-01A-11D-A34Z-10 TCGA-ED-A7XP-01A-11D-A356-05 TCGA-ED-A82E-01 TCGA-ED-A82E-01 TCGA-ED-A82E TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 60 3.8 4.3 5.1 TCGA-ED-A82E-F65333 TCGA-ED-A82E TCGA-ED-A82E-01A 0.1 0.4 4.1 5.8 2.8 -22234 78 0 408 0 20 4 2014-9-22 FEMALE 150 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1320 0.3 1.3 NO NO G2 NO true No M0 N0 T3a Stage IIIA TCGA-ED-A82E.2FE90807-3C01-4956-B565-A5A18A08C93C.pdf A82E TUMOR FREE 261 150 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 44 2013 TCGA-ED-A82E-01A-11D-A34Y-01 TCGA-ED-A82E-01A-11D-A34Y-01 TCGA-ED-A82E-01A-11D-A34Z-10 TCGA-ED-A82E-01 TCGA-ED-A82E-01 9BE4B145-9FD9-4A59-A317-9A969CF1A280 443ec308-d974-4e36-96f4-b7c0101bf5d5 TCGA-ED-A82E-01A-11D-A34Z-10 TCGA-ED-A82E-01 TCGA-ED-A82E-01 443ec308-d974-4e36-96f4-b7c0101bf5d5 TCGA-ED-A82E-01A-11D-A34Z-10 443ec308-d974-4e36-96f4-b7c0101bf5d5 443ec308-d974-4e36-96f4-b7c0101bf5d5 TCGA-ED-A82E-01A-11D-A34Z-10 TCGA-ED-A82E-01A-11D-A356-05 TCGA-ED-A8O5-01 TCGA-ED-A8O5-01 TCGA-ED-A8O5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 59 3.8 4.2 5.1 TCGA-ED-A8O5-F67146 TCGA-ED-A8O5 TCGA-ED-A8O5-01A 0.1 0.4 4.1 5.8 3.4 -21648 100 0 406 0 20 498 2014-10-31 FEMALE 165 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 950 0.3 1.3 NO NO G3 NO true No M0 N0 T3a Stage IIIA TCGA-ED-A8O5.6C198F5C-9B63-45D9-A83D-4CFEC01DDC8C.pdf A8O5 TUMOR FREE 171 150 400 NO NO 1.3 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 63 2013 TCGA-ED-A8O5-01A-11D-A35Y-01 TCGA-ED-A8O5-01A-11D-A35Y-01 TCGA-ED-A8O5-01A-11D-A35Z-10 TCGA-ED-A8O5-01 TCGA-ED-A8O5-01 92E61221-9B0A-411F-BA5F-B923CA216B07 0636fc10-cfb4-427b-b3fc-cd9d7c0c7db6 TCGA-ED-A8O5-01 TCGA-ED-A8O5-01 0636fc10-cfb4-427b-b3fc-cd9d7c0c7db6 0636fc10-cfb4-427b-b3fc-cd9d7c0c7db6 0636fc10-cfb4-427b-b3fc-cd9d7c0c7db6 TCGA-ED-A8O5-01A-11D-A369-05 TCGA-ED-A8O6-01 TCGA-ED-A8O6-01 TCGA-ED-A8O6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 50 3.8 2.8 5.1 TCGA-ED-A8O6-F68512 TCGA-ED-A8O6 TCGA-ED-A8O6-01A 0.1 2.3 4.1 5.8 2.8 -18572 97 56 0 6 0 20 3000 2014-11-21 FEMALE 165 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1030 0.3 1.3 NO NO G3 NO true No M0 N0 T3a Stage IIIA TCGA-ED-A8O6.0ABB9050-0248-42F0-AFEB-98FA5CE2DD55.pdf A8O6 TUMOR FREE 150 400 NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 45 2013 TCGA-ED-A8O6-01A-11D-A35Y-01 TCGA-ED-A8O6-01A-11D-A35Y-01 TCGA-ED-A8O6-01A-11D-A35Z-10 TCGA-ED-A8O6-01 TCGA-ED-A8O6-01 C22BF46A-9552-41FD-A467-E6DB6A14831B 7de41172-ca92-4cb9-b7de-b92fbeb5b3ef TCGA-ED-A8O6-01 TCGA-ED-A8O6-01 7de41172-ca92-4cb9-b7de-b92fbeb5b3ef 7de41172-ca92-4cb9-b7de-b92fbeb5b3ef 7de41172-ca92-4cb9-b7de-b92fbeb5b3ef TCGA-ED-A8O6-01A-11D-A369-05 TCGA-ED-A97K-01 TCGA-ED-A97K-01 TCGA-ED-A97K TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 54 3.8 8 5.1 TCGA-ED-A97K-F68560 TCGA-ED-A97K TCGA-ED-A97K-01A 0.1 1.0 4.0 5.8 4.6 -20073 92 0 6 0 20 3 2014-12-2 MALE 170 Alcohol consumption Hepatocholangiocarcinoma (Mixed) No C22.0 8180/3 C22.0 YES 1650 0.3 1.3 NO YES G2 NO true No M0 N0 T3a Stage IIIA TCGA-ED-A97K.518E0619-1C4F-475C-904E-009300CF1768.pdf A97K TUMOR FREE 264 150 400 NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen LIVING 64 2013 TCGA-ED-A97K-01A-21D-A381-01 TCGA-ED-A97K-01A-21D-A381-01 TCGA-ED-A97K-01A-21D-A382-10 TCGA-ED-A97K-01 TCGA-ED-A97K-01 169bde29-467d-44b1-9260-6dc8cfb1e207 TCGA-ED-A97K-01 TCGA-ED-A97K-01 169bde29-467d-44b1-9260-6dc8cfb1e207 169bde29-467d-44b1-9260-6dc8cfb1e207 169bde29-467d-44b1-9260-6dc8cfb1e207 TCGA-ED-A97K-01A-21D-A383-05 TCGA-EP-A12J-01 TCGA-EP-A12J-01 TCGA-EP-A12J TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 62 3.8 4.2 5.1 TCGA-EP-A12J-F40456 TCGA-EP-A12J TCGA-EP-A12J-01A 0.2 0.4 1 B 0.7 1.3 0.8 -22997 59 0 570 2013-2-20 MALE 173 Hepatitis C Sarcoidosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 300 NO NO G1 NO false No MX NX T1 Stage I TCGA-EP-A12J.CC7D4052-0068-425B-A5C3-873059716D44.pdf A12J TUMOR FREE 187 150 400 NO NO 1.1 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO EP 1.0 Liver None A LIVING 2010 TCGA-EP-A12J-01A-11D-A12Y-01 TCGA-EP-A12J-01A-11D-A12Y-01 TCGA-EP-A12J-01A-11D-A12Z-10 TCGA-EP-A12J-01 TCGA-EP-A12J-01 DAC6BB4F-6DDB-4478-A92E-C46567F9B24F 5453b1a0-b5c0-4d85-95b4-4591fdf05874 TCGA-EP-A12J-01A-11D-A12Z-10 TCGA-EP-A12J-01 TCGA-EP-A12J-01 5453b1a0-b5c0-4d85-95b4-4591fdf05874 TCGA-EP-A12J-01A-11D-A12Z-10 5453b1a0-b5c0-4d85-95b4-4591fdf05874 5453b1a0-b5c0-4d85-95b4-4591fdf05874 TCGA-EP-A12J-01A-11D-A12Z-10 TCGA-EP-A12J-01A-11D-A132-05 TCGA-EP-A12J-11 TCGA-EP-A12J-11 TCGA-EP-A12J TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 62 3.8 4.2 5.1 TCGA-EP-A12J-F40456 TCGA-EP-A12J TCGA-EP-A12J-11A 0.2 0.4 1 B 0.7 1.3 0.8 -22997 59 0 570 2013-2-20 MALE 173 Hepatitis C Sarcoidosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 410 NO NO G1 NO false No MX NX T1 Stage I A12J TUMOR FREE 187 150 400 NO NO 1.1 NO YES R0 Solid Tissue Normal 11 Segmentectomy, Single 7th YES NO EP 1.0 Liver None A LIVING 2010 TCGA-EP-A12J-11 5a1a1f96-bf4f-415d-b2a2-4481a72914cf TCGA-EP-A12J-11 5a1a1f96-bf4f-415d-b2a2-4481a72914cf 5a1a1f96-bf4f-415d-b2a2-4481a72914cf 5a1a1f96-bf4f-415d-b2a2-4481a72914cf TCGA-EP-A12J-11A-11D-A132-05 TCGA-EP-A26S-01 TCGA-EP-A26S-01 TCGA-EP-A26S TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 70 3.8 3.5 5.1 TCGA-EP-A26S-F39041 TCGA-EP-A26S TCGA-EP-A26S-01A 0.2 0.4 -25677 91 0 608 1 0 0 - No Fibrosis 2013-1-9 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 520 9.5 12.5 NO NO G2 NO false No MX N0 T1 Stage I TCGA-EP-A26S.078A6815-B1E3-47F5-A49B-C06B7D47F5E8.pdf A26S TUMOR FREE 234 140 415 NO NO 12.9 NO NO Primary Tumor 01 Segmentectomy, Single 7th YES NO EP 1.0 Liver None A LIVING 41 2011 TCGA-EP-A26S-01A-11D-A16U-01 TCGA-EP-A26S-01A-11D-A16U-01 TCGA-EP-A26S-01A-11D-A16V-10 TCGA-EP-A26S-01 TCGA-EP-A26S-01 98FBF2C6-DB11-4522-BD97-FC1C9546023D 7e6e755a-5503-4729-a3f4-249183687647 TCGA-EP-A26S-01A-11D-A16V-10 TCGA-EP-A26S-01 TCGA-EP-A26S-01 7e6e755a-5503-4729-a3f4-249183687647 TCGA-EP-A26S-01A-11D-A16V-10 7e6e755a-5503-4729-a3f4-249183687647 7e6e755a-5503-4729-a3f4-249183687647 TCGA-EP-A26S-01A-11D-A16V-10 TCGA-EP-A26S-01A-11D-A16X-05 TCGA-EP-A26S-11 TCGA-EP-A26S-11 TCGA-EP-A26S TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 70 3.8 3.5 5.1 TCGA-EP-A26S-F39041 TCGA-EP-A26S TCGA-EP-A26S-11A 0.2 0.4 -25677 91 0 608 1 0 0 - No Fibrosis 2013-1-9 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1140 9.5 12.5 NO NO G2 NO false No MX N0 T1 Stage I A26S TUMOR FREE 234 140 415 NO NO 12.9 NO NO Solid Tissue Normal 11 Segmentectomy, Single 7th YES NO EP 1.0 Liver None A LIVING 41 2011 TCGA-EP-A26S-11 3e1411dc-8c6d-4a87-bb4f-44ef5ff8761b TCGA-EP-A26S-11 3e1411dc-8c6d-4a87-bb4f-44ef5ff8761b 3e1411dc-8c6d-4a87-bb4f-44ef5ff8761b 3e1411dc-8c6d-4a87-bb4f-44ef5ff8761b TCGA-EP-A26S-11A-12D-A16X-05 TCGA-EP-A2KA-01 TCGA-EP-A2KA-01 TCGA-EP-A2KA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES 52 TCGA-EP-A2KA-F41362 TCGA-EP-A2KA TCGA-EP-A2KA-01A 2 1.0 0.7 -19214 106 627 0 111 433 433 0 0 13 1,2 - Portal Fibrosis 2013-3-15 FEMALE 178 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 400 NO NO G3 Brain Extrahepatic Recurrence No YES YES No false No MX NX T3a Stage IIIA TCGA-EP-A2KA.CCEFF8C5-E949-4F3F-93DA-67ECF5503C1C.pdf A2KA WITH TUMOR 435 140 415 NO NO NO YES R0 Primary Tumor 01 Lobectomy 7th YES NO EP Liver A DECEASED 2011 TCGA-EP-A2KA-01A-11D-A182-01 TCGA-EP-A2KA-01A-11D-A182-01 TCGA-EP-A2KA-01A-11D-A183-10 TCGA-EP-A2KA-01 TCGA-EP-A2KA-01 CF4018AA-83D5-4E96-B473-BAACD5D686FA e41bb478-2e81-4ce3-a0c7-e5412ea80490 TCGA-EP-A2KA-01A-11D-A183-10 TCGA-EP-A2KA-01 TCGA-EP-A2KA-01 e41bb478-2e81-4ce3-a0c7-e5412ea80490 TCGA-EP-A2KA-01A-11D-A183-10 e41bb478-2e81-4ce3-a0c7-e5412ea80490 e41bb478-2e81-4ce3-a0c7-e5412ea80490 TCGA-EP-A2KA-01A-11D-A183-10 TCGA-EP-A2KA-01A-11D-A17Z-05 TCGA-EP-A2KB-01 TCGA-EP-A2KB-01 TCGA-EP-A2KB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 46 3.8 3.8 5.1 TCGA-EP-A2KB-F41390 TCGA-EP-A2KB TCGA-EP-A2KB-01A 0.2 1.4 A 1.0 -16835 50 596 0 60 161 1 0 9 2128 2013-3-18 FEMALE 165 Hepatitis C Cirrhosis, Alcohol abuse Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1210 NO NO G2 Liver Locoregional Recurrence Yes NO YES No false No MX NX T1 Stage I TCGA-EP-A2KB.DF650AE0-E9E8-48A7-8D39-88A3F7EC2AC7.pdf A2KB WITH TUMOR 133 140 415 NO NO 1.4 NO NO R0 Primary Tumor 01 Other (specify) 7th YES NO EP 1.0 Liver None A DECEASED 81 2011 TCGA-EP-A2KB-01A-11D-A182-01 TCGA-EP-A2KB-01A-11D-A182-01 TCGA-EP-A2KB-01A-11D-A183-10 TCGA-EP-A2KB-01 TCGA-EP-A2KB-01 0C00E15C-9E8B-4BAA-9A46-4BA04403456A 0b233eab-4541-4b62-b9ae-baebf672403e TCGA-EP-A2KB-01A-11D-A183-10 TCGA-EP-A2KB-01 TCGA-EP-A2KB-01 0b233eab-4541-4b62-b9ae-baebf672403e TCGA-EP-A2KB-01A-11D-A183-10 0b233eab-4541-4b62-b9ae-baebf672403e 0b233eab-4541-4b62-b9ae-baebf672403e TCGA-EP-A2KB-01A-11D-A183-10 TCGA-EP-A2KB-01A-11D-A17Z-05 TCGA-EP-A2KC-01 TCGA-EP-A2KC-01 TCGA-EP-A2KC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 62 3.6 3.1 4.8 TCGA-EP-A2KC-F17206 TCGA-EP-A2KC TCGA-EP-A2KC-01A A -22677 30 19 0 0 0 43 2011-10-5 MALE 171 Hepatitis C Liver Cirrhosis, Moderate alcohol use on weekends Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 260 0.8 1.2 NO G3 NO false No MX NX T1 Stage I TCGA-EP-A2KC.F45A4E99-3856-4455-BF21-B767A0A4FA82.pdf A2KC TUMOR FREE 193 140 415 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO EP Liver None A DECEASED 2011 TCGA-EP-A2KC-01A-11D-A20V-01 TCGA-EP-A2KC-01A-11D-A20V-01 TCGA-EP-A2KC-01A-11D-A20W-10 TCGA-EP-A2KC-01 TCGA-EP-A2KC-01 5D6AB371-9255-4290-A182-CF58291CB2F7 43426760-46b7-422e-ab1b-d29d6c2ee21e TCGA-EP-A2KC-01A-11D-A20W-10 TCGA-EP-A2KC-01 TCGA-EP-A2KC-01 43426760-46b7-422e-ab1b-d29d6c2ee21e TCGA-EP-A2KC-01A-11D-A20W-10 43426760-46b7-422e-ab1b-d29d6c2ee21e 43426760-46b7-422e-ab1b-d29d6c2ee21e TCGA-EP-A2KC-01A-11D-A20W-10 TCGA-EP-A2KC-01A-11D-A20Z-05 TCGA-EP-A3JL-01 TCGA-EP-A3JL-01 TCGA-EP-A3JL TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 76 3.2 4.1 4.8 TCGA-EP-A3JL-F37140 TCGA-EP-A3JL TCGA-EP-A3JL-01A 0 0.6 A 0.60 1.10 -27886 22 0 303 0 0 9 13 2012-11-27 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 570 0.9 1.10 NO NO G2 NO false Yes MX NX T1 Stage I TCGA-EP-A3JL.B277ACF9-B233-474B-975A-52FDE44F27E3.pdf A3JL TUMOR FREE 149 130 386 NO NO NO NO Primary Tumor 01 Other (specify) 7th YES NO EP 1.2 Liver None A LIVING 73 2011 TCGA-EP-A3JL-01A-11D-A20V-01 TCGA-EP-A3JL-01A-11D-A20V-01 TCGA-EP-A3JL-01A-11D-A20W-10 TCGA-EP-A3JL-01 TCGA-EP-A3JL-01 7032F53E-C4EE-4462-819B-D9AE04F88821 0b20024b-a8dd-4683-9a3b-00fe4cb14f71 TCGA-EP-A3JL-01A-11D-A20W-10 TCGA-EP-A3JL-01 TCGA-EP-A3JL-01 0b20024b-a8dd-4683-9a3b-00fe4cb14f71 TCGA-EP-A3JL-01A-11D-A20W-10 0b20024b-a8dd-4683-9a3b-00fe4cb14f71 0b20024b-a8dd-4683-9a3b-00fe4cb14f71 TCGA-EP-A3JL-01A-11D-A20W-10 TCGA-EP-A3JL-01A-11D-A20Z-05 TCGA-EP-A3RK-01 TCGA-EP-A3RK-01 TCGA-EP-A3RK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES 73 3.5 4.3 4.8 TCGA-EP-A3RK-F40454 TCGA-EP-A3RK TCGA-EP-A3RK-01A 0.0 0.6 A -26985 14 0 363 320 0 0 7 1,2 - Portal Fibrosis 2013-2-20 MALE 178 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1040 0.9 1.2 NO NO G2 Liver Locoregional Recurrence NO YES No false No MX NX T3a Stage IIIA TCGA-EP-A3RK.49F4E752-EFBE-458F-85C0-1B81B9506D91.pdf A3RK WITH TUMOR 234 140 415 NO NO 1.1 NO NO Primary Tumor 01 Other (specify) 7th YES NO EP 1.2 Liver A LIVING 101 2012 TCGA-EP-A3RK-01A-11D-A22E-01 TCGA-EP-A3RK-01A-11D-A22E-01 TCGA-EP-A3RK-01A-11D-A22F-10 TCGA-EP-A3RK-01 TCGA-EP-A3RK-01 EC810F3B-2F51-41DC-9A52-4605BE1BA1B4 2412baac-c345-465e-9c6e-bd17d3797129 TCGA-EP-A3RK-01A-11D-A22F-10 TCGA-EP-A3RK-01 TCGA-EP-A3RK-01 2412baac-c345-465e-9c6e-bd17d3797129 TCGA-EP-A3RK-01A-11D-A22F-10 2412baac-c345-465e-9c6e-bd17d3797129 2412baac-c345-465e-9c6e-bd17d3797129 TCGA-EP-A3RK-01A-11D-A22F-10 TCGA-EP-A3RK-01A-11D-A22H-05 TCGA-EP-A3RK-11 TCGA-EP-A3RK-11 TCGA-EP-A3RK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES 73 3.5 4.3 4.8 TCGA-EP-A3RK-F40454 TCGA-EP-A3RK 0.0 0.6 A -26985 0 363 320 0 0 7 1,2 - Portal Fibrosis 2013-2-20 MALE 178 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.2 NO G2 Liver Locoregional Recurrence NO YES No No MX NX T3a Stage IIIA A3RK WITH TUMOR 234 140 415 NO NO 1.1 NO NO Solid Tissue Normal 11 Other (specify) 7th YES NO EP 1.2 Liver LIVING 101 2012 TCGA-EP-A3RK-11 ce3a2fa7-905e-491d-ade0-c8d5712c4afa TCGA-EP-A3RK-11 ce3a2fa7-905e-491d-ade0-c8d5712c4afa ce3a2fa7-905e-491d-ade0-c8d5712c4afa ce3a2fa7-905e-491d-ade0-c8d5712c4afa TCGA-ES-A2HS-01 TCGA-ES-A2HS-01 TCGA-ES-A2HS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 80 3.5 3.8 5.0 TCGA-ES-A2HS TCGA-ES-A2HS-01A 0 1.9 0 A 0.8 1.2 0.6 -29268 1113 688 0 1 0 8 1 0 - No Fibrosis 2011-9-28 MALE 180 No History of Primary Risk Factors No Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 320 0.8 1.2 NO G2 true Yes MX NX T1 Stage I TCGA-ES-A2HS.53AB28EC-71C0-4AF0-93DA-FE72CD7FE19B.pdf A2HS TUMOR FREE 119 150 450 1.3 NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES ES 1.0 Liver None A DECEASED 97 2008 TCGA-ES-A2HS-01A-11D-A182-01 TCGA-ES-A2HS-01A-11D-A182-01 TCGA-ES-A2HS-01A-11D-A183-10 TCGA-ES-A2HS-01 TCGA-ES-A2HS-01 4ADDC326-6E3D-420E-86B8-22FCD02FF7C7 e642839c-9891-4ff0-93c4-556d81572af9 TCGA-ES-A2HS-01A-11D-A183-10 TCGA-ES-A2HS-01 TCGA-ES-A2HS-01 e642839c-9891-4ff0-93c4-556d81572af9 TCGA-ES-A2HS-01A-11D-A183-10 e642839c-9891-4ff0-93c4-556d81572af9 e642839c-9891-4ff0-93c4-556d81572af9 TCGA-ES-A2HS-01A-11D-A183-10 TCGA-ES-A2HS-01A-11D-A17Z-05 TCGA-ES-A2HS-11 TCGA-ES-A2HS-11 TCGA-ES-A2HS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 80 3.5 3.8 5.0 TCGA-ES-A2HS TCGA-ES-A2HS-11A 0 1.9 0 A 0.8 1.2 0.6 -29268 1113 688 0 1 0 8 1 0 - No Fibrosis 2011-9-28 MALE 180 No History of Primary Risk Factors No Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 230 0.8 1.2 NO G2 true Yes MX NX T1 Stage I A2HS TUMOR FREE 119 150 450 1.3 NO R0 Solid Tissue Normal 11 Segmentectomy, Single 6th NO YES ES 1.0 Liver None A DECEASED 97 2008 TCGA-ES-A2HS-11A-11D-A17Z-05 TCGA-ES-A2HT-01 TCGA-ES-A2HT-01 TCGA-ES-A2HT TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 54 3.5 4.1 5.0 TCGA-ES-A2HT TCGA-ES-A2HT-01A 0 0.6 0 A 0.8 1.2 0.7 -20023 1392 438 0 1 0 10 4 0 - No Fibrosis 2011-9-30 MALE 174 Hepatitis C no Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 340 0.3 1.1 NO G2 true No MX NX T1 Stage I TCGA-ES-A2HT.FF97C711-0686-480B-BC53-3CADCAA4C4C1.pdf A2HT TUMOR FREE 135 150 450 1.1 NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES ES 1.0 Liver None A DECEASED 80 2007 TCGA-ES-A2HT-01A-12D-A182-01 TCGA-ES-A2HT-01A-12D-A182-01 TCGA-ES-A2HT-01A-12D-A183-10 TCGA-ES-A2HT-01 TCGA-ES-A2HT-01 2BB535EF-7136-49C8-AFF4-3045F4E37B8C e5e12896-2cf3-4d5d-8f79-00cd964fc132 TCGA-ES-A2HT-01A-12D-A183-10 TCGA-ES-A2HT-01 TCGA-ES-A2HT-01 e5e12896-2cf3-4d5d-8f79-00cd964fc132 TCGA-ES-A2HT-01A-12D-A183-10 e5e12896-2cf3-4d5d-8f79-00cd964fc132 e5e12896-2cf3-4d5d-8f79-00cd964fc132 TCGA-ES-A2HT-01A-12D-A183-10 TCGA-ES-A2HT-01A-12D-A17Z-05 TCGA-ES-A2HT-11 TCGA-ES-A2HT-11 TCGA-ES-A2HT TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 54 3.5 4.1 5.0 TCGA-ES-A2HT 0 0.6 0 A 0.8 1.2 0.7 -20023 438 0 1 0 10 4 0 - No Fibrosis 2011-9-30 MALE 174 Hepatitis C no Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.3 1.1 G2 No MX NX T1 Stage I A2HT TUMOR FREE 135 150 450 1.1 NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES ES 1.0 Liver None DECEASED 80 2007 TCGA-ES-A2HT-11 d5e3a3be-c4d9-41de-a39c-ae7aad3f3826 TCGA-ES-A2HT-11 d5e3a3be-c4d9-41de-a39c-ae7aad3f3826 d5e3a3be-c4d9-41de-a39c-ae7aad3f3826 d5e3a3be-c4d9-41de-a39c-ae7aad3f3826 TCGA-ES-A2HT-11A-11D-A17Z-05 TCGA-FV-A23B-01 TCGA-FV-A23B-01 TCGA-FV-A23B TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 70 TCGA-FV-A23B-F45565 TCGA-FV-A23B TCGA-FV-A23B-01A -25788 2030 1852 0 987 1453 2013-7-17 FEMALE Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 NO NO Liver Locoregional Recurrence Yes NO YES No false No M0 N0 T2 Stage II TCGA-FV-A23B.82010944-23DA-4FC5-934B-05AB3C238467.pdf A23B WITH TUMOR NO NO NO R0 Primary Tumor 01 Other (specify) 6th NO YES FV Liver A DECEASED 2005 TCGA-FV-A23B-01A-11D-A16U-01 TCGA-FV-A23B-01A-11D-A16U-01 TCGA-FV-A23B-01A-11D-A16V-10 TCGA-FV-A23B-01 TCGA-FV-A23B-01 C7818FEE-D630-4B0A-824A-6423A2251C05 5343646d-bb46-4acc-9361-7432813a886f TCGA-FV-A23B-01A-11D-A16V-10 TCGA-FV-A23B-01 TCGA-FV-A23B-01 5343646d-bb46-4acc-9361-7432813a886f TCGA-FV-A23B-01A-11D-A16V-10 5343646d-bb46-4acc-9361-7432813a886f 5343646d-bb46-4acc-9361-7432813a886f TCGA-FV-A23B-01A-11D-A16V-10 TCGA-FV-A23B-01A-11D-A16X-05 TCGA-FV-A23B-11 TCGA-FV-A23B-11 TCGA-FV-A23B TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 70 TCGA-FV-A23B-F45565 TCGA-FV-A23B -25788 1852 0 987 1453 2013-7-17 FEMALE Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO Liver Locoregional Recurrence Yes NO YES No No M0 N0 T2 Stage II A23B WITH TUMOR NO NO NO R0 Solid Tissue Normal 11 Other (specify) 6th NO YES FV Liver DECEASED 2005 TCGA-FV-A23B-11 a3eef529-ed7d-438c-b0be-ce569a846a8f TCGA-FV-A23B-11 a3eef529-ed7d-438c-b0be-ce569a846a8f a3eef529-ed7d-438c-b0be-ce569a846a8f a3eef529-ed7d-438c-b0be-ce569a846a8f TCGA-FV-A23B-11A-11D-A16X-05 TCGA-FV-A2QQ-01 TCGA-FV-A2QQ-01 TCGA-FV-A2QQ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 80 TCGA-FV-A2QQ-F57856 TCGA-FV-A2QQ TCGA-FV-A2QQ-01A -29354 71 0 729 2014-3-27 MALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 150 NO NO G2 NO false No MX N0 T1 Stage I TCGA-FV-A2QQ.350B10AF-C17B-41DA-BB21-A672DBB683B2.pdf A2QQ TUMOR FREE NO NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO FV Liver None A LIVING 2011 TCGA-FV-A2QQ-01A-11D-A22E-01 TCGA-FV-A2QQ-01A-11D-A22E-01 TCGA-FV-A2QQ-01A-11D-A22F-10 TCGA-FV-A2QQ-01 TCGA-FV-A2QQ-01 2B60F8A5-1528-4569-9B3E-40B28A275302 9ac9a050-720a-45bc-94d4-87802c8f0aba TCGA-FV-A2QQ-01A-11D-A22F-10 TCGA-FV-A2QQ-01 TCGA-FV-A2QQ-01 9ac9a050-720a-45bc-94d4-87802c8f0aba TCGA-FV-A2QQ-01A-11D-A22F-10 9ac9a050-720a-45bc-94d4-87802c8f0aba 9ac9a050-720a-45bc-94d4-87802c8f0aba TCGA-FV-A2QQ-01A-11D-A22F-10 TCGA-FV-A2QQ-01A-11D-A22H-05 TCGA-FV-A2QR-01 TCGA-FV-A2QR-01 TCGA-FV-A2QR TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 75 TCGA-FV-A2QR-F42770 TCGA-FV-A2QR TCGA-FV-A2QR-01A 1 1764 581 0 561 2013-4-30 MALE Other Male, IDDM for 30+years Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 NO NO G1 Extrahepatic Recurrence No NO YES No false No M0 N0 T1 Stage I TCGA-FV-A2QR.DE38B13D-FD4D-4077-ADBE-D034C2F5F003.pdf A2QR WITH TUMOR NO NO NO YES RX Primary Tumor 01 Lobectomy 6th NO YES FV Liver A DECEASED 2006 TCGA-FV-A2QR-01A-11D-A20V-01 TCGA-FV-A2QR-01A-11D-A20V-01 TCGA-FV-A2QR-01A-11D-A20W-10 TCGA-FV-A2QR-01 TCGA-FV-A2QR-01 3F858642-BFA2-4D05-B9CB-2233AFE9C0A3 4850e928-80c5-4ad3-9291-2e9d80fde8c6 TCGA-FV-A2QR-01A-11D-A20W-10 TCGA-FV-A2QR-01 TCGA-FV-A2QR-01 4850e928-80c5-4ad3-9291-2e9d80fde8c6 TCGA-FV-A2QR-01A-11D-A20W-10 4850e928-80c5-4ad3-9291-2e9d80fde8c6 4850e928-80c5-4ad3-9291-2e9d80fde8c6 TCGA-FV-A2QR-01A-11D-A20W-10 TCGA-FV-A2QR-01A-11D-A20Z-05 TCGA-FV-A2QR-11 TCGA-FV-A2QR-11 TCGA-FV-A2QR TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 75 TCGA-FV-A2QR-F42770 TCGA-FV-A2QR TCGA-FV-A2QR-11A 1 1764 581 0 561 2013-4-30 MALE Other Male, IDDM for 30+years Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 NO NO G1 Extrahepatic Recurrence No NO YES No false No M0 N0 T1 Stage I A2QR WITH TUMOR NO NO NO YES RX Solid Tissue Normal 11 Lobectomy 6th NO YES FV Liver A DECEASED 2006 TCGA-FV-A2QR-11 6fca2b4e-2aa2-42bb-9991-b0a69e6155cd TCGA-FV-A2QR-11 6fca2b4e-2aa2-42bb-9991-b0a69e6155cd 6fca2b4e-2aa2-42bb-9991-b0a69e6155cd 6fca2b4e-2aa2-42bb-9991-b0a69e6155cd TCGA-FV-A2QR-11A-11D-A20Z-05 TCGA-FV-A3I0-01 TCGA-FV-A3I0-01 TCGA-FV-A3I0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO 76 4.40 TCGA-FV-A3I0-F57854 TCGA-FV-A3I0 TCGA-FV-A3I0-01A 0.4 -28101 70 0 848 159 2014-3-27 FEMALE No History of Primary Risk Factors Hepatocholangiocarcinoma (Mixed) No C22.0 8171/3 C22.0 YES 190 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 NX T2 Stage II TCGA-FV-A3I0.B4DB59E9-FFBB-4716-9235-90A1DF17455B.pdf A3I0 WITH TUMOR NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO FV Liver Micro A LIVING 2011 TCGA-FV-A3I0-01A-11D-A22E-01 TCGA-FV-A3I0-01A-11D-A22E-01 TCGA-FV-A3I0-01A-11D-A22F-10 TCGA-FV-A3I0-01 TCGA-FV-A3I0-01 51d59e9b-2f54-4a54-b5f5-81376be2eb82 TCGA-FV-A3I0-01A-11D-A22F-10 TCGA-FV-A3I0-01 TCGA-FV-A3I0-01 51d59e9b-2f54-4a54-b5f5-81376be2eb82 TCGA-FV-A3I0-01A-11D-A22F-10 51d59e9b-2f54-4a54-b5f5-81376be2eb82 51d59e9b-2f54-4a54-b5f5-81376be2eb82 TCGA-FV-A3I0-01A-11D-A22F-10 TCGA-FV-A3I0-01A-11D-A22H-05 TCGA-FV-A3I0-11 TCGA-FV-A3I0-11 TCGA-FV-A3I0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO 76 4.40 TCGA-FV-A3I0-F57854 TCGA-FV-A3I0 TCGA-FV-A3I0-11A 0.4 -28101 70 0 848 159 2014-3-27 FEMALE No History of Primary Risk Factors Hepatocholangiocarcinoma (Mixed) No C22.0 8171/3 C22.0 YES 40 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 NX T2 Stage II A3I0 WITH TUMOR NO NO NO R0 Solid Tissue Normal 11 Lobectomy 7th YES NO FV Liver Micro A LIVING 2011 TCGA-FV-A3I0-11 07401514-29ef-43a8-8a7f-a4e147852470 TCGA-FV-A3I0-11 07401514-29ef-43a8-8a7f-a4e147852470 07401514-29ef-43a8-8a7f-a4e147852470 07401514-29ef-43a8-8a7f-a4e147852470 TCGA-FV-A3I1-01 TCGA-FV-A3I1-01 TCGA-FV-A3I1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 81 TCGA-FV-A3I1-F42771 TCGA-FV-A3I1 TCGA-FV-A3I1-01A 76 247 0 0 0 - No Fibrosis 2013-4-30 FEMALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 NO NO G2 NO false Yes MX N0 T2 Stage II TCGA-FV-A3I1.B40A8E73-2904-4C68-B2AD-6FC27211654B.pdf A3I1 TUMOR FREE NO NO NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO FV Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody DECEASED 2011 TCGA-FV-A3I1-01A-11D-A22E-01 TCGA-FV-A3I1-01A-11D-A22E-01 TCGA-FV-A3I1-01A-11D-A22F-10 TCGA-FV-A3I1-01 TCGA-FV-A3I1-01 1cc4f319-fc1d-46bb-9fbb-469d66bd23f2 TCGA-FV-A3I1-01A-11D-A22F-10 TCGA-FV-A3I1-01 TCGA-FV-A3I1-01 1cc4f319-fc1d-46bb-9fbb-469d66bd23f2 TCGA-FV-A3I1-01A-11D-A22F-10 1cc4f319-fc1d-46bb-9fbb-469d66bd23f2 1cc4f319-fc1d-46bb-9fbb-469d66bd23f2 TCGA-FV-A3I1-01A-11D-A22F-10 TCGA-FV-A3I1-01A-11D-A22H-05 TCGA-FV-A3I1-11 TCGA-FV-A3I1-11 TCGA-FV-A3I1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 81 TCGA-FV-A3I1-F42771 TCGA-FV-A3I1 TCGA-FV-A3I1-11A 76 247 0 0 0 - No Fibrosis 2013-4-30 FEMALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 NO NO G2 NO false Yes MX N0 T2 Stage II A3I1 TUMOR FREE NO NO NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 7th YES NO FV Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody DECEASED 2011 TCGA-FV-A3I1-11 61fcdecf-52ca-465a-b8f1-262b6540117f TCGA-FV-A3I1-11 61fcdecf-52ca-465a-b8f1-262b6540117f 61fcdecf-52ca-465a-b8f1-262b6540117f 61fcdecf-52ca-465a-b8f1-262b6540117f TCGA-FV-A3R2-01 TCGA-FV-A3R2-01 TCGA-FV-A3R2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 75 TCGA-FV-A3R2-F47054 TCGA-FV-A3R2 TCGA-FV-A3R2-01A 4 -27530 2555 194 0 2013-8-21 MALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 NO NO NO true Yes MX NX T1 Stage I TCGA-FV-A3R2.6F330991-CD7E-4387-AFE8-B9C6C8D98396.pdf A3R2 TUMOR FREE NO YES NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES FV Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody DECEASED 75 2005 TCGA-FV-A3R2-01A-11D-A22E-01 TCGA-FV-A3R2-01A-11D-A22E-01 TCGA-FV-A3R2-01A-11D-A22F-10 TCGA-FV-A3R2-01 92F08485-2808-4F9B-8F1F-A893D3CF6FD3 4cda696b-42da-43fd-9f6f-95dfc748a0ca TCGA-FV-A3R2-01A-11D-A22F-10 TCGA-FV-A3R2-01 4cda696b-42da-43fd-9f6f-95dfc748a0ca TCGA-FV-A3R2-01A-11D-A22F-10 4cda696b-42da-43fd-9f6f-95dfc748a0ca 4cda696b-42da-43fd-9f6f-95dfc748a0ca TCGA-FV-A3R2-01A-11D-A22F-10 TCGA-FV-A3R2-01A-11D-A22H-05 TCGA-FV-A3R2-11 TCGA-FV-A3R2-11 TCGA-FV-A3R2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 75 TCGA-FV-A3R2-F47054 TCGA-FV-A3R2 TCGA-FV-A3R2-11A 4 -27530 2555 194 0 2013-8-21 MALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 NO NO NO true Yes MX NX T1 Stage I A3R2 TUMOR FREE NO YES NO YES R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES FV Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody DECEASED 75 2005 TCGA-FV-A3R2-11 92462e76-eed1-4eab-8c38-4cf9897be417 TCGA-FV-A3R2-11 92462e76-eed1-4eab-8c38-4cf9897be417 92462e76-eed1-4eab-8c38-4cf9897be417 92462e76-eed1-4eab-8c38-4cf9897be417 TCGA-FV-A3R3-01 TCGA-FV-A3R3-01 TCGA-FV-A3R3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 38 3.4 2.0 5.0 TCGA-FV-A3R3-F64062 TCGA-FV-A3R3 TCGA-FV-A3R3-01A 0.0 0.4 0.6 1.3 1.3 -14231 28 366 0 4 1 2014-8-25 FEMALE 161 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 90 9.5 11.9 NO NO G2 NO true No MX NX T1 Stage I TCGA-FV-A3R3.FF0E1601-BC87-4E61-95BE-1776C9F85002.pdf A3R3 TUMOR FREE 323 150 450 NO NO 10.7 NO NO R0 Primary Tumor 01 Other (specify) 7th YES NO FV 1.0 Liver None A DECEASED 97 2012 TCGA-FV-A3R3-01A-11D-A22E-01 TCGA-FV-A3R3-01A-11D-A22E-01 TCGA-FV-A3R3-01A-11D-A22F-10 TCGA-FV-A3R3-01 91FC95B8-388B-4B2F-B3BC-0F1B5783E815 db848332-4ee8-4f22-b6c9-b2634bd35918 TCGA-FV-A3R3-01A-11D-A22F-10 TCGA-FV-A3R3-01 db848332-4ee8-4f22-b6c9-b2634bd35918 TCGA-FV-A3R3-01A-11D-A22F-10 db848332-4ee8-4f22-b6c9-b2634bd35918 db848332-4ee8-4f22-b6c9-b2634bd35918 TCGA-FV-A3R3-01A-11D-A22F-10 TCGA-FV-A3R3-01A-11D-A22H-05 TCGA-FV-A495-01 TCGA-FV-A495-01 TCGA-FV-A495 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 51 3.8 4.0 5.0 TCGA-FV-A495 TCGA-FV-A495-01A 0.3 1.0 1 0.6 1.1 1.0 -18740 56 0 1 0 8 39 3,4 - Fibrous Speta 2013-2-21 FEMALE 172 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 NO G2 NO false No M0 NX T2 Stage II TCGA-FV-A495.99D80D8A-88F7-445D-9B87-9B4B96C3C010.pdf A495 TUMOR FREE 258 140 440 YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO FV 1.9 Liver None A LIVING 70 2012 TCGA-FV-A495-01A-11D-A25U-01 TCGA-FV-A495-01A-11D-A25U-01 TCGA-FV-A495-01A-11D-A25V-10 TCGA-FV-A495-01 TCGA-FV-A495-01 6a2cafbb-2824-4727-b950-0c2bdcf26358 TCGA-FV-A495-01A-11D-A25V-10 TCGA-FV-A495-01 TCGA-FV-A495-01 6a2cafbb-2824-4727-b950-0c2bdcf26358 TCGA-FV-A495-01A-11D-A25V-10 6a2cafbb-2824-4727-b950-0c2bdcf26358 6a2cafbb-2824-4727-b950-0c2bdcf26358 TCGA-FV-A495-01A-11D-A25V-10 TCGA-FV-A495-01A-11D-A264-05 TCGA-FV-A496-01 TCGA-FV-A496-01 TCGA-FV-A496 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 84 3.8 2.8 5.0 TCGA-FV-A496 TCGA-FV-A496-01A 0.3 0.9 3 0.9 1.1 1.0 -30950 51 0 10 0 8 67 0 - No Fibrosis 2013-2-21 FEMALE 162 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 0.9 1.1 NO G2 NO false No M0 NX T1 Stage I TCGA-FV-A496.358A0018-5731-45D3-97B8-502A3BF95FA8.pdf A496 TUMOR FREE 167 140 440 1.0 YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO FV 1.9 Liver None A LIVING 54 2012 TCGA-FV-A496-01A-11D-A25U-01 TCGA-FV-A496-01A-11D-A25U-01 TCGA-FV-A496-01A-11D-A25V-10 TCGA-FV-A496-01 TCGA-FV-A496-01 DD8FB046-5CCE-442F-AEB9-748965BFD520 5c6d857a-55c1-4365-b8de-bde7e769ce77 TCGA-FV-A496-01A-11D-A25V-10 TCGA-FV-A496-01 TCGA-FV-A496-01 5c6d857a-55c1-4365-b8de-bde7e769ce77 TCGA-FV-A496-01A-11D-A25V-10 5c6d857a-55c1-4365-b8de-bde7e769ce77 5c6d857a-55c1-4365-b8de-bde7e769ce77 TCGA-FV-A496-01A-11D-A25V-10 TCGA-FV-A496-01A-11D-A264-05 TCGA-FV-A4ZP-01 TCGA-FV-A4ZP-01 TCGA-FV-A4ZP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 78 TCGA-FV-A4ZP-F64063 TCGA-FV-A4ZP TCGA-FV-A4ZP-01A -28771 2519 2486 0 1836 20326 2014-8-25 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 210 NO NO G2 Other, specify Extrahepatic Recurrence Adrenal Gland No YES YES No false Yes M0 NX T3 Stage IIIA TCGA-FV-A4ZP.B6B41E65-9EFD-4F60-A4F0-68270AC39D15.pdf A4ZP TUMOR FREE NO NO NO RX R1 Primary Tumor 01 Segmentectomy, Single 6th NO YES FV Liver Micro A DECEASED 69 2005 TCGA-FV-A4ZP-01A-12D-A25U-01 TCGA-FV-A4ZP-01A-12D-A25U-01 TCGA-FV-A4ZP-01A-12D-A25V-10 TCGA-FV-A4ZP-01 TCGA-FV-A4ZP-01 CC0156B0-2373-4CE8-83DC-B84FF14E29D9 36bb7b6e-9a6f-4215-b362-93b6db73c819 TCGA-FV-A4ZP-01A-12D-A25V-10 TCGA-FV-A4ZP-01 TCGA-FV-A4ZP-01 36bb7b6e-9a6f-4215-b362-93b6db73c819 TCGA-FV-A4ZP-01A-12D-A25V-10 36bb7b6e-9a6f-4215-b362-93b6db73c819 36bb7b6e-9a6f-4215-b362-93b6db73c819 TCGA-FV-A4ZP-01A-12D-A25V-10 TCGA-FV-A4ZP-01A-12D-A264-05 TCGA-FV-A4ZQ-01 TCGA-FV-A4ZQ-01 TCGA-FV-A4ZQ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 52 3.8 2.4 5.0 TCGA-FV-A4ZQ TCGA-FV-A4ZQ-01A 0.2 1.8 0.7 1.0 1.0 -19090 224 0 12 2013-3-15 MALE Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 2.0 3.0 NO G2 NO false No M0 NX T1 Stage I TCGA-FV-A4ZQ.C0B03F38-09C0-4B87-94BC-E2E8D9F7F922.pdf A4ZQ TUMOR FREE 1.1 R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO FV 1.2 Liver None A Hepatitis C Virus R LIVING 2012 TCGA-FV-A4ZQ-01A-11D-A25U-01 TCGA-FV-A4ZQ-01A-11D-A25U-01 TCGA-FV-A4ZQ-01A-11D-A25V-10 TCGA-FV-A4ZQ-01 TCGA-FV-A4ZQ-01 DFBDE418-4B11-4B96-A6AD-3A6A54F3D96D 43a21e6a-8b4e-4589-9236-0835dd7d7a00 TCGA-FV-A4ZQ-01A-11D-A25V-10 TCGA-FV-A4ZQ-01 TCGA-FV-A4ZQ-01 43a21e6a-8b4e-4589-9236-0835dd7d7a00 TCGA-FV-A4ZQ-01A-11D-A25V-10 43a21e6a-8b4e-4589-9236-0835dd7d7a00 43a21e6a-8b4e-4589-9236-0835dd7d7a00 TCGA-FV-A4ZQ-01A-11D-A25V-10 TCGA-FV-A4ZQ-01A-11D-A264-05 TCGA-G3-A25S-01 TCGA-G3-A25S-01 TCGA-G3-A25S TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES YES Mild 64 0.3 0.4 0.5 TCGA-G3-A25S-F33638 TCGA-G3-A25S TCGA-G3-A25S-01A 0 1.2 0 A 0.6 1.4 1.0 -23571 707 416 0 37 37 1 0 10 281 6 - Established Cirrhosis Scheduled Follow-up Submission 2012-7-11 MALE 166 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 480 0.9 1.1 NO G2 Other, specify Extrahepatic Recurrence Bone and Lung NO YES true No M0 N0 T1 Stage I TCGA-G3-A25S.F4DAEF13-D4B0-4C12-9617-04878D3FC98D.pdf A25S WITH TUMOR 313 150 400 NO NO 1.0 NO NO R1 Primary Tumor 01 Extended Lobectomy 6th NO YES G3 1.4 Liver Micro A DECEASED 73 2009 TCGA-G3-A25S-01A-11D-A16U-01 TCGA-G3-A25S-01A-11D-A16U-01 TCGA-G3-A25S-01A-11D-A16V-10 TCGA-G3-A25S-01 TCGA-G3-A25S-01 F0CB0DB4-1B18-4DC9-A779-F144ACE7265E 4fd1e10d-c21a-49f8-9d77-a5aa7850d883 TCGA-G3-A25S-01A-11D-A16V-10 TCGA-G3-A25S-01 TCGA-G3-A25S-01 4fd1e10d-c21a-49f8-9d77-a5aa7850d883 TCGA-G3-A25S-01A-11D-A16V-10 4fd1e10d-c21a-49f8-9d77-a5aa7850d883 4fd1e10d-c21a-49f8-9d77-a5aa7850d883 TCGA-G3-A25S-01A-11D-A16V-10 TCGA-G3-A25S-01A-11D-A16X-05 TCGA-G3-A25T-01 TCGA-G3-A25T-01 TCGA-G3-A25T TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 45 0.3 0.4 0.5 TCGA-G3-A25T-F33639 TCGA-G3-A25T 0 2.0 A 0.4 1.4 0.7 -16461 0 1553 452 452 0 0 10 7 0 - No Fibrosis Scheduled Follow-up Submission 2012-7-11 FEMALE 167 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.1 G2 Liver Intrahepatic Recurrence No YES YES No No M0 N0 T3 Stage IIIA A25T WITH TUMOR 306 150 400 NO NO 1.1 NO NO R0 R0 Primary Tumor 01 Lobectomy 6th NO YES G3 1.4 Liver None LIVING 64 2007 TCGA-G3-A25T-01A-11D-A16U-01 TCGA-G3-A25T-01A-11D-A16U-01 TCGA-G3-A25T-01A-11D-A16V-10 TCGA-G3-A25T-01 TCGA-G3-A25T-01 e54a0934-1fc9-4a54-98a1-63063dc61a1b TCGA-G3-A25T-01A-11D-A16V-10 TCGA-G3-A25T-01 TCGA-G3-A25T-01 e54a0934-1fc9-4a54-98a1-63063dc61a1b TCGA-G3-A25T-01A-11D-A16V-10 e54a0934-1fc9-4a54-98a1-63063dc61a1b e54a0934-1fc9-4a54-98a1-63063dc61a1b TCGA-G3-A25T-01A-11D-A16V-10 TCGA-G3-A25T-01A-11D-A16X-05 TCGA-G3-A25U-01 TCGA-G3-A25U-01 TCGA-G3-A25U TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 63 0.3 0.3 0.5 TCGA-G3-A25U-F33636 TCGA-G3-A25U TCGA-G3-A25U-01A 0 0.3 A 0.4 1.1 0.5 -23207 1281 0 1636 0 0 10 10 0 - No Fibrosis Scheduled Follow-up Submission 2012-7-11 FEMALE 153 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 350 0.9 1.1 NO G3 NO true No M0 N0 T1 Stage I TCGA-G3-A25U.2781ABF5-FC79-4973-BE15-037BC685FAFC.pdf A25U TUMOR FREE 113 150 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES G3 1.2 Liver None A LIVING 47 2007 TCGA-G3-A25U-01A-11D-A16U-01 TCGA-G3-A25U-01A-11D-A16U-01 TCGA-G3-A25U-01A-11D-A16V-10 TCGA-G3-A25U-01 TCGA-G3-A25U-01 67D384C8-9C42-4304-BFB3-1930B4422EAC 9d462109-5858-4282-abc2-81282089bc6a TCGA-G3-A25U-01A-11D-A16V-10 TCGA-G3-A25U-01 TCGA-G3-A25U-01 9d462109-5858-4282-abc2-81282089bc6a TCGA-G3-A25U-01A-11D-A16V-10 9d462109-5858-4282-abc2-81282089bc6a 9d462109-5858-4282-abc2-81282089bc6a TCGA-G3-A25U-01A-11D-A16V-10 TCGA-G3-A25U-01A-11D-A16X-05 TCGA-G3-A25V-01 TCGA-G3-A25V-01 TCGA-G3-A25V TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 68 0.3 0.4 0.5 TCGA-G3-A25V-F40088 TCGA-G3-A25V TCGA-G3-A25V-01A 0 0.6 0 A 0.6 1.4 0.7 -25144 223 0 860 489 2 0 10 15 6 - Established Cirrhosis 2013-2-12 MALE 187 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 0.9 1.1 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 N0 T1 Stage I TCGA-G3-A25V.F52224B9-1FAF-4F71-B017-22AAEBA8F75D.pdf A25V WITH TUMOR 139 150 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES G3 1.4 Liver None A LIVING 90 2010 TCGA-G3-A25V-01A-11D-A16U-01 TCGA-G3-A25V-01A-11D-A16U-01 TCGA-G3-A25V-01A-11D-A16V-10 TCGA-G3-A25V-01 TCGA-G3-A25V-01 43C544E8-3188-4140-BCAF-74B978F13CEF b3cf1b9e-aa69-452a-a9cc-f463ab4885be TCGA-G3-A25V-01A-11D-A16V-10 TCGA-G3-A25V-01 TCGA-G3-A25V-01 b3cf1b9e-aa69-452a-a9cc-f463ab4885be TCGA-G3-A25V-01A-11D-A16V-10 b3cf1b9e-aa69-452a-a9cc-f463ab4885be b3cf1b9e-aa69-452a-a9cc-f463ab4885be TCGA-G3-A25V-01A-11D-A16V-10 TCGA-G3-A25V-01A-11D-A16X-05 TCGA-G3-A25W-01 TCGA-G3-A25W-01 TCGA-G3-A25W TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 79 0.3 0.4 0.5 TCGA-G3-A25W-F40230 TCGA-G3-A25W TCGA-G3-A25W-01A 0 0.3 3 A 0.4 1.1 1.5 -29018 419 0 935 0 0 9 6 0 - No Fibrosis 2013-2-14 FEMALE 157 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 260 0.8 1.2 NO NO G2 NO true Yes M0 N0 T3b Stage IIIB TCGA-G3-A25W.F92FE7A0-15D4-45FD-BB39-E3022E30EB77.pdf A25W TUMOR FREE 308 150 400 NO NO 0.9 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES G3 1.2 Liver Macro A LIVING 48 2010 TCGA-G3-A25W-01A-11D-A16U-01 TCGA-G3-A25W-01A-11D-A16U-01 TCGA-G3-A25W-01A-11D-A16V-10 TCGA-G3-A25W-01 EBBA3C7B-D8A5-46DF-B278-39B1A8A8F25C TCGA-G3-A25W-01A-11D-A16V-10 TCGA-G3-A25W-01 TCGA-G3-A25W-01A-11D-A16V-10 TCGA-G3-A25W-01A-11D-A16V-10 TCGA-G3-A25W-01A-11D-A16X-05 TCGA-G3-A25W-11 TCGA-G3-A25W-11 TCGA-G3-A25W TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 79 0.3 0.4 0.5 TCGA-G3-A25W-F40230 TCGA-G3-A25W TCGA-G3-A25W-11A 0 0.3 3 A 0.4 1.1 1.5 -29018 419 0 935 0 0 9 6 0 - No Fibrosis 2013-2-14 FEMALE 157 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 440 0.8 1.2 NO NO G2 NO true Yes M0 N0 T3b Stage IIIB A25W TUMOR FREE 308 150 400 NO NO 0.9 NO YES R0 Solid Tissue Normal 11 Segmentectomy, Single 7th NO YES G3 1.2 Liver Macro A LIVING 48 2010 TCGA-G3-A25W-11A-12D-A16X-05 TCGA-G3-A25X-01 TCGA-G3-A25X-01 TCGA-G3-A25X TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 73 0.3 0.4 0.5 TCGA-G3-A25X-F33634 TCGA-G3-A25X TCGA-G3-A25X-01A 0.0 1.1 A 0.4 1.4 0.8 -26988 1346 0 1779 0 0 10 11 1,2 - Portal Fibrosis Scheduled Follow-up Submission 2012-7-11 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 0.9 1.1 NO G3 NO true No M0 N0 T2 Stage II TCGA-G3-A25X.7DF1A9E2-3A8F-4A9B-B918-4133D60E4F0A.pdf A25X TUMOR FREE 102 150 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES G3 1.4 Liver None A LIVING 65 2007 TCGA-G3-A25X-01A-11D-A16U-01 TCGA-G3-A25X-01A-11D-A16U-01 TCGA-G3-A25X-01 TCGA-G3-A25X-01 35B0DFC0-56DE-4318-AD0F-3FA0745DB6D9 11cbdb5a-82fd-471a-9b33-c5c1b9393716 TCGA-G3-A25X-01 TCGA-G3-A25X-01 11cbdb5a-82fd-471a-9b33-c5c1b9393716 11cbdb5a-82fd-471a-9b33-c5c1b9393716 11cbdb5a-82fd-471a-9b33-c5c1b9393716 TCGA-G3-A25X-01A-11D-A16X-05 TCGA-G3-A25X-11 TCGA-G3-A25X-11 TCGA-G3-A25X TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 73 0.3 0.4 0.5 TCGA-G3-A25X-F33634 TCGA-G3-A25X TCGA-G3-A25X-11A 0.0 1.1 A 0.4 1.4 0.8 -26988 1346 0 1779 0 0 10 11 1,2 - Portal Fibrosis Scheduled Follow-up Submission 2012-7-11 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 220 0.9 1.1 NO G3 NO true No M0 N0 T2 Stage II A25X TUMOR FREE 102 150 400 NO NO 1.0 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Single 6th NO YES G3 1.4 Liver None A LIVING 65 2007 TCGA-G3-A25X-11A-11D-A16X-05 TCGA-G3-A25Y-01 TCGA-G3-A25Y-01 TCGA-G3-A25Y TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 52 0.3 0.4 0.5 TCGA-G3-A25Y-F40098 TCGA-G3-A25Y TCGA-G3-A25Y-01A 0.0 0.7 A 0.4 1.1 0.6 -19055 1595 452 0 355 0 0 10 35 3,4 - Fibrous Speta 2013-2-12 FEMALE 158 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 440 0.9 1.1 NO NO G3 Liver Locoregional Recurrence No NO YES No true No M0 N0 T1 Stage I TCGA-G3-A25Y.5AEEF060-BA18-416A-BE3F-604891A9A6D2.pdf A25Y WITH TUMOR 166 150 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES G3 1.2 Liver None A DECEASED 57 2006 TCGA-G3-A25Y-01A-11D-A16U-01 TCGA-G3-A25Y-01A-11D-A16U-01 TCGA-G3-A25Y-01A-11D-A16V-10 TCGA-G3-A25Y-01 TCGA-G3-A25Y-01 9929B349-9D83-4C81-BA8A-D48236C70505 ca7f7d18-3f39-4454-8f72-eb432b800103 TCGA-G3-A25Y-01A-11D-A16V-10 TCGA-G3-A25Y-01 TCGA-G3-A25Y-01 ca7f7d18-3f39-4454-8f72-eb432b800103 TCGA-G3-A25Y-01A-11D-A16V-10 ca7f7d18-3f39-4454-8f72-eb432b800103 ca7f7d18-3f39-4454-8f72-eb432b800103 TCGA-G3-A25Y-01A-11D-A16V-10 TCGA-G3-A25Y-01A-11D-A16X-05 TCGA-G3-A25Z-01 TCGA-G3-A25Z-01 TCGA-G3-A25Z TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 58 0.3 0.4 0.5 TCGA-G3-A25Z-F33635 TCGA-G3-A25Z TCGA-G3-A25Z-01A 0 0.9 1 A 0.6 1.4 1.1 -21509 233 0 655 0 0 15 44 5 - Nodular Formation and Incomplete Cirrhosis Scheduled Follow-up Submission 2012-7-11 MALE 173 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 300 0.9 1.1 NO G2 NO true No M0 N0 T1 Stage I TCGA-G3-A25Z.001A2553-3F5F-4A74-88E6-03B42C061E6D.pdf A25Z TUMOR FREE 115 150 400 NO NO 1.0 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES G3 1.4 Liver None A LIVING 69 2010 TCGA-G3-A25Z-01A-11D-A16U-01 TCGA-G3-A25Z-01A-11D-A16U-01 TCGA-G3-A25Z-01A-11D-A16V-10 TCGA-G3-A25Z-01 TCGA-G3-A25Z-01 EA21A265-56D5-4C72-8665-00BF82A67B7D 859fc4fb-40f5-40ce-8784-13eae0fa446a TCGA-G3-A25Z-01A-11D-A16V-10 TCGA-G3-A25Z-01 TCGA-G3-A25Z-01 859fc4fb-40f5-40ce-8784-13eae0fa446a TCGA-G3-A25Z-01A-11D-A16V-10 859fc4fb-40f5-40ce-8784-13eae0fa446a 859fc4fb-40f5-40ce-8784-13eae0fa446a TCGA-G3-A25Z-01A-11D-A16V-10 TCGA-G3-A25Z-01A-11D-A16X-05 TCGA-G3-A3CG-01 TCGA-G3-A3CG-01 TCGA-G3-A3CG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Severe 80 0.3 0.4 0.5 TCGA-G3-A3CG-F40228 TCGA-G3-A3CG TCGA-G3-A3CG-01A 0.3 0.3 A 0.6 1.4 0.9 -29432 261 0 673 329 1 0 10 67 6 - Established Cirrhosis 2013-2-14 MALE 168 Hepatitis C Hepatocellular Carcinoma Yes C22.0 8170/3 C22.0 YES 270 0.9 1.1 NO NO G2 Liver Intrahepatic Recurrence No NO YES No false Yes M0 N0 T1 Stage I TCGA-G3-A3CG.6E2F9CE1-6D48-42DF-8737-64ED53BF8646.pdf A3CG WITH TUMOR 131 150 400 NO NO 1.1 NO NO R1 Primary Tumor 01 Lobectomy 7th NO YES G3 1.4 Liver Micro A LIVING 93 2011 TCGA-G3-A3CG-01A-11D-A20V-01 TCGA-G3-A3CG-01A-11D-A20V-01 TCGA-G3-A3CG-01A-11D-A20W-10 TCGA-G3-A3CG-01 203A6526-64B9-4978-8D9F-884898C1E79D b29ea742-8e19-4cdb-b237-5a7934f01381 TCGA-G3-A3CG-01A-11D-A20W-10 TCGA-G3-A3CG-01 b29ea742-8e19-4cdb-b237-5a7934f01381 TCGA-G3-A3CG-01A-11D-A20W-10 b29ea742-8e19-4cdb-b237-5a7934f01381 b29ea742-8e19-4cdb-b237-5a7934f01381 TCGA-G3-A3CG-01A-11D-A20W-10 TCGA-G3-A3CG-01A-11D-A20Z-05 TCGA-G3-A3CH-01 TCGA-G3-A3CH-01 TCGA-G3-A3CH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 53 0.3 0.3 0.5 TCGA-G3-A3CH-F40093 TCGA-G3-A3CH TCGA-G3-A3CH-01A 0 0.7 A 0.6 1.4 0.9 -19473 296 0 780 180 116 0 0 10 41 6 - Established Cirrhosis 2013-2-12 MALE 178 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 0.9 1.1 NO NO G2 Liver Intrahepatic Recurrence No YES YES No false No M0 N0 T3a Stage IIIA TCGA-G3-A3CH.735AAE4A-21E1-4481-9D86-385CCE5712D1.pdf A3CH WITH TUMOR 142 150 400 NO NO 1.2 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES G3 1.4 Liver None A LIVING 74 2010 TCGA-G3-A3CH-01A-11D-A22E-01 TCGA-G3-A3CH-01A-11D-A22E-01 TCGA-G3-A3CH-01A-11D-A22F-10 TCGA-G3-A3CH-01 TCGA-G3-A3CH-01 FB66ADBF-865D-44FD-8ACB-4362226607ED 7e48e392-4196-4188-bb39-bba65e88c2d5 TCGA-G3-A3CH-01A-11D-A22F-10 TCGA-G3-A3CH-01 TCGA-G3-A3CH-01 7e48e392-4196-4188-bb39-bba65e88c2d5 TCGA-G3-A3CH-01A-11D-A22F-10 7e48e392-4196-4188-bb39-bba65e88c2d5 7e48e392-4196-4188-bb39-bba65e88c2d5 TCGA-G3-A3CH-01A-11D-A22F-10 TCGA-G3-A3CH-01A-11D-A22H-05 TCGA-G3-A3CH-11 TCGA-G3-A3CH-11 TCGA-G3-A3CH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 53 0.3 0.3 0.5 TCGA-G3-A3CH-F40093 TCGA-G3-A3CH 0 0.7 A 0.6 1.4 0.9 -19473 0 780 180 116 0 0 10 41 6 - Established Cirrhosis 2013-2-12 MALE 178 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.1 NO G2 Liver Intrahepatic Recurrence No YES YES No No M0 N0 T3a Stage IIIA A3CH WITH TUMOR 142 150 400 NO NO 1.2 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 7th NO YES G3 1.4 Liver None LIVING 74 2010 TCGA-G3-A3CH-11 c8de0c98-c69a-44a1-bdf7-e6c731359aac TCGA-G3-A3CH-11 c8de0c98-c69a-44a1-bdf7-e6c731359aac c8de0c98-c69a-44a1-bdf7-e6c731359aac c8de0c98-c69a-44a1-bdf7-e6c731359aac TCGA-G3-A3CI-01 TCGA-G3-A3CI-01 TCGA-G3-A3CI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 71 0.3 0.4 0.5 TCGA-G3-A3CI-F40231 TCGA-G3-A3CI TCGA-G3-A3CI-01A 0 0.3 A 0.6 1.4 0.9 -26224 258 0 180 1 0 10 2 0 - No Fibrosis 2013-2-14 MALE 167 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 370 0.9 1.1 NO YES G2 false No M0 N0 T1 Stage I TCGA-G3-A3CI.42613B77-F014-4AE9-AEF8-C5E632125EFA.pdf A3CI TUMOR FREE 186 150 400 1.3 NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES G3 0.8 Liver None A LIVING 98 2011 TCGA-G3-A3CI-01A-11D-A20V-01 TCGA-G3-A3CI-01A-11D-A20V-01 TCGA-G3-A3CI-01A-11D-A20W-10 TCGA-G3-A3CI-01 TCGA-G3-A3CI-01 BC4F74DA-B45D-4D4B-AF29-E458B09200A6 b1ad5501-06e7-48c7-9fa9-f76527ae39f1 TCGA-G3-A3CI-01A-11D-A20W-10 TCGA-G3-A3CI-01 TCGA-G3-A3CI-01 b1ad5501-06e7-48c7-9fa9-f76527ae39f1 TCGA-G3-A3CI-01A-11D-A20W-10 b1ad5501-06e7-48c7-9fa9-f76527ae39f1 b1ad5501-06e7-48c7-9fa9-f76527ae39f1 TCGA-G3-A3CI-01A-11D-A20W-10 TCGA-G3-A3CI-01A-11D-A20Z-05 TCGA-G3-A3CJ-01 TCGA-G3-A3CJ-01 TCGA-G3-A3CJ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Severe 52 0.3 0.4 0.5 TCGA-G3-A3CJ-F40234 TCGA-G3-A3CJ TCGA-G3-A3CJ-01A 0 1.0 A 0.5 1.4 0.8 -19305 113 0 594 296 0 0 10 3 5 - Nodular Formation and Incomplete Cirrhosis 2013-2-14 MALE 174 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 0.9 1.1 NO NO G2 Lung Extrahepatic Recurrence No NO YES No false No M0 N0 T2 Stage II TCGA-G3-A3CJ.191868C4-3299-4E65-9DB2-C8C43CB83963.pdf A3CJ WITH TUMOR 185 150 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES G3 1.4 Liver Micro A LIVING 72 2011 TCGA-G3-A3CJ-01A-11D-A20V-01 TCGA-G3-A3CJ-01A-11D-A20V-01 TCGA-G3-A3CJ-01A-11D-A20W-10 TCGA-G3-A3CJ-01 TCGA-G3-A3CJ-01 699fc209-b99a-48f4-a8c5-ace6ca7e30a6 TCGA-G3-A3CJ-01A-11D-A20W-10 TCGA-G3-A3CJ-01 TCGA-G3-A3CJ-01 699fc209-b99a-48f4-a8c5-ace6ca7e30a6 TCGA-G3-A3CJ-01A-11D-A20W-10 699fc209-b99a-48f4-a8c5-ace6ca7e30a6 699fc209-b99a-48f4-a8c5-ace6ca7e30a6 TCGA-G3-A3CJ-01A-11D-A20W-10 TCGA-G3-A3CJ-01A-11D-A20Z-05 TCGA-G3-A3CK-01 TCGA-G3-A3CK-01 TCGA-G3-A3CK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 61 0.3 0.2 0.5 TCGA-G3-A3CK-F40227 TCGA-G3-A3CK TCGA-G3-A3CK-01A 0 0.8 1 A 0.6 1.4 1.1 -22462 132 0 585 0 0 10 3 6 - Established Cirrhosis 2013-2-14 MALE 170 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 520 0.9 1.1 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-G3-A3CK.ED5E5458-1E88-4126-B46B-96297F5A0FFF.pdf A3CK TUMOR FREE 143 150 400 NO NO 1.0 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES G3 1.4 Liver None A LIVING 67 2011 TCGA-G3-A3CK-01A-11D-A20V-01 TCGA-G3-A3CK-01A-11D-A20V-01 TCGA-G3-A3CK-01A-11D-A20W-10 TCGA-G3-A3CK-01 TCGA-G3-A3CK-01 5987458A-335D-4EC2-ABCC-48F89ED707B0 33da53e2-4fc2-4689-a651-1c596481af74 TCGA-G3-A3CK-01A-11D-A20W-10 TCGA-G3-A3CK-01 TCGA-G3-A3CK-01 33da53e2-4fc2-4689-a651-1c596481af74 TCGA-G3-A3CK-01A-11D-A20W-10 33da53e2-4fc2-4689-a651-1c596481af74 33da53e2-4fc2-4689-a651-1c596481af74 TCGA-G3-A3CK-01A-11D-A20W-10 TCGA-G3-A3CK-01A-11D-A20Z-05 TCGA-G3-A5SI-01 TCGA-G3-A5SI-01 TCGA-G3-A5SI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 44 3.3 2.8 4.8 TCGA-G3-A5SI-F59276 TCGA-G3-A5SI 0 0.7 A 0.6 1.4 0.4 -16126 768 0 447 1 0 10 9 6 - Established Cirrhosis 2014-5-7 MALE 177 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.1 NO G2 NO No M0 N0 T2 Stage II A5SI WITH TUMOR 145 150 400 NO NO 1.4 NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES G3 1.4 Liver None DECEASED 74 2011 TCGA-G3-A5SI-01A-31D-A27H-01 TCGA-G3-A5SI-01A-31D-A27H-01 TCGA-G3-A5SI-01A-31D-A27I-10 TCGA-G3-A5SI-01 TCGA-G3-A5SI-01 ddb29159-cbe9-4b6d-a86f-8115b859b2bb TCGA-G3-A5SI-01A-31D-A27I-10 TCGA-G3-A5SI-01 TCGA-G3-A5SI-01 ddb29159-cbe9-4b6d-a86f-8115b859b2bb TCGA-G3-A5SI-01A-31D-A27I-10 ddb29159-cbe9-4b6d-a86f-8115b859b2bb ddb29159-cbe9-4b6d-a86f-8115b859b2bb TCGA-G3-A5SI-01A-31D-A27I-10 TCGA-G3-A5SI-01A-31D-A27W-05 TCGA-G3-A5SJ-01 TCGA-G3-A5SJ-01 TCGA-G3-A5SJ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 59 3.3 4.1 4.8 TCGA-G3-A5SJ-F62744 TCGA-G3-A5SJ TCGA-G3-A5SJ-01A 0 0.5 B 0.6 1.4 1.3 -21848 285 0 698 0 0 10 3 6 - Established Cirrhosis 2014-7-24 MALE 171 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 290 0.9 1.1 NO NO G2 NO true No M0 NX T1 Stage I TCGA-G3-A5SJ.5237C744-2C11-4340-BC70-9AD10238F1E6.pdf A5SJ TUMOR FREE 136 150 400 NO NO 1 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES G3 1.4 Liver None A LIVING 87 2012 TCGA-G3-A5SJ-01A-11D-A27H-01 TCGA-G3-A5SJ-01A-11D-A27H-01 TCGA-G3-A5SJ-01A-11D-A27I-10 TCGA-G3-A5SJ-01 TCGA-G3-A5SJ-01 5AB22DCE-8485-42C1-A2E0-99B19FCD6E1A 9fc02f84-548e-42a4-8857-717cd8426575 TCGA-G3-A5SJ-01A-11D-A27I-10 TCGA-G3-A5SJ-01 TCGA-G3-A5SJ-01 9fc02f84-548e-42a4-8857-717cd8426575 TCGA-G3-A5SJ-01A-11D-A27I-10 9fc02f84-548e-42a4-8857-717cd8426575 9fc02f84-548e-42a4-8857-717cd8426575 TCGA-G3-A5SJ-01A-11D-A27I-10 TCGA-G3-A5SJ-01A-11D-A27W-05 TCGA-G3-A5SK-01 TCGA-G3-A5SK-01 TCGA-G3-A5SK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 58 3.3 3.3 4.8 TCGA-G3-A5SK-F62745 TCGA-G3-A5SK TCGA-G3-A5SK-01A A 0.6 1.4 0.6 -21320 251 0 744 483 0 6 - Established Cirrhosis 2014-7-24 MALE 169 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 650 0.9 1.1 NO NO G1 Liver Intrahepatic Recurrence Yes NO YES No true No M0 NX T1 Stage I TCGA-G3-A5SK.6FB76663-58FA-48DD-A0F8-136C975FE067.pdf A5SK WITH TUMOR 106 150 400 YES NO 1.1 NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES G3 Liver A LIVING 67 2012 TCGA-G3-A5SK-01A-11D-A27I-10 TCGA-G3-A5SK-01 TCGA-G3-A5SK-01 3B1F0D3C-CBF1-4992-A25B-FFBC4480E5A0 602123eb-3790-4882-b8b1-f118838d3027 TCGA-G3-A5SK-01A-11D-A27I-10 TCGA-G3-A5SK-01 602123eb-3790-4882-b8b1-f118838d3027 TCGA-G3-A5SK-01A-11D-A27I-10 602123eb-3790-4882-b8b1-f118838d3027 602123eb-3790-4882-b8b1-f118838d3027 TCGA-G3-A5SK-01A-11D-A27I-10 TCGA-G3-A5SK-01A-11D-A27W-05 TCGA-G3-A5SL-01 TCGA-G3-A5SL-01 TCGA-G3-A5SL TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 70 3.1 4.2 4.7 TCGA-G3-A5SL-F62747 TCGA-G3-A5SL TCGA-G3-A5SL-01A 0 0.8 0.6 1.4 1 -25671 236 0 621 0 0 10 4 0 - No Fibrosis 2014-7-24 MALE 180 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 220 0.9 1.3 NO NO G2 NO true No M0 NX T2 Stage II TCGA-G3-A5SL.7DB1AFB2-69C9-4277-904E-4CF9CBAE8360.pdf A5SL TUMOR FREE 295 150 400 NO NO 1 NO NO R0 Primary Tumor 01 Other (specify) 7th YES NO G3 1.40 Liver Micro A LIVING 88 2012 TCGA-G3-A5SL-01A-11D-A27H-01 TCGA-G3-A5SL-01A-11D-A27H-01 TCGA-G3-A5SL-01A-11D-A27I-10 TCGA-G3-A5SL-01 TCGA-G3-A5SL-01 37EB6B47-7ECB-45C7-9519-307452A2FC72 0856a2e8-f139-4809-a7c6-29546080c333 TCGA-G3-A5SL-01A-11D-A27I-10 TCGA-G3-A5SL-01 TCGA-G3-A5SL-01 0856a2e8-f139-4809-a7c6-29546080c333 TCGA-G3-A5SL-01A-11D-A27I-10 0856a2e8-f139-4809-a7c6-29546080c333 0856a2e8-f139-4809-a7c6-29546080c333 TCGA-G3-A5SL-01A-11D-A27I-10 TCGA-G3-A5SL-01A-11D-A27W-05 TCGA-G3-A5SM-01 TCGA-G3-A5SM-01 TCGA-G3-A5SM TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 58 3.3 3.2 4.8 TCGA-G3-A5SM-F62748 TCGA-G3-A5SM TCGA-G3-A5SM-01A 0 0.6 A 0.5 1.4 0.5 -21236 111 0 520 252 1 0 10 12 6 - Established Cirrhosis 2014-7-24 MALE 184 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 0.9 1.1 NO NO G3 Liver Intrahepatic Recurrence Yes NO YES No true No M0 NX T2 Stage II TCGA-G3-A5SM.791E29AD-22A6-402E-978C-69407C6B748F.pdf A5SM TUMOR FREE 260 150 400 YES NO 0.9 NO NO R0 Primary Tumor 01 Other (specify) 7th YES NO G3 1.4 Liver None A LIVING 106 2012 TCGA-G3-A5SM-01A-12D-A28W-01 TCGA-G3-A5SM-01A-12D-A28W-01 TCGA-G3-A5SM-01A-12D-A28X-10 TCGA-G3-A5SM-01 TCGA-G3-A5SM-01 506FD114-C312-4ADC-8DB8-3D004F3A72C1 cccf48e7-af9d-4039-9ed1-ae859f692678 TCGA-G3-A5SM-01A-12D-A28X-10 TCGA-G3-A5SM-01 TCGA-G3-A5SM-01 cccf48e7-af9d-4039-9ed1-ae859f692678 TCGA-G3-A5SM-01A-12D-A28X-10 cccf48e7-af9d-4039-9ed1-ae859f692678 cccf48e7-af9d-4039-9ed1-ae859f692678 TCGA-G3-A5SM-01A-12D-A28X-10 TCGA-G3-A5SM-01A-12D-A28Y-05 TCGA-G3-A6UC-01 TCGA-G3-A6UC-01 TCGA-G3-A6UC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 65 3.3 4.6 4.8 TCGA-G3-A6UC-F64551 TCGA-G3-A6UC TCGA-G3-A6UC-01A 0 1.0 A 0.6 1.4 0.9 -23793 266 0 671 639 0 0 10 4 6 - Established Cirrhosis 2014-9-4 MALE 182 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 410 0.9 1.1 NO NO G2 Liver Intrahepatic Recurrence No NO YES No true Yes M0 N0 T3b Stage IIIB TCGA-G3-A6UC.08415C4C-C645-4911-BA53-6E562E562FD4.pdf A6UC WITH TUMOR 257 150 400 NO NO 1.1 NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO G3 1.4 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody LIVING 91 2012 TCGA-G3-A6UC-01A-21D-A33B-01 TCGA-G3-A6UC-01A-21D-A33B-01 TCGA-G3-A6UC-01A-21D-A33K-10 TCGA-G3-A6UC-01 TCGA-G3-A6UC-01 914e6f58-48b5-40aa-9336-69166bd6970b TCGA-G3-A6UC-01A-21D-A33K-10 TCGA-G3-A6UC-01 TCGA-G3-A6UC-01 914e6f58-48b5-40aa-9336-69166bd6970b TCGA-G3-A6UC-01A-21D-A33K-10 914e6f58-48b5-40aa-9336-69166bd6970b 914e6f58-48b5-40aa-9336-69166bd6970b TCGA-G3-A6UC-01A-21D-A33K-10 TCGA-G3-A6UC-01A-21D-A33L-05 TCGA-G3-A7M5-01 TCGA-G3-A7M5-01 TCGA-G3-A7M5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 76 3.3 4.1 4.8 TCGA-G3-A7M5-F65810 TCGA-G3-A7M5 TCGA-G3-A7M5-01A 0 0.5 A 0.6 1.4 1.9 -27963 217 0 447 0 0 10 6 0 - No Fibrosis 2014-9-30 MALE 164 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 720 0.9 1.1 NO NO G2 NO true No MX NX T1 Stage I TCGA-G3-A7M5.9441C376-F0CE-4A84-A9C0-5FB1917216F2.pdf A7M5 TUMOR FREE 181 150 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO G3 1.4 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody LIVING 68 2013 TCGA-G3-A7M5-01A-11D-A33P-01 TCGA-G3-A7M5-01A-11D-A33P-01 TCGA-G3-A7M5-01A-11D-A33Q-10 TCGA-G3-A7M5-01 TCGA-G3-A7M5-01 1EB5B0C8-DBD5-4380-9721-A1FDA5225BFA a439fc68-c013-4f3a-9be7-2e3243938e12 TCGA-G3-A7M5-01A-11D-A33Q-10 TCGA-G3-A7M5-01 TCGA-G3-A7M5-01 a439fc68-c013-4f3a-9be7-2e3243938e12 TCGA-G3-A7M5-01A-11D-A33Q-10 a439fc68-c013-4f3a-9be7-2e3243938e12 a439fc68-c013-4f3a-9be7-2e3243938e12 TCGA-G3-A7M5-01A-11D-A33Q-10 TCGA-G3-A7M5-01A-11D-A341-05 TCGA-G3-A7M6-01 TCGA-G3-A7M6-01 TCGA-G3-A7M6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 60 3.3 3.6 4.8 TCGA-G3-A7M6-F67241 TCGA-G3-A7M6 TCGA-G3-A7M6-01A 0 0.5 A 0.4 1.1 0.6 -22205 212 0 632 584 0 0 10 24 1,2 - Portal Fibrosis 2014-11-3 FEMALE 158 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 680 0.9 1.1 NO NO G3 Liver Locoregional Recurrence No NO YES No true No MX NX T1 Stage I TCGA-G3-A7M6.BE9902BC-2818-4A37-AF40-768208EA15B9.pdf A7M6 WITH TUMOR 273 150 400 NO NO 0.9 NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO G3 1.2 Liver None A LIVING 77 2013 TCGA-G3-A7M6-01A-11D-A33P-01 TCGA-G3-A7M6-01A-11D-A33P-01 TCGA-G3-A7M6-01A-11D-A33Q-10 TCGA-G3-A7M6-01 TCGA-G3-A7M6-01 F9487472-3D9B-4E48-AF59-20F5268794EC b23af964-65f4-4f37-a750-16a7d460fb38 TCGA-G3-A7M6-01A-11D-A33Q-10 TCGA-G3-A7M6-01 TCGA-G3-A7M6-01 b23af964-65f4-4f37-a750-16a7d460fb38 TCGA-G3-A7M6-01A-11D-A33Q-10 b23af964-65f4-4f37-a750-16a7d460fb38 b23af964-65f4-4f37-a750-16a7d460fb38 TCGA-G3-A7M6-01A-11D-A33Q-10 TCGA-G3-A7M6-01A-11D-A341-05 TCGA-G3-A7M7-01 TCGA-G3-A7M7-01 TCGA-G3-A7M7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Severe 65 3.2 3.5 4.6 TCGA-G3-A7M7-F67243 TCGA-G3-A7M7 TCGA-G3-A7M7-01A 0 0.5 A 0.7 1.2 0.6 -24002 112 0 361 0 0 7 4 3,4 - Fibrous Speta 2014-11-3 MALE 181 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 750 0.9 1.1 NO NO G1 NO true No MX NX T1 Stage I TCGA-G3-A7M7.9EC72408-F4C7-4D95-ACE3-3BF44E10FF8C.pdf A7M7 TUMOR FREE 145 150 450 NO NO 1.1 NO R0 Primary Tumor 01 Lobectomy 7th YES NO G3 1.2 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 77 2013 TCGA-G3-A7M7-01A-12D-A34Y-01 TCGA-G3-A7M7-01A-12D-A34Y-01 TCGA-G3-A7M7-01A-12D-A34Z-10 TCGA-G3-A7M7-01 TCGA-G3-A7M7-01 2495B0BD-2941-4F5F-9C7D-2CE9F4075927 0c31e1a3-2920-48f3-8609-f2e7ecd5ec51 TCGA-G3-A7M7-01A-12D-A34Z-10 TCGA-G3-A7M7-01 TCGA-G3-A7M7-01 0c31e1a3-2920-48f3-8609-f2e7ecd5ec51 TCGA-G3-A7M7-01A-12D-A34Z-10 0c31e1a3-2920-48f3-8609-f2e7ecd5ec51 0c31e1a3-2920-48f3-8609-f2e7ecd5ec51 TCGA-G3-A7M7-01A-12D-A34Z-10 TCGA-G3-A7M7-01A-12D-A356-05 TCGA-G3-A7M8-01 TCGA-G3-A7M8-01 TCGA-G3-A7M8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 31 3.3 3.5 4.8 TCGA-G3-A7M8-F65814 TCGA-G3-A7M8 TCGA-G3-A7M8-01A 0 1.8 A 0.6 1.4 0.7 -11527 97 0 430 0 0 10 5 6 - Established Cirrhosis 2014-9-30 MALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 180 0.9 1.1 NO NO G1 NO true No MX NX T1 Stage I TCGA-G3-A7M8.77483096-0271-4EBD-BC39-2232A3DEFF69.pdf A7M8 TUMOR FREE 136 150 400 NO NO 1.1 NO RX Primary Tumor 01 Segmentectomy, Multiple 7th YES NO G3 1.2 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody LIVING 2013 TCGA-G3-A7M8-01A-11D-A33P-01 TCGA-G3-A7M8-01A-11D-A33P-01 TCGA-G3-A7M8-01A-11D-A33Q-10 TCGA-G3-A7M8-01 TCGA-G3-A7M8-01 E72366C0-4D1A-4197-B39D-BFA404F70675 26e8978a-77bb-459f-b727-51d3fc361670 TCGA-G3-A7M8-01A-11D-A33Q-10 TCGA-G3-A7M8-01 TCGA-G3-A7M8-01 26e8978a-77bb-459f-b727-51d3fc361670 TCGA-G3-A7M8-01A-11D-A33Q-10 26e8978a-77bb-459f-b727-51d3fc361670 26e8978a-77bb-459f-b727-51d3fc361670 TCGA-G3-A7M8-01A-11D-A33Q-10 TCGA-G3-A7M8-01A-11D-A341-05 TCGA-G3-A7M9-01 TCGA-G3-A7M9-01 TCGA-G3-A7M9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 70 3.3 3.3 4.8 TCGA-G3-A7M9-F65815 TCGA-G3-A7M9 TCGA-G3-A7M9-01A 0 0.4 A 0.6 1.4 1 -25588 86 56 0 0 0 10 22868 6 - Established Cirrhosis 2014-9-30 MALE 170 Hemochromatosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1500 0.9 1.1 NO NO G2 NO true Yes MX NX T3b Stage IIIB TCGA-G3-A7M9.0759EEFA-E337-43A5-A6B8-7FDB5FE579EB.pdf A7M9 187 150 400 NO NO 1.1 NO R0 Primary Tumor 01 Lobectomy 7th YES NO G3 1.4 Liver Macro A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody DECEASED 73 2013 TCGA-G3-A7M9-01A-23D-A34Y-01 TCGA-G3-A7M9-01A-23D-A34Y-01 TCGA-G3-A7M9-01A-23D-A34Z-10 TCGA-G3-A7M9-01 TCGA-G3-A7M9-01 E22249BF-0815-4034-B171-A69670314312 8bc6822e-7701-4719-a42a-3b7916cde80b TCGA-G3-A7M9-01A-23D-A34Z-10 TCGA-G3-A7M9-01 TCGA-G3-A7M9-01 8bc6822e-7701-4719-a42a-3b7916cde80b TCGA-G3-A7M9-01A-23D-A34Z-10 8bc6822e-7701-4719-a42a-3b7916cde80b 8bc6822e-7701-4719-a42a-3b7916cde80b TCGA-G3-A7M9-01A-23D-A34Z-10 TCGA-G3-A7M9-01A-23D-A356-05 TCGA-G3-AAUZ-01 TCGA-G3-AAUZ-01 TCGA-G3-AAUZ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Severe 48 3.3 3.8 4.8 TCGA-G3-AAUZ-F67244 TCGA-G3-AAUZ 0 0.3 A 0.6 1.4 0.8 -17760 0 480 0 0 10 3 1,2 - Portal Fibrosis 2014-11-3 MALE 160 Hepatitis B|Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.1 NO G2 NO No M0 N0 T1 Stage I AAUZ TUMOR FREE 214 150 400 NO NO 1 NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO G3 1.4 Liver None Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV D LIVING 77 2013 TCGA-G3-AAUZ-01A-11D-A381-01 TCGA-G3-AAUZ-01A-11D-A381-01 TCGA-G3-AAUZ-01A-11D-A382-10 TCGA-G3-AAUZ-01 TCGA-G3-AAUZ-01 fe0ae39e-cbfd-416c-9485-036d0f77531f TCGA-G3-AAUZ-01 TCGA-G3-AAUZ-01 fe0ae39e-cbfd-416c-9485-036d0f77531f fe0ae39e-cbfd-416c-9485-036d0f77531f fe0ae39e-cbfd-416c-9485-036d0f77531f TCGA-G3-AAUZ-01A-11D-A383-05 TCGA-G3-AAV0-01 TCGA-G3-AAV0-01 TCGA-G3-AAV0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 58 3.3 4.2 4.8 TCGA-G3-AAV0-F67245 TCGA-G3-AAV0 0 0.6 A 0.6 1.4 0.9 -21249 0 476 0 0 10 4 0 - No Fibrosis 2014-11-3 MALE 158 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.1 NO G2 NO No M0 N0 T1 Stage I AAV0 TUMOR FREE 193 150 400 NO NO 0.9 NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO G3 1.4 Liver None Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody LIVING 58 2013 TCGA-G3-AAV0-01A-11D-A36W-01 TCGA-G3-AAV0-01A-11D-A36W-01 TCGA-G3-AAV0-01A-11D-A36X-10 TCGA-G3-AAV0-01 TCGA-G3-AAV0-01 cc064dfb-026a-45a9-bf02-f57f473f21a0 TCGA-G3-AAV0-01 TCGA-G3-AAV0-01 cc064dfb-026a-45a9-bf02-f57f473f21a0 cc064dfb-026a-45a9-bf02-f57f473f21a0 cc064dfb-026a-45a9-bf02-f57f473f21a0 TCGA-G3-AAV0-01A-11D-A36Y-05 TCGA-G3-AAV1-01 TCGA-G3-AAV1-01 TCGA-G3-AAV1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 51 3.3 3.2 4.8 TCGA-G3-AAV1-F65936 TCGA-G3-AAV1 0 0.7 B 0.6 1.4 0.7 -18973 359 0 49 1 0 10 8 6 - Established Cirrhosis 2014-10-1 MALE 181 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.1 NO G3 Liver Locoregional Recurrence Yes NO YES No No M0 N0 T4 Stage IIIC AAV1 WITH TUMOR 115 150 400 NO NO 1.2 NO R0 Primary Tumor 01 Lobectomy 7th YES NO G3 1.4 Liver Micro Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV D DECEASED 99 2013 TCGA-G3-AAV1-01A-11D-A381-01 TCGA-G3-AAV1-01A-11D-A381-01 TCGA-G3-AAV1-01A-11D-A382-10 TCGA-G3-AAV1-01 TCGA-G3-AAV1-01 b7999182-43bb-4c38-a543-a0bc4dd5a3e3 TCGA-G3-AAV1-01 TCGA-G3-AAV1-01 b7999182-43bb-4c38-a543-a0bc4dd5a3e3 b7999182-43bb-4c38-a543-a0bc4dd5a3e3 b7999182-43bb-4c38-a543-a0bc4dd5a3e3 TCGA-G3-AAV1-01A-11D-A383-05 TCGA-G3-AAV2-01 TCGA-G3-AAV2-01 TCGA-G3-AAV2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 50 3.3 4.2 4.8 TCGA-G3-AAV2-F67246 TCGA-G3-AAV2 TCGA-G3-AAV2-01A 0 0.7 A 0.6 1.4 1 -18363 136 0 372 0 0 10 4 6 - Established Cirrhosis 2014-11-3 MALE Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 500 0.9 1.1 NO NO G1 NO true No M0 N0 T1 Stage I TCGA-G3-AAV2.A323CDD5-4022-486C-B77E-F0552FB9076B.pdf AAV2 TUMOR FREE 110 150 400 NO NO 1 NO R0 Primary Tumor 01 Lobectomy 7th YES NO G3 1.4 Liver None A Hepatitis C Antibody|Hepatitis C Virus R|Hepatitis B Surface Antigen|HBV Surface Antibody LIVING 2013 TCGA-G3-AAV2-01A-11D-A36W-01 TCGA-G3-AAV2-01A-11D-A36W-01 TCGA-G3-AAV2-01A-11D-A36X-10 TCGA-G3-AAV2-01 TCGA-G3-AAV2-01 5d587eff-228f-49e0-a132-da031a81ad0b TCGA-G3-AAV2-01 TCGA-G3-AAV2-01 5d587eff-228f-49e0-a132-da031a81ad0b 5d587eff-228f-49e0-a132-da031a81ad0b 5d587eff-228f-49e0-a132-da031a81ad0b TCGA-G3-AAV2-01A-11D-A36Y-05 TCGA-G3-AAV3-01 TCGA-G3-AAV3-01 TCGA-G3-AAV3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Severe 58 3.4 4.4 4.8 TCGA-G3-AAV3-F67247 TCGA-G3-AAV3 TCGA-G3-AAV3-01A 0 0.6 1 A 0.5 0.9 0.6 -21449 98 0 412 1 0 7 5 6 - Established Cirrhosis 2014-11-3 FEMALE 168 Alcohol consumption|Hepatitis C|Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 150 0.9 1.1 NO NO G2 NO true No M0 N0 T2 Stage II TCGA-G3-AAV3.275E9EDA-413F-40BE-943C-9521F8CC297A.pdf AAV3 TUMOR FREE 113 150 450 NO NO 1.1 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO G3 1.4 Liver None A LIVING 85 2013 TCGA-G3-AAV3-01A-11D-A36W-01 TCGA-G3-AAV3-01A-11D-A36W-01 TCGA-G3-AAV3-01A-11D-A36X-10 TCGA-G3-AAV3-01 TCGA-G3-AAV3-01 25225fb1-c5ff-4edf-9895-11a7aa21d390 TCGA-G3-AAV3-01 TCGA-G3-AAV3-01 25225fb1-c5ff-4edf-9895-11a7aa21d390 25225fb1-c5ff-4edf-9895-11a7aa21d390 25225fb1-c5ff-4edf-9895-11a7aa21d390 TCGA-G3-AAV3-01A-11D-A36Y-05 TCGA-G3-AAV4-01 TCGA-G3-AAV4-01 TCGA-G3-AAV4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 83 3.3 2.7 4.8 TCGA-G3-AAV4-F65940 TCGA-G3-AAV4 TCGA-G3-AAV4-01A 0 0.8 2 A 0.4 1.1 1.1 -30466 423 27 0 0 0 10 4 3,4 - Fibrous Speta 2014-10-1 FEMALE 156 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 470 0.9 1.1 NO NO G1 NO true No M0 N0 T1 Stage I TCGA-G3-AAV4.85CCE331-652C-4D5B-9ED6-ECA8B57AE1AF.pdf AAV4 TUMOR FREE 79 150 400 NO NO 1.2 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO G3 1.2 Liver None A DECEASED 56 2012 TCGA-G3-AAV4-01A-11D-A381-01 TCGA-G3-AAV4-01A-11D-A381-01 TCGA-G3-AAV4-01A-11D-A382-10 TCGA-G3-AAV4-01 TCGA-G3-AAV4-01 30325cae-b955-45a1-9803-84a42c37d130 TCGA-G3-AAV4-01 TCGA-G3-AAV4-01 30325cae-b955-45a1-9803-84a42c37d130 30325cae-b955-45a1-9803-84a42c37d130 30325cae-b955-45a1-9803-84a42c37d130 TCGA-G3-AAV4-01A-11D-A383-05 TCGA-G3-AAV5-01 TCGA-G3-AAV5-01 TCGA-G3-AAV5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO 67 3.3 4.2 4.8 TCGA-G3-AAV5-F65955 TCGA-G3-AAV5 0 0.4 A 0.6 1.4 0.8 -24655 0 354 117 1 6 - Established Cirrhosis 2014-10-1 MALE 165 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.1 NO G2 Liver Locoregional Recurrence Yes NO YES No No M0 N0 T2 Stage II AAV5 WITH TUMOR 326 150 400 YES YES 1 [Discrepancy] R0 Primary Tumor 01 Lobectomy 7th YES NO G3 1.4 Liver Macro Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 88 2013 TCGA-G3-AAV5-01A-11D-A36W-01 TCGA-G3-AAV5-01A-11D-A36W-01 TCGA-G3-AAV5-01A-11D-A36X-10 TCGA-G3-AAV5-01 TCGA-G3-AAV5-01 e155a2ba-8842-417b-ab5a-e49339136236 TCGA-G3-AAV5-01 TCGA-G3-AAV5-01 e155a2ba-8842-417b-ab5a-e49339136236 e155a2ba-8842-417b-ab5a-e49339136236 e155a2ba-8842-417b-ab5a-e49339136236 TCGA-G3-AAV5-01A-11D-A36Y-05 TCGA-G3-AAV6-01 TCGA-G3-AAV6-01 TCGA-G3-AAV6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 53 3.4 3.9 5.2 TCGA-G3-AAV6-F65959 TCGA-G3-AAV6 0 1.6 A 0.6 1.4 0.9 -19556 65 0 44 0 0 10 57875 0 - No Fibrosis 2014-10-1 FEMALE 165 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.2 NO G3 Liver Intrahepatic Recurrence No NO YES No No M0 N0 T3a Stage IIIA AAV6 WITH TUMOR 303 150 400 NO NO 1 NO R0 Primary Tumor 01 Extended Lobectomy 7th YES NO G3 1.2 Liver Micro Hepatitis B Surface Antigen DECEASED 78 2013 TCGA-G3-AAV6-01A-21D-A36W-01 TCGA-G3-AAV6-01A-21D-A36W-01 TCGA-G3-AAV6-01A-21D-A36X-10 TCGA-G3-AAV6-01 TCGA-G3-AAV6-01 ebb77266-2b85-4413-b433-4c8db194467a TCGA-G3-AAV6-01 TCGA-G3-AAV6-01 ebb77266-2b85-4413-b433-4c8db194467a ebb77266-2b85-4413-b433-4c8db194467a ebb77266-2b85-4413-b433-4c8db194467a TCGA-G3-AAV6-01A-21D-A36Y-05 TCGA-G3-AAV7-01 TCGA-G3-AAV7-01 TCGA-G3-AAV7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 38 3.3 4 4.8 TCGA-G3-AAV7-F67249 TCGA-G3-AAV7 TCGA-G3-AAV7-01A 0 0.9 A 0.6 1.4 1.1 -14229 52 0 361 0 0 10 3 5 - Nodular Formation and Incomplete Cirrhosis 2014-11-3 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 0.9 1.1 NO NO G2 NO true No M0 N0 T2 Stage II TCGA-G3-AAV7.0F368084-04F6-4DCE-9ADF-6B3B94D274AB.pdf AAV7 TUMOR FREE 179 150 400 NO NO 1 NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO G3 1.4 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV D LIVING 58 2013 TCGA-G3-AAV7-01A-11D-A381-01 TCGA-G3-AAV7-01A-11D-A381-01 TCGA-G3-AAV7-01A-11D-A382-10 TCGA-G3-AAV7-01 TCGA-G3-AAV7-01 33a8bccc-6989-4882-828b-1d8c0b5aa91a TCGA-G3-AAV7-01 TCGA-G3-AAV7-01 33a8bccc-6989-4882-828b-1d8c0b5aa91a 33a8bccc-6989-4882-828b-1d8c0b5aa91a 33a8bccc-6989-4882-828b-1d8c0b5aa91a TCGA-G3-AAV7-01A-11D-A383-05 TCGA-GJ-A3OU-01 TCGA-GJ-A3OU-01 TCGA-GJ-A3OU TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 59 3.5 3.2 5.0 TCGA-GJ-A3OU-F70294 TCGA-GJ-A3OU TCGA-GJ-A3OU-01A 0.0 0.9 1 0.6 1.4 0.6 -21671 69 0 879 879 0 25 8 2015-3-27 MALE 167 Alcohol consumption|Non-Alcoholic Fatty Liver Disease|Other hepatic cirrhosis Hepatocellular Carcinoma No C22.0 8174/3 C22.0 YES 130 0.8 1.2 NO NO G2 Liver Intrahepatic Recurrence NO YES No false No MX NX T1 Stage I TCGA-GJ-A3OU.4ABC92BD-6D5C-462D-8DDC-2A3CEE065C13.pdf A3OU [Discrepancy] 178 150 450 NO NO 1.1 NO YES RX Primary Tumor 01 Segmentectomy, Single 7th YES NO GJ 1.0 Liver None A Hepatitis C Antibody LIVING 172 2011 TCGA-GJ-A3OU-01A-31D-A381-01 TCGA-GJ-A3OU-01A-31D-A381-01 TCGA-GJ-A3OU-01A-31D-A382-10 TCGA-GJ-A3OU-01 TCGA-GJ-A3OU-01 5eeb70ae-b09e-4b6d-80f1-23ed3e20b33c TCGA-GJ-A3OU-01 TCGA-GJ-A3OU-01 5eeb70ae-b09e-4b6d-80f1-23ed3e20b33c 5eeb70ae-b09e-4b6d-80f1-23ed3e20b33c 5eeb70ae-b09e-4b6d-80f1-23ed3e20b33c TCGA-GJ-A3OU-01A-31D-A383-05 TCGA-GJ-A6C0-01 TCGA-GJ-A6C0-01 TCGA-GJ-A6C0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 75 TCGA-GJ-A6C0 TCGA-GJ-A6C0-01A 1 -27626 310 31 0 2013-11-27 FEMALE 160 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 NO G2 NO false No MX NX T2 Stage II TCGA-GJ-A6C0.D9F106D7-C163-46C5-8DDC-FF60ED1CF17B.pdf A6C0 NO NO NO YES RX Primary Tumor 01 Other (specify) 7th YES NO GJ Liver Micro A DECEASED 90 2012 TCGA-GJ-A6C0-01A-12D-A30U-01 TCGA-GJ-A6C0-01A-12D-A30U-01 TCGA-GJ-A6C0-01A-12D-A30V-10 TCGA-GJ-A6C0-01 TCGA-GJ-A6C0-01 FB0BE047-479A-4F5D-80F6-4654E627B05F 896ab3e0-3ea4-4459-b0bf-9ccd6b74578c TCGA-GJ-A6C0-01A-12D-A30V-10 TCGA-GJ-A6C0-01 TCGA-GJ-A6C0-01 896ab3e0-3ea4-4459-b0bf-9ccd6b74578c TCGA-GJ-A6C0-01A-12D-A30V-10 896ab3e0-3ea4-4459-b0bf-9ccd6b74578c 896ab3e0-3ea4-4459-b0bf-9ccd6b74578c TCGA-GJ-A6C0-01A-12D-A30V-10 TCGA-GJ-A6C0-01A-12D-A30Y-05 TCGA-GJ-A9DB-01 TCGA-GJ-A9DB-01 TCGA-GJ-A9DB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 68 3.5 4.5 5 TCGA-GJ-A9DB TCGA-GJ-A9DB-01A 0.0 0.5 1 0.8 1.4 1.1 -25020 132 67 0 2014-5-7 MALE 187 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 540 0.7 1.2 NO G2 NO false No MX N0 T1 Stage I TCGA-GJ-A9DB.8B2D3FA5-D673-4B70-B153-7EACE17A50E0.pdf A9DB 144 150 450 NO NO 0.9 NO YES R0 Primary Tumor 01 Other (specify) 7th YES NO GJ 1.0 Liver None A DECEASED 96 2013 TCGA-GJ-A9DB-01A-11D-A36W-01 TCGA-GJ-A9DB-01A-11D-A36W-01 TCGA-GJ-A9DB-01A-11D-A36X-10 TCGA-GJ-A9DB-01 TCGA-GJ-A9DB-01 6C5CDCF6-58BB-4CD3-BFA5-1F07E29A8E1C 60f5dada-7b3d-49b8-8a96-f2143e1d4c71 TCGA-GJ-A9DB-01 TCGA-GJ-A9DB-01 60f5dada-7b3d-49b8-8a96-f2143e1d4c71 60f5dada-7b3d-49b8-8a96-f2143e1d4c71 60f5dada-7b3d-49b8-8a96-f2143e1d4c71 TCGA-GJ-A9DB-01A-11D-A36Y-05 TCGA-HP-A5MZ-01 TCGA-HP-A5MZ-01 TCGA-HP-A5MZ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 78 TCGA-HP-A5MZ-F64772 TCGA-HP-A5MZ TCGA-HP-A5MZ-01A 62 120 124 -22702 91 0 2014-9-11 MALE 185 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 0.9 1.1 NO NO G2 NO false No M0 NX T1 Stage I TCGA-HP-A5MZ.BD5F2C9B-16EE-42B2-B09B-F9BE4FCB2F75.pdf A5MZ TUMOR FREE 231 150 400 NO NO 1.0 NO R0 Primary Tumor 01 Lobectomy 6th NO YES HP Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody DECEASED 82 TCGA-HP-A5MZ-01A-21D-A27H-01 TCGA-HP-A5MZ-01A-21D-A27H-01 TCGA-HP-A5MZ-01A-21D-A27I-10 TCGA-HP-A5MZ-01 TCGA-HP-A5MZ-01 EE037571-4D80-4766-81A9-7E1214F43496 c3d40f5f-e3df-4bf7-867d-7d17fa8fc3ad TCGA-HP-A5MZ-01A-21D-A27I-10 TCGA-HP-A5MZ-01 TCGA-HP-A5MZ-01 c3d40f5f-e3df-4bf7-867d-7d17fa8fc3ad TCGA-HP-A5MZ-01A-21D-A27I-10 c3d40f5f-e3df-4bf7-867d-7d17fa8fc3ad c3d40f5f-e3df-4bf7-867d-7d17fa8fc3ad TCGA-HP-A5MZ-01A-21D-A27I-10 TCGA-HP-A5MZ-01A-21D-A27W-05 TCGA-HP-A5N0-01 TCGA-HP-A5N0-01 TCGA-HP-A5N0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 90 3.5 2.6 4.8 TCGA-HP-A5N0-F70727 TCGA-HP-A5N0 TCGA-HP-A5N0-01A 3 0 0.9 0.5 -32120 1147 0 179 0 0 - No Fibrosis 2015-3-2 FEMALE 156 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8174/3 C22.0 YES 350 0.9 1.2 NO NO Liver Locoregional Recurrence No NO YES No false No M0 NX TX TCGA-HP-A5N0.0221A6F3-34F5-407E-8548-B62F27F66FCE.pdf A5N0 WITH TUMOR NO NO 1.2 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES HP Liver A DECEASED 65 TCGA-HP-A5N0-01A-11D-A28W-01 TCGA-HP-A5N0-01A-11D-A28W-01 TCGA-HP-A5N0-01A-11D-A28X-10 TCGA-HP-A5N0-01 TCGA-HP-A5N0-01 3630E5F3-9CEF-49D8-BFE5-2B3EDC4E200D 10285abf-91af-443f-8e5e-61b87c003165 TCGA-HP-A5N0-01A-11D-A28X-10 TCGA-HP-A5N0-01 TCGA-HP-A5N0-01 10285abf-91af-443f-8e5e-61b87c003165 TCGA-HP-A5N0-01A-11D-A28X-10 10285abf-91af-443f-8e5e-61b87c003165 10285abf-91af-443f-8e5e-61b87c003165 TCGA-HP-A5N0-01A-11D-A28X-10 TCGA-HP-A5N0-01A-11D-A28Y-05 TCGA-K7-A5RF-01 TCGA-K7-A5RF-01 TCGA-K7-A5RF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 64 TCGA-K7-A5RF-F64037 TCGA-K7-A5RF TCGA-K7-A5RF-01A -23557 102 0 631 5 2014-8-25 MALE 177 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1350 NO NO G1 NO true No MX NX T1 Stage I TCGA-K7-A5RF.04C26B7B-66EE-4F20-A059-52E19557C268.pdf A5RF TUMOR FREE YES NO NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO K7 Liver A Hepatitis C Virus R LIVING 75 2012 TCGA-K7-A5RF-01A-11D-A28W-01 TCGA-K7-A5RF-01A-11D-A28W-01 TCGA-K7-A5RF-01A-11D-A28X-10 TCGA-K7-A5RF-01 TCGA-K7-A5RF-01 6DBDC9AF-E565-46A3-BA78-14CE7C982DBF af1ae913-a82c-4d3f-9705-b45685a434ab TCGA-K7-A5RF-01A-11D-A28X-10 TCGA-K7-A5RF-01 TCGA-K7-A5RF-01 af1ae913-a82c-4d3f-9705-b45685a434ab TCGA-K7-A5RF-01A-11D-A28X-10 af1ae913-a82c-4d3f-9705-b45685a434ab af1ae913-a82c-4d3f-9705-b45685a434ab TCGA-K7-A5RF-01A-11D-A28X-10 TCGA-K7-A5RF-01A-11D-A28Y-05 TCGA-K7-A5RG-01 TCGA-K7-A5RG-01 TCGA-K7-A5RG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 66 TCGA-K7-A5RG-F64039 TCGA-K7-A5RG TCGA-K7-A5RG-01A 1 -24218 100 0 519 19 2014-8-25 MALE 173 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 630 NO NO G1 NO true No MX NX T1 Stage I TCGA-K7-A5RG.AADEAE33-3867-4F77-AAA6-072471B5A397.pdf A5RG TUMOR FREE NO NO NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO K7 Liver None A HCV Genotype LIVING 123 2012 TCGA-K7-A5RG-01A-11D-A28W-01 TCGA-K7-A5RG-01A-11D-A28W-01 TCGA-K7-A5RG-01A-11D-A28X-10 TCGA-K7-A5RG-01 TCGA-K7-A5RG-01 5046E74A-24C1-4365-A29E-1E5D89869E92 a8a41ad6-263c-4c76-987f-2f8a7dffefa1 TCGA-K7-A5RG-01A-11D-A28X-10 TCGA-K7-A5RG-01 TCGA-K7-A5RG-01 a8a41ad6-263c-4c76-987f-2f8a7dffefa1 TCGA-K7-A5RG-01A-11D-A28X-10 a8a41ad6-263c-4c76-987f-2f8a7dffefa1 a8a41ad6-263c-4c76-987f-2f8a7dffefa1 TCGA-K7-A5RG-01A-11D-A28X-10 TCGA-K7-A5RG-01A-11D-A28Y-05 TCGA-K7-A6G5-01 TCGA-K7-A6G5-01 TCGA-K7-A6G5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 66 TCGA-K7-A6G5-F64040 TCGA-K7-A6G5 TCGA-K7-A6G5-01A -24233 31 0 512 0 2014-8-25 MALE 184 Alcohol consumption|Hepatitis B|Hepatitis C|Hemochromatosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 60 NO NO G2 NO true No MX N0 T1 Stage I TCGA-K7-A6G5.BA14915C-0D72-4A11-AAFA-DD51FC6309B2.pdf A6G5 TUMOR FREE NO NO NO RX Primary Tumor 01 Lobectomy 7th YES NO K7 Liver None A HCV Genotype LIVING 80 2013 TCGA-K7-A6G5-01A-11D-A30U-01 TCGA-K7-A6G5-01A-11D-A30U-01 TCGA-K7-A6G5-01A-11D-A30V-10 TCGA-K7-A6G5-01 TCGA-K7-A6G5-01 42e83563-54b2-4848-b657-6367e71eac65 TCGA-K7-A6G5-01A-11D-A30V-10 TCGA-K7-A6G5-01 TCGA-K7-A6G5-01 42e83563-54b2-4848-b657-6367e71eac65 TCGA-K7-A6G5-01A-11D-A30V-10 42e83563-54b2-4848-b657-6367e71eac65 42e83563-54b2-4848-b657-6367e71eac65 TCGA-K7-A6G5-01A-11D-A30V-10 TCGA-K7-A6G5-01A-11D-A30Y-05 TCGA-K7-AAU7-01 TCGA-K7-AAU7-01 TCGA-K7-AAU7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 61 TCGA-K7-AAU7-F70895 TCGA-K7-AAU7 2 A -22476 0 359 58 0 0 10 290 2015-3-10 MALE Hepatitis C|Hemochromatosis Hepatocholangiocarcinoma (Mixed) No C22.0 8180/3 C22.0 YES 0 1.9 NO G2 Liver Intrahepatic Recurrence YES No MX NX T2a Stage II AAU7 WITH TUMOR 87 150 450 NO YES 0.9 NO YES RX Primary Tumor 01 Segmentectomy, Multiple 7th YES NO K7 Liver Micro LIVING 2013 TCGA-K7-AAU7-01A-11D-A381-01 TCGA-K7-AAU7-01A-11D-A381-01 TCGA-K7-AAU7-01A-11D-A382-10 TCGA-K7-AAU7-01 TCGA-K7-AAU7-01 e9f1e235-52ff-45fd-84ad-52135124cec9 TCGA-K7-AAU7-01 TCGA-K7-AAU7-01 e9f1e235-52ff-45fd-84ad-52135124cec9 e9f1e235-52ff-45fd-84ad-52135124cec9 e9f1e235-52ff-45fd-84ad-52135124cec9 TCGA-K7-AAU7-01A-11D-A383-05 TCGA-KR-A7K0-01 TCGA-KR-A7K0-01 TCGA-KR-A7K0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 65 3.5 2.8 4.9 TCGA-KR-A7K0 0.2 1.3 0.7 1.3 0.7 -23974 65 0 0 8 11 2014-5-28 MALE 174 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES G1 NO Yes M0 N0 T1 Stage I A7K0 TUMOR FREE 102 150 400 NO NO 1.4 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES KR 1.2 Liver None Hepatitis C Antibody DECEASED 66 2013 TCGA-KR-A7K0-01A-12D-A33P-01 TCGA-KR-A7K0-01A-12D-A33P-01 TCGA-KR-A7K0-01A-12D-A33Q-10 TCGA-KR-A7K0-01 TCGA-KR-A7K0-01 e926e7f1-c849-47b4-b466-b1c2d187fdd2 TCGA-KR-A7K0-01A-12D-A33Q-10 TCGA-KR-A7K0-01 TCGA-KR-A7K0-01 e926e7f1-c849-47b4-b466-b1c2d187fdd2 TCGA-KR-A7K0-01A-12D-A33Q-10 e926e7f1-c849-47b4-b466-b1c2d187fdd2 e926e7f1-c849-47b4-b466-b1c2d187fdd2 TCGA-KR-A7K0-01A-12D-A33Q-10 TCGA-KR-A7K0-01A-12D-A341-05 TCGA-KR-A7K2-01 TCGA-KR-A7K2-01 TCGA-KR-A7K2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 64 3.5 3.3 4.9 TCGA-KR-A7K2-F72748 TCGA-KR-A7K2 TCGA-KR-A7K2-01A 0.2 1.5 0.7 1.3 1.1 -23699 85 0 829 0 8 14 2015-11-24 MALE 166 Hepatitis C Hepatocholangiocarcinoma (Mixed) No C22.0 8180/3 C22.0 YES 70 NO NO G1 NO false No M0 N0 T1 Stage I TCGA-KR-A7K2.5121C5D6-3BCB-4A0F-B18A-51BA4E87778B.pdf A7K2 TUMOR FREE 178 150 400 NO NO 1 NO R0 Primary Tumor 01 Other (specify) 7th NO YES KR 1.2 Liver None A HCV Genotype LIVING 79 2013 TCGA-KR-A7K2-01A-12D-A33P-01 TCGA-KR-A7K2-01A-12D-A33P-01 TCGA-KR-A7K2-01A-12D-A33Q-10 TCGA-KR-A7K2-01 TCGA-KR-A7K2-01 2242b367-081f-4369-9761-bcd225c05124 TCGA-KR-A7K2-01A-12D-A33Q-10 TCGA-KR-A7K2-01 TCGA-KR-A7K2-01 2242b367-081f-4369-9761-bcd225c05124 TCGA-KR-A7K2-01A-12D-A33Q-10 2242b367-081f-4369-9761-bcd225c05124 2242b367-081f-4369-9761-bcd225c05124 TCGA-KR-A7K2-01A-12D-A33Q-10 TCGA-KR-A7K2-01A-12D-A341-05 TCGA-KR-A7K7-01 TCGA-KR-A7K7-01 TCGA-KR-A7K7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO 61 3.5 3.4 4.9 TCGA-KR-A7K7-F71440 TCGA-KR-A7K7 TCGA-KR-A7K7-01A 0.2 1.4 0.5 1.0 0.8 -22587 461 0 951 239 0 8 308836 2015-3-25 FEMALE 168 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 NO NO G1 Other, specify Extrahepatic Recurrence Adrenal No NO YES No false Yes M0 N0 T2 Stage II TCGA-KR-A7K7.8CE97410-9210-4B15-97FE-E61722535975.pdf A7K7 WITH TUMOR 130 150 400 NO NO 1.0 NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES KR 1.2 Liver Micro A LIVING 125 2012 TCGA-KR-A7K7-01A-11D-A33B-01 TCGA-KR-A7K7-01A-11D-A33B-01 TCGA-KR-A7K7-01A-11D-A33K-10 TCGA-KR-A7K7-01 TCGA-KR-A7K7-01 351556A0-38B2-41BD-8B08-8532588F0A8F c926906f-e63c-41e4-b117-87cf91206132 TCGA-KR-A7K7-01A-11D-A33K-10 TCGA-KR-A7K7-01 TCGA-KR-A7K7-01 c926906f-e63c-41e4-b117-87cf91206132 TCGA-KR-A7K7-01A-11D-A33K-10 c926906f-e63c-41e4-b117-87cf91206132 c926906f-e63c-41e4-b117-87cf91206132 TCGA-KR-A7K7-01A-11D-A33K-10 TCGA-KR-A7K7-01A-11D-A33L-05 TCGA-KR-A7K8-01 TCGA-KR-A7K8-01 TCGA-KR-A7K8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 57 3.5 3.3 4.9 TCGA-KR-A7K8-F71274 TCGA-KR-A7K8 TCGA-KR-A7K8-01A 0.2 1.9 1 0.7 1.3 1.1 -20914 435 0 906 0 8 154 2015-3-24 MALE 170 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 NO NO G1 NO false No M0 N0 T1 Stage I TCGA-KR-A7K8.9B449A83-1172-4EE0-9337-27BD5D3ECF4D.pdf A7K8 TUMOR FREE 103 150 400 NO NO 1.3 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES KR 1.2 Liver None A LIVING 109 2012 TCGA-KR-A7K8-01A-11D-A33B-01 TCGA-KR-A7K8-01A-11D-A33B-01 TCGA-KR-A7K8-01A-11D-A33K-10 TCGA-KR-A7K8-01 TCGA-KR-A7K8-01 1fbb2486-5c98-42af-a8b7-3c771a30702c TCGA-KR-A7K8-01A-11D-A33K-10 TCGA-KR-A7K8-01 TCGA-KR-A7K8-01 1fbb2486-5c98-42af-a8b7-3c771a30702c TCGA-KR-A7K8-01A-11D-A33K-10 1fbb2486-5c98-42af-a8b7-3c771a30702c 1fbb2486-5c98-42af-a8b7-3c771a30702c TCGA-KR-A7K8-01A-11D-A33K-10 TCGA-KR-A7K8-01A-11D-A33L-05 TCGA-LG-A6GG-01 TCGA-LG-A6GG-01 TCGA-LG-A6GG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 79 3.4 3.7 4.8 TCGA-LG-A6GG-F59890 TCGA-LG-A6GG TCGA-LG-A6GG-01A 0.2 0.8 A 0.4 1.1 0.6 -28871 35 0 387 0 2014-5-22 FEMALE 158 Other Cryptogenic Cirrhosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1140 9.4 12.2 NO NO G2 NO true Yes M0 NX T2 Stage II TCGA-LG-A6GG.A7F1EA5C-5797-42D1-AD35-E2E529B26409.pdf A6GG TUMOR FREE 93 150 450 NO NO 12.2 NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO LG 1.0 Liver Micro A LIVING 65 2013 TCGA-LG-A6GG-01A-11D-A30U-01 TCGA-LG-A6GG-01A-11D-A30U-01 TCGA-LG-A6GG-01A-11D-A30V-10 TCGA-LG-A6GG-01 TCGA-LG-A6GG-01 471985D8-4D5A-44A6-9659-B1B3F286BCA5 dc1a8da9-58bf-4394-a9f8-8e14da005ba7 TCGA-LG-A6GG-01A-11D-A30V-10 TCGA-LG-A6GG-01 TCGA-LG-A6GG-01 dc1a8da9-58bf-4394-a9f8-8e14da005ba7 TCGA-LG-A6GG-01A-11D-A30V-10 dc1a8da9-58bf-4394-a9f8-8e14da005ba7 dc1a8da9-58bf-4394-a9f8-8e14da005ba7 TCGA-LG-A6GG-01A-11D-A30V-10 TCGA-LG-A6GG-01A-11D-A30Y-05 TCGA-LG-A9QC-01 TCGA-LG-A9QC-01 TCGA-LG-A9QC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 48 3.5 4.7 5.0 TCGA-LG-A9QC-F69223 TCGA-LG-A9QC TCGA-LG-A9QC-01A 0.2 2.8 1 0.5 1.3 0.8 -17842 62 0 425 2014-12-30 MALE 188 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1080 9.4 12.2 NO NO G2 NO true No M0 NX T1 Stage I TCGA-LG-A9QC.AD8045A1-61EA-4713-9C8D-9AF200DB1424.pdf A9QC TUMOR FREE 275 150 450 NO NO 12.1 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO LG 1.0 Liver Micro A LIVING 103 2013 TCGA-LG-A9QC-01A-11D-A36W-01 TCGA-LG-A9QC-01A-11D-A36W-01 TCGA-LG-A9QC-01A-11D-A36X-10 TCGA-LG-A9QC-01 TCGA-LG-A9QC-01 84c348d8-a1a8-4ffe-938d-3a6789004e7a TCGA-LG-A9QC-01 TCGA-LG-A9QC-01 84c348d8-a1a8-4ffe-938d-3a6789004e7a 84c348d8-a1a8-4ffe-938d-3a6789004e7a 84c348d8-a1a8-4ffe-938d-3a6789004e7a TCGA-LG-A9QC-01A-11D-A36Y-05 TCGA-LG-A9QD-01 TCGA-LG-A9QD-01 TCGA-LG-A9QD TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 68 3.4 2.9 4.8 TCGA-LG-A9QD-F69200 TCGA-LG-A9QD TCGA-LG-A9QD-01A 0.0 0.5 3 0.7 1.5 0.9 -24969 28 0 366 2014-12-30 MALE 168 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1580 NO NO G2 NO true No M0 N0 T3a Stage IIIA TCGA-LG-A9QD.D5BAD949-7001-4FAC-A7B4-E9B426A53A76.pdf A9QD WITH TUMOR 320 150 450 NO YES NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO LG 1.2 Liver None A LIVING 74 2013 TCGA-LG-A9QD-01A-11D-A381-01 TCGA-LG-A9QD-01A-11D-A381-01 TCGA-LG-A9QD-01A-11D-A382-10 TCGA-LG-A9QD-01 TCGA-LG-A9QD-01 42f6b380-6c70-41ec-bac2-54fec52b4a49 TCGA-LG-A9QD-01 TCGA-LG-A9QD-01 42f6b380-6c70-41ec-bac2-54fec52b4a49 42f6b380-6c70-41ec-bac2-54fec52b4a49 42f6b380-6c70-41ec-bac2-54fec52b4a49 TCGA-LG-A9QD-01A-11D-A383-05 TCGA-MI-A75C-01 TCGA-MI-A75C-01 TCGA-MI-A75C TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 64 3.5 4.0 4.9 TCGA-MI-A75C-F62894 TCGA-MI-A75C 0.2 1.1 A 0.6 1.3 1.0 -23441 0 291 1 0 9 4 2014-7-28 MALE 175 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES YES G3 NO No M0 N0 T1 Stage I A75C TUMOR FREE 243 150 450 NO NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES MI 1.2 Liver None HBV Surface Antibody LIVING 84 2012 TCGA-MI-A75C-01A-11D-A32F-01 TCGA-MI-A75C-01A-11D-A32F-01 TCGA-MI-A75C-01A-11D-A32G-10 TCGA-MI-A75C-01 TCGA-MI-A75C-01 fe4a54d5-3270-4b53-a813-159b68764037 TCGA-MI-A75C-01A-11D-A32G-10 TCGA-MI-A75C-01 TCGA-MI-A75C-01 fe4a54d5-3270-4b53-a813-159b68764037 TCGA-MI-A75C-01A-11D-A32G-10 fe4a54d5-3270-4b53-a813-159b68764037 fe4a54d5-3270-4b53-a813-159b68764037 TCGA-MI-A75C-01A-11D-A32G-10 TCGA-MI-A75C-01A-11D-A32R-05 TCGA-MI-A75E-01 TCGA-MI-A75E-01 TCGA-MI-A75E TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 61 3.5 3.0 4.9 TCGA-MI-A75E-F62895 TCGA-MI-A75E TCGA-MI-A75E-01A 0.2 1.1 1 A 0.6 1.3 -22457 157 0 507 1 0 9 5 1,2 - Portal Fibrosis 2014-7-28 MALE 175 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 NO NO G2 NO true No M0 N0 T4 Stage IIIC TCGA-MI-A75E.F88435AB-695B-4481-BE6C-93FEE7954465.pdf A75E TUMOR FREE 158 150 450 NO NO NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES MI 1.2 Liver Micro A HCV Genotype LIVING 103 2013 TCGA-MI-A75E-01A-11D-A32F-01 TCGA-MI-A75E-01A-11D-A32F-01 TCGA-MI-A75E-01A-11D-A32G-10 TCGA-MI-A75E-01 TCGA-MI-A75E-01 1be67822-b74f-4321-b7b9-2d85032d3ce6 TCGA-MI-A75E-01A-11D-A32G-10 TCGA-MI-A75E-01 TCGA-MI-A75E-01 1be67822-b74f-4321-b7b9-2d85032d3ce6 TCGA-MI-A75E-01A-11D-A32G-10 1be67822-b74f-4321-b7b9-2d85032d3ce6 1be67822-b74f-4321-b7b9-2d85032d3ce6 TCGA-MI-A75E-01A-11D-A32G-10 TCGA-MI-A75E-01A-11D-A32R-05 TCGA-MI-A75G-01 TCGA-MI-A75G-01 TCGA-MI-A75G TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 63 3.5 2.3 4.9 TCGA-MI-A75G-F58603 TCGA-MI-A75G TCGA-MI-A75G-01A 0.2 1.7 1 B 0.6 1.3 0.5 -23284 427 0 698 1 0 9 6 6 - Established Cirrhosis 2014-7-28 MALE 178 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 NO YES G2 NO true No M0 N0 T2 Stage II TCGA-MI-A75G.30FAEBBF-0EEE-40F5-9463-50FDDE258D4B.pdf A75G TUMOR FREE 160 150 450 NO NO NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES MI 1.2 Liver None A HCV Genotype LIVING 69 2012 TCGA-MI-A75G-01A-11D-A32F-01 TCGA-MI-A75G-01A-11D-A32F-01 TCGA-MI-A75G-01A-11D-A32G-10 TCGA-MI-A75G-01 TCGA-MI-A75G-01 5d93dde1-846e-4ba9-b27e-107a9570deed TCGA-MI-A75G-01A-11D-A32G-10 TCGA-MI-A75G-01 TCGA-MI-A75G-01 5d93dde1-846e-4ba9-b27e-107a9570deed TCGA-MI-A75G-01A-11D-A32G-10 5d93dde1-846e-4ba9-b27e-107a9570deed 5d93dde1-846e-4ba9-b27e-107a9570deed TCGA-MI-A75G-01A-11D-A32G-10 TCGA-MI-A75G-01A-11D-A32R-05 TCGA-MI-A75H-01 TCGA-MI-A75H-01 TCGA-MI-A75H TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 77 3.5 3.3 4.9 TCGA-MI-A75H-F68684 TCGA-MI-A75H TCGA-MI-A75H-01A 0.2 2.3 B 0.6 1.3 -28371 287 0 747 307 1 0 9 11 6 - Established Cirrhosis 2015-1-9 MALE 173 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 NO NO Liver Intrahepatic Recurrence Yes NO YES No true Yes MX NX TCGA-MI-A75H.57959509-A138-4131-BE87-9A77ED365702.pdf A75H WITH TUMOR 138 150 450 YES NO 1.1 NO R0 R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES MI 1.2 Liver Micro A HCV Genotype LIVING 84 2012 TCGA-MI-A75H-01A-11D-A32F-01 TCGA-MI-A75H-01A-11D-A32F-01 TCGA-MI-A75H-01A-11D-A32G-10 TCGA-MI-A75H-01 TCGA-MI-A75H-01 5abe35ae-90bf-411e-b96f-b92c00718696 TCGA-MI-A75H-01A-11D-A32G-10 TCGA-MI-A75H-01 TCGA-MI-A75H-01 5abe35ae-90bf-411e-b96f-b92c00718696 TCGA-MI-A75H-01A-11D-A32G-10 5abe35ae-90bf-411e-b96f-b92c00718696 5abe35ae-90bf-411e-b96f-b92c00718696 TCGA-MI-A75H-01A-11D-A32G-10 TCGA-MI-A75H-01A-11D-A32R-05 TCGA-MI-A75I-01 TCGA-MI-A75I-01 TCGA-MI-A75I TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 61 TCGA-MI-A75I-F62897 TCGA-MI-A75I TCGA-MI-A75I-01A 3 A -22341 665 0 630 265 1 2014-7-28 MALE 188 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 50 NO NO G1 Liver YES true No MX NX T2 TCGA-MI-A75I.4630A897-45DC-4122-BB86-A2943FE27CEA.pdf A75I 153 150 450 NO NO NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES MI Liver A LIVING 100 2011 TCGA-MI-A75I-01A-11D-A32F-01 TCGA-MI-A75I-01A-11D-A32F-01 TCGA-MI-A75I-01A-11D-A32G-10 TCGA-MI-A75I-01 TCGA-MI-A75I-01 4b2926c2-e50c-43ed-93df-a85901fcf0a2 TCGA-MI-A75I-01A-11D-A32G-10 TCGA-MI-A75I-01 TCGA-MI-A75I-01 4b2926c2-e50c-43ed-93df-a85901fcf0a2 TCGA-MI-A75I-01A-11D-A32G-10 4b2926c2-e50c-43ed-93df-a85901fcf0a2 4b2926c2-e50c-43ed-93df-a85901fcf0a2 TCGA-MI-A75I-01A-11D-A32G-10 TCGA-MI-A75I-01A-11D-A32R-05 TCGA-MR-A520-01 TCGA-MR-A520-01 TCGA-MR-A520 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 58 TCGA-MR-A520-F48052 TCGA-MR-A520 TCGA-MR-A520-01A -21398 106 0 229 2012-9-14 MALE 179 Other Moderate alcohol consumption, anti TB drug used for TB positive testing Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 270 NO NO G1 NO true No MX NX T1 Stage I TCGA-MR-A520.FA4ACC09-F22B-4253-8667-6C04369E5DCA.pdf A520 TUMOR FREE NO NO NO Primary Tumor 01 Lobectomy 7th YES NO MR Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody LIVING 104 2012 TCGA-MR-A520-01A-11D-A25U-01 TCGA-MR-A520-01A-11D-A25U-01 TCGA-MR-A520-01A-11D-A25V-10 TCGA-MR-A520-01 TCGA-MR-A520-01 997F554C-50F9-482F-B08B-6AD76043FCA4 ee0b8b56-4246-45c7-800c-e8d37c8d6c4d TCGA-MR-A520-01A-11D-A25V-10 TCGA-MR-A520-01 TCGA-MR-A520-01 ee0b8b56-4246-45c7-800c-e8d37c8d6c4d TCGA-MR-A520-01A-11D-A25V-10 ee0b8b56-4246-45c7-800c-e8d37c8d6c4d ee0b8b56-4246-45c7-800c-e8d37c8d6c4d TCGA-MR-A520-01A-11D-A25V-10 TCGA-MR-A520-01A-11D-A264-05 TCGA-MR-A8JO-01 TCGA-MR-A8JO-01 TCGA-MR-A8JO TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 34 3.9 4.1 5.1 TCGA-MR-A8JO-F58923 TCGA-MR-A8JO TCGA-MR-A8JO-01A 0.2 0.8 -12669 184 0 330 2 2014-4-28 MALE 196 Alcohol consumption Fibrolamellar Carcinoma No C22.0 8171/3 C22.0 YES 350 NO NO G3 NO true No MX N0 T1 Stage I TCGA-MR-A8JO.DA03F6F5-2579-45B7-954B-8C0F8EFD0F75.pdf A8JO TUMOR FREE 162 150 450 NO NO NO NO RX Primary Tumor 01 Lobectomy 7th YES NO MR 1.3 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody LIVING 90 2013 TCGA-MR-A8JO-01A-12D-A35Y-01 TCGA-MR-A8JO-01A-12D-A35Y-01 TCGA-MR-A8JO-01A-12D-A35Z-10 TCGA-MR-A8JO-01 TCGA-MR-A8JO-01 B029C2F8-1F50-49BF-B2F1-84B6D973AE0E c43df6db-5556-449c-bbc6-a337873c588b TCGA-MR-A8JO-01 TCGA-MR-A8JO-01 c43df6db-5556-449c-bbc6-a337873c588b c43df6db-5556-449c-bbc6-a337873c588b c43df6db-5556-449c-bbc6-a337873c588b TCGA-MR-A8JO-01A-12D-A369-05 TCGA-NI-A4U2-01 TCGA-NI-A4U2-01 TCGA-NI-A4U2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 71 TCGA-NI-A4U2 TCGA-NI-A4U2-01A 3 0.8 -26011 2802 1791 0 0 5 1,2 - Portal Fibrosis 2013-6-28 MALE 171 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 320 NO G1 YES false No MX NX T3 Stage IIIA TCGA-NI-A4U2.3AC56788-7CF9-4E6E-B1B8-7620A33E32A0.pdf A4U2 WITH TUMOR 299 NO NO 1.0 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES NI Liver None A DECEASED 82 2005 TCGA-NI-A4U2-01A-11D-A28W-01 TCGA-NI-A4U2-01A-11D-A28W-01 TCGA-NI-A4U2-01A-11D-A28X-10 TCGA-NI-A4U2-01 TCGA-NI-A4U2-01 5CFD632E-6487-4356-AF69-2AB9F0CDA1A9 16336ca0-8d66-4a19-8a1a-3778aac6f291 TCGA-NI-A4U2-01A-11D-A28X-10 TCGA-NI-A4U2-01 TCGA-NI-A4U2-01 16336ca0-8d66-4a19-8a1a-3778aac6f291 TCGA-NI-A4U2-01A-11D-A28X-10 16336ca0-8d66-4a19-8a1a-3778aac6f291 16336ca0-8d66-4a19-8a1a-3778aac6f291 TCGA-NI-A4U2-01A-11D-A28X-10 TCGA-NI-A4U2-01A-11D-A28Y-05 TCGA-NI-A8LF-01 TCGA-NI-A8LF-01 TCGA-NI-A8LF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 74 1.2 TCGA-NI-A8LF-F69826 TCGA-NI-A8LF TCGA-NI-A8LF-01A 0.6 1 15 -27162 422 0 799 1 2015-1-21 MALE 171 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 NO NO G3 NO true No MX NX T1 Stage I TCGA-NI-A8LF.5B4751DF-719F-4F2B-8D27-D69E480F6881.pdf A8LF TUMOR FREE 132 NO NO NO YES R0 Primary Tumor 01 Other (specify) 7th NO YES NI Liver None A LIVING 104 2012 TCGA-NI-A8LF-01A-11D-A35Y-01 TCGA-NI-A8LF-01A-11D-A35Y-01 TCGA-NI-A8LF-01A-11D-A35Z-10 TCGA-NI-A8LF-01 TCGA-NI-A8LF-01 BFC51C69-BAF3-4872-A2F5-EDC4BC83FAF4 137c4106-77b9-4834-a060-6bf0af71ae08 TCGA-NI-A8LF-01 TCGA-NI-A8LF-01 137c4106-77b9-4834-a060-6bf0af71ae08 137c4106-77b9-4834-a060-6bf0af71ae08 137c4106-77b9-4834-a060-6bf0af71ae08 TCGA-NI-A8LF-01A-11D-A369-05 TCGA-O8-A75V-01 TCGA-O8-A75V-01 TCGA-O8-A75V TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 54 2.9 3.8 4.4 TCGA-O8-A75V-F66431 TCGA-O8-A75V TCGA-O8-A75V-01A 0.3 1.9 1 A 0.50 1.50 1 -19850 142 0 538 0 7 7 6 - Established Cirrhosis 2014-10-16 MALE 180 Alcohol consumption|Hepatitis B|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 270 9.3 13.1 NO NO G2 NO true No MX NX T1 Stage I TCGA-O8-A75V.F3642560-1DE2-43D1-A8B5-06308AFF325E.pdf A75V TUMOR FREE 211 140 450 NO NO 9.1 NO YES R1 Primary Tumor 01 Other (specify) 7th YES NO O8 1.2 Liver None A LIVING 92 2013 TCGA-O8-A75V-01A-11D-A32F-01 TCGA-O8-A75V-01A-11D-A32F-01 TCGA-O8-A75V-01A-11D-A32G-10 TCGA-O8-A75V-01 TCGA-O8-A75V-01 AB81048A-7344-493B-85D3-CDAC61D6D6AB a76c84d3-7243-465b-bbfe-087dbfba4b24 TCGA-O8-A75V-01A-11D-A32G-10 TCGA-O8-A75V-01 TCGA-O8-A75V-01 a76c84d3-7243-465b-bbfe-087dbfba4b24 TCGA-O8-A75V-01A-11D-A32G-10 a76c84d3-7243-465b-bbfe-087dbfba4b24 a76c84d3-7243-465b-bbfe-087dbfba4b24 TCGA-O8-A75V-01A-11D-A32G-10 TCGA-O8-A75V-01A-11D-A32R-05 TCGA-PD-A5DF-01 TCGA-PD-A5DF-01 TCGA-PD-A5DF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 58 TCGA-PD-A5DF TCGA-PD-A5DF-01A -21414 1906 639 0 2013-4-30 FEMALE 167 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 NO G2 NO true No M0 N0 T4 Stage IIIB TCGA-PD-A5DF.8D63D119-DC81-45FE-9F02-8228A7160C55.pdf A5DF WITH TUMOR NO YES NO YES Primary Tumor 01 6th NO YES PD Liver A DECEASED 72 2007 TCGA-PD-A5DF-01A-11D-A27H-01 TCGA-PD-A5DF-01A-11D-A27H-01 TCGA-PD-A5DF-01A-11D-A27I-10 TCGA-PD-A5DF-01 TCGA-PD-A5DF-01 0137FBC4-317A-4E7E-9D21-66DDB73097A7 41d56421-a998-43b9-b319-18535315c820 TCGA-PD-A5DF-01A-11D-A27I-10 TCGA-PD-A5DF-01 TCGA-PD-A5DF-01 41d56421-a998-43b9-b319-18535315c820 TCGA-PD-A5DF-01A-11D-A27I-10 41d56421-a998-43b9-b319-18535315c820 41d56421-a998-43b9-b319-18535315c820 TCGA-PD-A5DF-01A-11D-A27I-10 TCGA-PD-A5DF-01A-11D-A27W-05 TCGA-QA-A7B7-01 TCGA-QA-A7B7-01 TCGA-QA-A7B7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO Mild 48 3.5 4.2 4.8 TCGA-QA-A7B7-F65031 TCGA-QA-A7B7 0.3 1.0 A 0.7 1.2 1 -17636 0 94 88 1 0 8 1751 0 - No Fibrosis 2014-10-30 MALE 180 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 10.4 13.1 NO G2 Liver Locoregional Recurrence No NO YES No No MX NX T2 Stage II A7B7 WITH TUMOR 218 150 400 NO NO 11.5 NO NO RX Primary Tumor 01 Other (specify) 7th YES NO QA 1.2 Liver Micro LIVING 108 2013 TCGA-QA-A7B7-01A-11D-A32F-01 TCGA-QA-A7B7-01A-11D-A32F-01 TCGA-QA-A7B7-01A-11D-A32G-10 TCGA-QA-A7B7-01 TCGA-QA-A7B7-01 c30c0452-81d2-453d-91e2-2be1a07d02c7 TCGA-QA-A7B7-01A-11D-A32G-10 TCGA-QA-A7B7-01 TCGA-QA-A7B7-01 c30c0452-81d2-453d-91e2-2be1a07d02c7 TCGA-QA-A7B7-01A-11D-A32G-10 c30c0452-81d2-453d-91e2-2be1a07d02c7 c30c0452-81d2-453d-91e2-2be1a07d02c7 TCGA-QA-A7B7-01A-11D-A32G-10 TCGA-QA-A7B7-01A-11D-A32R-05 TCGA-RC-A6M3-01 TCGA-RC-A6M3-01 TCGA-RC-A6M3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 24 TCGA-RC-A6M3 -8899 0 0 2015-7-9 MALE 175 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES G3 No M0 N0 T2 Stage II A6M3 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES RC Liver Micro LIVING 2009 TCGA-RC-A6M3-01A-11D-A32F-01 TCGA-RC-A6M3-01A-11D-A32F-01 TCGA-RC-A6M3-01A-11D-A32G-10 TCGA-RC-A6M3-01 TCGA-RC-A6M3-01 e4fcb1f0-4637-49c4-ba32-3d037ccc25f2 TCGA-RC-A6M3-01A-11D-A32G-10 TCGA-RC-A6M3-01 TCGA-RC-A6M3-01 e4fcb1f0-4637-49c4-ba32-3d037ccc25f2 TCGA-RC-A6M3-01A-11D-A32G-10 e4fcb1f0-4637-49c4-ba32-3d037ccc25f2 e4fcb1f0-4637-49c4-ba32-3d037ccc25f2 TCGA-RC-A6M3-01A-11D-A32G-10 TCGA-RC-A6M3-01A-11D-A32R-05 TCGA-RC-A6M4-01 TCGA-RC-A6M4-01 TCGA-RC-A6M4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 74 3.5 2.3 4.8 TCGA-RC-A6M4 0.2 0.6 2 A 0.8 1.3 0.9 -27327 0 22 1 0 44 5 2015-7-9 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES G2 No MX NX T3 Stage IIIA A6M4 NO YES R1 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES RC 1.3 Liver None LIVING 87 2010 TCGA-RC-A6M4-01A-11D-A32F-01 TCGA-RC-A6M4-01A-11D-A32F-01 TCGA-RC-A6M4-01A-11D-A32G-10 TCGA-RC-A6M4-01 TCGA-RC-A6M4-01 e447c057-5e90-4fef-a916-6ab71092fcb5 TCGA-RC-A6M4-01A-11D-A32G-10 TCGA-RC-A6M4-01 TCGA-RC-A6M4-01 e447c057-5e90-4fef-a916-6ab71092fcb5 TCGA-RC-A6M4-01A-11D-A32G-10 e447c057-5e90-4fef-a916-6ab71092fcb5 e447c057-5e90-4fef-a916-6ab71092fcb5 TCGA-RC-A6M4-01A-11D-A32G-10 TCGA-RC-A6M4-01A-11D-A32R-05 TCGA-RC-A6M5-01 TCGA-RC-A6M5-01 TCGA-RC-A6M5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 20 3.5 3.9 4.8 TCGA-RC-A6M5 TCGA-RC-A6M5-01A 0.2 0.5 A 0.8 1.3 0.4 -7634 484 0 15 2015-7-9 FEMALE No History of Primary Risk Factors Fibrolamellar Carcinoma No C22.0 8171/3 C22.0 YES 50 0.9 1.2 NO G2 true No M0 N1 T1 Stage IVA TCGA-RC-A6M5.CFE4CEBF-2B23-4ABD-8F50-2B7C4A432AA6.pdf A6M5 317000 150000 400000 NO 1.2 NO R0 Primary Tumor 01 Lobectomy 7th NO YES RC 1.3 Liver None A LIVING 2012 TCGA-RC-A6M5-01A-11D-A32F-01 TCGA-RC-A6M5-01A-11D-A32F-01 TCGA-RC-A6M5-01A-11D-A32G-10 TCGA-RC-A6M5-01 TCGA-RC-A6M5-01 05246bfa-faf4-4d63-9890-88bb6f7a6546 TCGA-RC-A6M5-01A-11D-A32G-10 TCGA-RC-A6M5-01 TCGA-RC-A6M5-01 05246bfa-faf4-4d63-9890-88bb6f7a6546 TCGA-RC-A6M5-01A-11D-A32G-10 05246bfa-faf4-4d63-9890-88bb6f7a6546 05246bfa-faf4-4d63-9890-88bb6f7a6546 TCGA-RC-A6M5-01A-11D-A32G-10 TCGA-RC-A6M5-01A-11D-A32R-05 TCGA-RC-A6M6-01 TCGA-RC-A6M6-01 TCGA-RC-A6M6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 75 3.5 2.8 4.8 TCGA-RC-A6M6 TCGA-RC-A6M6-01A 0.2 2.3 B 0.8 1.3 0.8 -27649 748 0 9 0 44 12986 2015-7-9 MALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 0.9 1.2 NO G3 true No M0 NX T2 Stage II TCGA-RC-A6M6.210AAA2E-0B18-4C08-815D-BC523FF2A7D5.pdf A6M6 235000 150000 400000 NO 1.3 R1 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES RC 1.3 Liver None A LIVING 2011 TCGA-RC-A6M6-01A-11D-A32F-01 TCGA-RC-A6M6-01A-11D-A32F-01 TCGA-RC-A6M6-01A-11D-A32G-10 TCGA-RC-A6M6-01 TCGA-RC-A6M6-01 2D8C0C39-04E8-4B11-9CFE-E0650D8C090A 8cb97760-f404-486a-9957-f90d1026bc08 TCGA-RC-A6M6-01A-11D-A32G-10 TCGA-RC-A6M6-01 TCGA-RC-A6M6-01 8cb97760-f404-486a-9957-f90d1026bc08 TCGA-RC-A6M6-01A-11D-A32G-10 8cb97760-f404-486a-9957-f90d1026bc08 8cb97760-f404-486a-9957-f90d1026bc08 TCGA-RC-A6M6-01A-11D-A32G-10 TCGA-RC-A6M6-01A-11D-A32R-05 TCGA-RC-A7S9-01 TCGA-RC-A7S9-01 TCGA-RC-A7S9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 47 3.1 4.3 5.2 TCGA-RC-A7S9 TCGA-RC-A7S9-01A 0.1 0.8 A 0.3 1.20 0.7 -17403 383 0 640 0 0 20 10 6 - Established Cirrhosis 2014-7-21 FEMALE 161 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 0.8 1.30 NO G3 NO true No M0 N0 T1 Stage I TCGA-RC-A7S9.A537996A-E747-4906-B488-43181F3C7E17.pdf A7S9 TUMOR FREE 178000 150000 400000 NO NO 1.1 NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO RC 1.3 Liver None A LIVING 58 2012 TCGA-RC-A7S9-01A-11D-A33P-01 TCGA-RC-A7S9-01A-11D-A33P-01 TCGA-RC-A7S9-01A-11D-A33Q-10 TCGA-RC-A7S9-01 TCGA-RC-A7S9-01 811d94b6-2802-44ff-915f-7344886d93bb TCGA-RC-A7S9-01A-11D-A33Q-10 TCGA-RC-A7S9-01 TCGA-RC-A7S9-01 811d94b6-2802-44ff-915f-7344886d93bb TCGA-RC-A7S9-01A-11D-A33Q-10 811d94b6-2802-44ff-915f-7344886d93bb 811d94b6-2802-44ff-915f-7344886d93bb TCGA-RC-A7S9-01A-11D-A33Q-10 TCGA-RC-A7S9-01A-11D-A341-05 TCGA-RC-A7SB-01 TCGA-RC-A7SB-01 TCGA-RC-A7SB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 53 3.1 4.8 5.2 TCGA-RC-A7SB 0.1 3.7 B 0.3 1.20 1.1 -19698 0 588 0 0 20 3 0 - No Fibrosis 2014-7-21 MALE 166 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.30 G2 NO No M0 N0 T2 Stage II A7SB TUMOR FREE 196000 150000 400000 NO NO 1 NO R0 Primary Tumor 01 Lobectomy 7th YES NO RC 1.3 Liver None LIVING 61 2012 TCGA-RC-A7SB-01A-21D-A34Y-01 TCGA-RC-A7SB-01A-21D-A34Y-01 TCGA-RC-A7SB-01A-21D-A34Z-10 TCGA-RC-A7SB-01 TCGA-RC-A7SB-01 d1d1393b-5eda-4484-8254-a6bf11a19908 TCGA-RC-A7SB-01A-21D-A34Z-10 TCGA-RC-A7SB-01 TCGA-RC-A7SB-01 d1d1393b-5eda-4484-8254-a6bf11a19908 TCGA-RC-A7SB-01A-21D-A34Z-10 d1d1393b-5eda-4484-8254-a6bf11a19908 d1d1393b-5eda-4484-8254-a6bf11a19908 TCGA-RC-A7SB-01A-21D-A34Z-10 TCGA-RC-A7SB-01A-21D-A356-05 TCGA-RC-A7SF-01 TCGA-RC-A7SF-01 TCGA-RC-A7SF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 66 3.1 4.4 5.2 TCGA-RC-A7SF TCGA-RC-A7SF-01A 0.1 0.8 A 0.3 1.20 1.0 -24432 285 0 579 0 0 20 87 3,4 - Fibrous Speta 2014-7-21 MALE 170 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 0.8 1.30 NO G2 YES true No M0 N0 T1 Stage I TCGA-RC-A7SF.D4F398CC-0003-4C08-989F-3C60762B100F.pdf A7SF WITH TUMOR 209000 150000 400000 NO NO 0.9 NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO RC 1.3 Liver None A LIVING 76 2012 TCGA-RC-A7SF-01A-11D-A34Y-01 TCGA-RC-A7SF-01A-11D-A34Y-01 TCGA-RC-A7SF-01A-11D-A34Z-10 TCGA-RC-A7SF-01 TCGA-RC-A7SF-01 136abc20-19ec-4049-96f9-7fe8dcda7029 TCGA-RC-A7SF-01A-11D-A34Z-10 TCGA-RC-A7SF-01 TCGA-RC-A7SF-01 136abc20-19ec-4049-96f9-7fe8dcda7029 TCGA-RC-A7SF-01A-11D-A34Z-10 136abc20-19ec-4049-96f9-7fe8dcda7029 136abc20-19ec-4049-96f9-7fe8dcda7029 TCGA-RC-A7SF-01A-11D-A34Z-10 TCGA-RC-A7SF-01A-11D-A356-05 TCGA-RC-A7SH-01 TCGA-RC-A7SH-01 TCGA-RC-A7SH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 42 3.1 4.1 5.2 TCGA-RC-A7SH TCGA-RC-A7SH-01A 0.1 0.5 A 0.3 1.20 0.8 -15560 271 0 468 1 0 20 2466 3,4 - Fibrous Speta 2014-7-21 MALE 174 Hepatitis B Hepatocellular Carcinoma No C22.0 8174/3 C22.0 YES 10 0.8 1.30 NO G3 YES true No M0 N0 T2 Stage II TCGA-RC-A7SH.F862582D-03E2-41AB-85C8-B637C2573E74.pdf A7SH WITH TUMOR 225 150000 400000 NO NO 1.0 NO R0 Primary Tumor 01 Lobectomy 7th YES NO RC 1.3 Liver Micro A LIVING 68 2012 TCGA-RC-A7SH-01A-11D-A381-01 TCGA-RC-A7SH-01A-11D-A381-01 TCGA-RC-A7SH-01A-11D-A382-10 TCGA-RC-A7SH-01 TCGA-RC-A7SH-01 6bda7fe9-c8e8-4f79-8e4b-015ca56760b0 TCGA-RC-A7SH-01 TCGA-RC-A7SH-01 6bda7fe9-c8e8-4f79-8e4b-015ca56760b0 6bda7fe9-c8e8-4f79-8e4b-015ca56760b0 6bda7fe9-c8e8-4f79-8e4b-015ca56760b0 TCGA-RC-A7SH-01A-11D-A383-05 TCGA-RC-A7SK-01 TCGA-RC-A7SK-01 TCGA-RC-A7SK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 59 3.1 4.3 5.2 TCGA-RC-A7SK TCGA-RC-A7SK-01A 0.1 0.6 A 0.3 1.20 1 -21814 232 0 472 0 0 20 25 1,2 - Portal Fibrosis 2014-7-21 MALE 169 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 0.8 1.30 NO G3 YES true No M0 N0 T1 Stage I TCGA-RC-A7SK.5C08444C-DD26-44C1-BDF3-E6E581126F38.pdf A7SK TUMOR FREE 138000 150000 400000 NO NO 1 NO R0 Primary Tumor 01 Lobectomy 7th YES NO RC 1.3 Liver Micro A LIVING 60 2013 TCGA-RC-A7SK-01A-11D-A34Y-01 TCGA-RC-A7SK-01A-11D-A34Y-01 TCGA-RC-A7SK-01A-11D-A34Z-10 TCGA-RC-A7SK-01 TCGA-RC-A7SK-01 34982e2a-db69-4bc1-ac82-39ea181190d2 TCGA-RC-A7SK-01A-11D-A34Z-10 TCGA-RC-A7SK-01 TCGA-RC-A7SK-01 34982e2a-db69-4bc1-ac82-39ea181190d2 TCGA-RC-A7SK-01A-11D-A34Z-10 34982e2a-db69-4bc1-ac82-39ea181190d2 34982e2a-db69-4bc1-ac82-39ea181190d2 TCGA-RC-A7SK-01A-11D-A34Z-10 TCGA-RC-A7SK-01A-11D-A356-05 TCGA-RG-A7D4-01 TCGA-RG-A7D4-01 TCGA-RG-A7D4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 69 3 3 5 TCGA-RG-A7D4-F71159 TCGA-RG-A7D4 TCGA-RG-A7D4-01A 1 1 2 A 1 2 1 -25302 530 0 1098 0 9 5650 2015-3-19 MALE 172 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 1 2 NO NO G2 NO true No M0 N0 T2 Stage II TCGA-RG-A7D4.C8724B8E-5FC3-419B-9CC8-E6046D671D96.pdf A7D4 TUMOR FREE 175 150 400 NO NO 1 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO RG 2 Liver A Hepatitis C Antibody LIVING 87 2012 TCGA-RG-A7D4-01A-12D-A33P-01 TCGA-RG-A7D4-01A-12D-A33P-01 TCGA-RG-A7D4-01A-12D-A33Q-10 TCGA-RG-A7D4-01 TCGA-RG-A7D4-01 DFF361AE-94B2-4034-BFC1-B8BD4CE3A9A0 7796772d-d52f-4909-ae88-e961e827c962 TCGA-RG-A7D4-01A-12D-A33Q-10 TCGA-RG-A7D4-01 TCGA-RG-A7D4-01 7796772d-d52f-4909-ae88-e961e827c962 TCGA-RG-A7D4-01A-12D-A33Q-10 7796772d-d52f-4909-ae88-e961e827c962 7796772d-d52f-4909-ae88-e961e827c962 TCGA-RG-A7D4-01A-12D-A33Q-10 TCGA-RG-A7D4-01A-12D-A341-05 TCGA-T1-A6J8-01 TCGA-T1-A6J8-01 TCGA-T1-A6J8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 68 TCGA-T1-A6J8-F68334 TCGA-T1-A6J8 TCGA-T1-A6J8-01A -24853 77 0 23 2014-11-14 MALE 188 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 340 NO YES G2 true Yes M0 NX T1 TCGA-T1-A6J8.CEAA3A97-FE48-4408-9DCA-21D924287CAC.pdf A6J8 TUMOR FREE RX Primary Tumor 01 Segmentectomy, Multiple 7th NO YES T1 Liver None A LIVING 65 2013 TCGA-T1-A6J8-01A-11D-A32F-01 TCGA-T1-A6J8-01A-11D-A32F-01 TCGA-T1-A6J8-01A-11D-A32G-10 TCGA-T1-A6J8-01 6CF069EB-CE3B-4706-AC56-8E556CDCE42C 366c514e-877d-4aa6-bb14-610c8a93191b TCGA-T1-A6J8-01A-11D-A32G-10 TCGA-T1-A6J8-01 366c514e-877d-4aa6-bb14-610c8a93191b TCGA-T1-A6J8-01A-11D-A32G-10 366c514e-877d-4aa6-bb14-610c8a93191b 366c514e-877d-4aa6-bb14-610c8a93191b TCGA-T1-A6J8-01A-11D-A32G-10 TCGA-T1-A6J8-01A-11D-A32R-05 TCGA-UB-A7MA-01 TCGA-UB-A7MA-01 TCGA-UB-A7MA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 62 3.4 4.0 5.0 TCGA-UB-A7MA-F67133 TCGA-UB-A7MA TCGA-UB-A7MA-01A 0 1.2 A 0.4 0.90 0.7 -22843 109 0 848 478 0 0 8 2008 0 - No Fibrosis 2015-11-24 FEMALE 165 No History of Primary Risk Factors Hepatocholangiocarcinoma (Mixed) No C22.0 8180/3 C22.0 YES 500 0.9 1.2 NO NO G2 Liver Intrahepatic Recurrence No NO YES No true No M0 N0 T2b Stage II TCGA-UB-A7MA.82349CD5-39AA-42F8-80A1-B438B2300D09.pdf A7MA WITH TUMOR 600 140 450 NO YES 0.9 NO NO R1 Primary Tumor 01 Extended Lobectomy 7th YES NO UB 1.0 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody LIVING 85 2013 TCGA-UB-A7MA-01A-11D-A33P-01 TCGA-UB-A7MA-01A-11D-A33P-01 TCGA-UB-A7MA-01A-11D-A33Q-10 TCGA-UB-A7MA-01 TCGA-UB-A7MA-01 79D472C1-7A6A-4AAE-8252-CE0DA5ED5FDC a23fd611-d413-4ea7-9061-8caeba4b39ff TCGA-UB-A7MA-01A-11D-A33Q-10 TCGA-UB-A7MA-01 TCGA-UB-A7MA-01 a23fd611-d413-4ea7-9061-8caeba4b39ff TCGA-UB-A7MA-01A-11D-A33Q-10 a23fd611-d413-4ea7-9061-8caeba4b39ff a23fd611-d413-4ea7-9061-8caeba4b39ff TCGA-UB-A7MA-01A-11D-A33Q-10 TCGA-UB-A7MA-01A-11D-A341-05 TCGA-UB-A7MB-01 TCGA-UB-A7MB-01 TCGA-UB-A7MB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 24 3.5 3.1 4.8 TCGA-UB-A7MB-F67159 TCGA-UB-A7MB TCGA-UB-A7MB-01A 0.2 0.4 A 0.7 1.2 0.4 -8951 176 0 601 48 0 0 8 1865 0 - No Fibrosis 2014-10-31 MALE 180 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 0.9 1.2 NO NO G3 Liver Intrahepatic Recurrence Yes NO YES No true No MX NX T2 Stage II TCGA-UB-A7MB.8B239487-4D0E-45EF-84EB-F61B23C42FE7.pdf A7MB WITH TUMOR 583 140 450 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO UB 1.3 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody LIVING 62 2013 TCGA-UB-A7MB-01A-11D-A33P-01 TCGA-UB-A7MB-01A-11D-A33P-01 TCGA-UB-A7MB-01A-11D-A33Q-10 TCGA-UB-A7MB-01 TCGA-UB-A7MB-01 4E09D005-7D96-4F25-8386-F2E64E95B561 a18a49c7-e3e8-422a-b8e5-e5632604191a TCGA-UB-A7MB-01A-11D-A33Q-10 TCGA-UB-A7MB-01 TCGA-UB-A7MB-01 a18a49c7-e3e8-422a-b8e5-e5632604191a TCGA-UB-A7MB-01A-11D-A33Q-10 a18a49c7-e3e8-422a-b8e5-e5632604191a a18a49c7-e3e8-422a-b8e5-e5632604191a TCGA-UB-A7MB-01A-11D-A33Q-10 TCGA-UB-A7MB-01A-11D-A341-05 TCGA-UB-A7MC-01 TCGA-UB-A7MC-01 TCGA-UB-A7MC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES Mild 59 3.5 3.9 4.8 TCGA-UB-A7MC-F67161 TCGA-UB-A7MC TCGA-UB-A7MC-01A 0.2 1.5 A 0.7 1.2 0.7 -21733 88 0 500 359 0 0 8 126 1,2 - Portal Fibrosis 2014-10-31 MALE 176 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 540 0.9 1.2 NO NO G3 Other, specify Extrahepatic Recurrence Adrenal glands Yes NO YES No true No MX N0 T3a Stage IIIA TCGA-UB-A7MC.B391B6EA-425D-411D-AA4C-EE43B861E807.pdf A7MC WITH TUMOR 200 140 450 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO UB 1.3 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV D LIVING 78 2013 TCGA-UB-A7MC-01A-11D-A33P-01 TCGA-UB-A7MC-01A-11D-A33P-01 TCGA-UB-A7MC-01A-11D-A33Q-10 TCGA-UB-A7MC-01 TCGA-UB-A7MC-01 85185E12-7503-412A-BDE8-972CF9657638 86eb0a1e-45f3-4bc1-a2f8-6e369292b113 TCGA-UB-A7MC-01A-11D-A33Q-10 TCGA-UB-A7MC-01 TCGA-UB-A7MC-01 86eb0a1e-45f3-4bc1-a2f8-6e369292b113 TCGA-UB-A7MC-01A-11D-A33Q-10 86eb0a1e-45f3-4bc1-a2f8-6e369292b113 86eb0a1e-45f3-4bc1-a2f8-6e369292b113 TCGA-UB-A7MC-01A-11D-A33Q-10 TCGA-UB-A7MC-01A-11D-A341-05 TCGA-UB-A7MD-01 TCGA-UB-A7MD-01 TCGA-UB-A7MD TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 67 3.5 3.5 4.8 TCGA-UB-A7MD-F63729 TCGA-UB-A7MD TCGA-UB-A7MD-01A 0.2 0.8 A 0.7 1.2 1.0 -24717 128 52 0 0 0 8 23 6 - Established Cirrhosis 2014-8-15 MALE 175 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 0.9 1.2 NO NO G3 NO true No MX N0 T1 Stage I TCGA-UB-A7MD.DF3145A4-6311-4DCD-914F-3B3AABE4DAE7.pdf A7MD TUMOR FREE 201 140 450 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO UB 1.3 Liver Micro A Hepatitis C Antibody|Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen DECEASED 57 2013 TCGA-UB-A7MD-01A-12D-A34Y-01 TCGA-UB-A7MD-01A-12D-A34Y-01 TCGA-UB-A7MD-01A-12D-A34Z-10 TCGA-UB-A7MD-01 TCGA-UB-A7MD-01 3C88AF72-B1F7-4099-B99B-67ECD6F24E6C 8a1c649e-43ae-4024-83d5-7ec8da50667f TCGA-UB-A7MD-01A-12D-A34Z-10 TCGA-UB-A7MD-01 TCGA-UB-A7MD-01 8a1c649e-43ae-4024-83d5-7ec8da50667f TCGA-UB-A7MD-01A-12D-A34Z-10 8a1c649e-43ae-4024-83d5-7ec8da50667f 8a1c649e-43ae-4024-83d5-7ec8da50667f TCGA-UB-A7MD-01A-12D-A34Z-10 TCGA-UB-A7MD-01A-12D-A356-05 TCGA-UB-A7ME-01 TCGA-UB-A7ME-01 TCGA-UB-A7ME TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 51 3.5 4.2 4.8 TCGA-UB-A7ME-F67165 TCGA-UB-A7ME 0.2 0.6 B 0.7 1.2 1.1 -18846 0 486 0 0 8 1388 1,2 - Portal Fibrosis 2014-10-31 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.2 NO G2 NO No MX NX T1 Stage I A7ME TUMOR FREE 181 140 450 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO UB 1.3 Liver None Hepatitis B Surface Antigen|HBV Core Antibody|HBV D LIVING 75 2013 TCGA-UB-A7ME-01A-11D-A33B-01 TCGA-UB-A7ME-01A-11D-A33B-01 TCGA-UB-A7ME-01A-11D-A33K-10 TCGA-UB-A7ME-01 TCGA-UB-A7ME-01 c9e807fc-4988-461d-a918-bff25f639bac TCGA-UB-A7ME-01A-11D-A33K-10 TCGA-UB-A7ME-01 TCGA-UB-A7ME-01 c9e807fc-4988-461d-a918-bff25f639bac TCGA-UB-A7ME-01A-11D-A33K-10 c9e807fc-4988-461d-a918-bff25f639bac c9e807fc-4988-461d-a918-bff25f639bac TCGA-UB-A7ME-01A-11D-A33K-10 TCGA-UB-A7ME-01A-11D-A33L-05 TCGA-UB-A7MF-01 TCGA-UB-A7MF-01 TCGA-UB-A7MF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 56 3.5 3.6 4.8 TCGA-UB-A7MF TCGA-UB-A7MF-01A 0.2 1.1 1 A 0.7 1.2 0.9 -20815 240 214 0 0 8 2505 6 - Established Cirrhosis 2014-8-16 MALE 195 Hepatitis B|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 380 0.9 1.2 NO G2 YES true Yes MX NX T3a Stage IIIA TCGA-UB-A7MF.7A3E5345-5272-4D82-8E97-40CCE9BAF330.pdf A7MF WITH TUMOR 130 140 450 NO NO 1.0 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO UB 1.3 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody|HBV D DECEASED 95 2013 TCGA-UB-A7MF-01A-11D-A33B-01 TCGA-UB-A7MF-01A-11D-A33B-01 TCGA-UB-A7MF-01A-11D-A33K-10 TCGA-UB-A7MF-01 TCGA-UB-A7MF-01 98F4D8EA-6240-4134-A6C1-6E1D60DDF427 0fd5e345-f535-42ef-9cf5-0db512d2ad73 TCGA-UB-A7MF-01A-11D-A33K-10 TCGA-UB-A7MF-01 TCGA-UB-A7MF-01 0fd5e345-f535-42ef-9cf5-0db512d2ad73 TCGA-UB-A7MF-01A-11D-A33K-10 0fd5e345-f535-42ef-9cf5-0db512d2ad73 0fd5e345-f535-42ef-9cf5-0db512d2ad73 TCGA-UB-A7MF-01A-11D-A33K-10 TCGA-UB-A7MF-01A-11D-A33L-05 TCGA-UB-AA0U-01 TCGA-UB-AA0U-01 TCGA-UB-AA0U TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES Mild 60 3.5 3.9 4.8 TCGA-UB-AA0U-F67166 TCGA-UB-AA0U TCGA-UB-AA0U-01A 0.2 0.7 2 A 0.7 1.2 0.6 -21985 18 0 327 106 0 0 8 26 0 - No Fibrosis 2014-10-31 MALE 178 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 730 0.9 1.2 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No MX NX T2 Stage II TCGA-UB-AA0U.00C0CD33-615E-47A6-8CEF-EE3A67F277D3.pdf AA0U TUMOR FREE 227 140 450 NO NO 1.1 NO YES R1 Primary Tumor 01 Segmentectomy, Single 7th YES NO UB 1.3 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody LIVING 93 2013 TCGA-UB-AA0U-01A-11D-A381-01 TCGA-UB-AA0U-01A-11D-A381-01 TCGA-UB-AA0U-01A-11D-A382-10 TCGA-UB-AA0U-01 TCGA-UB-AA0U-01 5055524c-95b9-40d3-a373-401ce12ec223 TCGA-UB-AA0U-01 TCGA-UB-AA0U-01 5055524c-95b9-40d3-a373-401ce12ec223 5055524c-95b9-40d3-a373-401ce12ec223 5055524c-95b9-40d3-a373-401ce12ec223 TCGA-UB-AA0U-01A-11D-A383-05 TCGA-UB-AA0V-01 TCGA-UB-AA0V-01 TCGA-UB-AA0V TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 69 3.5 3.8 4.8 TCGA-UB-AA0V-F67169 TCGA-UB-AA0V TCGA-UB-AA0V-01A 0.2 1.0 1 A 0.5 1.0 0.7 -25340 7 0 314 0 0 8 3 0 - No Fibrosis 2014-10-31 FEMALE 175 Hemochromatosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 0.9 1.2 NO NO G1 NO true Yes MX NX [Discrepancy] Stage I TCGA-UB-AA0V.0BEA5A64-9DDE-45A8-A788-5EE2CEC6F6E4.pdf AA0V TUMOR FREE 273 140 450 NO NO 0.9 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO UB 1.3 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody LIVING 57 2013 TCGA-UB-AA0V-01A-11D-A381-01 TCGA-UB-AA0V-01A-11D-A381-01 TCGA-UB-AA0V-01A-11D-A382-10 TCGA-UB-AA0V-01 TCGA-UB-AA0V-01 9e1bd81b-74bb-4909-ba0d-1e6bdf98b066 TCGA-UB-AA0V-01 TCGA-UB-AA0V-01 9e1bd81b-74bb-4909-ba0d-1e6bdf98b066 9e1bd81b-74bb-4909-ba0d-1e6bdf98b066 9e1bd81b-74bb-4909-ba0d-1e6bdf98b066 TCGA-UB-AA0V-01A-11D-A383-05 TCGA-WJ-A86L-01 TCGA-WJ-A86L-01 TCGA-WJ-A86L TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 68 3.4 4.2 4.8 TCGA-WJ-A86L-F65568 TCGA-WJ-A86L TCGA-WJ-A86L-01A 0.1 0.5 A 0.5 1.1 0.9 -25018 95 0 345 1 6 16 0 - No Fibrosis 2014-9-26 FEMALE 159 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8310/3 C22.0 YES 270 2.0 3.0 NO NO G2 NO false No MX NX T1 Stage I TCGA-WJ-A86L.2C93F65E-88FD-405F-86F1-0E35C7F46DC2.pdf A86L TUMOR FREE 257000 125000 415000 NO NO 0.9 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO WJ 1.2 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody LIVING 56 2013 TCGA-WJ-A86L-01A-12D-A38W-01 TCGA-WJ-A86L-01A-12D-A38W-01 TCGA-WJ-A86L-01A-12D-A45V-10 TCGA-WJ-A86L-01 TCGA-WJ-A86L-01 24863244-1cee-4da9-b730-742a0269ee58 TCGA-WJ-A86L-01 TCGA-WJ-A86L-01 24863244-1cee-4da9-b730-742a0269ee58 24863244-1cee-4da9-b730-742a0269ee58 24863244-1cee-4da9-b730-742a0269ee58 TCGA-WJ-A86L-01A-12D-A39G-05 TCGA-WQ-A9G7-01 TCGA-WQ-A9G7-01 TCGA-WQ-A9G7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 71 3.5 3.5 5 TCGA-WQ-A9G7-F66632 TCGA-WQ-A9G7 TCGA-WQ-A9G7-01A 0.3 0.7 0.4 1 0.4 165 0 30 2014-10-21 FEMALE 157 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 0.8 1.2 NO NO G3 NO false No M0 NX T3a TCGA-WQ-A9G7.211B2C4B-7DEB-4031-A3D2-5464A7386245.pdf A9G7 TUMOR FREE 266 150 400 NO NO 1.3 NO NO R0 Primary Tumor 01 Other (specify) 7th NO YES WQ 1.2 Liver None A LIVING 69 2013 TCGA-WQ-A9G7-01A-11D-A36W-01 TCGA-WQ-A9G7-01A-11D-A36W-01 TCGA-WQ-A9G7-01A-11D-A36X-10 TCGA-WQ-A9G7-01 TCGA-WQ-A9G7-01 0EF14962-BDC1-4ECB-9947-3E8A600899EA a27a9d35-4804-4b24-8889-4128e4434487 TCGA-WQ-A9G7-01 TCGA-WQ-A9G7-01 a27a9d35-4804-4b24-8889-4128e4434487 a27a9d35-4804-4b24-8889-4128e4434487 a27a9d35-4804-4b24-8889-4128e4434487 TCGA-WQ-A9G7-01A-11D-A36Y-05 TCGA-WQ-AB4B-01 TCGA-WQ-AB4B-01 TCGA-WQ-AB4B TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 62 3.5 3.3 5 TCGA-WQ-AB4B-F66633 TCGA-WQ-AB4B 0.3 1.7 A 0.4 1.2 1.1 -22769 0 395 273 0 15 5 2014-10-21 MALE 175 Alcohol consumption|Non-Alcoholic Fatty Liver Disease|Other Hepatic Encephalopathy Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.2 NO G2 Intrahepatic Recurrence No YES No No M0 NX T2 Stage II AB4B WITH TUMOR NO NO 1.3 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES WQ 1.2 Liver Micro LIVING 122 2013 TCGA-WQ-AB4B-01A-11D-A40O-01 TCGA-WQ-AB4B-01A-11D-A40O-01 TCGA-WQ-AB4B-01A-11D-A40P-10 TCGA-WQ-AB4B-01 TCGA-WQ-AB4B-01 a2dee72c-85ab-44fc-b37f-bb8c82ced8a2 TCGA-WQ-AB4B-01 TCGA-WQ-AB4B-01 a2dee72c-85ab-44fc-b37f-bb8c82ced8a2 a2dee72c-85ab-44fc-b37f-bb8c82ced8a2 a2dee72c-85ab-44fc-b37f-bb8c82ced8a2 TCGA-WQ-AB4B-01A-11D-A40X-05 TCGA-WX-AA44-01 TCGA-WX-AA44-01 TCGA-WX-AA44 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 64 3.5 4.4 5.0 TCGA-WX-AA44-F68251 TCGA-WX-AA44 TCGA-WX-AA44-01A 0 0.5 A 0.5 1.2 0.6 -23654 924 0 615 1 0 6 48 6 - Established Cirrhosis 2014-11-14 FEMALE 152 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 90 0.9 1.2 NO YES G3 YES true No MX NX T1 Stage I TCGA-WX-AA44.759F0B44-92DC-4E47-BA10-7B19C4272485.pdf AA44 WITH TUMOR 215 150 350 YES YES 0.9 YES NO RX Primary Tumor 01 Other (specify) 7th YES NO WX 1.20 Liver None A Hepatitis C Antibody LIVING 61 2011 TCGA-WX-AA44-01A-11D-A38W-01 TCGA-WX-AA44-01A-11D-A38W-01 TCGA-WX-AA44-01A-11D-A38X-10 TCGA-WX-AA44-01 TCGA-WX-AA44-01 8f0b105f-e2de-4433-bd6a-dd81cb6c0c93 TCGA-WX-AA44-01 TCGA-WX-AA44-01 8f0b105f-e2de-4433-bd6a-dd81cb6c0c93 8f0b105f-e2de-4433-bd6a-dd81cb6c0c93 8f0b105f-e2de-4433-bd6a-dd81cb6c0c93 TCGA-WX-AA44-01A-11D-A39G-05 TCGA-WX-AA46-01 TCGA-WX-AA46-01 TCGA-WX-AA46 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 61 3.5 4.6 5.0 TCGA-WX-AA46-F68250 TCGA-WX-AA46 TCGA-WX-AA46-01A 0 1.3 3 A 0.5 1.2 1.2 -22639 456 0 756 0 0 6 1 0 - No Fibrosis 2014-11-14 MALE 156 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 0.8 1.1 NO NO G1 NO true No MX NX T2 Stage II TCGA-WX-AA46.A767B73F-5C51-47E8-A569-E112DBB987FF.pdf AA46 TUMOR FREE 205 150 350 NO NO 1.0 NO YES R0 Primary Tumor 01 Other (specify) 7th NO YES WX 1.2 Liver Macro A Hepatitis C Antibody LIVING 75 2012 TCGA-WX-AA46-01A-11D-A38W-01 TCGA-WX-AA46-01A-11D-A38W-01 TCGA-WX-AA46-01A-11D-A38X-10 TCGA-WX-AA46-01 TCGA-WX-AA46-01 1c666252-0438-4c4d-bbb8-99a06b90ab76 TCGA-WX-AA46-01 TCGA-WX-AA46-01 1c666252-0438-4c4d-bbb8-99a06b90ab76 1c666252-0438-4c4d-bbb8-99a06b90ab76 1c666252-0438-4c4d-bbb8-99a06b90ab76 TCGA-WX-AA46-01A-11D-A39G-05 TCGA-WX-AA47-01 TCGA-WX-AA47-01 TCGA-WX-AA47 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 33 3.5 2.8 5.0 TCGA-WX-AA47 TCGA-WX-AA47-01A 0.2 A 0.5 1.2 0.6 -12056 626 556 0 2 0 6 1 0 - No Fibrosis 2014-6-10 FEMALE 168 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 60 0.8 1.1 NO G2 YES true No MX NX T3a Stage IIIA TCGA-WX-AA47.473868C8-CFDF-42E6-B6DC-48A737697D07.pdf AA47 WITH TUMOR 423 150 350 NO YES 0.9 YES NO R0 Primary Tumor 01 Lobectomy 7th NO YES WX 1.2 Liver Macro A Hepatitis C Antibody DECEASED 63 2012 TCGA-WX-AA47-01A-11D-A38W-01 TCGA-WX-AA47-01A-11D-A38W-01 TCGA-WX-AA47-01A-11D-A38X-10 TCGA-WX-AA47-01 TCGA-WX-AA47-01 676d126f-b0c7-4c79-b4b6-852207b31437 TCGA-WX-AA47-01 TCGA-WX-AA47-01 676d126f-b0c7-4c79-b4b6-852207b31437 676d126f-b0c7-4c79-b4b6-852207b31437 676d126f-b0c7-4c79-b4b6-852207b31437 TCGA-WX-AA47-01A-11D-A39G-05 TCGA-XR-A8TC-01 TCGA-XR-A8TC-01 TCGA-XR-A8TC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 43 3.5 3.9 4.8 TCGA-XR-A8TC-F72317 TCGA-XR-A8TC TCGA-XR-A8TC-01A 0.2 0.2 A 0.7 1.5 0.7 -15817 908 0 1339 0 6 6 47 6 - Established Cirrhosis 2015-5-20 FEMALE 155 Hepatitis B Hepatocellular Carcinoma Yes C22.0 8170/3 C22.0 YES 110 1.3 1.3 NO NO G2 NO true Yes MX NX T1 Stage I TCGA-XR-A8TC.681B14A0-98E6-4F74-89B0-3DFB3A97C0E1.pdf A8TC WITH TUMOR 318000 150000 450000 YES NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES XR 1.2 Liver None A LIVING 52 2011 TCGA-XR-A8TC-01A-11D-A35Z-10 TCGA-XR-A8TC-01 TCGA-XR-A8TC-01 81166064-A9F8-462A-9563-F72A39C24E59 7e61e7f1-2c5e-45e4-a0cc-b0ab27c29bc3 TCGA-XR-A8TC-01 7e61e7f1-2c5e-45e4-a0cc-b0ab27c29bc3 7e61e7f1-2c5e-45e4-a0cc-b0ab27c29bc3 7e61e7f1-2c5e-45e4-a0cc-b0ab27c29bc3 TCGA-XR-A8TC-01A-11D-A369-05 TCGA-XR-A8TD-01 TCGA-XR-A8TD-01 TCGA-XR-A8TD TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 49 3.5 3.8 4.8 TCGA-XR-A8TD-F72319 TCGA-XR-A8TD 0.2 0.7 A 0.7 1.5 0.5 -17908 0 1030 1 6 6 188 0 - No Fibrosis 2015-5-20 FEMALE 156 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8174/3 C22.0 YES 0 1.3 NO G3 No NO NO No No M0 N0 T3 Stage IIIB A8TD TUMOR FREE 334000 150000 450000 NO NO 1.1 NO R0 Primary Tumor 01 Extended Lobectomy 7th NO YES XR 1.2 Liver None LIVING 69 2012 TCGA-XR-A8TD-01A-12D-A38W-01 TCGA-XR-A8TD-01A-12D-A38W-01 TCGA-XR-A8TD-01A-12D-A38X-10 TCGA-XR-A8TD-01 TCGA-XR-A8TD-01 ed43b946-0700-4e19-8a04-d2a5720a7cdb TCGA-XR-A8TD-01 TCGA-XR-A8TD-01 ed43b946-0700-4e19-8a04-d2a5720a7cdb ed43b946-0700-4e19-8a04-d2a5720a7cdb ed43b946-0700-4e19-8a04-d2a5720a7cdb TCGA-XR-A8TD-01A-12D-A39G-05 TCGA-XR-A8TE-01 TCGA-XR-A8TE-01 TCGA-XR-A8TE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 16 3.2 3.9 4.5 TCGA-XR-A8TE-F72321 TCGA-XR-A8TE 0.7 1.5 0.4 -5862 0 925 244 210 0 6 6 809 0 - No Fibrosis 2015-5-20 MALE 157 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.3 1.3 NO G1 Liver Intrahepatic Recurrence No YES YES No No MX N0 T3 Stage IIIA A8TE WITH TUMOR 206000 150000 450000 NO YES 1.0 NO NO R0 R0 Primary Tumor 01 Extended Lobectomy 7th NO YES XR Liver None LIVING 43 2012 TCGA-XR-A8TE-01A-11D-A35Y-01 TCGA-XR-A8TE-01A-11D-A35Y-01 TCGA-XR-A8TE-01A-11D-A35Z-10 TCGA-XR-A8TE-01 TCGA-XR-A8TE-01 b9ddaaef-028b-4db4-ad31-e70931bd8e44 TCGA-XR-A8TE-01 TCGA-XR-A8TE-01 b9ddaaef-028b-4db4-ad31-e70931bd8e44 b9ddaaef-028b-4db4-ad31-e70931bd8e44 b9ddaaef-028b-4db4-ad31-e70931bd8e44 TCGA-XR-A8TE-01A-11D-A369-05 TCGA-XR-A8TF-01 TCGA-XR-A8TF-01 TCGA-XR-A8TF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 74 3.5 3.9 4.8 TCGA-XR-A8TF-F72323 TCGA-XR-A8TF TCGA-XR-A8TF-01A 0.2 0.8 A 0.7 1.5 0.8 -27145 481 693 0 271 231 0 6 6 39 3,4 - Fibrous Speta 2015-5-20 MALE 166 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 0 1.3 NO NO G1 Liver Intrahepatic Recurrence No YES YES No true No MX NX T1 Stage I TCGA-XR-A8TF.A0557F82-3ACC-43E5-9ED3-902BEDD36939.pdf A8TF TUMOR FREE 194000 150000 450000 NO NO 1.1 NO NO R1 R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES XR 1.2 Liver None A DECEASED 57 2012 TCGA-XR-A8TF-01A-11D-A35Y-01 TCGA-XR-A8TF-01A-11D-A35Y-01 TCGA-XR-A8TF-01A-11D-A35Z-10 TCGA-XR-A8TF-01 TCGA-XR-A8TF-01 B132756A-0CF8-4DFB-B839-AF3E192AC614 1f676139-c73f-49d7-95c1-f5f955a27669 TCGA-XR-A8TF-01 TCGA-XR-A8TF-01 1f676139-c73f-49d7-95c1-f5f955a27669 1f676139-c73f-49d7-95c1-f5f955a27669 1f676139-c73f-49d7-95c1-f5f955a27669 TCGA-XR-A8TF-01A-11D-A369-05 TCGA-XR-A8TG-01 TCGA-XR-A8TG-01 TCGA-XR-A8TG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 58 3.5 4.3 4.8 TCGA-XR-A8TG-F72325 TCGA-XR-A8TG TCGA-XR-A8TG-01A 0.2 0.5 2 0.7 1.5 0.9 -21544 439 0 898 350 0 6 6 1 6 - Established Cirrhosis 2015-5-20 MALE 184 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 0 1.5 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES Yes true Yes M0 NX T1 Stage I TCGA-XR-A8TG.B6CBB321-E73F-4A24-8557-E10E94B2B8C6.pdf A8TG TUMOR FREE 80000 150000 450000 YES NO 1.1 YES YES R0 R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES XR 1.2 Liver None A LIVING 71 2012 TCGA-XR-A8TG-01A-11D-A35Y-01 TCGA-XR-A8TG-01A-11D-A35Y-01 TCGA-XR-A8TG-01A-11D-A35Z-10 TCGA-XR-A8TG-01 TCGA-XR-A8TG-01 7cbc59c1-c767-4b50-a6fe-fc3e3365b5cf TCGA-XR-A8TG-01 TCGA-XR-A8TG-01 7cbc59c1-c767-4b50-a6fe-fc3e3365b5cf 7cbc59c1-c767-4b50-a6fe-fc3e3365b5cf 7cbc59c1-c767-4b50-a6fe-fc3e3365b5cf TCGA-XR-A8TG-01A-11D-A369-05 TCGA-YA-A8S7-01 TCGA-YA-A8S7-01 TCGA-YA-A8S7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 68 3.5 2.1 5.0 TCGA-YA-A8S7 TCGA-YA-A8S7-01A 0.2 3.8 0.60 1.3 0.7 -25188 383 412 0 8 56 2014-4-8 MALE 164 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 0.9 1.2 NO G3 YES false No MX N0 T3a Stage IIIA TCGA-YA-A8S7.CFF98B7F-C09E-441D-BE5F-48A06036735B.pdf A8S7 WITH TUMOR NO YES 1.2 NO NO R0 Primary Tumor 01 Other (specify) 7th NO YES YA 1.0 Liver None A DECEASED 73 2012 TCGA-YA-A8S7-01A-11D-A36W-01 TCGA-YA-A8S7-01A-11D-A36W-01 TCGA-YA-A8S7-01A-11D-A36X-10 TCGA-YA-A8S7-01 TCGA-YA-A8S7-01 F2A3D58A-4976-4B4B-A693-39EC9D7641AB 8f1e9042-ffcf-44b4-9854-7f7be7e92f24 TCGA-YA-A8S7-01 TCGA-YA-A8S7-01 8f1e9042-ffcf-44b4-9854-7f7be7e92f24 8f1e9042-ffcf-44b4-9854-7f7be7e92f24 8f1e9042-ffcf-44b4-9854-7f7be7e92f24 TCGA-YA-A8S7-01A-11D-A36Y-05 TCGA-ZP-A9CV-01 TCGA-ZP-A9CV-01 TCGA-ZP-A9CV TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Severe 59 3.5 4 5.7 TCGA-ZP-A9CV-F57756 TCGA-ZP-A9CV TCGA-ZP-A9CV-01A 0.2 0.5 A 0.7 1.3 0.8 -21633 955 1088 0 142 1 0 8 48 2014-3-28 MALE 173 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 NO NO G1 NO false No MX NX T1 TCGA-ZP-A9CV.382219F6-24AD-49BD-96D1-FC7A9B2CDFDB.pdf A9CV WITH TUMOR 114000 163000 369000 NO NO NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES ZP 1.0 Liver None A DECEASED 59 2011 TCGA-ZP-A9CV-01A-11D-A381-01 TCGA-ZP-A9CV-01A-11D-A381-01 TCGA-ZP-A9CV-01A-11D-A382-10 TCGA-ZP-A9CV-01 TCGA-ZP-A9CV-01 86f6c86d-d218-4721-86fd-1dd70ee454eb TCGA-ZP-A9CV-01 TCGA-ZP-A9CV-01 86f6c86d-d218-4721-86fd-1dd70ee454eb 86f6c86d-d218-4721-86fd-1dd70ee454eb 86f6c86d-d218-4721-86fd-1dd70ee454eb TCGA-ZP-A9CV-01A-11D-A383-05 TCGA-ZP-A9CY-01 TCGA-ZP-A9CY-01 TCGA-ZP-A9CY TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 66 3.5 3.9 5.2 TCGA-ZP-A9CY-F57752 TCGA-ZP-A9CY 0.2 0.9 1 A -24223 0 782 1 6 - Established Cirrhosis 2014-3-28 FEMALE 152 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 9.6 12.6 NO G1 NO No MX NX T1 A9CY TUMOR FREE 93000 163000 369000 NO NO 11 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES ZP 1.2 Liver None LIVING 83 2011 TCGA-ZP-A9CY-01A-11D-A381-01 TCGA-ZP-A9CY-01A-11D-A381-01 TCGA-ZP-A9CY-01A-11D-A382-10 TCGA-ZP-A9CY-01 TCGA-ZP-A9CY-01 f3490052-6688-4279-9d92-0aca9fe94382 TCGA-ZP-A9CY-01 TCGA-ZP-A9CY-01 f3490052-6688-4279-9d92-0aca9fe94382 f3490052-6688-4279-9d92-0aca9fe94382 f3490052-6688-4279-9d92-0aca9fe94382 TCGA-ZP-A9CY-01A-11D-A383-05 TCGA-ZP-A9CZ-01 TCGA-ZP-A9CZ-01 TCGA-ZP-A9CZ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 72 3.5 4.4 5.2 TCGA-ZP-A9CZ-F57754 TCGA-ZP-A9CZ TCGA-ZP-A9CZ-01A 0.2 0.5 2 A -26403 797 0 706 0 0 8 8 3,4 - Fibrous Speta 2014-3-28 MALE 167 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 50 9.6 12.6 NO NO G1 NO false No MX NX T1 TCGA-ZP-A9CZ.C3F4669C-9E5D-4A46-84A8-E78BF2D5EA92.pdf A9CZ TUMOR FREE NO NO 11.5 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES ZP 1.2 Liver None A Hepatitis B Surface Antigen LIVING 73 2011 TCGA-ZP-A9CZ-01A-11D-A381-01 TCGA-ZP-A9CZ-01A-11D-A381-01 TCGA-ZP-A9CZ-01A-11D-A382-10 TCGA-ZP-A9CZ-01 TCGA-ZP-A9CZ-01 7d467df3-8ea8-4979-a609-775baef7a680 TCGA-ZP-A9CZ-01 TCGA-ZP-A9CZ-01 7d467df3-8ea8-4979-a609-775baef7a680 7d467df3-8ea8-4979-a609-775baef7a680 7d467df3-8ea8-4979-a609-775baef7a680 TCGA-ZP-A9CZ-01A-11D-A383-05 TCGA-ZP-A9D0-01 TCGA-ZP-A9D0-01 TCGA-ZP-A9D0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 67 3.5 4.1 5.2 TCGA-ZP-A9D0-F69077 TCGA-ZP-A9D0 TCGA-ZP-A9D0-01A 0.2 1.4 A 0.5 1.1 0.9 -24525 723 0 1091 0 0 - No Fibrosis 2014-12-29 FEMALE 165 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 9.6 12.6 NO NO G1 NO false No MX NX T1 TCGA-ZP-A9D0.38325470-AA90-4CA4-A8C0-8BF1A9D595F9.pdf A9D0 TUMOR FREE 185000 163000 369000 NO NO 11 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES ZP 1.2 Liver None A LIVING 78 2011 TCGA-ZP-A9D0-01A-11D-A36W-01 TCGA-ZP-A9D0-01A-11D-A36W-01 TCGA-ZP-A9D0-01A-11D-A36X-10 TCGA-ZP-A9D0-01 TCGA-ZP-A9D0-01 78a9c934-1a9a-42a4-95ba-c99565afccd0 TCGA-ZP-A9D0-01 TCGA-ZP-A9D0-01 78a9c934-1a9a-42a4-95ba-c99565afccd0 78a9c934-1a9a-42a4-95ba-c99565afccd0 78a9c934-1a9a-42a4-95ba-c99565afccd0 TCGA-ZP-A9D0-01A-11D-A36Y-05 TCGA-ZP-A9D1-01 TCGA-ZP-A9D1-01 TCGA-ZP-A9D1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 56 TCGA-ZP-A9D1-F57746 TCGA-ZP-A9D1 TCGA-ZP-A9D1-01A 1 A -20584 699 0 21 0 0 8 8 5 - Nodular Formation and Incomplete Cirrhosis 2014-3-28 FEMALE 170 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 9.6 12.6 NO NO G2 NO false Yes MX NX T1 TCGA-ZP-A9D1.2FA60C52-0164-432D-BB08-A8638AAF2C2F.pdf A9D1 TUMOR FREE NO NO 12 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES ZP Liver None A LIVING 130 2012 TCGA-ZP-A9D1-01A-11D-A381-01 TCGA-ZP-A9D1-01A-11D-A381-01 TCGA-ZP-A9D1-01A-11D-A382-10 TCGA-ZP-A9D1-01 TCGA-ZP-A9D1-01 8a5804cb-d45f-4a6c-b7a0-af505b4b4237 TCGA-ZP-A9D1-01 TCGA-ZP-A9D1-01 8a5804cb-d45f-4a6c-b7a0-af505b4b4237 8a5804cb-d45f-4a6c-b7a0-af505b4b4237 8a5804cb-d45f-4a6c-b7a0-af505b4b4237 TCGA-ZP-A9D1-01A-11D-A383-05 TCGA-ZP-A9D2-01 TCGA-ZP-A9D2-01 TCGA-ZP-A9D2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 51 TCGA-ZP-A9D2-F57748 TCGA-ZP-A9D2 TCGA-ZP-A9D2-01A 1 A -18717 654 765 0 743 315 0 1,2 - Portal Fibrosis 2015-1-16 MALE 172 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 60 NO NO G2 Liver Intrahepatic Recurrence Yes NO NO No false No MX NX T2 TCGA-ZP-A9D2.260D67D7-9E8C-4A3B-B031-8AB4A05BC688.pdf A9D2 WITH TUMOR YES NO NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES ZP Liver Micro A Hepatitis C Virus R DECEASED 74 2012 TCGA-ZP-A9D2-01A-11D-A381-01 TCGA-ZP-A9D2-01A-11D-A381-01 TCGA-ZP-A9D2-01A-11D-A382-10 TCGA-ZP-A9D2-01 TCGA-ZP-A9D2-01 159b00ee-9db8-4de9-bd94-16e65b917502 TCGA-ZP-A9D2-01 TCGA-ZP-A9D2-01 159b00ee-9db8-4de9-bd94-16e65b917502 159b00ee-9db8-4de9-bd94-16e65b917502 159b00ee-9db8-4de9-bd94-16e65b917502 TCGA-ZP-A9D2-01A-11D-A383-05 TCGA-ZP-A9D4-01 TCGA-ZP-A9D4-01 TCGA-ZP-A9D4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 64 3.5 4.3 5.2 TCGA-ZP-A9D4-F57750 TCGA-ZP-A9D4 0.2 0.4 A 0.5 1.1 0.6 -23656 0 395 0 0 8 2 0 - No Fibrosis 2014-3-28 FEMALE 155 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G1 NO No MX NX T1 A9D4 TUMOR FREE 292000 163000 369000 NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES ZP 1.2 Liver None LIVING 55 2012 TCGA-ZP-A9D4-01A-11D-A36W-01 TCGA-ZP-A9D4-01A-11D-A36W-01 TCGA-ZP-A9D4-01A-11D-A36X-10 TCGA-ZP-A9D4-01 TCGA-ZP-A9D4-01 da0eec5b-54d6-421c-b850-c7d75e0a8a46 TCGA-ZP-A9D4-01 TCGA-ZP-A9D4-01 da0eec5b-54d6-421c-b850-c7d75e0a8a46 da0eec5b-54d6-421c-b850-c7d75e0a8a46 da0eec5b-54d6-421c-b850-c7d75e0a8a46 TCGA-ZP-A9D4-01A-11D-A36Y-05 TCGA-ZS-A9CD-01 TCGA-ZS-A9CD-01 TCGA-ZS-A9CD TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 73 36 48 50 TCGA-ZS-A9CD TCGA-ZS-A9CD-01A 0 8 A 62 106 73 -26915 1268 1386 0 1 5 - Nodular Formation and Incomplete Cirrhosis 2014-4-30 MALE Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 9 12 NO G2 YES true No MX NX T2 Stage II TCGA-ZS-A9CD.11C6E09D-89C3-43B9-B884-247278242067.pdf A9CD 198 150 400 NO NO 11.7 NO R0 Primary Tumor 01 Lobectomy 7th NO YES ZS 17 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 2010 TCGA-ZS-A9CD-01A-11D-A36W-01 TCGA-ZS-A9CD-01A-11D-A36W-01 TCGA-ZS-A9CD-01A-11D-A36X-10 TCGA-ZS-A9CD-01 TCGA-ZS-A9CD-01 35c7281c-ffe6-4fc4-b3de-da4f6a113397 TCGA-ZS-A9CD-01 TCGA-ZS-A9CD-01 35c7281c-ffe6-4fc4-b3de-da4f6a113397 35c7281c-ffe6-4fc4-b3de-da4f6a113397 35c7281c-ffe6-4fc4-b3de-da4f6a113397 TCGA-ZS-A9CD-01A-11D-A36Y-05 TCGA-ZS-A9CE-01 TCGA-ZS-A9CE-01 TCGA-ZS-A9CE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 79 36 44 50 TCGA-ZS-A9CE-F68444 TCGA-ZS-A9CE 0 5 A 44 80 78 -29051 0 1241 892 892 0 0 - No Fibrosis 2014-11-18 FEMALE Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 9 12 NO G1 Other, specify New Primary Tumor Right Temple No YES YES No Yes MX NX T2 Stage II A9CE TUMOR FREE 310 150 400 NO NO 36.4 NO R0 R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES ZS 15 Liver Micro Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 2011 TCGA-ZS-A9CE-01A-11D-A36W-01 TCGA-ZS-A9CE-01A-11D-A36W-01 TCGA-ZS-A9CE-01A-11D-A36X-10 TCGA-ZS-A9CE-01 TCGA-ZS-A9CE-01 d8b053f6-2674-43ec-9c36-ed652fe5ff7e TCGA-ZS-A9CE-01 TCGA-ZS-A9CE-01 d8b053f6-2674-43ec-9c36-ed652fe5ff7e d8b053f6-2674-43ec-9c36-ed652fe5ff7e d8b053f6-2674-43ec-9c36-ed652fe5ff7e TCGA-ZS-A9CE-01A-11D-A36Y-05 TCGA-ZS-A9CF-01 TCGA-ZS-A9CF-01 TCGA-ZS-A9CF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 64 36 51 50 TCGA-ZS-A9CF-F68445 TCGA-ZS-A9CF 0 19 62 106 89 -23510 0 2412 700 636 0 0 - No Fibrosis 2014-11-18 MALE Hemochromatosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 9 12 NO G2 Liver Intrahepatic Recurrence Yes YES YES No No MX NX T2 Stage II A9CF TUMOR FREE 259 150 400 NO NO 10.2 NO RX R0 Primary Tumor 01 Lobectomy 7th NO YES ZS 17 Liver Micro Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 2008 TCGA-ZS-A9CF-01A-11D-A381-01 TCGA-ZS-A9CF-01A-11D-A381-01 TCGA-ZS-A9CF-01A-11D-A382-10 TCGA-ZS-A9CF-01 TCGA-ZS-A9CF-01 b6a5831d-1a97-49f1-8dbc-c833abb60a20 TCGA-ZS-A9CF-01 TCGA-ZS-A9CF-01 b6a5831d-1a97-49f1-8dbc-c833abb60a20 b6a5831d-1a97-49f1-8dbc-c833abb60a20 b6a5831d-1a97-49f1-8dbc-c833abb60a20 TCGA-ZS-A9CF-01A-11D-A383-05 TCGA-ZS-A9CF-02 TCGA-ZS-A9CF-02 TCGA-ZS-A9CF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 64 36 51 50 TCGA-ZS-A9CF-F68445 TCGA-ZS-A9CF TCGA-ZS-A9CF-02A 0 19 62 106 89 -23510 2217 0 2412 700 636 0 0 - No Fibrosis 2014-11-18 MALE Hemochromatosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 9 12 NO NO G2 Liver Intrahepatic Recurrence Yes YES YES No false No MX NX T2 Stage II TCGA-ZS-A9CF.5D79D370-F174-4CCB-AF64-5617EBF352BE.pdf A9CF TUMOR FREE 259 150 400 NO NO 10.2 NO RX R0 Recurrent Tumor 02 Lobectomy 7th NO YES ZS 17 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 2008 TCGA-ZS-A9CF-02 3c670523-5f34-4518-bf25-cc0d725de814 TCGA-ZS-A9CF-02 3c670523-5f34-4518-bf25-cc0d725de814 3c670523-5f34-4518-bf25-cc0d725de814 3c670523-5f34-4518-bf25-cc0d725de814 TCGA-ZS-A9CF-02A-11D-A383-05 TCGA-ZS-A9CG-01 TCGA-ZS-A9CG-01 TCGA-ZS-A9CG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 55 35 40 50 TCGA-ZS-A9CG-F68446 TCGA-ZS-A9CG TCGA-ZS-A9CG-01A 0 5 A 62 106 72 -20100 201 0 341 0 0 - No Fibrosis 2014-11-18 MALE 179 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 50 9.5 14 NO NO G2 NO true No MX NX T2 Stage II TCGA-ZS-A9CG.8A0E7BA8-7262-4832-89DA-61893BE4B458.pdf A9CG TUMOR FREE 382 150 400 NO NO 10.8 NO R0 Primary Tumor 01 Extended Lobectomy 7th NO YES ZS 21 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 94 2013 TCGA-ZS-A9CG-01A-11D-A36W-01 TCGA-ZS-A9CG-01A-11D-A36W-01 TCGA-ZS-A9CG-01A-11D-A36X-10 TCGA-ZS-A9CG-01 TCGA-ZS-A9CG-01 23b47813-7a77-44ca-b650-31a319c1f497 TCGA-ZS-A9CG-01 TCGA-ZS-A9CG-01 23b47813-7a77-44ca-b650-31a319c1f497 23b47813-7a77-44ca-b650-31a319c1f497 23b47813-7a77-44ca-b650-31a319c1f497 TCGA-ZS-A9CG-01A-11D-A36Y-05